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Abstract 
 
The research presented herein describes the development of methods and 
applications of flow technology in discovery chemistry. The first two chapters 
highlight the use of several beneficial features offered by flow technology to increase 
the throughput, safety, and convenience of organic synthesis. The last two chapters 
describe the use of microfluidic technology as a platform for rapid reaction discovery.  
Working with researchers at Abbott Laboratories, a droplet-based library 
method was developed. This approach allowed for the preparation of a theoretically 
unlimited number of compounds in a single run using minimal amounts of material. 
The universal nature of this approach was subsequently demonstrated in the 
preparation of two 20-membered libraries based around thiazole and pyrazole cores.  
 A second methodology study, also completed with researchers at Abbott 
Laboratories, took advantage of the intrinsic closed environment of flow systems 
which enabled the creation, reaction, and removal of noxious chemicals in situ. Using 
these features an in situ synthesis of isocyanides, reagents notorious for their 
unpleasant smell, was developed. Coupling this method to the Ugi four-component 
reaction, a series of medicinally relevant amides was synthesized. Reactions 
performed in the flow system experienced an overall reduction in transformation time 
from two-days to two-hours and gave yields that were generally higher than those for 
the same reactions performed on the  benchtop or in the microwave. 
iv 
 
Expanding the application of this technology toward the discovery and 
development of new synthetic methodologies we partnered with the laboratory of Dr. 
John A. Porco, Jr. at Boston University to explore transformations of multifunctional 
substrates. Given the variant nature of these reactions, both a simple iminium ether 
and a densely functionalized iminium ether derived from a bicyclo[3.2.1]octanoid 
scaffold were explored. Multidimensional reaction screening on an automated 
microfluidic platform was employed to facilitate the simultaneous investigation of 
multiple reaction variables. While the majority of products obtained from the study 
resulted from expected modes of O- and N- alkylation, several interesting 
transformations were uncovered. These included the pseudo-dimerization of 
homophthalic anhydride, an unusual integration of the van Leusen sulfone, and an 
unexpected carbon-carbon bond forming event of ethyl diazoacetate and acetonitrile. 
Finally, in a follow-up study, collaboration with Boston University was 
continued to explore additional reactivity of the bicyclo[3.2.1]octanoid scaffold. 
Preliminary reaction screens uncovered the synthesis of a series of densely 
functionalized donor-acceptor cyclopropanes which resulted from the photochemical 
rearrangement of the bicyclic scaffolds. Expansion of the photochemical screening to 
a polycyclic iminium ether led to the first example of an aza-di-π reaction of a 
charged iminium species. Subjection of the new cyclopropane scaffolds to a variety 
of reaction conditions led to the discovery of additional rearrangement reactions 
affording several structurally diverse chemotypes including a fused dihydropyran, a 
fused pyrrole, a bicyclic imide, and a complex cyclic imine. 
v 
 
Acknowledgements 
 
I would like to express my sincere appreciation to my graduate advisor, 
Professor Jeffrey Aubé. It is through his guidance, motivation and unwavering 
support that I have grown both professionally and personally. I am truly grateful for 
the opportunities he has given me to gain experience and perspective. 
I would like to thank Professors Paul Hanson, Thomas Prisinzano and all 
those involved in the University of Kansas Dynamic Aspects Of Chemical Biology 
Training Grant. The experience, knowledge, and friendships I have gained through 
participation in this grant have been invaluable to me, thank you. 
I would like to extend special thanks to Professor John A. Porco, Jr. and Dr. 
Stevan Djuric for their kindness, mentorship, and inspiration. To Dr. John Goodell 
and Dr. Christina Thompson, I am deeply grateful for your guidance and the integral 
roles you have played in my graduate career. 
I would like to thank all my colleagues in the Aubé group with whom I have 
had the opportunity to work. In particular, I would like to thank Dr. Thomas Coombs 
and Angelica Meyer for their stimulating scientific discussions, constant motivation, 
and support. It has been a wonderful experience to be a part of the Aubé group over 
these years. 
I am grateful to all my family and friends for their loving encouragement and 
unwavering faith.  
vi 
 
To my husband Eric, I am eternally thankful for your love. I could never have 
completed this program without you. You are my best friend, the love of my life, and 
an endless source of support. 
Finally, I would like to extend my deepest thanks to my mom, the most 
amazing woman I know. You have been the rock of my life. Thank you for always 
encouraging me to reach for the stars, be the best that I can be, and never give up.  
 
“I‟ll love you forever, I‟ll love you for always, 
as long as I‟m living my Mommy you‟ll be.”  
 Robert Munsch 
 
This dissertation is dedicated in her honor. 
 
vii 
 
Table of Contents 
 
 Page 
Abstract iii 
Acknowledgements v 
List of Figures x 
List of Tables xiii 
Chapter 1. Introduction 1 
Reaction discovery and high-throughput technology 2 
Discovery chemistry and flow technology 13 
Chapter 2. Heterocycle Synthesis in Droplets 24 
Heterocycles in medicinal chemistry 24 
Heterocycle library synthesis in flow 26 
Flow instrument design and droplet technique 32 
Heterocycle synthesis in flow  35 
Summary 38 
Chapter 3. In situ Reagent Generation with Continuous Flow 39 
Isocyanides and the Ugi reaction  39 
Isocyanides in a multi-step flow process  44 
viii 
 
Development of a two-step Ugi sequence 46 
Flow apparatus design 53 
Study of Ugi reaction scope in flow 56 
Summary 58 
Chapter 3. Reaction Discovery Using Microfluidic-Based Screening of 
Polycyclic Iminium Ethers 
 
59 
Synthesis and reactivity of cyclic iminium ethers  60 
Microfluidic-based multidimensional reaction screening  63 
Iminium ether substrate selection 65 
Multidimensional screening of iminium ether substrates 77 
Iminium ether reaction discovery products and mechanisms 80 
Summary 88 
Chapter 5. Reaction Discovery of Donor-Acceptor (D-A) Cyclopropanes 89 
Synthesis and reactivity of D-A cyclopropanes  89 
Oxa-di-π rearrangement of bicyclo[3.2.1]octanoid  93 
Grignard reactions of polycyclic D-A cyclopropanes 98 
Azido-Schmidt reactions of polycyclic D-A cyclopropanes 102 
Cycloadditions of polycyclic D-A cyclopropanes 105 
Aza-di-π rearrangement of polycyclic iminium ethers 109 
Summary 114 
ix 
 
Chapter 6. Experimental Section 116 
References  246 
Appendix 258 
X-Ray structure determination of compound 153 258 
X-Ray structure determination of compound 159 262 
X-Ray structure determination of compound 163 270 
Additional spectrum 273 
 
x 
 
List of Figures 
 
  Page 
Figure 1. Combinatorial multicomponent reactions. 7 
Figure 2. High-throughput oxidative catalyst discovery. 
 
10 
Figure 3. DNA-Encoded reaction discovery. 12 
Figure 4. Curtius rearrangement as performed in continuous flow. 14 
Figure 5. Applications of flow technology in drug development. 
 
15 
Figure 6. Africa flow platform manufactured by Syrris. 16 
Figure 7. Integrated flow model for rapid chemical discovery and 
optimization. 
 
19 
Figure 8.  Arrangements available for combined flow processes 20 
Figure 9.  Advantages and challenges of flow-based reaction 
technology.  
 
21 
Figure 10. Heterocycles in modern drugs. 25 
Figure 11. FlowSyn mesoscale continuous flow platform. 32 
Figure 12. Droplet formation in continuous flow. 33 
Figure 13. Isocyanides in tetrazole synthesis, Passerini, and Ugi 
reaction. 
 
40 
Figure 14. General routes to isocyanides. 41 
Figure 15. Variability of the Ugi 4-CR products. 42 
Figure 16. Medicinally relevant compounds derived from IMCRs. 43 
Figure 17.  Isocyanides in traditional settings vs. flow settings.  45 
xi 
 
Figure 18. Isocyanide synthesis through formamide dehydration. 47 
Figure 19. Formamides not viable in the two-step microwave 
sequence. 
 
52 
Figure 20. Diagram of the continuous flow platform for the two-
step Ugi 4-CR. 
 
54 
Figure 21. Synthesis and reactivity of cyclic iminium ethers. 60 
Figure 22. Mechanism of the azido-Schmidt reaction with 
hydroxyalkyl azides.  
 
61 
Figure 23. Multidimensional reaction screening workflow. 64 
Figure 24. Microfluidic reaction screening platform. 65 
Figure 25. Multidimensional screening parameters for substrate 
selection. 
 
66 
Figure 26. Regioselectivity analysis for the reaction of 
bicyclo[3.2.1]octanoid ketones. 
 
75 
Figure 27.  Multidimensional screening substrates, partners, and 
conditions. 
 
77 
Figure 28. Representative UPLC/ELSD traces of crude screening 
products. 
 
79 
Figure 29. Reactivity of vicinally substituted donor-acceptor 
cyclopropanes. 
 
90 
Figure 30. Reaction modes of donor-acceptor cyclopropanes. 91 
Figure 31. Variants of the di-π-methane rearrangement. 93 
Figure 32. Reactivity trends of the di-π-methane rearrangement. 92 
Figure 33. Photoflow apparatus used in reaction discovery. 94 
Figure 34. Mechanism of the oxa-di-π rearrangement of 
bicyclo[3.2.1]octanoids. 
 
96 
xii 
 
Figure 35. Mechanism of Grignard addition and rearrangement of 135. 100 
Figure 36. Mechanism of rearrangement and epimerization of 141. 101 
Figure 37.  Mechanism for the fragmentation and azido-Schmidt 
reaction of 145. 
 
103 
Figure 38. Iminium ether expansion pathways. 105 
Figure 39. Fragmentation mechanism of fragmentation for 
polycyclic imine 159. 
 
108 
Figure 40. Photochemical iminium reactivity. 110 
Figure 41. Photochemical reaction pathways of iminium ether 
67a,b. 
 
111 
Figure 42. New chemotypes derived from donor-acceptor 
cyclopropane 135. 
114 
 
xiii 
 
List of Tables 
 
  Page 
Table 1. Reactions developed for use in flow platforms. 17 
Table 2. Solubility studies for the synthesis of thiazoles. 28 
Table 3. Thiazole library. 36 
Table 4. Pyrazole library. 37 
Table 5.  benchtop survey of the two-step dehydrationUgi 4-CR 
sequence. 
 
49 
Table 6. Microwave survey of the two-step dehydrationUgi 4-CR 
sequence. 
 
50 
Table 7. Formamide scope in the dehydrationUgi 4-CR 
microwave sequence. 
 
51 
Table 8.  Study of the two-step Ugi 4-CR stoichiometry in flow. 56 
Table 9.  Study of the two-step Ugi 4-CR substrate scope. 57 
Table 10. Nucleophilic addition reactions of iminium ethers. 62 
Table 11. Survey of bicyclo[3.2.1]octanoid 63 in reaction with 
hydroxyalkyl azides. 
 
67 
Table 12. Bicyclo[3.2.1]octanoid ketone substrates. 69 
Table 13. Bicyclo[3.2.1]octanoid ketones in the azido-Schmidt 
reaction. 
 
70 
Table 14. Acid survey of bicyclo[3.2.1]octanoid 63 in the azido-
Schmidt reaction. 
 
71 
Table 15. Condition survey for the azido-Schmidt reaction of 
bicyclo[3.2.1]octanoid 63. 
 
74 
Table 16. Heteroatom nucleophile addition to iminium ethers 67a,b. 76 
xiv 
 
Table 17. Productive reactions tabulated from crude screening 
UPLC/ELSD analysis. 
 
80 
Table 18.  Products resulting from reaction with iminium ether 87. 81 
Table 19. Products resulting from reaction with iminium ether 67a,b. 82 
Table 20. Substrate scope of the oxa-di-π rearrangement. 97 
Table 21.  Grignard additions of cyclopropane 135. 99 
Table 22. Grignard additions of cyclopropane 141. 100 
Table 23. Cycloadditions of cyclopropane substrates. 106 
Table 24. Cycloadditions investigated using cyclopropane 
substrate 135. 
 
109 
Table 25. Nucleophilic ring-opening reactions of α-cyclopropyl 
iminium ether 165. 
 
113 
 
 
 
 
 
 
 
 
1 
 
Chapter 1 
Introduction 
 
Reaction discovery has historically been guided by problems in total 
synthesis, interest in developing specific chemical transformations, or an underlying 
biological need. An emerging area that has recently gained momentum is the 
development of novel and diverse sets of transformations and chemotypes which can 
be used to access unique chemical entities and probe new chemical space.
1
 
Traditionally, the pursuit of innovative reactivity through reaction discovery and 
development has been expensive and time consuming, generating substantial 
quantities of waste with little return on the investment. Standard techniques still rely 
upon the tedious systematic evaluation of individual reaction parameters such as 
stoichiometry, solvent, temperature, and additives. Advances in instrumentation and 
automation over the past 20 years have greatly streamlined these processes such that 
chemical exploration and technology now regularly go hand-in-hand. Now, in 
addition to the discovery of unique reactions and chemotypes, an equally beneficial 
side product of the search for new reactivity is the development of innovative tools 
that aim to expand the scope and reduce the waste of rapid chemical synthesis. 
Much of the technology used today in discovery chemistry is derived from 
advancements in efficiency of high-throughput biological screening and in the advent 
of combinatorial synthetic chemistry. Automated screening approaches allow many 
reaction parameters to be assessed simultaneously in an array format, producing 
2 
 
exponentially large amounts of data detailing the ideal conditions per reaction. Using 
these technologies, reactions can be performed faster, in fewer numbers, and on an 
ultra-small scale, reducing both the overall cost and waste of these processes.  
While many different platforms have been designed for reaction discovery, 
flow technology has flourished particularly well in this area. The popularity of flow 
technology arises primarily from the versatility of the platform, being capable of 
performing many different kinds of tasks across a number of fields, from biology to 
chemistry to material science. In this chapter the general strategies and challenges of 
reaction discovery and development will be discussed alongside fundamental 
considerations for performing reactions in flow.  
 
Reaction discovery and high-throughput technology. From the ancient 
days of alchemy to the modern synthetic lab, scientists have continually searched for 
new and better methods to synthesize molecules. Chemists continue to refine the 
conventions on how chemical entities react together to form new molecules. A 
number of criteria have been developed to evaluate the ideality of each transformation 
including complexity, efficiency, generality, chemo-, regio- or enantioselectively and 
diversity potential.
2
 While many different strategies may be envisioned to uncover 
new transformations,
3
 most approaches fall into two naturally broad categories: 
 Intelligent design 
o Building from known reactivity 
o Combining known reactions 
 Serendipity 
3 
 
Intelligent reaction design is often the most difficult method by which to 
develop new reactions. This technique requires an acute knowledge of molecular 
reactivity. For even the most experienced chemist, it can be difficult to predict how 
particular components will behave in combination or under given conditions. More 
likely, upon finding new reactions, the product and order of events are speculated 
upon and verified retrospectively. 
Two common sub-types of intelligent design are building from known 
reactivity and combining known reactions. Both of these concepts build on 
knowledge derived from previous work to form a successful approach toward 
discovery. As implied by the name, “building from known reactivity” involves 
considering the most productive pairing of known functionality. On the other hand, 
“combining known reactions” generates additional complexity by bringing together 
two previously separate transformations. In both techniques, the reactivity and 
compatibility of various components must be assessed to determine the likelihood of 
a reaction being viable. Nevertheless a period of trial and error is common in the 
successful application of these approaches. 
In an elegant example of reactivity-based discovery, Kelly et. al. designed a 
one-pot synthesis of complex pyridines by merging a previously identified 
Knoevenagel route to pyridines with known enolate chemistry (Scheme 1).
4
 Overall, 
this three-component reaction (3-CR) offers a straightforward method for the 
assembly of pyridine cores with up to five different substituents and full regiocontrol 
in a single operation. 
4 
 
 
Scheme 1 
 
 
An example of intelligent design through combining known reactions was 
demonstrated by Grieco et. al. in the design of a 3-CR for the synthesis of 
tetrahydroquinolines from aromatic amines, aldehydes, and electron-rich dienophiles 
(Scheme 2).
5
 The sequence entails the initial formation of an imine through the 
combination of an aldehyde and an amine. Following imine formation an aza-Diels-
Alder cycloaddition occurs between the imine intermediate and dienophile to form a 
tetrahydroquinoline product. Both phases of the 3-CR were known as individual 
reactions prior to the reported transformation; however, the recognition that the 
dienophile was inert prior to imine formation was required to successfully complete 
such a synthesis.
3
  
 
Scheme 2 
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Perhaps the most famous example of combining two or more known reactions 
is the Robinson annulation.
6
 In this reaction two fundamental organic 
transformations, the Michael addition and the aldol reaction, are joined for the 
preparation of substituted six-membered cyclic ketones. Certain variants of this 
reaction have proven so useful in synthesis that the products themselves have 
common names. For example, reaction of 1,3-cyclohexadione with methyl vinyl 
ketone yields the Wieland-Miescher ketone (Scheme 3)
7
 and reaction of 1,3-
cyclopentadione with methyl vinyl ketone yields the Hajos-Parrish ketone.
8
 Both 
products are widely available and popular starting points in total synthesis. 
 
Scheme 3 
 
 
Considering the difficulty associated with intelligent reaction design, 
computational methods have been created to facilitate the conception of reactions.
3,9
 
These programs are commonly fashioned to search databases of reaction prototypes 
that describe the reactivity of atomic arrangements. The proposed reactions are then 
computationally assessed in terms of their calculated thermodynamics to determine 
the likelihood of observing the predicted product.  
6 
 
One such program, designed for computational reaction discovery, is the 
Daylight reaction toolkit program suite.
10
 Among the numerous reactions proposed 
using this program was a Lewis-acid catalyzed hetero-Diels-Alder reaction between 
an imine and a silylenol ether diene for the formation of α,-unsaturated 
piperidinones (Scheme 4). Although a version of this reaction was originally reported 
by Danishefsky in the 1980‟s, Gálves et. al. demonstrated the validity of the proposed 
reaction and applied the transformation to the synthesis of piperidine cores.
11
  
 
Scheme 4 
 
 
Serendipitous reaction discovery is a common event in many labs. A frequent 
by-product of target-oriented synthesis is the discovery of an unexpected, if not 
always entirely unknown, transformation. In this way, reactions have been repeatedly 
discovered and rediscovered throughout history. These transformations are often 
considered novelties and of limited utility, since they give alternatives to the targeted 
product. However, these side reactions can often be manipulated into valuable 
transformations with broad application. Serendipitous reaction discovery is 
particularly valuable for the creation of scaffold diversity and producing new 
chemotypes, desirable traits for researchers who aim to patent their work. 
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Weber et. al. demonstrated a thorough approach to serendipitous reaction 
discovery using a high-throughput combinatorial method (Figure 1).
12
 Starting from 
ten reagents varying in functionality, all of the possible multi-component reaction 
combinations were studied systematically. Mathematically, the total count of 
reactions possible for any given number of components can be determined using the 
equation in figure 1. Given the ten predefined components, the equation directs that 
only one 10-CR is possible, only ten 9-CR are possible, and so on. Summing the 
entire set from 10-CR to 2-CR a total of 1013 reactions are possible!
13
 Using 
automated parallel synthesis techniques Weber et. al. tested all 1013 reaction 
combinations. So doing, the team discovered two new transformations, one of which 
provided the 4-CR product seen in the center of the circle (Figure 1). In addition, they 
uncovered several previously identified MCRs of isocyanides and aldehydes.
12
  
 
 
Figure 1. Combinatorial multicomponent reactions.
9,13
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When constructing new transformations, a combination of approaches is 
typically used, and trial and error is natural. When conducting searches for new 
reactions or chemotypes with traditional  benchtop techniques, a range of 
spectroscopic methods are available to assess and characterize the progress of 
transformations. Reaction discovery performed in this manner is low-throughput and 
can take weeks, months, or even years to produce an interesting result. For such 
cases, implementing a high-throughput screening approach of small-scale reactions 
has proven most successful in accessing new reactivity in a time-efficient manner.  
Many techniques used in combinatorial and high-throughput reaction 
discovery are simple variations of those used in combinatorial and high-throughput 
synthesis. Similarly these methods are derived from advances and automation of 
high-throughput biological screening. The technology used for performing high-
throughput reactions encompasses a variety of solid-phase and solution-phase 
chemistry methods.
14
 To date, discovery efforts have been reported using polymer-
supported beads,
15
 homogenous solution-phase polymer-supported scaffolds,
16
 
automated synthesizers,
17
 microchips,
18
 and DNA-tethered supports.
19
 The option of 
manual versus automated reaction platforms also gives the user control over the 
development of discovery and productivity.
3
  
The choice of reaction platform is often limited by the techniques available for 
analysis and identification of transformations. While many methods exist to gauge the 
productivity and identify the products of a reaction, the high-throughput nature of 
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discovery chemistry necessitates that key features be present in a desirable analysis 
method. The ideal analysis method includes:
20
  
 Minimal sample preparation 
 Programmable automobility 
 Short analysis time for high sample throughput 
 High sensitivity for the analysis of small quantities of compounds 
 A nondestructive measurement method to minimize compound loss 
Few methods exist which can meet all of these requirements so multiple 
analysis techniques are usually coupled together or used in parallel.
21
 Instrumentation 
regularly used for chemical identification include chromatographic methods (HPLC, 
UPLC, GC, or TLC),
22
 mass spectrometry (MS),
22c
 one-dimensional and multi-
dimensional nuclear magnetic resonance spectroscopy (NMR),
22a,23
 infrared (IR) 
thermography,
24
 calorimetric methods, colorimetric methods,
25
 capillary 
electrophoresis,
26
 fluorescence spectroscopy
24a,27
 and fluorescence resonance energy 
transfer (FRET).
28
 In the case of standard solid- and solution-phase syntheses, the 
most common analysis methods are traditionally HPLC, GC, MS, NMR and IR.  
Researchers in the field of catalysis were among the first to embrace 
combinatorial and high-throughput techniques for the discovery of new 
transformations.
22-29
 The vast majority of effective metal-based catalysts are 
complexes bearing ligands that direct the outcome of the reaction through control of 
the steric and electronic properties of the metal center. The nature of the interactions 
between metal and coordination environment is often poorly understood, making it 
10 
 
difficult to predict the optimal combination of metal and ligand for a given reaction. 
The lack of understanding necessary for the intelligent design of these catalysts make 
a serendipitous screening approach an attractive way to address this problem. 
 
 
Figure 2. High-throughput oxidative catalyst discovery.
30
  
 
Jacobsen and coworkers reported one of the earliest applications of this type 
of screening approach in the discovery of a catalyst to promote olefin epoxidation 
reactions using hydrogen peroxide (Figure 2).
30
 Their efforts were divided into two 
phases: lead discovery, screening a wide variety of metal complexes, and lead 
optimization, with systematic variation of ligand components and reaction conditions. 
The ligands were first synthesized using solid phase synthesis and split-and-pool 
techniques to achieve a pool of beads containing 192 different ligands. The ligand 
pool was then divided and subjected to reaction with 30 different metals for oxidation 
11 
 
of trans--methylstyrene (TBMS). The crude solution from reaction with each metal 
was analyzed by GC which demonstrated productive reactions with VOSO4 and 
FeCl2. The latter was chosen for subsequent follow-up experiments.
30
  
Upon identification of productive reaction conditions, the group set out to 
deconvolute the optimal ligand combination. A screen was set-up to investigate the 
optimal ligand “cap” and the beads were reacted in pools according to cap identity. 
GC analysis of the crude reaction solution showed two optimal caps, both pyridine 
derivatives. Finally, using the two pyridine-derived caps, each linker-cap combination 
was subjected to the reaction conditions individually and the crude solutions were 
again analyzed by GC. Identification of three productive linker-cap combinations 
provided insight into the optimal metal-ligand interactions for the desired reaction. 
This information was then used to repeat the sequence of discovery and further 
optimize the transformation.
30
  
When the use of more high-throughput analysis methods are desired, special 
synthetic techniques must be used. Visualization of productive reactions by 
fluorescence requires the immobilization of one set of reaction partners and the 
presence of a fluorophore in the second set of reaction partners. Similarly, while 
FRET can be completed in solution it also requires that a donor and acceptor 
fluorophore pair be present in the molecular pair prior to the reaction discovery 
event. While these analysis methods are very efficient, the complication of 
incorporating bulky fluorophores or immobilizing reagents may hinder some 
reactions that would otherwise be productive, leading to an increase in false 
12 
 
negatives. The incorporation of these moieties may also limit the available reaction 
conditions compatible with the platform, as seen in the next example. 
 
 
Figure 3. DNA-Encoded reaction discovery.
19
  
 
Liu and coworkers recently reported a novel approach to reaction discovery 
using DNA-templated organic synthesis and in vitro selection to simultaneously 
evaluate numerous potential reactions in a single solution (Figure 3).
19
 The 
stoichiometry of each reaction was controlled by Watson-Crick base pairing of the 
DNA tethered substrates. Bond-forming combinations were uncovered by in vitro 
selection using chromatographic methods, followed by PCR amplification, and 
DNA microarray analysis. Positive reactions were identified colorimetrically using a 
combination of two colored fluorophores. While this technique is limited to 
conditions and catalysts that are compatible with DNA, the versatility and efficiency 
of the method is evident by the discovery of reactions between a wide range of 
substrates. Included in these transformations were the Huisgen 1,3-dipolar 
13 
 
cycloaddition shown above and a novel palladium-mediated synthesis of α,-
unsaturated macrocyclic ketones.
19c
  
A major limiting factor of many high-throughput methods is the necessity of 
deconvolution.
31
 When performing multiple reactions in a single pot the presence of 
a successful transformation may be observed quickly, but an involved follow-up 
process must be completed to identify the components and products of the positive 
result. Alternatively, parallel synthesis techniques can be used to take advantage of 
the efficiency of combinatorial methods while bypassing the disadvantages of 
deconvolution and compound identification.
20
 While it is not possible to synthesize 
as many compounds by parallel technology as with other high-throughput 
techniques, parallel methods are particularly useful for reaction optimization and 
small-scale discovery efforts. 
When using various parallel synthesis techniques, compounds are separated 
by space or time. Typical parallel platforms include multi-welled block reactors, 
automated chemical synthesizers and flow reactors. While each of these platforms 
exhibits its own unique set of benefits and drawbacks, an area of major growth over 
the last few decades has focused around flow-based technologies.  
 
Discovery chemistry and flow technology. Fundamentally, flow technology 
encompasses the ability to perform a task within a continuously moving stream of 
solution in a network of interconnecting tubes or channels (Figure 4).
32
 The most 
elementary flow process simply involves the combination of reagents in a “reactor” 
14 
 
and flowing the solution until the transformation is complete, at which time the 
solution exits the instrument. A basic application of this technology was demonstrated 
by Ley and coworkers in the synthesis of amides from carboxylic acids via the 
Curtius rearrangement (Figure 4).
33
  
 
 
Figure 4. Curtius rearrangement as performed in continuous flow.
33
  
 
Flow technology has been prevalent in many industrial processes for decades 
with some of the most visible applications in the practices of oil refineries and the 
large-scale synthesis of pharmaceuticals.
34
 Over the past twenty years flow 
technology has begun to expand beyond its limited scope and has found new 
applications across the fields of chemistry, biology, and pharmacology. With such 
vast potential for multidisciplinary use, flow techniques have found value at almost 
every stage of the drug development process (Figure 5).
35
 In addition to various 
synthetic applications; biological assays,
36
 formulation studies, and pharmacologic 
profiling are among the assortment of operations that have been developed for 
flow.
18c,37
  
15 
 
 
Figure 5. Applications of flow technology in drug development. 
 
Flow platforms may be constructed using a wide assortment of materials and 
can be designed for a range of volumes, from microliter to multi-liter scale.
18a,18b
 
Typically, microreactors perform reactions on chips consisting of a network of 
miniature channels embedded in a flat surface, handling volume on the micro- to 
milliliter scale. Alternatively, mesoflow reactors typically perform reactions in tubes 
or coils and handle larger volumes ranging from milliliter to multi-liter.
39
 A variety of 
materials can be used to construct the reactor chip and coils including glass, quartz, 
silicon, stainless steel, metals, and polymers.
18b,38,40
 The optimal choice of material 
depends on the type of chemistry for which the platform is intended.
35
 With the recent 
popularity of flow chemistry, a number of standardized flow platforms are now 
commercially available (Figure 6). Some of the more versatile systems include the H-
cube,
41
 FlowSyn,
42
 Vapourtec,
43
 Africa, FRX,
44
 and CYTOS.
45
 While each system 
boasts its own unique set-up and features, the basic aspects of each platform remain 
16 
 
the same: an operating system, a pumping mode, a liquid handler, a reactor (chip, 
coil, or column) and a collection unit. 
 
 
Figure 6. Africa flow platform manufactured by Syrris.
44
  
 
Fluid can be moved through the reactor using a number of different methods 
including hydrodynamic pumping, electrokinetic pumping, and capillary flow.
18b
 The 
most straightforward and commonly used method is hydrodynamic pumping either by 
syringe or HPLC pump. Although less often used, electroosmotic flow (EOF) can be 
advantageous since it involves no moving parts, is easily miniaturized, and computer 
controlled. Capillary flow is the least versatile as it is limited to very small volumes 
and is not easily manipulated. Regardless of the mode of pumping, mixing in the 
channels is laminar and occurs by diffusion and convection.
18b
 Additional mixing 
regions, comprised of twists and turns in channels, can also be used early in the flow 
process to increase the turbulent integration of components. 
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Table 1. Reactions developed for use in flow platforms. 
 
Paal-Knorr Pyrrole Decarboxylation Nucleophilic Substitution 
Knorr Pyrazole Synthesis Williamson Ether Finkelstein Reaction 
Benzimidazole Synthesis 
 
Curtius Rearrangement Grignard Reaction 
Newman-Kwart Reaction Knoevenagel Reaction 1,2-Additions 
Fischer Indole Synthesis Claisen Rearrangement Eliminations 
Bohlmann-Rahtz Pyridine Diels-Alder Reaction 
Formation 
Amidation 
Hantzsch Pyridine Synthesis Suzuki-Miyaura Coupling 
Addition 
Enamine Formation 
Passerini Multicomponent Kumada Coupling Azide Reduction 
Biginelli Multicomponent Sonogashira Coupling Bromination 
Hoffmann Degradation Heck Coupling Fluorination 
Baylis-Hillman Reaction Ullman Coupling Nitration Reaction 
Mannich Reaction Swern-Moffatt Oxidation Nitro Reduction 
Michael Addition TPAP Oxidation Diazo Synthesis 
Aldol Condensation Hydrogenation Photocyanation 
Ester Formation Protection Phosphonium Ylide Prep. 
Ester Hydrolysis Deprotection Wittig Reaction 
Carbamate Formation SNAr Aza-Wittig Reaction 
 
 
The growing versatility in the set-up of flow platforms has enabled these 
systems to become amenable to many different types of reactions (Table 1).
32,38,46
 
Combining flow technology with other modern high-throughput synthesis techniques, 
reactions can be performed in liquid phase, liquid-solid phase, liquid-gas phase, and 
liquid-solid-gas phase.
18b,39
 Although chemical transformations involving solid 
reagents or intermediates are difficult to conduct in flow due to potential clogging of 
the channels, a number of alternative means for introducing solids in flow are 
available. For example, solution can be passed through columns of solid-supported 
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reagents or through channels coated with the solid reagent, as is commonly done for 
metal catalysts. Transformations using toxic gases are actually made safer using flow 
systems since the flow of the gas can be precisely controlled and integrated gas-liquid 
separators can be used to separate the gaseous phase at the end of the reaction.
18b
  
While direct in-line reaction monitoring is still in the early stages of 
development, most common analytical and purification techniques are easily 
amenable to flow processes upon completion. Aligning these techniques in flow 
provides a direct connection of these instruments to in-line reaction synthesis and 
increases the overall efficiency of discovery operations.
39
 Analytical detection 
methods currently available for flow include electrochemical methods, mass 
spectrometry, optical methods such as absorption
40
 infrared, and fluorescence 
spectroscopy, chromatographic methods (HPLC, UPLC, GC), and NMR 
spectroscopy.
18c
 Connecting the synthetic steps directly to purification and analysis 
enables an exponential enhancement in the throughput of chemical screening. This 
concept can be extended to also include high-throughput biological assays. 
Computational systems have also been developed which are capable of automatically 
interpreting analytical data. This information can then be used to direct which 
compounds should be synthesized next, creating an automatic intelligence feedback 
loop to direct discovery efforts (Figure 7).
38
  
Reactions performed in flow can benefit greatly from many features unique to 
flow technology. For instance, the small dimensions and increased surface-to-volume 
ratio of flow reactors make mass and heat transport significantly more efficient than 
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in batch reactors. At these small scales, the mixing of reagents can be very fast and 
heat exchange between the reaction and the environment is highly efficient. These 
features allow reactions performed in flow to be precisely controlled and have 
increased homogeneity, leading to a decrease in unwanted side-reactions and by-
products to afford cleaner reactions.
18b
 This precise control also enables the 
completion of reactions with unstable intermediates with increased efficiency.
47
  
 
  
Figure 7. Integrated flow model for rapid chemical discovery and optimization.
38
  
 
Despite the relatively small volumes used in micro- and mesoflow techniques 
scale-up options are available. Reactions performed in flow can provide large 
amounts of material simply by flowing longer, “scaling-out”, or by connecting 
several reactors in parallel, “numbering-up” (Figure 8).
46
 Use of these techniques help 
avoid the problem of reoptimization of a transformation during scale-up. Continuous 
flow processes can also address problems commonly related to the scale-up of batch 
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reactions such as accurate control of the reaction time and continuity of mixing. 
Problematic, hazardous, and runaway reactions are made safer and easier by allowing 
the chemist this precise control at critical points within the reaction.
32,47
  
 
 
Figure 8. Arrangements available for combined flow processes.
46
  
 
The complexity of a synthetic scheme can be increased by combining the lines 
of multiple flow reactors to complete linear, divergent, or convergent multi-step 
syntheses (Figure 8). When performing multi-step syntheses in flow, all steps must be 
compatible with one another concerning the solvent, by-products, and reaction time.
48
 
If the reactions are not well-matched in these respects, break points can be inserted 
into the synthetic scheme to allow for a solvent switch, purification, or change in the 
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flow rate.
46
 Reactions performed in flow also typically have shorter reaction times. 
The closed nature of the flow system enable the reactor to pressurize and achieve 
solvent temperatures beyond the boiling point of the solvent (superheating),
35
 
resulting in an increase in the overall rate of reaction. 
 
 
Figure 9. Advantages and challenges of flow-based reaction technology. 
 
Alongside the many benefits of flow technology is an equally long list of 
challenges and limitations (Figure 9).
49
 When completing several reactions in series, 
the compatibility of reagents, solvents, and possible by-products for each 
transformation must be considered. A simple process using  benchtop chemistry, such 
as changing solvent, can prove difficult in flow reactors. Although reactions 
performed using flow technology tend to be of high purity, by-products can gradually 
accumulate across multiple steps and make late-sequence transformation less 
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efficient. Problems such as these often limit the maximum number of sequential steps 
that are feasible before purification is necessary. Upon completion of a sequence in a 
flow reactor, a number of techniques have been devised to quench and work-up 
reactions in-line.
32,39
 Unfortunately, these methods are far fewer in number and less 
convenient than those available for reactions in batch. Common work-up procedures 
typically include using one or more of the following approaches: addition of water or 
aqueous solutions, passing reactions through columns of solid supported reagents or 
scavengers, or complex separation techniques.
39
 All things considered, these 
manipulations add length and complexity to the overall process. When performing 
multiple reactions in a continuous flowing solvent stream using segmented flow, 
dispersion of the reaction into the spacer solvent typically occurs.
50
 The extent of 
dispersion is dependent upon the flow rate and path length, with slower, longer 
reactions experiencing greater mixing. Dispersion of reactions can complicate many 
aspects of an otherwise straightforward sequence, including the addition of reagents, 
timing of the run, and material collection from the instrument. 
 As is evident from the discussion above, flow technology possesses many 
attributes which make chemical discovery faster, more cost effective, and less 
wasteful. Yet, despite all of the advantages flow technology currently offers there are 
still many challenges to overcome for each experiment performed on this platform. 
Further investigations using flow technologies can instruct not only about the 
chemical transformations being performed but also about the capabilities of this 
valuable technology. 
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Throughout this dissertation flow technology will be used in various ways to 
enhance reaction throughput, reaction development, and reaction discovery. In the 
first chapter, the separation of reactions by space and time in a flow reactor was used 
to produce a library of biologically relevant heterocycles. In the second chapter, the 
closed nature of the flow reactor was used to create a safe and efficient protocol for 
the in situ synthesis and use of isocyanide reagents in synthetic protocols. Finally, the 
last two chapters describe the use of flow technology as a platform for reaction 
discovery. 
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Chapter 2 
Heterocycle Synthesis in Droplets 
 
In conjunction with researchers at Abbott Laboratories a droplet based library 
synthesis method was developed which allowed for the preparation of a theoretically 
unlimited number of compounds using a single Teflon loop and very minimal 
amounts of solvent. This method exploited the ability of flow technology to spatially 
separate library members along the length of a tube by employing immiscible 
solvents as spacers. The utility of the droplet-based library method was demonstrated 
through the synthesis of two 20-membered libraries derived from heterocyclic cores.  
 
Heterocycles in medicinal chemistry. Heterocycles are cyclic organic 
molecules wherein at least one atom within the ring is a heteroatom (not carbon). 
From this broad definition, it is found that more than half of all known organic 
compounds are heterocyclic.
51
 These molecules play an essential biological role in the 
basis of life, being key components of fundamental processes such as provision of 
energy, transmission of nerve impulses, sight, metabolism, and the transfer of 
hereditary information.
52
  
Much of the interest in heterocycles surrounds their ability to mimic 
biologically important functional groups such as amides and peptide ligands. 
Heterocycles often exhibit a type of stability that natural ligands lack, making them 
more resistant to degradation in vivo, allowing them to be biologically useful.
52
 This 
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class of molecules can be involved in an extraordinarily large range of reaction types 
and depending on the reagents, conditions, and reaction medium, heterocycles can act 
as nucleophiles, electrophiles, oxidizers, reductants or can be exceptionally inert. 
They are known to participate in all different types of bonding including covalent, 
ionic, hydrogen bonding, and van der Waals interactions. It is the moderate nature of 
heterocycles that makes them particularly useful as components in current drug 
therapies.
51
 In fact, the vast majority of existing small molecule-based drugs are either 
built around a heterocyclic core or contain a heterocyclic appendage (Figure 10).
53
  
 
 
Figure 10. Heterocycles in modern drugs. 
 
With such a large variety of heterocycles available, the choice of which to 
introduce in an experimental agent is primarily determined by key medicinal 
evidence. Considering the pharmacological impact of varying the ring size and 
heteroatom placement, the ultimate goal is to maintain or enhance the biological 
activity of the agent while optimizing its ADMET (absorption, metabolic stability, 
toxicity) properties.
54
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In almost all cases, before the optimal agent is found, a variety of different 
heterocyclic types are investigated in a high-throughput format. Companies, 
institutions, and federal agencies amass large collections of diverse heterocycles in an 
effort to expedite this bottleneck in the discovery process. New compounds are 
continually added to these collections to try and obtain the most optimal compounds 
early in the drug discovery process. A quick and efficient method, by which, 
numerous types of heterocycles could be synthesized would greatly facilitate this 
practice. 
 
Heterocycle library synthesis in flow. Flow platforms offer many key 
advantages for performing rapid heterocyclic library synthesis. Reactions performed 
in flow have precise timing and temperature control which leads to increased 
homogeneity and ultimately cleaner reactions requiring less purification. Segmented 
flow enables a single-reaction flow platform to be transformed into a multi-reaction 
system through the introduction of an immiscible solvent which spatially separates 
different reactions across the length of the channel, thus creating individual reaction 
droplets. This ability to separate reactions in time and space along the length of a 
continuous flow path allows a theoretically unlimited number of reactions to be 
performed continuously. The ability to perform multiple, unrelated reactions in a 
single run permits this type of method to have an extremely high throughput, which is 
ideal when the goal is to make small quantities of many different compounds as 
quickly and efficiently as possible.
37b,50
 Reactions performed in flow are part of a 
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closed system so solvents may be superheated, using high temperatures and pressures 
to enhance the rate of the reactions and shortening the overall time of the process. If a 
larger quantity of a compound originally synthesized in flow is desired more material 
may be accessed simply by scaling out, making further optimization unnecessary. 
 In the development of such a method some challenges exist which must be 
addressed. Heterocycles are inherently polar, a property which can create problems 
when trying to perform reactions in typical organic solvents. Often, the insoluble 
nature of either the reagents or the heterocyclic products, leads to precipitation and 
sluggish reactions, which are obstacles for processes completed in flow. First, both 
the reagents and products must remain soluble throughout the reaction. Precipitation 
of any component within the flow apparatus can cause a blockage leading to a break 
in the flow line or instrument failure. Second, a minimum flow rate must be 
maintained within the apparatus to ensure that reaction droplet integrity is maintained. 
This requires reactions to be completed in a short amount of time.  
With the above limitations in mind, we set out to find transformations that met 
the optimal properties for performing successful heterocycle syntheses in flow. The 
desired features included: 
 Single step transformations 
 Solubility of both reagents and products 
 Reaction completion in less than 10 minutes 
To begin, a number of known heterocycle-forming transformations were 
investigated in the microwave under superheating conditions to gauge their potential 
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for use in flow. Reactions found to be successful in the microwave were then pursued 
further to gauge if the synthetic method would be viable in a continuous flow library 
setting. The syntheses targeted for investigation focused on various routes to 5- and 6-
membered heterocyclic rings containing oxygen, nitrogen, and sulfur in assorted 
placements. The first heterocycle-forming reaction that showed promise from the 
scouting efforts was the synthesis of thiazole from N-alkylthioureas and 2-bromo-1-
arylpropan-1-ones (Table 2).
55
  
 
Table 2. Solubility studies for the synthesis of thiazoles. 
 
entry solvent additive temp. (ºC) time (min.) outcome
a 
1 MeCN  60 15 precipitate 
2 MeCN  80 15 precipitate 
3 MeCN Et3N 60 15 precipitate 
4 DMSO Et3N 80 15 no reaction 
5 DMF:MeCN (1:3) Et3N 60 15 soluble 
6 DMF:MeCN (1:1) Et3N 60 15 soluble 
7 DMF:MeCN (3:1) Et3N 60 15 soluble 
8 DMF Et3N 60 15 soluble 
 
 
a
Outcome based on visual observation. 
 
Early attempts to perform this transformation in the microwave in acetonitrile 
led to low conversions and precipitation of the starting thiourea (Table 2, entries 1-3). 
Changing the solvent to from acetonitrile to dimethyl sulfoxide greatly increased the 
solubility of the reagents; however, no reaction was observed upon heating (Table 2, 
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entry 4). Use of a N,N-dimethylformamide:acetonitrile mixture led to both the desired 
increase in reagent solubility and an increase in the efficiency of conversion to the 
desired product as observed by LCMS/ELSD (Table 2, entries 5-8).  
 
Scheme 5 
 
 
After optimization it was determined that N,N-dimethylformamide was the best 
solvent for the reaction to be performed in flow since it maintained reagent and 
product solubility in addition to exhibiting an acceptable reactivity profile. Using 
similar bromoketone and thiourea components reaction in the microwave, heating the 
components in N,N-dimethylformamide at 80 ºC for 6 minutes, gave a 51% yield of 
the desired thiazole (Scheme 5). 
 
Scheme 6 
 
 
Similar solubility and condition studies were performed using 3,4-
methylpentane-2,4-dione and phenylhydrazine for the synthesis of pyrazoles (Scheme 
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6), and hexane-2,5-dione and allyl amine for the synthesis of pyrroles (Scheme 7). In 
the first case, the conditions used for the thiazole synthesis also were found amenable 
to the synthesis of pyrazoles. Initial investigations of the pyrrole syntheses showed 
that product formation was possible using the conditions listed above (DMF, W 80 
ºC, 6 min). However, the limited commercial availability of 1,4-diketones and narrow 
substrate scope prevented the use of this reaction in a library setting. 
 
Scheme 7 
 
  
After a small survey of catalysts, it was found that the synthesis of triazoles 
was also amenable to the common reaction conditions (DMF, 80 ºC, 6 min) when a 
copper (I) source was added to the solution (Scheme 8). Preliminary tests using 
copper iodide showed only slight insolubility due to the addition of the catalyst. Upon 
heating in the microwave the copper became completely soluble and gave 
quantitative conversion to the triazole by LCMS. Efforts to transfer this sequence to 
the flow setting, however, showed that the initial insolubility of the catalyst was a 
problem. Designs to increase solubility of the copper catalyst by pre-heating, pre-
mixing with the reagents, and switching to other copper(I) sources were unsuccessful. 
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In light of these complications the triazole synthesis was also abandoned and the 
library was not completed in flow.  
 
Scheme 8 
 
 
In addition to the four syntheses mentioned above, routes toward a number of 
alternative heterocycle-forming reactions were investigated, including imidazoles,
56
 
furans,
57
 thiophenes, oxazoles, isoxazoles, pyridines, and indoles.
58
 For many of these 
attempts a central limitation was the short reaction time. Even a high reaction 
temperature and pressurized environment in the microwave could not compensate for 
the abridged reaction time. Under these conditions most transformations gave less 
than 10% conversion to the desired product by LCMS, if product was observed at all. 
Using the successful heterocycle syntheses described above (thiazole and 
pyrazole), two 20-membered libraries were synthesized in flow. Because both 
reactions required the same flow rate, temperature, and solvent; synthesis of both 
heterocycles could be performed in a single run without changing any setting on the 
flow instrument.  
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Flow instrument design and droplet technique. The commercially available 
Uniqsis FlowSyn continuous flow apparatus
42
 was used to perform the synthesis of 
heterocycles in droplets. The standard instrument included two injection ports, two 
HPLC pumps, a variant temperature flow coil (Teflon or metal), a variant temperature 
solid-support reagent column, and two solvent storage bottles (Figure 11). The 
apparatus could be controlled in automatic or manual mode through a computerized 
control panel at the base of the instrument. The control panel was used for 
programming the flow rate, temperature, injection, and collection. The operating 
system also continually monitored the system pressure to ensure user safety and an 
automatic system shut-down was triggered if the internal pressure reached an unsafe 
level. 
 
 
Figure 11. FlowSyn mesoscale continuous flow platform.
42
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Taking advantage of the ability to separate reactions by time and space in 
flow, it was possible to perform multiple reactions in a single sitting using a 
continuously flowing stream of solvent. Fluorous solvent was used as the carrier 
stream since it is immiscible with most organic solvents, which enables the fluorous 
solvent to form a physical spacer between reaction plugs. Manual injection of pre-
made reagent component solutions into the fluorous solvent stream formed reaction 
droplets in the flow coil. Substitution of the reaction components with colored dye 
enabled visualization of the droplets and showed the efficiency of droplet separation 
using fluorous solvent (Figure 12). The separation meniscus between the reaction 
droplet and solvent spacer was observable even for colorless organic reactions. The 
integrity of the droplets was best when a highly viscous solvent (DMF or DMSO) was 
used in the reaction. If a less viscous solvent (MeCN, THF, CH2Cl2) was used the 
droplets tended to break apart and exhibit variable flow rates inconsistent with the 
instrument settings.  
 
 
  
Figure 12. Droplet formation in continuous flow.
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Library reactions completed in the continuous flow apparatus were performed 
using stock solutions of library reaction partners prepared by dissolving 2.0 mmol of 
each component in 2.0 mL of anhydrous DMF. Each solution was sufficient to 
perform up to 10 reactions in flow with each component injection at a volume of 0.1 
mL of solution. The concentrations of component solutions were elevated to 
maximize the amount of material synthesized within each plug for each library 
product (35 – 75 mg expected material). Insolubility of the reaction partners at these 
elevated concentrations was a limiting factor since it occasionally caused reagent or 
product precipitation and clogged the instrument. Many viable reaction partners were 
dropped or substituted as a result of this reoccurring problem. 
Each reaction droplet was injected into the FlowSyn using the manual 
injection feature and pre-measured injection loops. The loops were filled in between 
injections using pre-filled syringes of each reaction component solution. Each loop 
injected 0.1 mL of reaction partner stock solution into the fluorous stream to give a 
total droplet volume of 0.2 mL. The flow rate was set to 1.3 mL/min to achieve a 
reaction time of 5.0 min within the instrument. Droplet injection occurred every 1.0 
minute with a wash droplet of anhydrous N,N-dimethylformamide injected in 
between each droplet. Therefore library members were injected on odd minutes 
(1,3,5, etc.) and washes on even minutes (2,4,6, etc.). The inclusion of washes 
increased the overall recovery of library material and limited contamination between 
adjacent droplets. Each run took a total of 45 minutes to complete reaction of all 20 
library members. 
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Upon completion of each library member the droplets exiting the reactor were 
collected manually in tubes (by visualization). The crude material was then extracted 
from the excess fluorous solvent directly. Although the fluorous solvent was largely 
immiscible with the N,N-dimethylformamide-based reaction droplets, some 
dispersion of reaction material into the fluorous spacer was observed. To address this 
problem the adjacent fluorous spacer solvent for each library member was extracted 
at least three times with equal parts of N,N-dimethylformamide and the combined 
extracts were reduced to obtain the final products. Failure to complete this extraction 
process resulted in very poor product recovery. After product extraction, the fluorous 
solvent was recycled and reused in multiple libraries. The crude material collected 
from the reactions was often of very high quality and required little purification. 
Purification was completed using an automated HPLC/MS MDF system. On a few 
occasions, the purity of the material was so high that it spontaneously crystallized, 
either directly in the instrument, upon cooling or collection. This was particularly 
problematic since it created a blockage within the flow tubing and caused the 
instrument to shutdown.  
 
Heterocycle synthesis in flow. Based on the preliminary investigations 
mentioned above, two 20-membered heterocycle libraries were completed in flow to 
generate thiazoles and pyrazoles. Stock solutions from each reagent measuring 0.10 
mL were used per reaction. Concentrations of the stock solutions were set as to aim 
for a minimum of 35 mg of material for each library member.  
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Thiazoles were synthesized by the combination of various α-bromoketone and 
thiourea reaction components (Table 3). The reactions were performed in N,N-
dimethylformamide at 80 ºC with a reaction time of 5 minutes (1.3 mL/min flow 
rate). Yields from the library were moderate, ranging from 12% to 63%, with most 
compounds achieving yields around 50%. 
 
Table 3. Thiazole library. 
 
entry R1 R2 R3 product yield (%)
a 
1 Ph CH3 CH3 1 61 
2 Ph CH3 Ph 2 40 
3 Ph CH3 m-FC6H4 3 31 
4 Ph CH3 allyl 4 41 
5 -C6H4-2-CH2- CH3 5 53 
6 -C6H4-2-CH2- Ph 6 34 
7 -C6H4-2-CH2- m-FC6H4 7 24 
8 -C6H4-2-CH2- allyl 8 12 
9 t-Bu H CH3 9 36 
10 t-Bu H Ph 10 40 
11 t-Bu H m-FC6H4 11 49 
12 t-Bu H allyl 12 50 
13 p-CNC6H4 H CH3 13 48 
14 p-CNC6H4 H Ph 14 48 
15 p-CNC6H4 H m-FC6H4 15 49 
16 p-CNC6H4 H allyl 16 42 
17 p-FC6H4 H CH3 17 55 
18 p-FC6H4 H Ph 18 31 
19 p-FC6H4 H m-FC6H4 19 46 
20 p-FC6H4 H allyl 20 63 
a
Isolated yield after MDF. 
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Pyrazoles were synthesized by the combination of various 1,3-diketone and 
hydrazine reaction components (Table 4). The reactions were performed in N,N-
dimethylformamide at 80 ºC with a reaction time of 5 minutes (1.3 mL/min flow 
rate). Yields from the library were moderate and ranged from 9% to 79%, with most 
compounds achieving yields around 30%. 
 
Table 4. Pyrazole library results. 
 
entry R1 R2 R3 R4 product yield (%)
a 
1 CH3 CH3 CH3 Ph 21 33 
2 CH3 CH3 CH3 m,m-Cl2C6H4 22 26 
3 CH3 CH3 CH3 CH3 23 44 
4 CH3 CH3 CH3 (CH2)2OH 24 37 
5 CH3 CH3 CH3 Cy 25 34 
6 CF3 H CH3 Ph 26 38 
7 CF3 H CH3 m,m-Cl2C6H4 27 15 
8 CF3 H CH3 CH3 28 0 
9 CF3 H CH3 (CH2)2OH 29 17 
10 CF3 H CH3 Cy 30 23 
11 CH3 H Ph Ph 31 29 
12 CH3 H Ph m,m-Cl2C6H4  32
b 
23 
13 CH3 H Ph CH3  33
b 
21 
14 CH3 H Ph (CH2)2OH  34
b 
79 
15 CH3 H Ph Cy 35 26 
16 CH3 -(CH2)3- Ph 36 32 
17 CH3 -(CH2)3- m,m-Cl2C6H4  37
b 
9 
18 CH3 -(CH2)3- CH3 38 43 
19 CH3 -(CH2)3- (CH2)2OH  39
b 
50 
20 CH3 -(CH2)3- Cy  40
b 
40 
a
Isolated yield after MDF. 
b
Isolated as a mixture of regioisomers. 
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Summary. A continuous flow method was developed using a segmented flow 
approach to perform the synthesis of a theoretically unlimited number of heterocycle 
libraries in droplets. It was demonstrated that different types of heterocycles could be 
interchangeably synthesized in a single run without stopping the flow of the 
instrument or altering the condition settings (temperature, carrier solvent and flow 
rate). The technique was applied for library synthesis around two heterocyclic cores, 
each containing 20 members. While overall yields from the libraries were moderate, 
each reaction afforded greater than 35 mg of material in high purity and produced 
very minimal waste. When considered together these features reveal the utility a 
droplet-based library approach can exhibit for the rapid and efficient synthesis of 
drug-like molecules.  
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Chapter 3 
In situ Reagent Generation with Continuous Flow 
 
 A second methodology study, completed in conjunction with researchers at 
Abbott Laboratories, aimed to take advantage of the unique closed environment 
inherently maintained by flow platforms. The intrinsic closed nature of flow systems 
enables the creation, reaction, and removal of noxious chemicals in situ, making the 
overall process safer by limiting chemical exposure of the user and allowing for only 
small quantities of the noxious chemical to be present at any one time. Aimed at this 
purpose an in situ synthesis of isocyanides, reagents notorious for their unpleasant 
smell, was developed. In a demonstration of the applicability of this method, the in 
situ isocyanide preparation was coupled to the Ugi four-component reaction for the 
synthesis of a series of complex amines, eliminating exposure of the user to 
isocyanides and their odor. 
 
Isocyanides and the Ugi reaction. The field of isocyanide chemistry began in 
1859 when Lieke reported the first synthesis of allyl isocyanide from allyl iodide and 
silver cyanide.
60
 Following this discovery came the development of two classical 
isocyanide syntheses from Gautier
61
 and Hoffmann
62
 in the late 1800s. For the 
remainder of the century only 12 isocyanides were prepared due to the unreliability of 
the synthetic methods63 and their universally unpleasant odor. Even in this period of 
limited availability, exploration and expansion of the chemistry of this small 
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functional group had begun. The first important uses of isocyanides were for the 
synthesis of tetrazoles from hydrazoic acid and in the Passerini three-component 
reaction (Passerini 3-CR) (Figure 13).
64a
  
 
 
Figure 13. Isocyanides in tetrazole synthesis, Passerini, and Ugi reaction. 
 
The next notable advancement in this field did not occur until the 1950s when 
the naturally derived isocyanide-containing antibiotic O,O’-dimethylxanthocillin was 
prepared through the dehydration of the diformylamine with benzenesulfonyl chloride 
and pyridine.
64
 The applicability of this dehydration method to a wide range of 
substrates for the first time demonstrated a general, high-yielding approach for the 
synthesis of isocyanides. (Figure 14).
64a
 With the development of a reliable synthetic 
method and increasing commercial availability, isocyanides found use in numerous 
synthetic applications for the formation of amides and various heterocycles. They 
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have been known to participate in a variety of reactions including free radical 
additions, organometallic reactions, polymerizations, and multicomponent reactions.
65
  
 
 
Figure 14. General routes to isocyanides.
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In 1961 Ivar Karl Ugi introduced perhaps the most popular application of 
isocyanides in a four-component coupling reaction, which later became known as the 
Ugi four-component reaction (Ugi 4-CR) (Figure 13).
64a
 The scope of the four 
components makes this reaction particularly dynamic since the products can not only 
differ in substituent but also in structure. The components of the Ugi 4-CR are 
isocyanides, amines (ammonia, mono- and disubstituted amines, hydroxylamine, and 
suitable derivatives), carbonyl compounds (aldehydes and ketones), and acid 
components or related compounds (water, thiosulfates, hydrogen selenide, hydrazoic 
acid, hydrogen cyanate and thiocyanate, aminocyanic acid, carboxylic acids, and 
thioacids, alkoxycarboxylic acids and amines) (Figure 15).
64a
 Considering the 
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commercially available permutations of carboxylic acids, amines, aldehydes, ketones, 
and isocyanides alone, the theoretical combinations of Ugi 4-CRs span a chemical 
space greater than 10
14
 small molecules.
64a
 Such implicit potential makes this 
transformation a powerful tool for the rapid construction of organic molecules.
66  
 
 
Figure 15. Variability of the Ugi 4-CR products. 
 
Use of the isocyanide-based multicomponent reactions (IMCR) was 
popularized in the early 1990s as combinatorial chemistry became a major focus in 
both industry and academia. Performing the Ugi 4-CR in a semi-automatic liquid- or 
solid-phase format enabled chemists to exponentially increase their productivity and 
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facilitated the investigation of millions of compounds annually.
67
 Products derived 
from the Ugi 4-CR or Passerini 3-CR have found medicinal application across a wide 
range of disease states including antibacterial, antiviral, anticancer, ion channel 
blockers and GPCR modulators (Figure 16).
67
 These transformations have also 
proved useful for rapid access to the medicinally privileged structures of 
benzodiazopines and spiropiperidines.
67
 The breadth of scope of the IMCR and 
efficient access to these structures have greatly facilitated the study of these popular 
agents.  
 
 
Figure 16. Medicinally relevant compounds derived from IMCRs.
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The increase in availability of IMCR chemotypes initially generated concerns 
surrounding the peptidic nature of the products because such compounds typically 
exhibit short half-lives and are quickly metabolized in biological systems. Fortunately 
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further transformations of these scaffolds can give compounds with good 
pharmacokinetic properties.
67
  
 
Isocyanides in a multi-step flow process. Isocyanides are among the most 
versatile functional groups, however their intense offensive odor has greatly 
discouraged their use. Ugi himself stated, “The development of the chemistry of 
isonitriles has probably suffered through the characteristic odor of volatile isonitriles, 
which has been described by Hofmann and Gautier as „highly specific, almost 
overpowering‟, „horrible‟, and „extremely distressing‟”.
62,65,68,69
 This characteristic 
has been known to cause migraines upon sensitization and even prompted their 
investigation as non-lethal weapons.
65,70
  
While isocyanides with high molecular weights are commonly solid and 
odorless the majority of commercially available isocyanides are of low molecular 
weight and volatile.
66
 One method to embrace the versatility of the isocyanide 
without dealing with the problems of direct handling (i.e. volatility) is to devise a 
procedure wherein the isocyanide is made in situ and quenched at the end of the 
sequence, prior to exposure of the user. For this purpose, the inherent closed nature of 
a flow system makes it the ideal platform for the development of such a method 
(Figure 17). 
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Figure 17. Isocyanides in traditional settings vs. flow settings. 
 
Flow reactors have been used previously to generate noxious, toxic, unstable, 
explosive, or dangerous chemical in situ, with removal of these agents before the 
reaction exits the instrument. In this way the user is never directly exposed to the 
offending agent and the scale of the instrument is such that only a small amount of the 
problematic material is present at any given time during the reaction. These benefits 
make difficult or dangerous reactions safer and more convenient. In addition, flow 
reactors have many of the same advantages as microwaves, namely the ability to 
pressurize and superheat reactions causing an increase in rate. Flow reactors also have 
the added benefit of scalability where essentially endless amounts of material may be 
made simply by flowing continuously.  
Performing these reactions in flow does present challenges which must be 
considered. Isocyanides are typically synthesized using harsh condition and the 
chosen method of formation must be compatible with the flow apparatus components 
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(pump, injectors, tubing, connectors, etc.). In addition, any excess reagents or by-
products must not interfere with any succeeding reactions performed on the 
isocyanide. Isocyanide formation and subsequent reactions also must be fast since the 
flow rates accessible through the system impose a limitation on the maximum 
reaction time.  
 
Development of a two-step Ugi sequence. As the Ugi 4-CR is a versatile 
reaction and creates products of medicinal relevance, we set out to exhibit the utility 
of a flow isocyanide synthesis through the creation of a two-step Ugi sequence. The 
Ugi 4-CR was specifically chosen for its close tie to relevant medicinal applications, 
as shown above. The envisioned sequence consisted of the in situ generation of 
isocyanides followed by their immediate use in the Ugi 4-CR, and ultimately 
hydrolysis of the isocyanide prior to the product exiting the instrument.  
 The first challenge in the development of the two-step Ugi 4-CR sequence 
was to choose the optimal method for isocyanide synthesis in flow. Traditional 
methods for the preparation of isocyanides from alkylhalides and alkylamines are 
known to be unreliable, low-yielding, and harsh (Figure 15). In addition, these 
methods use salt-based forms of cyanide (AgCN, KCN), which would create 
solubility problems in the flow reactor. The most reliable method of isocyanide 
preparation, as discussed previously, is the dehydration of formamides (Figure 18).  
Many reagents have been used to promote the dehydration of formamides for 
the synthesis of isocyanides. By far the most consistent and widely used reagent has 
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been phosgene;
63
 however for our purposes a less toxic and less reactive reagent was 
needed to carry through the multistep sequence. 
 
 
Figure 18. Isocyanide synthesis through formamide dehydration. 
 
The optimal conditions for dehydration in flow were determined by gauging 
reactions using traditional  benchtop techniques. From there, successful reagent 
combinations were tested in the microwave under superheating temperatures to 
simulate conditions in flow. With this plan in place, a number of reagents were 
investigated including, but not limited to, Burgess reagent,
71
 oxalyl chloride,
72
 and 
polymer-supported triphenylphosphine.
73
 Three formamides (cyclohexyl, p-
bromophenyl, o-chlorophenyl) were subjected to these dehydration conditions using 
various reaction times, temperatures, solvents, and additives. Initial attempts to follow 
the dehydrations using LMCS/ELSD/MS were unsuccessful as the isocyanide 
products exhibited little to no UV activity and showed poor mass response. As a 
result, it was determined that the most reliable method to test the efficiency of 
isocyanide formation was by performing a standard Ugi 4-CR using the crude 
isocyanide mixture and subsequently comparing the outcome of the two-step 
procedures directly.  
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Scheme 9 
 
 
The Ugi 4-CR of cyclohexyl formamide, p-chlorobenzoic acid, benzaldehyde, 
and allylamine was chosen as the model reaction from which to establish the optimal 
dehydration conditions. As a benchmark, the Ugi 4-CR was performed using 
cyclohexyl isocyanide purchased from commercial sources (Scheme 9). For this 
reaction, all four-components were combined in equal equivalents at the start of the 
reaction. Heating in an oil bath at 60 ºC for two hours afforded 90% of the desired 
Ugi 4-CR product. 
 Using this result, the transformation was investigated starting from the 
dehydration of cyclohexyl formamide and a limited survey of dehydration conditions 
was performed (Table 5). The reactions were completed according to their optimized 
literature procedures.
71-73
 Ultimately Burgess reagent gave the most promising result 
(Table 5, entry 4), yielding 50% of the desired product. However, to achieve this 
yield the two-step sequence required continual stirring at room temperature for three 
days. For any flow-based technique to be viable a much shorter reaction time was 
needed. The minimum flow rate of the HPLC pumps required reactions to be 
completed on the order of hours rather than days.  
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Table 5.  benchtop survey of the two-step dehydrationUgi 4-CR sequence. 
 
 Dehydration Ugi  
entry reagents time temp. solvent time solvent yield 
  (min) (ºC)  (h)  (%)
a 
3 oxalyl chloride 60 40 CH2Cl2 24 MeOH/CH2Cl2  
1 PS-PPh3, Et3N 15 80 CCl4 24 MeOH/CCl4  
2 PS-PPh3, Et3N 15 80 CCl4 72 MeOH/CCl4 20 
4 Burgess salt 24 rt CH2Cl2 72 MeOH/CH2Cl2 50 
 
a
Isolated yield. 
 
 To determine the effect of superheating conditions on the rate, and potentially 
decrease the overall transformation time, a series of microwave reactions were 
completed simulating prospective scenarios in flow. The two-step process involving 
formamide dehydration with Burgess reagent followed by Ugi 4-CR of the preformed 
isocyanide was completed using variations of the component ratio, temperature, time, 
and solvent for both the dehydration and Ugi steps. Starting at 90 ºC and using a five 
minute reaction time for each step (Table 6, entry 1 and 2), a drop in the conversion 
was observed when methanol was used as the only solvent. A gradual increase in the 
reaction time lead to a jump (up to 75%) in the overall conversion (Table 6, entries 2 
and 3). With this result the two-step process became feasible for flow applications, 
achieving adequate conversions in fewer than two hours.   
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The optimal microwave-based procedure was found to use two equivalents of 
both Burgess reagent and formamide in dichloromethane heating at 65 ºC for 2 hours. 
This was followed by addition of a premixed solution of aldehyde, amine, and acid in 
methanol, and heating at 90 ºC for an additional hour. The overall process gave 95% 
conversion to the desired product (Table 6, entry 5). Use of a single equivalent of 
Burgess reagent and formamide under these conditions gave very little conversion 
(Table 6, entry 6), demonstrating that the reaction outcome had a strong dependence 
on the component stoichiometry. 
 
Table 6. Microwave survey of the two-step dehydrationUgi 4-CR sequence. 
 
Dehydration Ugi  
entry amide temp. time solvent temp time solvent conversion 
 (equiv.) (ºC) (min.)  (ºC) (min.)  (%)
a 
1 2 90 5 CH2Cl2 90 5 MeOH/CH2Cl2 30 
2 2 90 5 MeOH 90 5 MeOH 15 
3 2 90 30 CH2Cl2 90 60 MeOH/CH2Cl2 75 
4 2 90 60 CH2Cl2 90 60 MeOH/CH2Cl2 75 
5 2 65 120 CH2Cl2 90 60 MeOH/CH2Cl2 95 
6 1 65 120 CH2Cl2 90 60 MeOH/CH2Cl2 10 
a
Conversion estimated by LMCS/ELSD 
 
Using the optimized microwave conditions a small subset of formamides were 
subjected to the two-step procedure to gauge the scope of the sequence (Table 7). 
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Overall the isolated yields were much lower than predicted by LCMS. This 
discrepancy was initially attributed to problems encountered during purification. The 
highly lipophilic nature of the Ugi 4-CR products complicated purification and made 
isolation of the pure material difficult. In addition, an unknown by-product co-eluted 
with the desired Ugi 4-CR products, further complicating isolation.  
  
Table 7. Formamide scope in the dehydrationUgi 4-CR microwave sequence. 
 
entry R conversion yield 
  (% by LCMS)
a 
(% by isolation)
 
1 Cy 95 61 
2 t-Bu 75 66 
3 C5H11 75 68 
4 Bn 30 
 
5 Ph 10  
 
a
Estimated according to LCMS data of crude reaction. 
 
Despite the unexpected low yields, the reaction appeared to work best for 
alkyl formamides (Table 7, entries 1-3). Benzyl and phenyl formamides performed 
poorly and gave no isolated product despite some conversion observed by the 
LCMS/ELSD/MS (Table 7, entries 4 and 5). In addition to those listed in Table 6, 
four other formamides were tested using the optimized microwave two-step sequence 
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but, for reasons such as poor solubility and polymerization, these substrates failed to 
yield the desired product (Figure 19).  
 
 
Figure 19. Formamides not viable in the two-step microwave sequence. 
 
 While the vast majority of organic transformations benefit from the 
advantages of microwave heating, previous studies focused on the use of isocyanides 
in microwaves suggest that these conditions may actually exhibit a detrimental effect 
on isocyanide-based reactions.
66
 Often the use of microwaves in IMCRs leads to 
different, unexpected, or unwanted products. Several classes of isocyanides are 
known to be highly prone to polymerization; the concentrated conditions and high 
temperatures used in microwave synthesis can enhance this process leading to a larger 
quantity of unwanted side products. In addition, a number of reactive intermediates 
generated during the course of the MCR can react with unintended partners present in 
solution (solvent, intramolecular reactions, etc.) to promote polymerization, 
oligomerization and other unwanted side products. It was speculated that these 
difficulties contributed to the low yields and conversion for some of the formamides 
investigated in the microwave study. Also, it was initially unknown if these problems 
would carry over to transformations performed in a flow setting. Even so, we hoped 
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that the use of dilute conditions and precise heating in flow could diminish the 
potential for these problems. 
 
Flow apparatus design. The continuous flow apparatus employed for in situ 
isocyanide formation and Ugi 4-CR was created by combining two commercially 
available flow units, the Uniqsis FlowSyn and the Vapourtec R Series (Figure 20).
42,43
 
In the design of the instrument, the FlowSyn heating coil was used to synthesize the 
isocyanides by mixing formamide and Burgess reagent. Upon exiting the FlowSyn 
heating coil the newly formed isocyanide was combined with a premixed solution of 
aldehyde, amine, and acid. The two solutions were united using a T-joint. The 
mixture was then passed through the Vapourtec heating coil which was used to 
complete the Ugi 4-CR. Finally, upon exiting the Vapourtec coil the solution was 
passed through a column filled with solid-supported p-toluenesulfonic acid located on 
the FlowSyn base. Upon passing through the column the excess isocyanide was 
hydrolyzed back to formamide before the solution exited the instrument.
74
  
 Although the individual reaction platforms were both automated, the timing of 
each reaction had to be dictated to each machine individually and accompanied by a 
physical switch between solvent and reaction solution. Therefore, system injection of 
both the initial dehydration reaction and the subsequent Ugi 4-CR was controlled 
manually. To determine the injection time for the Ugi 4-CR components, a plug of 
colored dye was sent through the instrument to measure the path length (length of 
tubing) and residence time at various flow rates. Injection was completed by 
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continuous flow using standard HPLC pumps equipped on both the FlowSyn and 
Vapourtec instruments. 
 
 
Figure 20. Diagram of the continuous flow platform for the two-step Ugi 4-CR.  
 
Reactions completed in the continuous flow apparatus were performed by 
combining 0.750 mmol (101 mg, 2 equiv.) of formamide with 1.50 mmol (206 mg, 2 
equiv.) of Burgess reagent in 1.5 mL of anhydrous dichloromethane in a sealed 
conical-tipped vial. An injector tube was inserted through a hole in the vial cap and 
extended until it touched the bottom of the vial. The solution was allowed to flow 
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continuously into the reactor at a flow rate of 0.1 mL/min (equivalent to one hour 
reaction time), the maximum reproducible reaction time which could be achieved 
using the FlowSyn. The total injection time for the dehydration step of the sequence 
was approximately one hour, after which point the primary injection line was 
switched to anhydrous dichloromethane to move the remaining reaction solution 
through the instrument. The flushing solvent injection required one additional hour. 
During this time, a solution of the remaining Ugi 4-CR components was 
prepared by combining 0.375 mmol (1 equiv.) of acid, 0.375 mmol (1 equiv.) of 
aldehyde, and 0.375 mmol (1 equiv.) of amine in 1.5 mL of anhydrous methanol in a 
sealed conical-tipped vial. The combined solution was allowed to sit for 1-2 hours 
prior to injection into the instrument. Prior to the start of the Ugi 4-CR component 
injection, a solution of anhydrous methanol was pumped through the instrument to 
maintain the appropriate backpressure. As the newly-formed isocyanide reached the 
T-joint merge point an injector tube was inserted through a hole in the vial cap of the 
Ugi 4-CR component solution and extended until it touched the bottom of the vial. 
The solution was allowed to flow continuously into the Vapourtec reactor at a rate of 
0.1 mL/min (equivalent to one hour reaction time), which was the longest reaction 
time which could be achieved reproducibly by the instrument. The total injection time 
for the Ugi 4-CR step of the sequence equaled approximately one hour, after which 
point the second injection line was switched to anhydrous methanol to move the 
remaining reacting solution through the instrument. Flushing of the Ugi 4-CR took 
approximately one additional hour. The time from the start of the dehydration 
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injection to the exit of all reaction material from the instrument measured a total of 
three hours.  
 
Study of Ugi reaction scope in flow. During the initial investigation of the 
optimal dehydration conditions using the microwave, it was observed that the overall 
yield of the two-step sequence fluctuated in response to variation in the stoichiometry 
(Table 6, entry 5 vs. entry 6). To address this phenomenon and determine the optimal 
stoichiometric ratio of reactants, the relationship between the Burgess reagent, 
formamide, and the remaining Ugi 4-CR components was briefly investigated in flow 
(Table 8). Reactions were performed in both the microwave and in continuous flow 
for direct comparison. In most cases, reactions performed in flow had yields 
equivalent to or slightly better than those performed in the microwave. 
 
Table 8. Study of the two-step Ugi 4-CR stoichiometry in flow. 
 
entry A B C microwave flow 
 (equiv.) (equiv.) (equiv.)  (% yield)
a 
(% yield)
b 
1 3 2 1 46 41 
2 2 2 1 76 79 
3 2 1 1 26 37 
4 1 1 1 40 48 
a
Both dehydration and Ugi reactions completed in microwave at 90 ºC for 1 h. 
b
Both dehydration and Ugi reactions completed in continuous flow at 90 ºC for 1h. 
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The optimal stoichiometry was found as two equivalents of Burgess reagent 
and formamide for each equivalent of the remaining three components (aldehyde, 
amine, and acid). This combination gave the highest isolated yield for reactions 
completed both in the microwave (76%) and in flow (79%) (Table 8, entry 2). In all 
other cases, different stoichiometric combinations gave lower yields (40-50% 
overall). With a general understanding of the stoichiometry, the substrate scope of the 
two-step flow sequence was then investigated (Table 9).  
 
Table 9. Study of the two-step Ugi 4-CR substrate scope. 
 
      W flow 
entry R1 R2 R3 R4 product (%)
a,b 
(%)
a,b 
1 Bn Ph Bn 2-Br,4-ClC6H3 41 14 79 
2 Cy Ph Bn 2-Br,4-ClC6H3 42 47 75 
3 t-Bu Ph Bn 2-Br,4-ClC6H3 43 20 60 
4 p-ClC6H4 Ph Bn 2-Br,4-ClC6H3 44 14 52 
5 Ph Ph Bn 2-Br,4-ClC6H3 45 18 48 
6 EtOCOCH
2 
Ph Bn 2-Br,4-ClC6H3 46 17 46 
7 Bn H Bn Ph 47 52 83 
8 Bn p-ClC6H4 Bn Ph 48 42 78 
9 Bn Ph Bn Ph 49 53 72 
10 Bn nPr Bn Ph 50 6 28 
11 Ph Ph Bn Ph 51 33 43 
12 Ph Ph p-ClC6H4 Ph 52 13 28 
13 Cy Ph Bn Ph 53 64 83 
14 Cy Ph Bn p-ClC6H4 54 43 79 
15 Cy Ph Bn nPr 55 77 57 
16 Cy Ph Bn CH3 56 51 54 
a
Both dehydration and Ugi reactions completed at 90 ºC for 1 h. 
b
Isolated yield. 
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Once again, reactions were performed both in continuous flow and in the 
microwave, under identical heating and reaction time, for comparison purposes. The 
majority of the reactions gave good to excellent yields across the two-step process. 
Yields from the microwave transformations were overall lower than those for 
reactions completed using the flow process. The decrease in product observed from 
the microwave reaction may be attributed to a number of factors. One consideration is 
that in order to directly compare the two reaction techniques the optimized flow 
parameters were used for both the microwave and flow-based reactions. As a result, 
microwave-based experiments were shortened and run under increased temperatures. 
This decrease in time and increase in temperature may have contributed to an increase 
in unwanted by-products and an overall decrease in yield of the desired product. 
 
Summary. Overall, the good yields and large substrate scope demonstrate the 
general and robust nature of the continuous flow two-step method. In addition, the 
sequence was completed in only three hours using the continuous flow method, a vast 
improvement over the  benchtop method which required reaction times greater than 
three days. While reactions performed in the microwave were also completed in a 
matter of hours, the sequence still required exposure to isocyanides during the 
addition of the Ugi 4-CR components and extensive purification. The flow 
methodology enabled reactions to be completed rapidly while eliminating direct 
exposure of the user to isocyanides, increasing the safety and convenience of these 
reactions.  
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Chapter 4 
Reaction Discovery Using Microfluidic-Based Screening of  
Polycyclic Iminium Ethers 
 
 In cooperation with the laboratory of Dr. John A. Porco, Jr. at Boston 
University (BU) we aimed to extend the use of flow technology to include 
applications of reaction discovery and development of synthetic methodologies. 
Starting from two iminium ether substrates, a simple bicyclic iminium ether and a 
densely functionalized bicyclo[3.2.1]octanoid derived iminium ether, a high-
throughput flow-based method was designed to probe the variety of chemotypes that 
are accessible from these intermediates. The highly condition-dependent nature of 
iminium ether transformations makes them particularly excellent candidates for 
multidimensional reaction screening on a microfluidic platform. Accordingly, 
systematic screening of substrates, reaction partners, additives, and conditions in an 
array format was completed to access the greatest breadth of substrate reactivity. 
Moreover, use of an automated microfluidics reaction screening platform allowed for 
the reactions to be completed on an analytical scale in continuous succession, 
resulting in considerable savings of both time and material. This chapter details the 
development of a multidimensional reaction screen for polycyclic iminium ethers the 
resulting chemotypes derived from those experiments. 
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Synthesis and reactivity of cyclic iminium ethers. Cyclic iminium ethers are 
ambident electrophilic intermediates that react with a range of nucleophiles in a 
highly condition-dependent manner. Iminium ether stability, nucleophile identity, 
solvent, reaction time, and temperature, among other factors, have all been shown to 
influence the course of iminium ether reactions.
75
 Nevertheless, these reactive 
intermediate have demonstrated particular utility in the synthesis of densely 
functionalized heterocycles.
76
 Acyclic iminium ethers are typically formed through 
the O-alkylation of amides, while cyclic and bicyclic versions can be formed through 
the direct N-alkylation of oxazolines and dihydrooxazines (Figure 21)
77
 or by reaction 
of ketones with hydroxyalkyl azides (Figure 22).
78
 The ambident electrophilic nature 
of these species gives access to different reaction pathways (path a-c) within a single 
substrate (Figure 21).
75,79
  
 
 
Figure 21. Synthesis and reactivity of cyclic iminium ethers.  
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While multiple products are possible, in practice most substrate combinations 
give rise to a single dominate species. These features make iminium ethers 
particularly attractive substrates for reaction screening, as there is the possibility for 
multiple chemotypes to arise from a single substrate while one path is typically 
favored to afford acceptable conversion to a major product. In addition, a wide range 
of structurally diverse iminium ethers are available and their capacity to react with a 
wide selection of nucleophiles further increases the potential for these substrates to 
generate a unique set of functionalized products. 
 
 
Figure 22. Mechanism of the azido-Schmidt reaction with hydroxyalkyl azides. 
 
 Previous studies conducted within the Aubé group, based on early work by 
Hünig, revealed two predominate modes of addition for 5,7-bicyclic iminium ethers 
(Table 10).
78
 It was found that while path a was kinetically favored it was also often 
reversible, which led to a greater percentage of product isolated from path b. Path a 
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products resulted from instances where the initial nucleophile addition was either 
irreversible or where iminium ether ring opening successfully competed with 
nucleophile ejection (Table 10, entries 1-4). Path b products arose when nucleophiles 
were able to undergo elimination from the initial-formed adduct and ultimately 
underwent addition at the carbon adjacent to the imine center (Table 10, entries 5-8). 
A small group of stabilized carbon-based nucleophiles were also investigated but the 
mode of addition was found to differ according to the nature of the stabilizing anion 
and the nucleophile size (Table 10, entries 9-11).
78
  
 
Table 10. Nucleophilic addition reactions of iminium ethers.
78
  
 
entry nucleophile X path yield (%)
a 
1 H2 H,H a 87 
2 Na2S S a 57 
3 H2NBn NBn a 88 
4 H2NNMe2 NNMe2 a 88 
5 NaSPh SPh b 95 
6 NaOPh OPh b 74 
7 NaN3 N3 b 85 
8 NaCN CN b 82 
9 NaCH(CO2Me)2 OCOCH2CO2Me b 34 
10 NaCH(SO2Ph)2 CH(SO2Ph)2 b 54 
11 NaCH(CN)2 C(CN)2 a 71 
 
a
Isolated yield as reported. 
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 Based on these findings, it was initially unclear how the majority of carbon-
based nucleophiles would behave with these systems. Given that a key aim in organic 
chemistry is the pursuit of carbon-carbon bond forming reactions, this was an 
important question to address. In addition, previous studies of these systems were 
limited and did not examine differences in reaction conditions or substrate identity. In 
order to gain a greater understanding of iminium ether reactivity the plan was to: 
 Investigate more complex and functionalized cyclic iminium ethers 
 Explore a broad range of carbon-based nucleophiles 
 Expand the breadth of reaction conditions 
In order to complete these aims in a time and material efficient manner a 
microfluidic-based multidimensional screening approach was employed.  
 
Microfluidic-based multidimensional reaction screening. Inspired by 
advances in the miniaturization and automation of biological screening, applications 
of this technology to the realm of chemical synthesis and reaction discovery have 
been an active field of research in recent years. The development of similar small-
scale automated techniques using microfluidic technologies has enabled high-
throughput reaction screening using only small quantities of material.
80
  
A multidimensional screening workflow
82
 was developed based on the use of 
an automated microfluidics platform (Figure 23).
80
 Reactions performed in the 
microfluidic reactor could be completed in a time-efficient manner and on an 
analytical scale (2 mol). Upon recovery from the instrument, the crude reaction 
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solution was analyzed by UPLC/MS/ELSD to determine each reaction outcome. 
Reactions affording greater than 20% conversion to a single product were deemed 
“productive” and suitable for follow-up studies. All productive reactions were 
repeated using traditional  benchtop techniques. Isolation of the products was 
completed using either silica gel column chromatography or preparative HPLC. 
Traditional structure elucidation techniques such as NMR, IR, and MS were then used 
to determine the identity of the reaction product. If the newly discovered 
transformation was deemed interesting, additional optimization of the reaction was 
completed. 
 
 
Figure 23. Multidimensional reaction screening workflow.
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An automated microfluidic reaction screening platform, previously developed 
at the BU-CMLD, was used for the multidimensional screen.
80
 The microfluidic 
platform consisted of a multi-head syringe pump, liquid handler, a microreactor, and 
a UV-triggered fraction collector (Figure 24). The platform was controlled using a 
Trilution

 operating system and was capable of combining specified reagents in a 
sequential format. The liquid handler systematically injected pulses of reactants into a 
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continuously flowing solvent stream driven by the multi-head syringe pump. The 
three reagent pulses converged in the microreactor to undergo mixing and become a 
single reaction pulse. The reactions were quenched upon exiting the reactor with a 
continuously flowing stream of quenching solution, giving each reaction a finite 
endpoint. UV triggered collection allowed for the isolation of the most concentrated 
region of the reaction pulse by setting an acceptable absorbance, thus selectively 
extracting individual reaction mixtures form the pulse stream. 
 
 
Figure 24. Microfluidic reaction screening platform.
80
  
 
Iminium ether substrate selection. At the outset, a complex scaffold was 
sought which could be used to examine iminium ether reactivity. To this end, a small  
benchtop multidimensional reactivity screen was set systematically reacting five 
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multifunctional ketones 79–83
80,83
 with two hydroxyalkyl azides (2-azido-1-ethanol 
77, 3-azido-1-propanol 78) and four additives (BF3·OEt2, TfOH, PPh3, t-BuOK) 
(Figure 25). Due to the inherent hydrolytic instability of iminium ethers, upon 
completion each reaction was hydrolyzed with saturated aqueous NaHCO3 to ease 
product identification.
78
 The outcome of each reaction was determined by LCMS 
analysis of the crude sample. The majority of reaction attempts resulted in 
dehydration, decomposition, or no observable reaction. Of these, only 
bicyclo[3.2.1]octanoid 63 led to an appreciable quantity of novel products. 
 
 
Figure 25. Multidimensional screening parameters for substrate selection. 
 
Further investigation of the reaction of bicyclo[3.2.1]octanoid 63 with 
hydroxyalkyl azides 57 and 58 in the presence of acid revealed three identifiable 
products, a ketal, an iminium ether, and a lactam (Table 11). In all cases, isolation of 
ketal was only possible in reactions of 2-azido-1-propanol and BF3·OEt2. All attempts 
to induce further reaction from the ketal by treatment with strong acid lead only to 
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recovered starting material. Lactam product was recovered in small quantities from 
reactions of both BF3·OEt2 and TfOH; however, when TfOH was used the iminium 
ether became the major product but the still contained minor contamination from the 
lactam. Changing the work-up procedure from saturated aqueous NaHCO3 to a quick 
deionized water wash afforded the desired iminium ether as the exclusive product in 
excellent yield. 
  
Table 11. Survey of bicyclo[3.2.1]octanoid 63 in reaction with hydroxyalkyl azides. 
 
entry acid azide (n) work-up ketal iminium lactam 
 (equiv.) (equiv.) (aqueous) (%)
a 
ether (%)
a 
(%)
a,b 
1 BF3·OEt2 (2.0) 57 (1.5) NaHCO3 23   
2 BF3·OEt2 
(excess) 
57 (1.5) NaHCO3   13 
3 BF3·OEt2 (2.0) 57 (excess) NaHCO3 45  13 
4 TfOH (1.0) 57 (1.0) NaHCO3    
5 TiCl4 (5.0) 57 (1.5) NaHCO3    
6 BF3·OEt2 (2.0) 58 (1.5) NaHCO3    
7 TfOH (3.0) 58 (1.5) NaHCO3  54 15 
8 BF3·OEt2 (3.0) 58 (1.5) H2O    
9 TfOH (3.0) 58 (1.5) H2O  87  
10 HBF4 (4.0) 58 (1.5) H2O    
a
Isolated yield. 
b
 Isolated as a mixture of regioisomers. 
 
Characterization of the resulting iminium ether and lactam revealed the 
formation of a mixture of regioisomeric products arising from differential migration 
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of the carbon centers adjacent to the bridgehead ketone. At this point it was also 
found that the hydrolytic instability of the iminium ether prevented traditional normal 
and reverse phase chromatographic purification techniques from being used. Efforts 
to purify the iminium ethers in this manner led to the recovery of a large percentage 
of lactam hydrolysis product. In addition, the soft triflate counter ion gave the 
iminium ether salt an amorphous appearance, thereby preventing purification by 
recrystallization. Modification of the work-up allowed for isolation of the iminium 
ether intermediates as a mixture of regioisomers. Ultimately, the iminium ethers 
derived from 63 were deemed suitably complex substrates for the present study. 
 
Scheme 10 
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Bicyclo[3.2.1]octanoid 63 was derived from a [5+2] cycloaddition between 
quinone monoketal 72 and trans-β-methylstyrene (Scheme 10).
80,84
 Use of this 
methodology allowed for the synthesis of four additional bicyclo[3.2.1]octanoid 
ketone scaffolds 74-77 (Table 12).  
 
Table 12. Bicyclo[3.2.1]octanoid ketone substrates. 
entry monoketal alkene bicyclo[3.2.1]octanoid product (yield, %)
a 
1 
  
 
63 (50) 
2 
   
74 (38) 
3 
   
75 (75) 
4 
  
 
76 (54) 
5 
  
 
77 (56) 
a
Isolated yield.
80 
 
All bicycles were synthesized starting from 3,4-dimethoxyphenol. Direct 
oxidation with phenyl iododiacetate afforded the quinone monoketal. In cases where 
R1 of the bicyclo[3.2.1]octanoids is equal to allyl, the allyl group was installed prior 
to oxidation through a sequence of phenolic O-allylation followed by Claisen 
rearrangement. An acid-catalyzed [5+2] cycloaddition was then used to couple the 
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quinone monoketals with various styrenes. This reaction yielded three major 
products, the ratio of which depended on the concentration of water within the 
solution. An excess or shortage of water within the reaction afforded either a quinone 
or a 7-membered cyclic diene as the major product, respectively. Using the optimized 
amount of water (0.75 equiv.), bicyclo[3.2.1]octanoids were isolated as the major 
component of the product mixture (Table 12).
80
 Each of the five 
bicyclo[3.2.1]octanoid scaffolds was then evaluated for its performance in the azido-
Schmidt reaction with 3-azido-1-propanol (Table 13).  
 
Table 13. Bicyclo[3.2.1]octanoid ketones in the azido-Schmidt reaction. 
 
entry R1 bicyclo[3.2.1]octanoid product (yield %)
a 
a:b ratio
b 
1 H 63 69 (88) 3:1 
2 H 74 78 (49) 2:1 
3 H 75 79 (40) 2:1 
4 allyl 76 80 ()  
5 allyl 77 81 ()  
a
Isolated yield of regioisomeric mixture. 
b
Ratio estimated by crude 
1
H NMR 
 
Bicyclo[3.2.1]octanoid scaffolds bearing an allyl group in the R1 position 
failed to react under typical azido-Schmidt conditions (Table 13, entries 4 and 5). 
However, when R1 was hydrogen a mixture of regioisomeric lactams was isolated 
(Table 13, entries 1-3).
80
 Substrate 63, synthesized from trans-β-methylstyrene, gave 
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both the greatest overall yield (88%) and the best regioselectivity (3:1) in this study. 
Therefore, substrate 63 was chosen as the scaffold for multidimensional screening 
studies and additional optimization. 
 
Table 14. Acid survey of bicyclo[3.2.1]octanoid 63 in the azido-Schmidt reaction. 
a
Isolated yield. 
b
Estimated conversion by UPLC. 
 
The azido-Schmidt reaction of 63 was further explored to determine the effect 
of the acid promoter, hydroxyalkyl azide, solvent, and temperature on the yield and 
regioselectivity of the transformation. A series of protic, Brønsted, lanthanide, and 
mixed acid conditions were examined (Table 14). Of the acids tested, only those in 
entry acid equiv. outcome product (conversion %) 
1 Sc(OTf)3 0.20 ester 82 (94)
a 
2 La(OTf)3 0.20 no reaction  
3 Zn(OTf)2 0.20 no reaction  
4 Yb(OTf)3/PhCO2H 0.02/1.0 no reaction  
5 La(OTf)3/PhCO2H 0.02/1.0 no reaction  
6 Zn(OTf)2/PhCO2H 0.02/1.0 no reaction  
7 PTSA 3.0 no reaction  
8 CSA (+) 3.0 no reaction  
9 TFA 3.0 no reaction  
10 BF3·OEt2 3.0 lactam 69a,b (trace) 
11 HBF4 3.0 lactam 69a,b (trace) 
12 Tf2NH2 3.0 lactam 69a,b (51)
b 
13 TMSOTf 3.0 lactam 69a,b (65)
b 
14 TfOH 3.0 lactam 69a,b (100)
b 
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which triflic acid was present or produced gave significant amounts of product; triflic 
acid itself afforded full conversion. The majority of acids investigated gave no 
observable reaction and resulted in the recovery of the starting bicyclic ketone. 
Interestingly, despite previous reports of Sc(OTf)3 use as a promoter in the azido-
Schmidt reaction, the only product isolated from this reaction was the retro-
Dieckmann azidoester 82. Notably, none of the remaining lanthanides used in the 
study gave either of these products.  
 
Table 15. Condition survey for the azido-Schmidt reaction bicyclo[3.2.1]octanoid 63. 
 
 
entry azide (n) solvent temp. (ºC) time (h.) a:b ratio
a 
1 1 CH3CN -20 7 6.5:1
b 
2 1 CH3CN -20 12 7.3:1 
3 1 (1:1) CH3CN:CH2Cl2 -20 7 5.9:1
b 
4 1 (1:1) CH3CN:CH2Cl2 -20 12 7.6:1 
5 1 CH2Cl2 -20 7 6.7:1
b 
6 1 CH2Cl2 -20 12 7.6:1 
7 1 CH3CN 0 → rt 12 6.1:1 
8 1 (1:1) CH3CN:CH2Cl2 0 → rt 12 5.8:1 
9 1 CH2Cl2 0 → rt 12 4.8:1 
10 2 CH3CN -20 12 2.8:1 
11 2 (1:1) CH3CN:CH2Cl2 -20 12 3.1:1 
12 2 CH2Cl2 -20 12 3.2:1 
13 2 CH3CN 0 → rt 12 2.4:1 
14 2 (1:1) CH3CN:CH2Cl2 0 → rt 12 2.2:1 
15 2 CH2Cl2 0 → rt 12 3.1:1 
a
Regioisomeric ratio based on crude 
1
H NMR. 
b
Full conversion was not obtained. 
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Next, the effects of hydroxylalkyl azide, solvent, and temperature on the 
regioselectivity of the reaction were investigated (Table 15). A marked increase in 
regioselectivity was observed when 2-azido-1-ethanol was substituted for 3-azido-1-
propanol. The regioselectivity also showed significant temperature dependence when 
2-azido-1-ethanol was employed. Conversely, this effect was not observed in 
reactions using 3-azido-1-propanol. Changes in solvent appeared to have little effect 
on the regioselectivity. 
 
Scheme 11 
 
 
Iminium ethers 67a and 67b were obtained as a 3:1 mixture of regioisomers 
by carrying out the hydroxyalkyl azide addition step according to the conditions noted 
above (Table 15, entry 15) followed by a water wash (Scheme 11). It was previously 
reported that some iminium ethers can be purified by column chromatography, but 
the compounds under investigation proved unstable to silica gel chromatography. 
Therefore, the regioisomeric mixture of 67a/67b was used without further 
purification in multidimensional screening experiments. The regioisomeric ratio was 
determined by spectroscopic analysis and by its conversion to 69a/69b upon 
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treatment with mild aqueous base (Scheme 11). In all but a few cases, the products 
from the 67a/67b mixture were separable by silica gel chromatography. In contrast, 
the iminium ethers arising from the reaction of 63 and 2-azido-1-ethanol (Table 15, 
entry 1-9) proved unstable when isolated and were not further used in the study. 
Previous work has shown that the regiochemical outcome of ring expansion 
reactions of hydroxyalkyl azides and -substituted cyclic ketones is dependent both 
on the influence of the steric environment and the electronic nature of the migrating 
centers.
85
 Thus, while reactions of methyl and ethyl -substituted ketones were 
generally nonselective, migration of the more highly substituted carbon was favored 
when bulkier substituents were used. In contrast, when inductively electron-
withdrawing substituents were placed  to the ketone, selective (up to 9:1) migration 
was observed for the less-substituted carbon. However, there are no obvious steric 
differences in the two potentially migrating carbons of bicyclo[3.2.1]octanoid (63), 
leaving open the question of what forces are responsible for the modest but 
systematic regioselectivity of its reactions with hydroxyalkyl azides. Assuming 
antiperiplanar migration relative to the N2
+
 leaving group, two mechanistic scenarios 
arising from the intermediate oxonium ion are possible (Figure 26). Thus, addition of 
azide can occur from either face of the oxonium ion species (paths a and b as 
depicted), in each case leading to a mixture of N-diazoniumoxazinane intermediates. 
In this scenario, it is conceivable that path a would be favored due to the 
presence of steric interactions arising from the methyl group in path b. Prior reports 
suggest that azide adducts formed in this way can equilibrate via chair–chair 
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interconversion prior to loss of N2 and formation of the iminium ether
85 at which 
point the reaction trajectory is determined and regiochemistry is fully established. 
Given the relatively low energy differences leading to 69a over 69b and lack of 
obvious preference between the two chair forms of the oxazinanes shown to the left 
of the diagram in Figure 26, it was not possible to speculate further on the cause of 
the preference for 69a. 
 
 
Figure 26. Regioselectivity analysis for the reaction of bicyclo[3.2.1]octanoids.  
 
 
The proficiency of these multifunctional iminium ethers in ring-opening 
screens was validated by treatment of 67a,b with nucleophilic reagents previously 
shown to react with 5,7-bicyclic iminium ethers (Table 16). Products resulting from 
reactions at both the cationic center (path a) and the O-alkyl portion of the iminium 
ether (path b) were observed in accordance with previously reported examples.
78
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Table 16. Heteroatom nucleophile addition to iminium ethers 67a,b. 
 
entry reagent X path product yield (%)
a 
1 sat. aq. NaHCO3 O a 69 89 
2 NaBH4 H,H a 83 59
b 
3 NaSPh SPh b 84 62 
4 NaN3 N3 b 85 70 
a
Isolated yield corresponds to major regioisomer. 
b
Enone reduced to allylic alcohol. 
 
 
Iminium ether 87 was also selected for screening and prepared according to 
the previously reported protocol (Scheme 12).
78
 This compound was selected based 
on its simplicity, similarity to previously studied examples,
78
 and the presence of a 
phenyl substituent, which provided a chromophore to aid in product detection and 
analysis. As usual, this iminium ether could be subjected to base hydrolysis to afford 
lactam 88.  
 
Scheme 12 
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Multidimensional screening of iminium ether substrates. Using the 
microfluidic-based multidimensional screening platform depicted in Figure 24,
80
 
scaffolds 67a,b and 87 were evaluated using 23 nucleophilic reaction partners and 
two non-nucleophilic bases (Figure 27). 
  
 
Figure 27. Multidimensional reaction screening substrates, partners, and conditions. 
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Reaction partners were chosen for their potential to participate in both 
condensations and cycloadditions. Since there are only a few examples of carbon-
carbon bond-forming reactions of iminium ethers, particular attention was focused on 
the expansion of carbon-based nucleophilic reaction partners. The reactions were 
screened under neutral conditions as well as in the presence of non-nucleophilic bases 
N,N-diisopropylethylamine (DIEA, pKa = 9.5) and 1,8-diazabicyclo[5.4.0]-undec-7-
ene (DBU, pKa = 12) in order to generate reactive nucleophilic species. 
Reactions completed in the microfluidic system were performed using 2 μmol 
(ca. 1 mg of 67 or 0.6 mg of 87) of substrate with 3.0 equiv. of reaction partner and 
3.0 equiv. of base (if used). Reagents were prepared as stock solutions in dimethyl 
sulfoxide (ca. 0.25 M for 67 and 87, 0.75 M for reaction partners and bases) with 
minimal exposure to air and stored in oven-dried glass sleeves housed in the inert 
reagent storage block. Each reaction used 8 μL from each desired stock solution for a 
total reaction volume of 24 μL (reaction concentration 1.75 M). Flow rates for the 
system were set at either 4.5 μL/min or 1.2 μL/min to achieve reaction times of 5 min 
or 20 min, respectively.  
To ensure comparable reaction times for each addition, reactions were 
quenched by the addition of water (excess) prior to exiting the microreactor. The 
resulting solutions were analyzed in 96 well-plates without further treatment using 
UPLC/MS/ELSD (Figure 28).
86
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Figure 28. Representative UPLC/ELSD traces of crude screening products. 
 
Previous reports showed that nucleophilic additions to iminium ethers, such as 
those attempted within this screen, may require longer reaction times than may be 
achieved using the microfluidic platform.
78
 To ensure that no productive reactions 
were overlooked due to insufficient reaction time, reactions were also completed 
under similar conditions using capped glass sleeves in an orbital shaker. After 24 
hours the reactions were quenched with excess water, transferred to 96 well plates, 
and analyzed by UPLC/MS/ELSD. 
In general, the reactions performed at 90 ºC were far more productive than 
those performed at 30 ºC (Table 17). After eliminating the redundant positive results 
across the three condition sets, five reaction partners were identified with positive 
outcomes for iminium ether 87 and ten reaction partners were identified for iminium 
ether 67. These reactions were subsequently scaled up, the products were isolated and 
structures elucidated using traditional bench methods. For comparison purposes, the 
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scale-up reactions of both 87 and 67 were carried out on all of the reaction partners 
that were found to be productive in the initial screens. Additionally, scale-up 
reactions were carried out in acetonitrile instead of dimethyl sulfoxide to increase the 
ease of product isolation and overall yield. N,N-Diisopropylethylamine was selected 
as the only base for the scale-up studies, since 1,8-diazabicyclo[5.4.0]undec-7-ene 
was found to react with the iminium ether substrates which led to adduct formation 
and results from the original screen suggested this switch would not greatly influence 
the outcome of the reactions. 
 
Table 17. Productive reactions tabulated from the crude UPLC/ELSD analysis. 
 iminium  microfluidics
a 
orbital shaker
a 
entry ether base 5 min, 30 ºC 30 min, 90 ºC 24 h, 90 ºC 
1 87 blank  1 1 
2 87 DIEA 2 3 3 
3 87 DBU 2 3 3 
4 67a,b blank   1 
5 67a,b DIEA  7 5 
6 67a,b DBU  7 5 
a
All positive reactions shown. Redundant results are not excluded. 
 
Iminium ether reaction discovery products and mechanisms. All products 
isolated from the scale-up process were the result of nucleophilic addition to the 
iminium ethers at the position adjacent to the imine center, distal to the nitrogen 
(Tables 18 and 19) via path b (Table 16). The preference for product formation via 
one path over another, as mentioned earlier, is dependent upon several reaction 
variables, including nucleophile size and the nature of the anion-stabilizing group.
78
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Since all of the reaction partners used in this study were larger than those previously 
observed to result in path a products, it was not surprising that the observed outcome 
was the less hindered mode of addition.
78
  
 
Table 18. Products resulting from reaction with iminium ether 87. 
 
a
Reaction Conditions: Nucleophile (3.0 equiv.), DIEA (3.0 equiv.), MeCN, 80 °C, 
24h. 
b
Reaction conditions: Nucleophile (3.0 equiv.), KH (3.0 equiv.), DMF, 80 °C, 
24h. 
c
Reaction Conditions: Nucleophile (3.0 equiv.), MeCN, 80 °C, 24 h. 
 
Previous cases involving the addition of carbon nucleophiles to iminium 
ethers included the use of pre-formed sodium salts of stabilized carbon species.
78
 In 
these instances, elimination followed the initial reversible addition via path a to 
provide products irreversibly. Since the reaction partners employed in this screen 
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were not used as stabilized anions, and the basic additives may not have been capable 
of inducing the irreversible elimination required to stabilize the products resulting 
from path a. Even if products derived from other pathways were formed, they were 
neither observed nor isolated. 
 
Table 19. Products resulting from reaction with iminium ethers 67a,b. 
 
a
Reaction Conditions: Nucleophile (3.0 equiv.), DIEA (3.0 equiv.), MeCN, 80 °C, 
24h. 
b
Isolated yield corresponding to single major regioisomer. 
c
Isolated yield 
corresponding to a mixture of regioisomers. Only major regioisomer is shown. 
 
 
Products resulting from enolate formation frequently favored O-alkylation, 
including compounds 113, 116, 117, and 118 originating from substrate 87, as well as 
83 
 
compounds 123, 125, 127 and 128 derived from substrate 67a,b. This type of addition 
was described above in the case where dimethylmalonate sodium salt was used as the 
nucleophile (Table 10, entry 9).
78
 Interestingly, the reaction between 3-phenyl-5-
isoxazolone 101 and substrate 87 gave exclusive N-alkylation whereas the reaction 
with substrate 67a,b produced a mixture (approx. 1:1) of both N-alkylation (124) and 
O-alkylation (125) products. The lack of regioselectivity may have been a result of 
the increased steric bulk present in 67a,b as compared to the relatively unhindered 87.  
Esters 113 and 123 may also be derived from a form of O-alkylation on the 
iminium ether which was preceded by the pseudo-dimerization of homophthalic 
anhydride to first produce acid 131 (Scheme 13).  
 
Scheme 13 
 
 
Similar dimerization processes, where one or both of the anhydride molecules 
were replaced by the corresponding free acid, have been previously reported.
87
 Since 
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this process is only catalytic in water, a trace amount of water would be sufficient to 
initiate the dimerization of this reaction partner. Once dimerization is complete, the 
resulting acid may then open the iminium ether under the basic reaction conditions to 
provide the observed products. An alternative mechanism may also be feasible in 
which the homophthalic anhydride first opens the iminium ether, then subsequent 
dimerization and hydrolysis occurs upon work-up. Further mechanistic investigation 
would be required to differentiate between these two possibilities. 
Treatment of the densely functionalized iminium ether 67 with ethyl 
bromoacetate 106 afforded a ring-opened alkyl bromide 129. The synthesis of 129 is 
likely the result of bromide addition via path b. Formation of a bromide anion under 
the reaction conditions could be attributed to the long reaction times and higher 
temperatures under which these reactions were completed. Such conditions may 
induce displacement or elimination of bromide anion, which may then re-add to the 
iminium ether to give the observed γ-bromolactam. Interestingly, when iminium ether 
107 was treated with ethyl bromoacetate 106 under the same conditions, the same 
reactivity was not observed. In this case, the only product isolated was lactam 119, 
albeit in low yield. Lactam 119 may arise from initial iminium ether hydrolysis 
followed by displacement of -halogenated 106. It is unclear as to why ethyl 
bromoacetate gave bromination in decent yield upon reaction with 67, yet gave little 
to no reaction with 107. In this instance, the stabilizing ability of the counter ion may 
have a notable influence on the reaction. The formation of 87 as a tetrafluoroborate 
salt imparts greater stability to the complex as compared to the triflate salt of 67. 
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Attempts made to exchange the triflate anion of 67 for the tetrafluoroborate anion 
were unsuccessful.  
 
Scheme 14 
 
 
Reactions using isonitrile 110 (TosMIC) afforded lactams 121 and 130 from 
87 and 67 respectively (Tables 18 and 19). The structural assignment of 121 was 
verified by the spectroscopic comparison of the identical product synthesized through 
an alternative route (Scheme 14). TosMIC (110) is commonly used to prepare a 
variety of heterocycles.
88
 Often, in this purpose, p-toluenesulfonate (tosyl) 132 serves 
as a leaving group to enable product aromatization, giving a positive driving force to 
the overall sequence. In the absence of an adequate cyclization partner, however, 
decomposition of TosMIC is known to occur.
89
 Early reports proposed that the tosyl 
group may be released by direct substitution of the TosMIC anion.
90
 However, more 
recent studies suggest a more complex decomposition route is responsible for tosyl 
release.
89a
 Rather than direct substitution, solvent participation
89a
 or the self-
cyclization of TosMIC may result in the release of tosyl (132) along with a complex 
mixture of by-products (Scheme 15). The instability of the resulting by-products, in 
turn make the isolation and identification of these species difficult. 
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Scheme 15 
 
 
Once free in solution, anion (132) may directly add to the electrophilic 
iminium ethers 87 and 67 to produce sulfones 121 and 130, respectively. While the 
stabilized tosyl anion is commonly used in the preparation of sulfones,
89c,90
 the 
reaction of tosyl with an electrophile following ejection from TosMIC was not 
previously reported.  
Ethyl diazoacetate (107) was the only reaction partner of the set found to form 
a new carbon-carbon bond upon addition to the iminium ether, albeit in low yield. 
Interestingly, the product isolated from the scale-up reaction did not correspond to the 
product observed in the original screen. This was apparent as the structure obtained 
from the scale-up study incorporated one equivalent of acetonitrile which was not 
present in the original reaction screen. Efforts made to reproduce the original reaction 
in dimethyl sulfoxide were unsuccessful. The proposed mechanism of this 
transformation involves the initial decomposition of ethyl diazoacetate in the presence 
of excess acetonitrile to furnish nitrilium ion 133.
91
 Nucleophilic addition of 133 to 
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iminium ether 87 completes the carbon-carbon bond formation to generate amide 134. 
Hydrolysis upon work-up provides the observed product 120 (Scheme 16, Table 18). 
It is likely that iminium ether 87 solely participated in this reaction due to the 
presence of residual BF3 contaminating substrate 87 present from the initial iminium 
ether formation. This residual promoter would not have been present in substrate 67, 
which used TfOH in iminium ether formation (Scheme 11).  
 
Scheme 16 
 
 
Although reaction partners 97 and 109 were also classified as productive in 
the original reaction screen, scaled up reactions with these nucleophiles afforded 
complex mixtures of products which could not be identified or isolated. All attempts 
to favor successful recovery through modification of the reaction conditions, such as 
use of alternative solvents, times, and temperatures, were unsuccessful. 
 
88 
 
Summary. This work exemplifies the benefits of using microfluidics 
technology for the discovery of new reactions of bicyclic iminium ethers. The 
regioselective addition of various carbon nucleophiles was examined under several 
reaction conditions in an array format to multidimensionally screen the condition-
dependent nature of these transformations. Over 400 reactions were completed and 
analyzed on an analytical scale resulting in the discovery of both interesting reagent 
behavior (e.g. homophthalic anhydride pseudo-dimerization prior to iminium ether 
addition) and new reaction products (e.g. sulfone formation from reactions with 
TosMIC). 
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Chapter 5 
Reaction Discovery of Donor-Acceptor Cyclopropanes 
 
Reaction discovery presents an effective means for the development of new 
synthetic methodologies affording complex chemotypes.
80,82,92
 Previous reaction 
screening efforts utilizing bicyclo[3.2.1]octanoids led to the discovery of a number of 
diverse scaffolds,
80,92b
 some of which were described in the previous chapter.
92a
 In 
this follow-up study, collaboration with the laboratory of Dr. John A. Porco, Jr. at 
Boston University was continued to explore additional reactivity of the 
bicyclo[3.2.1]octanoid scaffold. Preliminary reaction screens performed by 
researchers at Boston University uncovered the synthesis of a densely functionalized 
donor-acceptor cyclopropane resulting from the photochemical rearrangement of such 
bicyclic scaffolds. Subjection of the new cyclopropane scaffold to a variety of 
reaction conditions enabled the discovery of additional rearrangement reactions to 
access further sets of structurally diverse chemotypes which will be discussed.  
 
Synthesis and reactivity of donor-acceptor cyclopropanes. Donor-acceptor 
(D-A) cyclopropanes possess great potential as versatile building blocks for organic 
synthesis.
93
 Activation of the ring system through the addition of electron-donating or 
-accepting substituents is often necessary to make these polar processes more 
favorable. Geminally substituted D-A cyclopropanes are significantly less reactive 
than vicinally substituted D-A cyclopropanes since the substituents do not act in a 
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synergistic manner. Vicinally substituted D-A cyclopropanes, on the other hand, are 
properly substituted for synergistic activation and are highly useful for a number of 
valuable transformations. Formally, vicinally substituted D-A cyclopropanes behave 
analogous to a 1,3-dipolar synthon (Figure 29).  
 
 
Figure 29. Reactivity of vicinally substituted donor-acceptor cyclopropanes. 
 
The formal 1,3-charge relationship in the D-A cyclopropane synthon means 
that many reactions involving these substrates may be regarded as involving a formal 
umpolung of reactivity, and therefore afford unique products that are not easily 
accessible by alternate methods. The majority of D-A cyclopropane reactions utilize 
carbonyl functionality as the acceptor group whereas the most common donor groups 
are various forms of oxygen- and nitrogen-based groups. A wide variety of reactions 
can be derived from these multifunctional substrates to quickly generate diversity and 
complexity (Figure 30).
93
  
Many synthetically useful methods are known for the synthesis of D-A 
cyclopropanes. The most common syntheses of simple D-A cyclopropanes involve 
the formal [2+1] cycloaddition of carbenes to alkenes, additions to cyclopropanes, 
and intramolecular cyclization reactions.
93
 These methods are particularly useful for 
the synthesis of monocyclic D-A cyclopropanes, however low conversion and side 
reactions may result when more complex substrates are used.  
91 
 
 
Figure 30. Reaction modes of donor-acceptor cyclopropanes.  
 
One mild and highly selective method for the synthesis of D-A cyclopropanes 
in complex systems is the di-π-methane rearrangement. Generally described, the di-π-
methane rearrangement involves the photolysis of substrates containing two π 
moieties connected to an sp
3
-hybridized carbon leading to the formation of a π-
substituted cyclopropane (Figure 31).
94
 The ease of preparation of the di-π substrates 
in comparison to the cyclopropyl products make this transformation of particular use 
synthetically. It is often the case that the resulting photoadducts are not accessible 
through alternative synthetic routes.  
Common variants of the di-π-methane rearrangement involve substitution of 
one alkene for a ketone (oxa-di-π) or imine (aza-di-π). Oxa-di-π transformations 
result in the formation of α-cyclopropyl carbonyl compounds, like those seen in the 
D-A cyclopropane scaffolds. Depending on the position of the imine nitrogen, aza-di-
92 
 
π transformations produce either α-cyclopropyl imines or N-cyclopropyl imines. 
Hydrolysis of the resulting imines can afford α-cyclopropyl carbonyl compounds, as 
obtained in the oxa-di-π rearrangement, or N-cyclopropyl amines, respectively.
94
  
 
 
Figure 31. Variants of the di-π-methane rearrangement. 
 
Since di-π-methane rearrangements are promoted by photo-excitation, the 
efficiency of the reaction is enhanced as substrates become increasingly strained 
(Figure 32). Non-cyclic substrates exhibit low efficiency since the numerous 
rotational modes are able to dissipate the excitation energy before productive 
rearrangement can occur. Because of this, substrates whose rotation and vibration are 
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constrained by a bridged, bicyclic, or polycyclic scaffold exhibit highly efficient and 
often fast reactivity in the di-π-methane rearrangement to afford extremely complex 
scaffolds in excellent yields.
94
  
 
 
Figure 32. Reactivity trends of the di-π-methane rearrangement. 
 
The prearranged ,-unsaturated carbonyl and constricted rotation of the 
bicyclo[3.2.1]octanoid scaffold introduced in the previous chapter,
80
 make it a 
particularly attractive candidate for the oxa-di-π rearrangement. Successful 
rearrangement of this substrate would provide a highly functionalized polycyclic 
donor-acceptor scaffold ideal for reaction discovery experiments.  
 
Oxa-di-π rearrangement of bicyclo[3.2.1]octanoids. Multidimensional 
reaction screening of a range of scaffolds was initially completed by researches at 
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Boston University using a high-throughput photoflow platform (Figure 33). This 
apparatus was created through modification of the microfluidic platform described in 
the previous chapter.
80,92a
 Various aspects of each photo reaction were investigated in 
series, including the choice of solvent, sensitizer, and light source.  
 
 
 
Figure 33. Photoflow apparatus used in reaction discovery.
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Examination of products resulting from the screen revealed that 
bicyclo[3.2.1]octanoid scaffold 63 readily underwent an oxa-di-π-methane 
rearrangement
 
(Scheme 17). UV irradiation of bicyclo[3.2.1]octanoid 63 for four 
hours, in the absence of a triplet sensitizer, afforded the polycyclic cyclopropane 
product 155 in quantitative yield. The cleanest versions of this transformation resulted 
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from reaction in acetonitrile. However, this reaction was also viable in acetone and 
afforded acceptable yields of the desired product.  
 
Scheme 17 
 
 
In order to unequivocally assign the structure of the newly formed polycycle, 
researchers at Boston University further derivatized donor-acceptor cyclopropane 135 
using a retro-Dieckmann-type fragmentation.
80
 Based on previously reported 
methodology, cyclopropane 135 was treated with p-bromobenzylamine in the 
presence of base to afford hemiaminal 136 as a crystalline solid (Scheme 18). X-ray 
crystallographic analysis of the resulting hemiaminal 136 confirmed the expected 
structure
94
 and by analogy the structure of cyclopropane 135. 
 
Scheme 18 
 
96 
 
While oxa-di-π-methane rearrangements often require triplet sensitization,
95
 in 
the case of the bicyclo[3.2.1]octanoid scaffolds it is possible that the enone 
functionality is able to undergo singlet excitation followed by intersystem crossing to 
achieve the required triplet state. The proposed mechanism of the transformation 
begins with photo-excitation of either the ketone or the enone to form a diradical 
(Figure 34). The carbon-based radical then attacks the adjacent unsaturated moiety to 
form the first bond. From this species, homolytic bond cleavage of the intermediary 
cyclopropane leads to reformation of the ketone and produces the observed polycyclic 
cyclopropane product.  
 
 
Figure 34. Mechanism of the oxa-di-π rearrangement of bicyclo[3.2.1]octanoids. 
 
To evaluate the scope and limitations of the rearrangement analogous 
reactions were carried out on several bicyclo[3.2.1]octanoid scaffolds. From this 
study it was found that the oxa-di-π-methane rearrangement was limited to 
bicyclo[3.2.1]octanoids 63, 75, 77, and 137, each containing an ,-unsaturated 
ketone (Table 20). Tertiary alcohol 138 failed to undergo rearrangement. 
97 
 
Surprisingly, cycloheptenone 139 also failed to react using either direct irradiation or 
triplet sensitization with benzoquinone. 
 
Table 20. Substrate scope of the oxa-di-π rearrangement. 
 
entry substrate ketone solvent cyclopropane product yield
b 
1 
 
63 MeCN 
 
135 99 
2 
 
75 acetone 
 
140 96 
3 
 
137
a 
acetone 
 
141 99 
4 
 
77 acetone 
 
142 97 
5 
 
138
a 
benzoquinone 
 
143 0
c 
6 
 
139
a 
benzoquinone 
 
144 0
c 
 
a
Synthesized using a route analogous to that seen in Scheme 10.
80
 
 
 b
Isolated yield given as percentage. 
c
No reaction observed. 
 
98 
 
With this set of densely functionalized donor-acceptor cyclopropanes readily 
available, work began to probe the reactivity of these unique scaffolds for reactions 
leading to new chemotypes. Using the previously observed reactivity of donor-
acceptor cyclopropanes as a model, a diverse array of reaction types were 
investigated including nucleophilic additions, cycloadditions, fragmentations, and 
rearrangements.  
 
Grignard reactions of polycyclic donor-acceptor cyclopropanes. To probe 
the reactivity of the polycyclic donor-acceptor cyclopropanes in the presence of 
nucleophiles, cyclopropanes 135 and 141 were subjected to a series of Grignard 
reactions. Treatment of cyclopropane 135 with methylmagnesium bromide at 0 ºC 
resulted in facially selective addition of the Grignard reagent to the bridgehead 
ketone, affording tertiary alcohol 145 (Scheme 19 and Table 21, entry 1). This was in 
contrast to the similar reaction of the bicyclo[3.2.1]octanoid scaffold 63, which 
favored selective addition to the α-methoxy carbonyl affording tertiary alcohol 146.
80
  
 
Scheme 19 
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Interestingly, when the reaction of cyclopropane 135 and methylmagnesium 
bromide was warmed to room temperature, further rearrangement occurred to yield 
dihydrofuran 147 (Table 21, entry 2). A similar rearrangement was observed upon 
treatment of 135 with the bulkier 3-methoxyphenylmagnesium bromide. Reactions 
performed with this Grignard reagent at 0 ºC and at room temperature both afforded 
exclusively dihydrofuran 148 as a single product (Table 21, entry 3).  
 
Table 21. Grignard additions of cyclopropane 135. 
 
entry R temp.  product A (% yield)
a 
B (% yield)
a 
1 CH3 0 ºC 145 75  
2 CH3 0 ºCrt 147  82 
3 m-OCH3C6H4 0 ºC 148  77 
a
Isolated yield. 
 
The proposed mechanism of rearrangement to dihydrofuran begins with 
methyl Grignard addition to the exo-face of the bicyclo[3.2.1]octanoid ketone. At this 
point, warming of the solution causes a retro-Dieckmann fragmentation to form a 
fused 3,6-ring system. Rearrangement of the cyclopropane and cyclization completes 
formation of the dihydrofuran (Figure 35). 
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Figure 35. Mechanism of Grignard addition and rearrangement of 135. 
 
Performing similar Grignard reactions using cyclopropane 141 afforded only 
tertiary alcohols 149 and 150 (Table 22, entries 1 and 2). All efforts to obtain a 
dihydrofuran product from either cyclopropane 141 or tertiary alcohol 149 using 3-
methoxyphenylmagnesium bromide failed to give the desired dihydrofuran. Efforts to 
favor the rearrangement by warming the reactions to room temperature resulted only 
in epimerization of the tertiary alcohol (Table 22, entry 3).  
 
Table 22. Grignard additions of cyclopropane 141. 
 
entry R temp. product A (%)
a
 B (%)
a
 C (%)
a
 
1 CH3 0 ºC 149 83   
2 m-OCH3C6H4 0 ºC 150 82   
3 m-OCH3C6H4 rt 151  88  
       a
Isolated yield. 
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Applying the same analysis to the reaction of cyclopropane 135, it is 
suspected that upon warming the bicyclic scaffold A undergoes a retro-Dieckmann 
fragmentation (Figure 36); however, in this slightly more complex structure, the rate 
of recyclization to the tertiary alcohol must be greater than the rate of rearrangement 
to the dihydrofuran. Furthermore, it is suspected that there may be poor orbital 
alignment between the fragmenting bond for tertiary alcohol B, this would make re-
fragmentation of alcohol B slightly more difficult than alcohol A and explain why B 
is ultimately the major product observed.  
 
 
Figure 36. Mechanism of rearrangement and epimerization of 141. 
 
Cyclopropanes 140 and 142 reacted similarly to cyclopropane 141, suggesting 
that the greater structural rigidity and functionality in these scaffolds, as compared to 
cyclopropane 135, may also hinder rearrangement to the dihydrofuran. 
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Azido-Schmidt reactions of polycyclic donor-acceptor cyclopropanes. To 
investigate the behavior of donor-acceptor cyclopropanes in the presence of 
conditions that typically induce rearrangement, tertiary alcohols 145, 150, and 151 
were subjected to a series of azido-Schmidt reactions.
78,96
 Alcohol 145 was combined 
with 3-azido-1-propanol and the resulting solution was treated with super-
stoichiometric amounts of triflic acid. Unexpectedly, bicyclic imide 152 was the lone 
product isolated from the reaction, albeit in poor yield. Imides had not been 
previously reported as products from an azido-Schmidt reaction (Scheme 20). To 
confirm the structure of 152, the -hydroxyl of the imide was derivatized by reaction 
with p-bromobenzoyl chloride in the presence of pyridine to produce the p-
bromobenzoyl ester 153 (Scheme 20). The structure of 153 was confirmed by X-ray 
crystallographic analysis. 
94 
 
Scheme 20 
 
 
It is proposed that under strong Brønsted acid conditions, a Grob-type 
fragmentation occurs through the elimination of water leading to the formation of 
diketone intermediate 155. Comparable fragmentations have been previously 
observed for similar ring systems upon treatment with strong acids.
97
 A subsequent 
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azido-Schmidt ring expansion on the intermediary diketone then produces the 
intermediary iminium ether which, upon work-up with base, affords the 
corresponding imido alcohol 152 (Figure 37). An attempt was made to verify this 
mechanism through the isolation of the intermediate diketone or iminium ether but 
these experiments were ultimately unsuccessful. Treatment of alcohol 145 with triflic 
acid in the absence of hydroxyalkyl azide led only to the formation of an 
unidentifiable by-product and not the anticipated diketone. 
 
 
Figure 37. Mechanism for the fragmentation and azido-Schmidt reaction of 145. 
 
An alternative mechanism could be suggested proceeding with the azido-
Schmidt reaction first and the Grob-type fragmentation second, however there are two 
pieces of evidence that contest this order of events. First, as demonstrated above in 
the Grignard additions, nucleophilic addition to the α-methoxy ketone is hindered 
such that methylmagnesium bromide adds to the less electrophilic ketone to avoid 
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interactions upon addition. If a small nucleophile such as methylmagnesium bromide 
does not add to this center, it is unlikely that the hydroxyalkyl azide would be able to 
add to this ketone and form the oxonium ion necessary to initiate the Schmidt 
rearrangement. Second, even if addition of the hydroxyalkyl azide to this hindered 
ketone were possible, and the Schmidt reaction were to take place, previous study of 
α-methoxy ketone substrates shows preferential migration of the bond not adjacent to 
the methoxy group. Therefore, if this mechanism were occurring, the opposite 
regiochemistry would be expected, resulting in an α-keto amide rather than an imide. 
Ultimately, however, the possibility of alternative mechanisms cannot be fully 
discredited in the absence of additional work. 
Analogous treatment of alcohols 150 and 151 with 3-azido-1-propanol 
afforded a mixture of imide 155 and ester 156 in varying ratios (Scheme 21). Upon 
performing this reaction multiple times it was found that the ratio of imide to ester 
varied slightly in response to differing work-up conditions.
85,98
  
 
Scheme 21 
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Both the imide and ester product can arise from a common iminium ether 
intermediate (Figure 38). Upon hydrolysis, two routes are available for fragmentation 
of the aminal. Heterolytic division of the CO bond (path a) leads to the -hydroxy 
imide product 155, while heterolytic division of the CN bond (path b) leads to the 
ester product 156. Previous studies of simple iminium ethers described a similar 
dependence between the nature of the quenching reagent and the preferred mode of 
iminium ether intermediate ring opening. These studies suggest that the product ratio 
between 155 and 156 may be ultimately controlled by altering the work-up 
protocol.
85,98
 In addition, the increased skeletal rigidity of carbocycle 166 as 
compared to carbocycles 150 and 151, as seen for the Grignard reactivity, may 
influence the overall strain of the system leading to the observed differences in 
iminium ether reactivity between alcohols 145, 150, and 151. 
 
 
Figure 38. Iminium ether expansion pathways. 
 
Cycloadditions of polycyclic donor-acceptor cyclopropanes. A number of 
elegant examples have been reported in the literature of donor-acceptor 
cyclopropanes undergoing ionization upon treatment with TMSOTf.
99
 The resulting 
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zwitterions are known to participate in cycloaddition reactions in the presence of a 
wide variety of dipolarophiles. Accordingly, cyclopropane 135 was investigated for 
reaction with various dipolarophiles upon treatment with TMSOTf (Table 23).  
 
Table 23. Cycloadditions of cyclopropane substrates. 
 
entry substrate dipolarophile imine product yield (%)
a 
1 135  
 
157 51 
2 135  
 
158 90 
3 135  
 
159 90 
4 135 
 
 
160 44 
5 141  
 
161 54 
 a
Isolated yield. 
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Subjection of cyclopropane 135 to a series of nitriles in the presence of 
TMSOTf afforded polycyclic imines 157-161 (Table 23, entries 1-4). The structural 
identity of 159 was confirmed through X-ray crystallographic analysis;
94
 additional 
structures in the series were then assigned by analogy. Extension of this reaction 
using cyclopropane 141 and p-methoxybenzonitrile was also successful and afforded 
the desired tetracyclic imine in acceptable yield (Table 23, entry 5). 
Further investigations of the polycyclic imine scaffolds resulted in the 
discovery of an interesting retro-Dieckmann fragmentation of imine 159 (Scheme 
22). Heating polycyclic imine 159 in anhydrous methanol at 100 ºC for 24 hours 
resulted in formation of pyrrole 162. As there were two potential regiochemical 
outcomes possible from this rearrangement, further structural confirmation was 
required. Methylation of the pyrrole nitrogen was achieved by reaction of 162 with 
methyliodide and potassium carbonate in acetonitrile, heating at reflux for 12 hours. 
Two-dimensional NMR analysis of methylated pyrrole 163 was used to confirm the 
regiochemical outcome, and by analogy, the identity of pyrrole 162 (Scheme 22).  
 
Scheme 22 
 
 
108 
 
The mechanism of the rearrangement presumably begins with addition of 
methanol to the less hindered ketone (Figure 39). Next, fragmentation of the bond α 
to the ketone occurs through a retro-Dieckmann process which opens the bridged 
bicycle to produce a new fused 5,6-ring system. This process is facilitated through the 
resonance stabilization available within the adjacent α-methoxy ketone moiety. Next, 
a series of proton exchanges and loss of the α-methoxy group as methanol finally 
produces the observed pyrrole product. 
 
 
Figure 39. Fragmentation mechanism of polycyclic imine 159. 
 
As is evident from the immediate discussion, cycloadditions to donor-acceptor 
cyclopropanes hold a great wealth of potential for creating new and interesting 
chemotypes. Inspired by the success of nitriles in undergoing cycloadditions with the 
donor-acceptor cyclopropanes, the scope of available dipolarophiles was investigated.  
In this study, donor-acceptor cyclopropane 135 was subjected to reactions 
with alkenes, alkynes, ketones, enol ethers, cyanopyridines, and indoles (Table 24). If 
successful, reaction with these partners would have provided access to a diverse and 
interesting array of polycyclic products and involve the formation of CC, CO, and 
109 
 
CN bonds. Unfortunately, however, none of the dipolarophiles tested gave any 
appreciable amount of desired product.  
 
Table 24. Cycloadditions investigated using cyclopropane substrate 135. 
 
entry dipolarophile anticipated 
product 
entry dipolarophile anticipated 
product 
1 
 
 
4 
 
 
2 
 
 
5 
 
 
3  
 
6  
 
 
 
Aza-di-π rearrangement of polycyclic iminium ethers. As described above, 
imines are the primary substrates known to participate in the typical aza-di-π methane 
rearrangement.
93,100
 Charged iminium ions typically exhibit reactivity different from 
that of imines upon photochemical irradiation (Figure 40).
101
 In cases where a single 
iminium ion is the only π moiety within the molecule, intermolecular addition 
reactions can occur with alkenes, alkynes and other radical acceptors free in 
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solution.
102
 When additional centers of unsaturation are present within the iminium 
substrate, intramolecular cyclization reactions typically occur prior to any 
intermolecular additions.
101,103
  
 
 
Figure 40. Photochemical iminium reactivity. 
 
Iminium ethers exhibit reactivity patterns distinctive from both imines and 
iminium ions. While iminium ethers are charged species, the products resulting from 
their reaction are not always the result of direct addition to the imine center. Given 
this unique reactivity profile, it was initially unknown how an iminium ether would 
act upon photoirradiation (Figure 41). It was feasible that the iminium ether may 
behave like an iminium ion and cyclize to give a compound like 164. It was also 
possible that it may behave as an imine, undergoing an aza-di-π rearrangement to give 
a compound like 165. Alternatively, both reaction pathways could be viable, resulting 
in a mixture of products.  
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Figure 41. Photochemical reaction pathways of polycyclic iminium ether 67a,b. 
 
The photochemical reactivity of iminium ethers 67a,b was investigated. The 
regioisomeric mixture of iminium ethers was derived from bicyclo[3.2.1]octanoid 63 
using the azido-Schmidt reaction conditions described in the previous chapter 
(Chapter 4, Scheme 11).
80,92a
 Photoirradiation of the iminium ether mixture 67a,b 
(>300 nm) in acetone afforded cyclopropane 165 as a single product (Scheme 23).  
 
Scheme 23 
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The assigned structure was confirmed using 1D and 2D NMR techniques. The 
reaction is presumed to proceed through an analogous aza-di-π methane 
rearrangement. This result shows that despite their charged nature, these iminium 
ethers behaved more like imines than iminium ions upon photochemical irradiation. 
Examining the structures of iminium ethers 67a and 67b, it is evident that polycycle 
67a, containing a prearranged ,-unsaturated system, is properly aligned to favor the 
aza-di-π rearrangement. Alternatively, iminium ether 67b, which lacks this 
prearranged ,-unsaturated system, is unable to undergo a similar transformation. As 
a result only a single regioisomeric product was isolated from the reaction which 
arose from the major component of the iminium ether mixture. The minor iminium 
ether decomposed upon irradiation and was not observed in the crude product 
material. 
As observed with previous iminium ethers,
78
 α-cyclopropyl iminium ether 165 
underwent ring opening transformations with various nucleophilic reagents (Table 
25). A small series of heteroatom nucleophiles were used in the study to demonstrate 
addition to both the imine center (sat. aq. NaHCO3) and the center adjacent to the 
oxygen (NaSPh and NaN3). The ring-opening transformations were completed using 
the crude α-cyclopropyl iminium ether since the compound proved unstable to silica 
gel chromatography. Yields of the lactam product were good to excellent and similar 
to those previously observed for heteroatom nucleophilic additions to iminium 
ethers.
78
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Table 25. Nucleophilic ring-opening reactions of α-cyclopropyl iminium ether 165. 
 
entry nucleophile X product yield (%)
a 
1 NaSPh SPh 166 99 
2 NaN3 N3 167 91 
3 sat. aq NaHCO3 OH 168 68 
a
Isolated yield calculated according to major regioisomer. 
 
Additional investigations geared toward probing the reactivity of both the α-
cyclopropyl iminium ether and the α-cyclopropyl lactam were completed in a manner 
analogous that for the α-cyclopropyl polycyclic donor-acceptor ketone described 
above. Nucleophilic addition reactions to these scaffolds were explored using lithium 
reagents. Treatment of lactam 168 with methyl lithium resulted in the selective 
addition of methyl to the α-methoxy ketone on the exo-face, to yield tertiary alcohol 
169 (Scheme 24). 
 
Scheme 24 
 
 
114 
 
 The reactivity of the lactam and iminium ether scaffolds was further probed 
for their utility in cycloaddition, fragmentation, and rearrangement reactions. 
However, despite extensive condition screening no additional reactivity was observed 
from these substrates. 
 
Summary. Photochemical reaction screening of a series of 
bicyclo[3.2.1]octanoid scaffolds resulted in the formation of a set of donor-acceptor 
cyclopropanes via an oxa-di-π methane rearrangement. Exposure of the newly 
synthesized donor-acceptor cyclopropanes to various conditions led to the discovery 
of new and distinctive chemotypes, each arising from a single common starting point 
(Figure 42).  
 
 
Figure 42. New chemotypes derived from donor-acceptor cyclopropane 135. 
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In conjunction, investigation of similar photochemical reaction screens led to 
the first known example of an aza-di-π methane rearrangement of a ,-unsaturated 
iminium ether. The breadth of chemotypes accessed in this study demonstrates the 
vast potential reaction screening of multifunctional substrates possesses for the rapid 
discovery of new and unique compounds. 
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Chapter 6 
Experimental Section 
 
General Information: All reactions were performed under an argon 
atmosphere in flame-dried glassware. The stainless steel needles used for handling 
anhydrous solvents and reagents were oven dried, cooled in a desiccator, and flushed 
with dry argon prior to use. Plastic syringes were flushed with dry argon before use. 
Methylene chloride and acetonitrile were purified using a solvent purification 
system.
104
 Acetonitrile for the iminium ether project was further purified by drying 
over 4 Å molecular sieves, as was methanol and N,N-dimethylformamide. The 
hydroxyalkyl azides were prepared from the corresponding hydroxyalkyl bromides 
according to previously published procedures.
78
 N,N-Diisopropylethylamine (DIEA) 
was purified by distillation. All other reagents were purchased from commercial 
sources and used without further purification. All nuclear magnetic resonance spectra 
were recorded on either a Varian or Bruker spectrometer. All NMR samples were 
recorded in deuterochloroform unless otherwise noted. Chemical shifts are reported in 
parts per million (ppm) and are referenced to the deuterosolvent centerline of 
deuterochloroform (δ 7.26 ppm 
1
H NMR, 77.0 ppm 
13
C NMR), deuterodimethyl 
sulfoxide (δ 2.50 ppm 
1
H NMR, 39.52 ppm 
13
C NMR), or deuteroacetone (δ 2.05 
ppm 
1
H NMR, 30.8 ppm 
13
C NMR). Data for 
1
H NMR are reported as follows: 
chemical shift, integration, multiplicity (br = broad, ovrlp = overlapping, s = singlet, d 
= doublet, t = triplet, q = quartet, qt = quintuplet, m = multiplet) and coupling 
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constants are reported as values in hertz (Hz). All 
13
C NMR spectra were recorded 
with complete proton decoupling. Where discernible, rotamers and inseparable minor 
regioisomers are denoted with (*). When regioisomers were not completely separable 
the major rotamer peaks are denoted with (

). Infrared spectra were recorded on 
either a Nicolet Nexus 670 FT-IR, Shimadzu FTIR-8400S, or a Perkin Elmer 
Spectrum 100 FT-IR spectrophotometer. Melting points were recorded on either a 
Mel-Temp (Laboratory Devices), SRS OptiMelt, or Thomas-Hoover melting point 
apparatus and are uncorrected. High-resolution mass spectra were obtained in the 
Boston University Chemical Instrumentation Center using a Waters Q-TOF mass 
spectrometer or at Kansas University using a Waters LCT Premier Micromass from 
MS Technologies. Analytical LC was performed on a Waters Acquity UPLC with 
PDA, ELS and SQ detectors. An Acquity UPLC BEH 2.1 x 50 mm 1.7 M C18 
column was used for analytical LC. All chromatograms shown were generated using 
MassLynx 4.1. ormed using 0.25 mm 
silica gel 60-F plates. Analytical HPLC-MS analysis was completed using a Waters 
Alliance 2795 HPLC, a Waters LCT Premier TOF mass spectrometer, the Waters 
XBridge C-18 column (5 μM, 4.6 x 150 mm w/ 20 mm guard column), and a Waters 
2996 Photodiode Array at 214 nm for sample detection. A gradient elution of 5% 
CH3CN to 95% CH3CN over 8.6 minutes was used, where the second mobile phase 
was water for neutral compounds, 0.05% formic acid in water for acidic compounds, 
or pH 9.8 ammonium formate in water for basic compounds. Preparative mass-
directed fractionation was preformed using a Waters Mass Directed Fractionation 
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HPLC with a 2767 sample manager, a 2525 binary pump and a 515 make-up pump. A 
Waters XBridge C-18 column was used (5 μM, 19 x 150 mm w/ 10 mm guard 
column). The Waters ZQ quadrapole mass spectrometer and the Waters 2487 Dual 
Wavelength UV spectrometer were used for sample detection as a dual UV/MS 
fraction trigger. The same gradient elution and mobile phases were invoked as for the 
analytical run and the flow rate was set to 18 mL/min. Otherwise, flash 
chromatography was performed using 200-400 mesh silica gel (Scientific Absorbent 
Incorporated). Yields refer to chromatographically and spectroscopically pure 
materials, unless otherwise stated. Acetonitrile, DCM,
S1
 THF, and toluene were 
purified by passing through two packed columns of neutral alumina (Innovative 
Technologies, MA). Chemical names were generated using MDL AutoNom 2000. All 
structural assignments were made based on correlation of the proposed structure with 
HRMS and IR data. 
HMBC correlation: COSY correlation: NOESY correlation:
KEY
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Heterocycle Synthesis in Droplets 
 
 General procedure for the synthesis of thiazoles in droplets. (Synthesis of 
thiazoles 1-20). Stock solutions of each bromoketone and thiourea starting material 
were first created by adding 2 mmol of a given starting material to a 20 mL 
scintillation vial. To each of these vials was then added 2 mLs of dry DMF, and the 
vials were then sonicated to form clear solutions. For each library member, 100 uL of 
stock solution from each of the required building blocks was loaded into a metering 
loop of known volume on a Uniqsis flow system. The machine then injected both 
metering loops to form a single cohesive droplet that was then flowed at 1.3 mL/min 
through an 80 °C heated coil, giving a final reaction time of 5 minutes. One minute 
after the library member was injected, a blank plug of 200 mL of DMF was added to 
the machine, and both the library droplet and the wash droplet were collected into 
culture tubes. The DMF layer was then removed, the fluorous layer was extracted 
with DMF, and the collective DMF solution was evaporated under warm nitrogen. 
The resulting residue was purified by preparative HPLC on a Waters Symmetry C8 
column (25 mm x 100 mm, 7 m particle size) using a gradient of 10% to 100% 
acetonitrile:0.1% aqueous TFA over 8 min (10 min run time) at a flow rate of 40 
ml/min to give the desired compound.  
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N,5-Dimethyl-4-phenylthiazol-2-amine (1). 2-Bromo-1-phenylpropan-1-one 
(66.5 mg, 0.314 mmol) and 1-methylthiourea (28.2 mg, 0.314 mmol) afford thiazole 1 
(39.3 mg, 0.192 mmol, 61%). 
1
H NMR (500 MHz, DMSO-d6) δH 7.55 (d, J = 7.5 Hz, 
1H), 7.49 (t, J = 7.6 Hz, 1H), 7.43 (t, J = 7.2 Hz, 1H), 2.96 (d, J = 13.9 Hz, 2H), 2.27 
(d, J = 23.5 Hz, 2H);
 13
C NMR (101 MHz, DMSO-d6) δc 166.8, 134.0, 129.4, 128.9, 
128.7, 128.2, 114.5, 31.9, 11.6; MS (DCI+) m/z calcd for C11H13N2S (M+H
+
): 205.0, 
found 205.2.  
 
 
 5-Methyl-N,4-diphenylthiazol-2-amine (2). 2-Bromo-1-phenylpropan-1-one 
(64.0 mg, 0.302 mmol) and 1-phenylthiourea (45.9 mg, 0.302 mmol) afford thiazole 2 
(32.2 mg, 0.108 mmol, 40%). 
1
H NMR (500 MHz, DMSO-d6) δH 10.05 (s, 1H), 7.66 
(dd, J = 12.6, 8.3 Hz, 4H), 7.46 (t, J = 7.6 Hz, 2H), 7.37-7.26 (m, 3H), 6.92 (td, J = 
7.4, 0.9 Hz, 1H), 2.43 (s, 3H);
 13
C NMR (101 MHz, DMSO-d6) δc 159.5, 144.8, 
141.2, 134.8, 129.0, 128.3, 128.0, 121.2, 116.9, 116.3, 11.9; MS (DCI+) m/z calcd for 
C16H15N2S (M+H
+
): 267.0, found 267.2. 
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 N-(3-Fluorophenyl)-5-methyl-4-phenylthiazol-2-amine (3). 2-Bromo-1-
phenylpropan-1-one (81.4 mg, 0.384 mmol) and 1-(3-fluorophenyl)thiourea (65.2 mg, 
0.384 mmol) afford thiazole 3 (33.9 mg, 0.119 mmol, 31%). 
1
H NMR (500 MHz, 
DMSO-d6) δH 10.30 (s, 1H), 7.74 (d, J = 12.2 Hz, 1H), 7.67 (d, J = 8.0 Hz, 2H), 7.47 
(t, J = 7.6 Hz, 2H), 7.40-7.24 (m, 3H), 6.82-6.65 (m, 1H), 2.44 (s, 3H);
 13
C NMR 
(101 MHz, DMSO-d6) δc 163.4, 161.5, 158.7, 145.3, 142.9, 142.8, 134.9, 130.4, 
130.3, 128.3, 127.9, 127.1, 117.0, 112.5, 107.1, 106.9, 103.3, 103.1, 11.9; MS (DCI+) 
m/z calcd for C16H14FN2S (M+H
+
): 285.0, found 285.4.  
  
 
 N-Allyl-5-methyl-4-phenylthiazol-2-amine (4). 2-Bromo-1-phenylpropan-1-
one (80.5 mg, 0.380 mmol) and 1-allylthiourea (44.0 mg, 0.380 mmol) afford thiazole 
4 (35.9 mg, 0.156 mmol, 41%). 
1
H NMR (500 MHz, DMSO-d6) δH 7.55 (d, J = 8.1 
Hz, 2H), 7.46 (t, J = 7.6 Hz, 2H), 7.38 (t, J = 7.3 Hz, 1H), 5.91 (dtd, J = 15.8, 10.5, 
5.3 Hz, 1H), 5.30 (d, J = 10.2 Hz, 1H), 5.18 (d, J = 10.3 Hz, 1H), 3.95 (s, 2H), 2.31 
(s, 3H);
 13
C NMR (101 MHz, DMSO-d6) δc 166.5, 136.8, 132.6, 129.9, 128.8, 128.6, 
128.6, 117.3, 114.5, 47.4, 11.6; MS (DCI+) m/z calcd for C13H15N2S (M+H
+
): 231.0, 
found 231.2.  
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 N-Methyl-8H-indeno[1,2-d]thiazol-2-amine (5). 2-Bromo-2,3-dihydro-1H-
inden-1-one (66.0 mg, 0.314 mmol) and 1-methylthiourea (28.2 mg, 0.314 mmol) 
afford thiazole 5 (33.7 mg, 0.166 mmol, 53%). 
1
H NMR (500 MHz, DMSO-d6) δH 
7.51-7.44 (m, 2H), 7.32 (t, J = 7.5 Hz, 1H), 7.19 (t, J = 7.5 Hz, 1H), 3.72 (s, J = 18.8 
Hz, 2H), 2.96 (s, J = 5.4 Hz, 3H);
 13
C NMR (101 MHz, DMSO-d6) δc 173.8, 145.3, 
136.3, 126.6, 124.7, 124.4, 122.0, 117.7, 32.6, 31.1; MS (DCI+) m/z calcd for 
C11H11N2S
 
(M+H
+
): 203.0, found 203.3.  
  
 
 N-Phenyl-8H-indeno[1,2-d]thiazol-2-amine (6). 2-Bromo-2,3-dihydro-1H-
inden-1-one (55.6 mg, 0.265 mmol) and 1-phenylthiourea (40.2 mg, 0.265 mmol) 
afford thiazole 6 (23.8 mg, 0.0901 mmol, 34%). 
1
H NMR (500 MHz, DMSO-d6) δH 
10.33 (s, 1H), 7.73 (d, J = 7.9 Hz, 2H), 7.54 (dd, J = 17.7, 7.4 Hz, 2H), 7.37-7.31 (m, 
J = 7.5, 3.9 Hz, 3H), 7.21 (t, J = 9.5, 5.4 Hz, 1H), 6.97 (t, J = 7.3 Hz, 1H), 3.81 (s, 
2H);
 13
C NMR (101 MHz, DMSO-d6) δc 167.4, 156.1, 145.4, 141.0, 137.3, 129.0, 
126.7, 124.7, 124.4, 121.2, 117.7, 116.9, 32.2; MS (DCI+) m/z calcd for C16H13N2S 
(M+H
+
): 265.0, found 265.1.  
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 N-(3-Fluorophenyl)-8H-indeno[1,2-d]thiazol-2-amine (7). 2-Bromo-2,3-
dihydro-1H-inden-1-one (45.8 mg, 0.218 mmol) and 1-(3-fluorophenyl)thiourea (37.0 
mg, 0.218 mmol) afford thiazole 7 (14.8 mg, 0.0524 mmol, 24%). 
1
H NMR (500 
MHz, DMSO-d6) δH 7.81 (d, J = 7.3 Hz, 1H), 7.58 (d, J = 7.5 Hz, 1H), 7.53 (d, J = 
7.4 Hz, 1H), 7.38-7.32 (m, 3H), 7.22 (t, J = 7.5 Hz, 1H), 6.81-6.75 (m, 1H), 3.83 (s, 
2H);
 13
C NMR (101 MHz, DMSO-d6) δc 166.9, 163.8, 161.4, 156.1, 145.3, 142.6, 
137.2, 130.4, 126.7, 125.1, 124.8, 124.5, 117.8, 112.7, 107.5, 107.3, 103.7, 103.4, 
32.3; MS (DCI+) m/z calcd for C16H12FN2S (M+H
+
): 283.0, found 283.3.  
 
 
 N-Allyl-8H-indeno[1,2-d]thiazol-2-amine (8). 2-Bromo-1-phenylpropan-1-
one (56.6 mg, 0.270 mmol) and 1-allylthiourea (31.3 mg, 0.270 mmol) afford thiazole 
8 (7.4 mg, 0.0324 mmol, 12%). 
1
H NMR (500 MHz, DMSO-d6) δH 7.47 (dd, J = 
13.3, 7.4 Hz, 2H), 7.31 (t, J = 7.5 Hz, 1H), 7.18 (t, J = 7.4 Hz, 1H), 5.95 (ddt, J = 
17.0, 10.4, 5.3 Hz, 1H), 5.41-5.22 (m, 1H), 5.17 (dd, J = 10.2, 1.4 Hz, 1H), 4.02 (s, 
1H);
 13
C NMR (101 MHz, DMSO-d6) δc 173.0, 145.4, 136.7, 134.3, 126.6, 124.7, 
124.3, 122.5, 117.6, 46.7, 32.4; MS (DCI+) m/z calcd for C13H13N2S (M+H
+
): 229.0, 
found 229.1. 
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 4-tert-Butyl-N-mthythiazol-2-amine (9). 1-Bromo-3,3-dimethylbutan-2-one 
(59.0 mg, 0.332 mmol) and 1-methylthiourea (29.9 mg, 0.332 mmol) afford thiazole 9 
(20.4 mg, 0.119 mmol, 36%). 
1
H NMR (500 MHz, DMSO-d6) δ 6.50 (s, 1H), 2.97 (s, 
3H), 1.32 (s, 9H); 
13
C NMR (101 MHz, DMSO-d6) δc 170.2, 162.2, 148.8, 100.1, 
35.9, 33.1, 32.9, 28.3; MS (DCI+) m/z calcd for C8H15N2S (M+H
+
): 171.0, found 
171.3.  
 
 
 4-tert-Butyl-N-phenylthiazol-2-amine (10). 1-Bromo-3,3-dimethylbutan-2-
one (58.0 mg, 0.326 mmol) and 1-phenylthiourea (49.6 mg, 0.326 mmol) afford 
thiazole 10 (30.3 mg, 0.130 mmol, 40%). 
1
H NMR (500 MHz, DMSO-d6) δH 10.08 
(s, 1H), 7.68-7.54 (m, 2H), 7.30 (t, J = 7.7 Hz, 2H), 6.92 (t, J = 7.3 Hz, 1H), 6.41 (s, 
1H), 1.31 (s, 9H);
 13
C NMR (101 MHz, DMSO-d6) δc 162.9, 160.8, 141.2, 128.9, 
121.1, 116.8, 99.2, 34.3, 29.5; MS (DCI+) m/z calcd for C13H17N2S (M+H
+
): 233.1, 
found 233.2.  
 
 
 4-tert-Butyl-N-(3-fluorophenyl)thiazol-2-amine (11). 1-Bromo-3,3-
dimethylbutan-2-one (49.5 mg, 0.278 mmol) and 1-(3-fluorophenyl)thiourea (47.2 
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mg, 0.278 mmol) afford thiazole 11 (34.1 mg, 0.136 mmol, 49%). 
1
H NMR (500 
MHz, DMSO-d6) δH 10.33 (s, 1H), 7.82-7.65 (m, 1H), 7.41-7.16 (m, 2H), 6.71-6.65 
(m, 1H), 6.57-6.38 (m, 1H), 1.27 (s, 9H); 
13
C NMR (101 MHz, DMSO-d6) δc 163.5, 
162.0, 161.6, 161.5, 143.1, 130.4, 130.3, 112.4, 107.0, 106.8, 103.3, 103.1, 99.9, 34.3, 
29.5; MS (DCI+) m/z calcd for C13H16FN2S (M+H
+
): 251.1, found 251.1.  
 
 
 N-Allyl-4-tert-butylthiazol-2-amine (12). 1-Bromo-3,3-dimethylbutan-2-one 
(58.9 mg, 0.331 mmol) and 1-allylthiourea (38.4 mg, 0.331 mmol) afford thiazole 12 
(32.5 mg, 0.165 mmol, 50%). 
1
H NMR (500 MHz, DMSO-d6) δH 6.46 (s, 1H), 5.88 
(m, 1H), 5.31 (d, J = 17.2 Hz, 1H), 5.23 (d, J = 10.3 Hz, 1H), 3.96 (s, J = 4.1 Hz, 2H), 
1.24 (s, 9H);
 13
C NMR (101 MHz, DMSO-d6) δc 169.7, 149.3, 131.7, 117.9, 100.0, 
48.1, 33.2, 28.3; MS (DCI+) m/z calcd for C10H17N2S (M+H
+
): 197.1, found 197.1.  
 
 
 4-(2-(Methylamino)thiazol-4-yl)benzonitrile (13). 4-(2-
Bromoacetyl)benzonitrile (63.7 mg, 0.286 mmol) and 1-methylthiourea (25.8 mg, 
0.286 mmol) afford thiazole 13 (29.6 mg, 0.137 mmol, 48%). 
1
H NMR (500 MHz, 
DMSO-d6) δH 8.01 (d, J = 8.2 Hz, 2H), 7.90 (d, J = 8.2 Hz, 2H), 7.39 (s, 1H), 3.15 (s, 
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3H); 
13
C NMR (101 MHz, DMSO-d6) δc 169.4, 147.7, 138.6, 132.5, 126.2, 119.0, 
109.3, 104.8, 31.0; MS (DCI+) m/z calcd for C11H10N3S (M+H
+
): 216.0, found 216.3.  
 
 
 4-(2-(Phenylamino)thiazol-4-yl)benzonitrile (14). 4-(2-
Bromoacetyl)benzonitrile (61.9 mg, 0.278 mmol) and 1-phenylthiourea (42.4 mg, 
0.278 mmol) afford thiazole 14 (37.1 mg, 0.133 mmol, 48%). 
1
H NMR (500 MHz, 
DMSO-d6) δH 10.36 (s, 1H), 8.11 (d, J = 8.4 Hz, 2H), 7.90 (d, J = 8.4 Hz, 2H), 7.72 
(d, J = 7.9 Hz, 2H), 7.66 (s, 1H), 7.36 (t, J = 7.9 Hz, 2H), 6.99 (t, J = 7.3 Hz, 1H); 
13
C 
NMR (126 MHz, DMSO-d6) δC 163.3, 148.3, 140.9, 138.5, 132.7, 129.0, 126.2, 
121.4, 119.0, 116.9, 109.5, 106.8; MS (DCI+) m/z calcd for C16H12N3S (M+H
+
): 
278.0, found 278.3.  
 
 
 4-(2-(3-Fluorophenylamino)thiazol-4-yl)benzonitrile (15). 4-(2-
Bromoacetyl)benzonitrile (56.2 mg, 0.252 mmol) and 1-(3-fluorophenyl)thiourea 
(42.8 mg, 0.252 mmol) afford thiazole 15 (36.5 mg, 0.123 mmol, 49%). 
1
H NMR 
(500 MHz, DMSO-d6) δH 10.61 (s, 1H), 8.10 (d, J = 8.3 Hz, 2H), 7.92 (d, J = 8.3 Hz, 
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2H), 7.78 (d, J = 11.8 Hz, 1H), 7.72 (s, 1H), 7.44-7.27 (m, 3H), 6.80 (m, 1H); 
13
C 
NMR (101 MHz, DMSO-d6) δc 162.9, 163.5, 161.5,148.3, 142.5, 138.3, 132.7, 130.6, 
126.2, 118.9, 112.8, 109.7, 107.7, 107.5, 103.6, 103.4; MS (DCI+) m/z calcd for 
C16H11FN3S (M+H
+
): 296.0, found 296.3.  
 
 
 4-(2-(Allylamino)thiazol-4-yl)benzonitrile (16). 4-(2-
Bromoacetyl)benzonitrile (62.5 mg, 0.280 mmol) and 1-allylthiourea (32.5 mg, 0.280 
mmol) afford thiazole 16 (28.4 mg, 0.117 mmol, 42%). 
1
H NMR (500 MHz, DMSO-
d6) δH 8.00 (d, J = 8.4 Hz, 3H), 7.83 (d, J = 8.3 Hz, 2H), 7.41 (s, 1H), 5.94 (ddd, J = 
22.5, 10.5, 5.4 Hz, 1H), 5.28 (d, J = 17.2 Hz, 1H), 5.14 (d, J = 10.2 Hz, 1H), 3.93 (d, 
J = 19.5 Hz, 2H); 
13
C NMR (101 MHz, DMSO-d6) δC 168.3, 147.9, 138.8, 134.7, 
132.4, 126.1, 119.0, 115.9, 109.3, 105.0, 46.6; MS (DCI+) m/z calcd for C13H12N3S 
(M+H
+
): 242.0, found 242.1. 
 
 
 4-(4-Fluorophenyl)-N-methylthiazol-2-amine (17). 2-Bromo-1-(4-
fluorophenyl)ethanone (60.2 mg, 0.278 mmol) and 1-methylthiourea (25.0 mg, 0.278 
mmol) afford thiazole 17 (31.9 mg, 0.153 mmol, 55%). 
1
H NMR (500 MHz, DMSO-
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d6) δH 7.90-7.80 (m, 2H), 7.28-7.18 (m, 2H), 7.23 (s, 1H), 2.91 (s, 3H);
 13
C NMR 
(101 MHz, DMSO-d6) δc 169.4, 162.4, 160.5, 130.9, 127.6, 127.6, 115.3, 115.1, 
100.7; MS (DCI+) m/z calcd for C10H10FN2S (M+H
+
): 209.0, found 209.2. 
 
 
 4-(4-Fluorophenyl)-N-phenylthiazol-2-amine (18). 2-Bromo-1-(4-
fluorophenyl)ethanone (51.8 mg, 0.240 mmol) and 1-phenylthiourea (36.4 mg, 0.240 
mmol) afford thiazole 18 (20.1 mg, 0.0744 mmol, 31%). 
1
H NMR (500 MHz, 
DMSO-d6) δH 10.27 (s, 1H), 8.03-7.89 (m, 2H), 7.72 (d, J = 8.3 Hz, 2H), 7.42-7.30 
(m, 2H), 7.24-7.30 (t, J = 7.2 Hz, 2H), 6.98 (t, J = 6.9 Hz, 1H);
 13
C NMR (101 MHz, 
DMSO-d6) δC 163.1, 162.8, 160.3, 149.0, 141.1, 131.1-131.1 (d, J = 3.0 Hz, 1C), 
129.0, 127.6-127.5 (d, J = 8.0 Hz, 1C), 121.2, 116.8, 115.5, 115.3, 102.6; MS (DCI+) 
m/z calcd for C15H12FN2S (M+H
+
): 271.0, found 271.3.  
 
 
 N-(3-Fluorophenyl)-4-(4-fluorophenyl)thiazol-2-amine (19). 2-Bromo-1-
(4-fluorophenyl)ethanone (58.5 mg, 0.270 mmol) and 1-(3-fluorophenyl)thiourea 
(45.9 mg, 0.270 mmol) afford thiazole 19 (35.9 mg, 0.124 mmol, 46%). 
1
H NMR 
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(500 MHz, DMSO-d6) δH 10.52 (s, 1H), 7.95 (dd, J = 8.4, 5.7 Hz, 2H), 7.79 (d, J = 
11.0 Hz, 1H), 7.42-7.32 (m, 3H), 7.29 (t, J = 8.8 Hz, 2H), 6.78 (m, 1H);
 13
C NMR 
(101 MHz, DMSO-d6) δc 162.7, 163.5, 162.6, 161.5, 160.1, 149.0, 142.7, 142.6, 
130.9, 130.9, 130.5, 130.4, 127.6, 127.5, 115.6, 115.4, 112.7, 112.6, 107.5, 107.3, 
103.5, 103.3; MS (DCI+) m/z calcd for C15H11F2N2S (M+H
+
): 289.0, found 289.4.  
 
 
 N-Allyl-4-(4-fluorophenyl)thiazol-2-amine (20). 2-Bromo-1-(4-
fluorophenyl)ethanone (68.6 mg, 0.318 mmol) and 1-allylthiourea (36.9 mg, 0.318 
mmol) afford thiazole 20 (46.9 mg, 0.200 mmol, 63%). 
1
H NMR (500 MHz, DMSO-
d6) δH 7.90-7.74 (m, 2H), 7.21 (t, J = 8.8 Hz, 2H), 7.06 (s, 1H), 5.93-5.85 (m, 1H), 
5.28 (d, J = 8.8 Hz, 2H), 5.15 (d, J = 10.3 Hz, 2H), 3.95 (d, J = 5.2 Hz, 1H); 
13
C 
NMR (101 MHz, DMSO-d6) δC 168.3, 147.9, 138.8, 134.7, 126.1, 119.0, 115.9, 
109.3, 109.1, 105.0, 46.6; MS (DCI+) m/z calcd for C12H12FN2S (M+H
+
): 235.0, 
found 235.2.  
 
 
General procedure for the synthesis of pyrazoles in droplets. (Synthesis of 
pyrazoles 21-40). Stock solutions of each diketone and hydrazine starting material 
were first created by adding 2.0 mmol of a given starting material to a 20 mL 
scintillation vial. To each of these vials was then added 2 mLs of dry DMF, and the 
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vials were then sonicated to form clear solutions. For each library member, 100 L of 
stock solution from each of the required building blocks was loaded into a metering 
loop of known volume on a Uniqsis flow system. The machine then injected both 
metering loops to form a single cohesive droplet that was then flowed at 1.3 mL/min 
through an 80 °C heated coil, giving a final reaction time of 5 minutes. One minute 
after the library member was injected, a blank plug of 200 mL of DMF was added to 
the machine, and both the library droplet and the wash droplet were collected into 
culture tubes. The DMF layer was then removed, the fluorous layer was extracted 
with DMF, and the collective DMF solution was evaporated under warm nitrogen. 
The resulting residue was purified by preparative HPLC on a Waters Symmetry C8 
column (25 mm x 100 mm, 7 m particle size) using a gradient of 10% to 100% 
acetonitrile:0.1% aqueous TFA over 8 min (10 min run time) at a flow rate of 40 
ml/min to give the desired compound. 
 
 
 3,4,5-Trimethyl-1-phenyl-1H-pyrazole (21). 3-Methylpentane-2,4-dione 
(23.2 mg, 0.203 mmol) and phenylhydrazine (21.9 mg, 0.203 mmol) afford pyrazole 
21 (12.5 mg, 0.0671 mmol, 33%). 
1
H NMR (400 MHz, DMSO-d6) δH 7.53-7.40 (m, 
4H), 7.40-7.26 (m, 1H), 2.20 (s, 3H), 2.13 (s, 3H), 1.93 (m, 3H); 
13
C NMR (101 
MHz, DMSO-d6) δc 147.0, 139.7, 135.8, 129.0, 126.7, 124.0, 112.8, 11.6, 10.7, 7.90; 
MS (DCI+) m/z calcd for C12H15N2 (M+H
+
): 187.1, found 187.3. 
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 1-(3,5-Dichlorophenyl)-3,4,5-trimethyl-1H-pyrazole (22). 3-
Methylpentane-2,4-dione (22.4 mg, 0.196 mmol) and (3,5-dichlorophenyl)hydrazine 
(34.4 mg, 0.196 mmol) afford pyrazole 22 (13.0 mg, 0.0511 mmol, 26%). 
1
H NMR 
(400 MHz, DMSO-d6) δH 7.67-7.43 (m, 3H), 2.27 (s, 3H), 2.12 (s, 3H), 1.92 (s, 3H);
 
13
C NMR (101 MHz, DMSO-d6) δC 148.6, 141.8, 136.2, 134.3, 125.6, 121.7, 114.1, 
11.6, 10.8, 7.8;
 13
C NMR (101 MHz, DMSO-d6) δc 148.6, 141.8, 136.3, 134.3, 125.8, 
121.8, 114.1, 11.7, 10.8, 7.87; MS (DCI+) m/z calcd for C12H13Cl2N2 (M+H
+
): 255.0, 
found 255.1. 
 
 
 1,3,4,5-Tetramethyl-1H-pyrazole (23). 3-Methylpentane-2,4-dione (24.4 
mg, 0.214 mmol) and methylhydrazine (9.86 mg, 0.214 mmol) afford pyrazole 23 
(11.7 mg, 0.0942 mmol, 44%). 
1
H NMR (400 MHz, DMSO-d6) δH 3.57 (s, 3H), 2.08 
(s, 3H), 1.99 (s, 3H), 1.82 (s, 3H); 
13
C NMR (101 MHz, DMSO-d6) δc 143.9, 135.3, 
110.0, 35.4, 11.5, 9.05, 7.85; MS (DCI+) m/z calcd for C7H13N2 (M+H
+
): 125.1, 
found 125.2. 
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 2-(3,4,5-Trimethyl-1H-pyrazol-1-yl)ethanol (24). 3-Methylpentane-2,4-
dione (23.0 mg, 0.201 mmol) and 2-hydrazinylethanol (15.3 mg, 0.201 mmol) afford 
pyrazole 24 (11.5 mg, 0.0746 mmol, 37%). 
1
H NMR (400 MHz, DMSO-d6) δH 4.06 
(t, J = 5.6 Hz, 2H), 3.64 (t, J = 5.6 Hz, 2H), 2.18 (s, 3H), 2.11 (s, 3H), 1.90-1.82 (s, 
3H); 
13
C NMR (101 MHz, DMSO-d6) δc 143.4, 139.3, 111.5, 59.8, 50.6, 10.5, 9.19, 
7.44; MS (DCI+) m/z calcd for C11H8Cl2F3N2 (M+H
+
): 155.1, found 155.1. 
 
 
 1-Cyclohexyl-3,4,5-trimethyl-1H-pyrazole (25). 3-Methylpentane-2,4-dione 
(23.0 mg, 0.202 mmol) and cyclohexylhydrazine (23.0 mg, 0.202 mmol) afford 
pyrazole 25 (13.2 mg, 0.0686 mmol, 34%). 
1
H NMR (400 MHz, DMSO-d6) δH 4.11-
3.86 (m, 1H), 2.16 (s, 3H), 2.08 (s, 3H), 1.85 (s, 3H), 1.82-1.57 (m, 7H), 1.50-1.27 
(m, 2H), 1.26-1.02 (m, 1H); 
13
C NMR (101 MHz, DMSO-d6) δc 143.5, 137.5, 111.2, 
56.6, 32.0, 25.0, 24.8, 10.8, 9.05, 7.43; MS (DCI+) m/z calcd for C12H21N2 (M+H
+
): 
193.1, found 193.2. 
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 5-Methyl-1-phenyl-3-(trifuloromethyl)-1H-pyrazole (26). 1,1,1-
Trifluoropentane-2,5-dione (30.3 mg, 0.197 mmol) and phenylhydrazine (21.3 mg, 
0.197 mmol) afford pyrazole 26 (17.0 mg, 0.0751 mmol, 38%). 
1
H NMR (400 MHz, 
DMSO-d6) δH 7.55 (m, 5H), 6.76 (s, 1H), 2.36 (s, 3H); 
13
C NMR (101 MHz, DMSO-
d6) δc 141.5, 138.4, 129.3, 129.2, 128.7, 125.5, 125.0, 104.8, 11.8; MS (DCI+) m/z 
calcd for C11H10F3N2 (M+H
+
): 227.0, found 227.2. 
 
 
 1-(3,5-Dichlorophenyl)-5-methyl-3-(trifuloromethyl-1H-pyrazole (27). 
1,1,1-Trifluoropentane-2,5-dione (30.7 mg, 0.199 mmol) and (3,5-
dichlorophenyl)hydrazine (35.0 mg, 0.199 mmol) afford pyrazole 27 (8.80 mg, 
0.0299 mmol, 15%). 
1
H NMR (400 MHz, DMSO-d6) δH 7.84 (dt, J = 16.5, 1.8 Hz, 
1H), 7.76 (d, J = 1.8 Hz, 2H), 6.81 (s, 1H), 2.40 (s, 3H);
 13
C NMR (101 MHz, 
DMSO-d6) δc 151.3, 144.7, 133.8, 127.3, 125.3, 125.0, 120.0, 119.1, 114.4, 92.6, 
92.3, 92.1, 91.8, 47.7, 15.3; MS (DCI+) m/z calcd for C11H8Cl2F3N2 (M+H
+
): 295.0, 
found 295.1  
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 1,5-Dimethyl-3-(trifuloromethyl)-1H-pyrazole (28). 1,1,1-Trifluoropentane-
2,5-dione (31.3 mg, 0.203 mmol) and methylhydrazine (9.38 mg, 0.203 mmol) afford 
pyrazole 28 (0.00 mg, 0.00 mmol, 0.0%).  
 
 
 2-(5-Methyl-3-(trifuloromethyl)-1H-pyrazole-1-yl)ethanol (29). 1,1,1-
Trifluoropentane-2,5-dione (30.8 mg, 0.200 mmol) and 2-hydrazinylethanol (15.2 
mg, 0.200 mmol) afford pyrazole 29 (6.60 mg, 0.0340 mmol, 17%). 
1
H NMR (400 
MHz, DMSO-d6) δH 6.45 (s, 1H), 4.92 (t, J = 5.4 Hz, 1H), 4.21-4.08 (m, 2H), 3.71 
(q, J = 5.5 Hz, 2H), 2.30 (dd, J = 17.1, 10.9 Hz, 3H); MS (DCI+) m/z calcd for 
C7H10F3N2O (M+H
+
): 195.0, found 195.1. 
 
 
 1-Cyclohexyl-5-methyl-3-(trifuloromethyl)-1H-pyrazole (30). 1,1,1-
Trifluoropentane-2,5-dione (30.5 mg, 0.198 mmol) and cyclohexylhydrazine (22.6 
mg, 0.198 mmol) afford pyrazole 30 (10.6 mg, 0.0456 mmol, 23%). 
1
H NMR (400 
MHz, DMSO-d6) δH 6.43 (s, 1H), 4.18 (tt, J = 11.5, 3.9 Hz, 1H), 2.32 (s, 3H), 1.85-
1.60. (m, 8H), 1.48-1.34 (m, 2H), 1.28-1.14 (m, 1H); 
13
C NMR (101 MHz, DMSO-
d6) δc 139.6, 139.5, 139.1, 138.8, 138.4, 125.8, 123.1, 120.4, 117.8, 103.0, 57.0, 32.2, 
24.8, 10.3; MS (DCI+) m/z calcd for C11H16F3N2 (M+H
+
): 233.1 found 233.3.  
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 5-Methyl-1,3-diphenyl-1H-pyrazole (31). 1-Phenylbutane-1,3-dione (32.4 
mg, 0.200 mmol) and phenylhydrazine (21.6 mg, 0.200 mmol) afford pyrazole 31 
(13.6 mg, 0.0580 mmol, 29%). 
1
H NMR (400 MHz, DMSO-d6) δH 7.46-7.26 (m, 
6H), 7.27-7.13 (m, 3H), 6.45 (s, 1H), 2.25 (s, 3H); 
13
C NMR (101 MHz, DMSO-d6) 
δc 148.5, 143.1, 139.8, 130.2, 128.9, 128.5, 128.3, 128.9, 127.3, 124.9, 107.8, 13.2; 
MS (DCI+) m/z calcd for C16H15N2 (M+H
+
): 235.1, found 235.3.  
 
 
 1-(3,5-Dichlorophenyl)-3-methyl-5-phenyl-1H-pyrazole (32a). 1-
Phenylbutane-1,3-dione (32.7 mg, 0.202 mmol) and (3,5-dichlorophenyl)hydrazine 
(35.5 mg, 0.202 mmol) afford a mixture of regioisomeric pyrazoles (14.1 mg, 0.0466 
mmol, 23%). Regioisomer 32a (5.60 mg, 0.0185 mmol, 10%). 
1
H NMR (400 MHz, 
DMSO-d6) δH 7.57 (t, J = 1.9 Hz, 1H), 7.47-7.36 (m, 3H), 7.32-7.25 (m, 3H), 7.26 (d, 
J = 0.6 Hz, 1H), 6.48 (s, 1H), 2.24 (d, J = 34.1 Hz, 3H); MS (DCI+) m/z calcd for 
C16H13Cl2N2 (M+H
+
): 303.0, found 303.2. 
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 1-(3,5-Dichlorophenyl)-5-methyl-3-phenyl-1H-pyrazole (32b). 1-
Phenylbutane-1,3-dione (32.7 mg, 0.202 mmol) and (3,5-dichlorophenyl)hydrazine 
(35.5 mg, 0.202 mmol) afford a mixture of regioisomeric pyrazoles (14.1 mg, 0.0466 
mmol, 23%). Regioisomer 32b (8.10 mg, 0.0268 mmol, 13%). 
1
H NMR (400 MHz, 
DMSO-d6) δH 7.85 (dt, J = 8.2, 1.7 Hz, 2H), 7.75 (d, J = 1.8 Hz, 2H), 7.70 (t, J = 1.8 
Hz, 1H), 7.38-7.32 (m, 2H), 6.81 (d, J = 0.8 Hz, 1H), 2.45 (d, J = 0.5 Hz, 3H);
 13
C 
NMR (101 MHz, DMSO-d6) δc 149.7, 143.5, 141.4, 134.0, 129.6, 128.7, 128.7, 
128.5, 126.3, 122.9, 109.0, 13.2; MS (DCI+) m/z calcd for C16H13Cl2N2 (M+H
+
): 
303.0, found 303.2.  
 
 
1,3-Dimethyl-5-phenyl-1H-pyrazole (33a). 1-Phenylbutane-1,3-dione (9.32.2 mg, 
0.199 mmol) and methylhydrazine (9.17 mg, 0.199 mmol) afford a mixture of 
regioisomeric pyrazoles (7.20 mg, 0.0418 mmol, 21%). Regioisomer 33a (1.90 mg, 
0.0110 mmol, 6%). 
1
H NMR (400 MHz, DMSO-d6) δH 7.61-7.27 (m, 5H), 6.18 (s, 
1H), 3.76 (s, 3H), 2.20 (s, 3H); MS (DCI+) m/z calcd for C11H13N2 (M+H
+
): 173.1, 
found 173.1. 
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 1,5-Dimethyl-3-phenyl-1H-pyrazole (33b). 1-Phenylbutane-1,3-dione (32.2 
mg, 0.199 mmol) and methylhydrazine (9.17 mg, 0.199 mmol) afford a mixture of 
regioisomeric pyrazoles (7.20 mg, 0.0418 mmol, 21%). Regioisomer 33b (5.30 mg, 
0.0307 mmol, 15%). 
1
H NMR (400 MHz, DMSO-d6) δH 7.72 (dt, J = 8.1, 1.6 Hz, 
2H), 7.41-7.31 (m, 2H), 7.31-7.17 (m, 1H), 6.46 (s, 1H), 3.75 (s, 3H), 2.25 (s, 3H); 
13
C NMR (101 MHz, DMSO-d6) δc 146.0, 148.5, 130.1, 128.7, 128.3, 128.3, 105.2, 
37.0, 13.1; MS (DCI+) m/z calcd for C11H13N2 (M+H
+
): 173.1, found 173.1. 
 
 
 2-(3-Methyl-5-phenyl-1H-pyrazol-1-yl)ethanol (34a). 1-Phenylbutane-1,3-
dione (32.4 mg, 0.200 mmol) and 2-hydrazinylethanol (15.2 mg, 0.200 mmol) afford 
a mixture of regioisomeric pyrazoles (32.0 mg, 0.158 mmol, 79%). Regioisomer 34a 
(8.90 mg, 0.0440 mmol, 22%). 
1
H NMR (400 MHz, DMSO-d6) δ 7.64-7.27 (m, 5H), 
6.15 (s, 1H), 4.03 (t, J = 5.9 Hz, 2H), 3.75 (t, J = 5.9 Hz, 2H), 2.20 (s, 3H); MS 
(DCI+) m/z calcd for C12H15N2O (M+H
+
): 203.1, found 203.1. 
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 2-(5-Methyl-3-phenyl-1H-pyrazol-1-yl)ethanol (34b). 1-Phenylbutane-1,3-
dione (32.4 mg, 0.200 mmol) and 2-hydrazinylethanol (15.2 mg, 0.200 mmol) afford 
a mixture of regioisomeric pyrazoles (32.0 mg, 0.158 mmol, 79%). Regioisomer 34b 
(23.1 mg, 0.114 mmol, 57%). 
1
H NMR (400 MHz, DMSO-d6) δH 7.73 (dd, J = 8.3, 
1.2 Hz, 2H), 7.44-7.31 (m, 2H), 7.25 (ddd, J = 8.6, 2.6, 1.3 Hz, 1H), 6.44 (s, 1H), 
4.09 (t, J = 5.8 Hz, 2H), 3.72 (t, J = 5.8 Hz, 2H), 2.30 (s, 3H); 
13
C NMR (101 MHz, 
DMSO-d6) δc 146.6, 144.4, 130.4, 128.8, 128.7, 128.3, 105.3, 59.9, 50.8, 13.2; MS 
(DCI+) m/z calcd for C12H15N2O (M+H
+
): 203.1, found 203.1. 
 
 
 1-Cyclohexyl-5-methyl-3-phenyl-1H-pyrazole (35). 1-Phenylbutane-1,3-
dione (32.5 mg, 0.201 mmol) and cyclohexylhydrazine (23.0 mg, 0.201 mmol) afford 
pyrazole 35 (12.6 mg, 0.0524 mmol, 26%). 
1
H NMR (400 MHz, DMSO-d6) δ 7.57-
7.27 (m, 5H), 6.06 (s, 1H), 3.98 (tt, J = 11.2, 4.2 Hz, 1H), 2.19 (s, 3H), 2.00-1.68 (m, 
6H), 1.52-1.50 (m, 1H), 1.36-1.01 (m, 3H); 
13
C NMR (101 MHz, DMSO-d6) δc 
146.1, 142.9, 130.6, 128.8, 128.6, 128.4, 105.2, 56.8, 33.0, 25.1, 24.8, 13.4; MS 
(DCI+) m/z calcd for C16H20N2 (M+H
+
): 241.1, found 241.2. 
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 3-Methyl-1-phenyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole (36). 2-
Acetylcyclopentanone (24.8 mg, 0.197 mmol) and phenylhydrazine (21.3 mg, 0.197 
mmol) afford pyrazole 36 (12.5 mg, 0.0630 mmol, 32%). 
1
H NMR (400 MHz, 
DMSO-d6) δH 7.59 (d, J = 8.8 Hz, 2H), 7.51-7.34 (m, 2H), 7.31-7.14 (m, 1H), 3.10-
2.91 (m, 2H), 2.15 (s, 3H); 
13
C NMR (101 MHz, DMSO-d6) δc 148.6, 143.0, 139.9, 
129.4, 127.9, 125.0, 118.0, 30.5, 26.2, 21.7, 12.5; MS (DCI+) m/z calcd for C13H15N2 
(M+H
+
): 199.1, found 199.2.  
 
 
 2-(3,5-Dichlorophenyl)-3-methyl-2,4,5,6-tetrahydrocyclopenta[c]pyrazole 
(37a). 2-Acetylcyclopentanone (22.1 mg, 0.175 mmol) and (3,5-
dichlorophenyl)hydrazine (30.6 mg, 0.175 mmol) afford a mixture of regioisomeric 
pyrazoles (4.70 mg, 0.0176 mmol, 9%). Regioisomer 37a (0.50 mg, 0.00187 mmol, 
1%). 
1
H NMR (400 MHz, DMSO-d6) δH 7.59 (m, 3H), 2.63 (t, J = 7.4 Hz, 2H), 2.56 
(t, J = 7.1 Hz, 2H), 2.39-2.33 (m, 2H), 2.33 (s, 3H); MS (DCI+) m/z calcd for 
C13H12Cl2N2 (M+H
+
): 267.0, found 267.1. 
 
 
1-(3,5-Dichlorophenyl)-3-methyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole (37b). 
2-Acetylcyclopentanone (22.1 mg, 0.175 mmol) and (3,5-dichlorophenyl)hydrazine 
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(30.6 mg, 0.175 mmol) afford a mixture of regioisomeric pyrazoles (4.70 mg, 0.0176 
mmol, 9%). Regioisomer 37b (4.20 mg, 0.0176 mmol, 8%). 
1
H NMR (400 MHz, 
DMSO-d6) δH 7.57 (d, J = 1.8 Hz, 2H), 7.45 (t, J = 1.8 Hz, 1H), 3.05 (m, 2H), 2.59-
2.49 (m, 4H), 2.16 (s, 3H);
 13
C NMR (101 MHz, DMSO-d6) δc 149.3, 144.7, 141.6, 
134.8, 129.2, 124.1, 116.2, 30.3, 26.1, 21.6, 12.5; MS (DCI+) m/z calcd for 
C13H12Cl2N2 (M+H
+
): 267.0, found 267.1.  
 
 
 1,3-Dimethyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole (38). 2-
Acetylcyclopentanone (29.2 mg, 0.232 mmol) and methylhydrazine (10.7 mg, 0.232 
mmol) afford pyrazole 38 (13.6 mg, 0.0999 mmol, 43%). 
1
H NMR (400 MHz, 
DMSO-d6) δH 3.57 (s, 1H), 2.59 (m, 1H), 2.42 (m, 1H), 1.98 (m, 1H); 
13
C NMR (101 
MHz, DMSO-d6) δc 150.1, 139.7, 123.9, 36.2, 30.6, 23.1, 22.5, 12.3; MS (DCI+) m/z 
calcd for C8H13N2 (M+H
+
): 137.1, found 137.1. 
 
 
 2-(3-Methyl-5,6-dihydrocyclopenta[c]pyrazol-1(4H)-yl)ethanol (39). 2-
Acetylcyclopentanone (25.0 mg, 0.199 mmol) and 2-hydrazinylethanol (15.2 mg, 
0.199 mmol) afford a mixture of regioisomeric pyrazoles (16.6 mg, 0.0999 mmol, 
50%). 
1
H NMR (400 MHz, DMSO-d6) δH 3.94 (t, J = 5.6 Hz, 2H), 3.63 (t, J = 5.6 
141 
 
Hz, 2H), 2.70-2.65 (m, 2H), 2.48-2.40 (m, 4H), 2.07 (s, 3H);
 13
C NMR (101 MHz, 
DMSO-d6) δc 158.6*, 158.4*, 153.9, 139.1, 124.9, 60.4*, 59.4, 52.4*, 51.0, 29.8, 
29.4*, 24.2*, 23.7, 22.0, 11.0, 10.1*; MS (DCI+) m/z calcd for C9H15N2O (M+H
+
): 
167.1, found 167.2. 
 
 
 2-Cyclohexyl-3-methyl-2,4,5,6-tetrahydrocyclopenta[c]pyrazole (40). 2-
Acetylcyclopentanone (25.4 mg, 0.201 mmol) and cyclohexylhydrazine (22.9 mg, 
0.201 mmol) afford a mixture of regioisomeric pyrazoles (16.5 mg, 0.0.807 mmol, 
40%). 
1
H NMR (400 MHz, DMSO-d6) δH 4.04 (ddd, J = 11.9, 8.1, 3.9 Hz, 1H), 2.88-
2.69 (m, 2H), 2.49-2.35 (m, 4H), 2.15 (s, 3H), 2.01-1.89 (m, 2H), 1.85-1.74 (m, 2H), 
1.74-1.57 (m, 3H), 1.35 (qd, J = 13.0, 9.7 Hz, 2H), 1.27-1.09 (m, 1H); 
13
C NMR (101 
MHz, DMSO-d6) δc 151.4, 138.8, 125.1, 59.7, 31.8, 29.8, 24.8, 24.6, 24.4, 21.6, 11.1; 
MS (DCI+) m/z calcd for C13H21N2
 
(M+H
+
): 205.2, found 205.3. 
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In situ Reagent Generation with Continuous Flow 
 
 General procedure for two-step dehydrationUgi 4-CR in continuous 
flow. (Continuous flow synthesis of amides 41-56). Reactions completed in the 
continuous flow apparatus were performed by combining 0.750 mmol (101 mg, 2 
equiv.) of formamide with 1.50 mmol (206 mg, 2 equiv.) of Burgess reagent in 1.5 
mL of anhydrous dichloromethane in a sealed conical-tipped vial. An injector tube 
was inserted through a hole in the vial cap and extended until it touched the bottom of 
the vial. The solution was allowed to flow continuously into the reactor at a flow rate 
of 0.1 mL/min (equivalent to one hour reaction time), which was the maximum 
reproducible reaction time achievable using the FlowSyn. The total injection time for 
the dehydration step of the sequence was approximately one hour, after which point 
the first injection line was switched to anhydrous dichloromethane to move the 
remaining reacting solution through the instrument. The final solvent injection 
required one additional hour. During this time, a solution of the remaining Ugi 4-CR 
components was prepared by combining 0.375 mmol (1 equiv.) of acid, 0.375 mmol 
(1 equiv.) of aldehyde, and 0.375 mmol (1 equiv.) of amine in 1.5 mL of anhydrous 
methanol in a sealed conical-tipped vial. The combined solution was allowed to sit for 
1-2 hours prior to injection into the instrument. Prior to the start of the Ugi 4-CR 
component injection, a solution of anhydrous methanol was pumped through the 
instrument to maintain the appropriate backpressure. As the newly-formed isocyanide 
reached the T-joint merge point an injector tube was inserted through a hole in the 
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vial cap of the Ugi 4-CR component solution and extended until it touched the bottom 
of the vial. The solution was allowed to flow continuously into the flow reactor at a 
rate of 0.1 mL/min (equivalent to one hour reaction time), which was the maximum 
reproducible reaction time achievable using the Vapourtec. The total injection time 
for the Ugi 4-CR step of the sequence equaled approximately one hour, after which 
point the second injection line was switched to anhydrous methanol to move the 
remaining reacting solution through the instrument, which took approximately one 
additional hour. From the start of the dehydration injection to the exit of all reaction 
material from the instrument took a total of 3 hours. The reaction solution collected 
from the flow instrument was concentrated and the crude material was purified by 
silica gel chromatography. 
 
General procedure for two-step dehydrationUgi 4-CR in the microwave. 
(Microwave synthesis of amides 41-56). A solution of formamide (0.839 mmol) and 
Burgess reagent (0.839 mmol) in anhydrous CH2Cl2 (2.0 mL) were mixed in a 
microwave vial, the vial was sealed, and heated at 90 ºC in the microwave for 1 h. 
While dehydrating the formamide, a solution of aldehyde (0.419 mmol), amine (0.419 
mmol), and acid (0.419 mmol) in MeOH (2.0 mL) was prepared and stirred for 1 h at 
rt Upon completion of isocyanide synthesis the Ugi component solution was added to 
the isocyanide solution in one portion. The microwave vial was resealed and again 
heated at 90 ºC in the microwave for 1 h. The final solution was then concentrated 
and the crude material was purified by mass directed fractionation. Characterization 
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data was collected using microwave produced samples. All compounds used for 
characterization had purity >90% according to final LCMS analysis. Where 
appropriate, NMR spectrum were taken at -30 ºC in order to enhance resolution of the 
rotamers. 
 
 
 N-Benzyl-N-(2-(benzylamino)-2-oxo-1-phenylethyl)-2-bromo-4-
chlorobenzamide (41). N-Benzylformamide (113 mg, 0.839 mmol), Burgess reagent 
(200 mg, 0.839 mmol), benzaldehyde (44.4 mg, 0.419 mmol), benzylamine (44.8 mg, 
0.419 mmol), and 2-bromo-4-chlorobenzoic acid (98.6 mg, 0.419 mmol) afforded Ugi 
product 41 (33.1 mg, 0.0606 mmol, 14%) as a white solid. The product appeared as a 
mixture of three rotamers while in solution. The major rotamer is denoted by (

) 
where discernable. Rf = 0.25 (25% EtOAc/Hex); mp 152.4-155.0 ºC; 
1
H NMR at -30 
ºC (500 MHz, CDCl3) δH 7.60-6.82 (m, 18H), 6.02-6.01 (m, 1H), 5.30-5.13 (m, 1H), 
4.62-4.09 (m, 3H); 
13
C NMR at -30 ºC (125 MHz, CDCl3) δC 169.8, 169.3, 169.2

, 
169.0, 168.8, 168.1

, 137.7, 137.5

, 137.4, 137.2, 136.1, 135.8, 135.6, 135.5

, 
135.2

, 135.2

, 135.1, 134.0

, 133.7, 132.3, 132.2, 132.1, 132.0

, 130.1, 129.7

, 
129.1

, 129.1

, 128.8, 128.8, 128.7, 128.5, 128.5, 128.5

, 128.4

, 128.4

, 128.0, 
127.9, 127.8

, 127.8

, 127.5

, 127.5

, 127.4, 127.4, 127.3, 127.2, 127.2

, 127.1

, 
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127.1, 127.0, 126.7

, 126.0, 119.6, 119.4

, 118.7, 66.2, 64.0

, 63.0, 51.8

, 51.6, 
47.6, 43.3, 43.3

, 43.2; IR (neat) 1671, 1624, 1412, 907 cm
-1
; MS (ES+) m/z 547.0 
(M+H
+
); HRMS calcd for C29H25BrClN2O2 (M+H
+
): 547.0788, found 547.0775. 
 
 
 N-Benzyl-2-bromo-4-chloro-N-(2-(cyclohexylamino)-2-oxo-1-
phenylethyl)benzamide (42). N-Cyclohexyl formamide (106.6 mg, 0.839 mmol), 
Burgess reagent (200 mg, 0.839 mmol), benzaldehyde (44.4 mg, 0.419 mmol), 
benzylamine (44.8 mg, 0.419 mmol), and 2-bromo-4-chlorobenzoic acid (98.6 mg, 
0.419 mmol) afforded Ugi product 42 (105.5 mg, 0.196 mmol, 47%) as a white solid. 
The major rotamer is denoted by (

) where discernable. Rf = 0.33 (25% EtOAc/Hex); 
mp 144.0-147.4 ºC; 
1
H NMR at -30 ºC (500 MHz, CDCl3) δH 7.68-6.80 (m, 13H), 
6.04-4.93 (m, 2H), 4.55-4.25 (m, 1H), 3.82 (brs, 1H), 2.23-0.57 (m, 10H); 
13
C NMR -
30 ºC (125 MHz, CDCl3) δC 169.9, 169.5, 169.2

, 168.0, 167.8, 167.2

, 137.9, 136.3, 
136.0, 135.8, 135.6

, 135.5, 135.4

, 135.2

, 135.0, 134.2, 134.1, 132.6, 132.5, 132.1, 
132.0

, 130.0, 129.6, 129.5

, 129.1

, 128.9, 128.8, 128.7, 128.7, 128.5, 128.4

, 
128.2, 128.0, 128.0, 127.9

, 127.7, 127.5, 127.4, 127.3

, 127.3, 127.0, 126.6

, 126.5, 
119.6, 119.4

, 119.0, 66.6

, 64.0

, 62.8, 51.7

, 48.8 (br), 47.2, 32.6 (br), 25.1

, 24.8 
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(br); IR (neat) 2930, 1670, 1619, 1584, 1416 cm
-1
; MS (ES+) m/z 539.1 (M+H
+
); 
HRMS calcd for C28H29BrClN2O2 (M+H
+
): 539.1101, found 539.1075. 
  
 
 N-Benzyl-2-bromo-N-(2-(tert-butylamino)-2-oxo-1-phenylethyl-4-
chlorobenzamide (43). N-tert-Butylformamide (84.8 mg, 0.839 mmol), Burgess 
reagent (200 mg, 0.839 mmol), benzaldehyde (44.4 mg, 0.419 mmol), benzylamine 
(44.8 mg, 0.419 mmol), and 2-bromo-4-chlorobenzoic acid (98.6 mg, 0.419 mmol) 
afforded Ugi product 43 (42.4 mg, 0.0827 mmol, 20%) as a white solid. The major 
rotamer is denoted by (

) where discernable. Rf = 0.37 (25% EtOAc/Hex); mp 156.0-
157.5 ºC; 
1
H NMR at -30 ºC (500 MHz, CDCl3) δH 7.65-6.70 (m, 13H), 6.03-5.20 (m, 
1H), 4.60-4.26 (m, 2H), 1.36-1.25 (m, 9H); 
13
C NMR -30 ºC (125 MHz, CDCl3) δC 
169.8, 169.3

, 168.2, 167.1

, 136.4, 135.7, 135.7

, 135.1, 135.0, 134.4

, 134.3, 
132.2, 132.0

, 129.5, 129.4

, 129.0

, 128.8

, 128.6

, 128.5, 128.3

, 127.9

, 127.6

, 
127.3, 127.2

, 127.1

, 126.9, 126.5

, 119.8, 119.3

, 64.1

, 62.8, 51.7, 51.6, 51.5

, 
51.4, 51.3, 40.5

, 28.3, 28.1

; IR (neat) 1673, 1618, 1416, 729 cm
-1
; MS (ES+) m/z 
513.0 (M+H
+
); HRMS calcd for C26H27BrClN2O2 (M+H
+
): 513.0944, found 
513.0956. 
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 N-Benzyl-2-bromo-4-chloro-N-(2-(4-chlorophenylamino)-2-oxo-1-
phenylethyl)benzamide (44). 4-Chloro-N-phenylformamide (130 mg, 0.839 mmol), 
Burgess reagent (200 mg, 0.839 mmol), benzaldehyde (44.4 mg, 0.419 mmol), 
benzylamine (44.8 mg, 0.419 mmol), and 2-bromo-4-chlorobenzoic acid (98.6 mg, 
0.419 mmol) afforded Ugi product 44 (32.6 mg, 0.0575 mmol, 14%) as a dark yellow 
solid. The major rotamer is denoted by (

) where discernable. Rf = 0.37 (25% 
EtOAc/Hex); mp 143.4-146.7 ºC; 
1
H NMR at -30 ºC (500 MHz, CDCl3) δH 7.62-6.84 
(m, 17H), 6.43-5.30 (m, 1H), 4.64-4.33 (m, 2H); 
13
C NMR -30 ºC (125 MHz, CDCl3) 
δC 170.4

, 169.8, 169.6, 167.8, 167.6, 166.7

, 136.3, 136.1, 135.8, 135.6, 135.6, 
135.4

, 135.3, 135.2, 135.0, 133.4, 133.1

, 132.4, 132.1

, 132.1

, 132.0, 130.1, 
129.8

, 129.6

, 129.4, 129.3

, 129.2

, 128.9, 128.9, 128.8, 128.7, 128.7

, 128.6, 
128.4

, 128.4

, 128.3

, 128.0

, 127.7, 127.5, 127.5, 127.5, 127.1, 127.1

, 127.0, 
126.5

, 121.2

, 121.0, 120.6

, 119.4, 119.4, 66.7, 66.0, 63.5

, 51.3, 51.2

; IR (neat) 
1697, 1619, 1491, 1399, 827 cm
-1
; MS (ES+) m/z 567.0 (M+H
+
); HRMS calcd for 
C28H23BrCl2N2O2 (M+H
+
): 567.0242, found 567.0222. 
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 N-Benzyl-2-bromo-4-chloro-N-(2-oxo-1-phenyl-2-
(phenylamino)ethyl)benzamide (45). N-Phenylformamide (101 mg, 0.839 mmol), 
Burgess reagent (200 mg, 0.839 mmol), benzaldehyde (44.4 mg, 0.419 mmol), 
benzylamine (44.8 mg, 0.419 mmol), and 2-bromo-4-chlorobenzoic acid (98.6 mg, 
0.419 mmol) afforded Ugi product 45 (40.1 mg, 0.0752 mmol, 18%) as a pale yellow 
solid. The major rotamer is denoted by (

) where discernable. Rf = 0.33 (25% 
EtOAc/Hex); mp 84.9-88.8 ºC; 
1
H NMR at -30 ºC (500 MHz, CDCl3) δH 7.65-6.56 
(m, 18H), 5.87-5.34 (m, 0.5H), 4.69-4.29 (m, 1H), 3.51-3.49 (m, 1H), 2.63-2.21 (m, 
0.5H); 
13
C NMR -30 ºC (125 MHz, CDCl3) δC 170.3

, 169.7, 169.6, 168.6, 167.8, 
167.6, 166.7

, 137.7, 137.4

, 137.0

, 136.5, 136.4, 135.9, 135.7, 135.4, 135.4, 135.2, 
135.1, 134.5, 133.7, 133.6, 132.7, 132.4, 132.2, 132.0

, 130.3

, 130.1, 129.8

, 
129.5

, 129.1, 129.1

, 129.0, 128.9, 128.8, 128.7, 128.7

, 128.6, 128.6

, 128.5, 
128.4, 128.4, 128.3, 128.2

, 128.1, 128.1, 128.0, 127.9

, 127.8, 127.7, 127.4, 127.3, 
127.2

, 127.1

, 127.0, 126.9, 126.8, 126.4

, 126.2, 124.6, 124.2

, 123.9, 123.9

, 
66.7, 65.9

, 63.4, 63.3, 55.0, 54.0, 51.3

, 47.8; IR (neat) 1692, 1625, 1599, 1584, 
1548, 1494, 1442, 906 cm
-1
; MS (ES+) m/z 533.0 (M+H
+
); HRMS calcd for 
C28H24BrClN2O2 (M+H
+
): 533.0631, found 533.0642. 
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 Ethyl-2-(2-(N-benzyl-2-bromo-4-chlorobenzamido)-2-
phenylacetamido)acetate (46). N-Formylglycine ethyl ester (109 mg, 0.839 mmol), 
Burgess reagent (200 mg, 0.839 mmol), benzaldehyde (44.4 mg, 0.419 mmol), 
benzylamine (44.8 mg, 0.419 mmol), and 2-bromo-4-chlorobenzoic acid (98.6 mg, 
0.419 mmol) afforded Ugi product 46 (38.6 mg, 0.0712 mmol, 17%) as a pale yellow 
solid. The major rotamer is denoted by (

) where discernable. Rf = 0.17 (25% 
EtOAc/Hex); mp 61.7-73.2 ºC; 
1
H NMR at -30 ºC (500 MHz, CDCl3) δH 7.67-6.16 
(m, 13H), 5.37-5.19 (m, 1H), 4.55-4.20 (m, 2H), 4.22-4.09 (m, 3H), 3.99-3.86 (m, 
1H), 1.30-1.23 (m, 3H); 
13
C NMR -30 ºC (125 MHz, CDCl3) δC 169.8

, 169.5, 169.4, 
169.4, 169.2, 169.2

, 168.2

, 136.0, 135.7, 135.6, 135.5, 135.4

, 135.3

, 135.2

, 
135.1, 133.7

, 133.4, 132.4, 132.3, 132.3, 132.1, 132.1

, 130.2

, 130.0

, 129.6

, 
129.2

, 129.1

, 128.9, 128.8, 128.8

, 128.6, 128.5

, 128.4, 128.3

, 128.2, 127.9

, 
127.7

, 127.4

, 127.3

, 127.0, 126.9, 126.6

, 126.0, 119.6, 119.5

, 119.3, 119.0, 
66.4, 65.9, 64.8, 63.6

, 62.3, 61.6, 61.5

, 51.0

, 51.3, 47.7, 41.3

, 41.0, 40.4, 15.2, 
14.0, 13.9

; IR (neat) 1747, 1683, 1630, 1584, 1409, 1197 cm
-1
; MS (ES+) m/z 543.0 
(M+H
+
); HRMS calcd for C26H25BrClN2O4 (M+H
+
): 543.0686, found 543.0698.  
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 N-Benzyl-N-(2-(benzylamino)-2-oxoethyl)benzamide (47). N-
Benzylformamide (113 mg, 0.839 mmol), Burgess reagent (200 mg, 0.839 mmol), 
37% formaldehyde in H2O (33.7 mg, 0.419 mmol), benzylamine (44.8 mg, 0.419 
mmol), and benzoic acid (51.1 mg, 0.419 mmol) afforded Ugi product 47 (78.3 mg, 
0.218 mmol, 52%) as a white solid. The major rotamer is denoted by (

) where 
discernable. Rf = 0.33 (25% EtOAc/Hex); mp 108.0-109.9 ºC; 
1
H NMR at -30 ºC 
(500 MHz, CDCl3) δH 7.45-7.17 (m, 15H), 4.72-4.61 (m, 2H), 4.38-4.37 (m, 2H), 
4.09-3.77 (m, 2H); 
13
C NMR -30 ºC (125 MHz, CDCl3) δC 172.8

, 172.4, 168.4

, 
168.0, 137.8, 137.7

, 135.5, 135.4

, 134.4, 134.2

, 130.2

, 130.0, 128.7

, 128.6, 
128.4

, 128.3

, 127.9, 127.6

, 127.6, 127.4

, 127.5, 127.1, 126.5, 126.5

, 126.5, 
53.8

, 51.3, 48.9, 48.2

, 43.0, 42.9

; IR (neat) 1665, 1628, 1453, 1427, 1241 cm
-1
; 
MS (ES+) m/z 359.1 (M+H
+
); HRMS calcd for C23H23N2O2 (M+H
+
): 359.1760, 
found 359.1768. 
 
 
151 
 
 N-Benzyl-N-(2-(benzylamino)-1-(4-chlorophenyl)2-oxoethyl)benzamide 
(48). N-Benzylformamide (113 mg, 0.839 mmol), Burgess reagent (200 mg, 0.839 
mmol), 4-chlorobenzaldehyde (58.6 mg, 0.419 mmol), benzylamine (44.8 mg, 0.419 
mmol), and benzoic acid (51.1 mg, 0.419 mmol) afforded Ugi product 48 (82.7 mg, 
0.176 mmol, 42%) as a white solid. The major rotamer is denoted by (

) where 
discernable. Rf = 0.13 (25% EtOAc/Hex); mp 159.6-162.0 ºC; 
1
H NMR at -30 ºC 
(500 MHz, CDCl3) δH 7.52-6.77 (m, 19H), 5.56-5.48 (m, 1H), 5.05-4.81 (m, 1H), 
4.49-4.18 (m, 3H); 
13
C NMR -30 ºC (125 MHz, CDCl3) δC 172.9

, 172.6, 168.7

, 
168.5, 137.6

, 137.5, 137.4, 136.3

, 135.2, 134.9

, 134.2

, 133.9, 132.6

, 132.5, 
130.9

, 130.6, 129.9

, 129.7, 128.6, 128.6

, 128.4, 128.3

, 128.2

, 128.2

, 128.1, 
127.7, 127.6, 127.2, 127.1

, 126.9

, 126.9

, 126.7, 126.4

, 126.3, 126.3

, 125.8, 
65.6, 63.0

, 52.3

, 47.5, 43.0

, 40.1; IR (neat) 1670, 1623, 1492, 1408, 906 cm
-1
; MS 
(ES+) m/z 469.1 (M+H
+
); HRMS calcd for C29H26ClN2O2 (M+H
+
): 469.1683, found 
469.1686. 
 
 
N-Benzyl-N-(2-(benzylamino)-2-oxo-1-phenylethyl)benzamide (49). N-
Benzylformamide (113 mg, 0.839 mmol), Burgess reagent (200 mg, 0.839 mmol), 
benzaldehyde (44.4 mg, 0.419 mmol), benzylamine (44.8 mg, 0.419 mmol), and 
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benzoic acid (51.1 mg, 0.419 mmol) afforded Ugi product 49 (97.3 mg, 0.224 mmol, 
53%) as a white solid. The major rotamer is denoted by (

) where discernable. Rf = 
0.11 (25% EtOAc/Hex); mp 114.4-118.0 ºC; 
1
H NMR at -30 ºC (500 MHz, CDCl3) 
δH 7.57-6.99 (m, 20H), 5.64-5.40 (m, 1H), 4.99-4.84 (m, 1H), 4.53-4.37 (m, 3H); 
13
C 
NMR -30 ºC (125 MHz, CDCl3) δC 172.8

, 172.7, 168.9

, 168.8, 137.7

, 137.6, 
137.4, 136.4

, 135.5, 135.0

, 134.0

, 134.0, 129.9

, 129.6, 129.4

, 129.2, 128.7

, 
128.6

, 128.4, 128.3, 128.3

, 128.2

, 128.2

, 127.7, 127.6, 127.2, 127.1

, 126.9

, 
126.8

, 126.5

, 126.3

, 126.1, 126.0, 66.5, 65.8, 64.1

, 52.4

, 47.5, 43.0

; IR (neat) 
1666, 1623, 1495, 1453, 1408, 907 cm
-1
; MS (ES+) m/z 435.2 (M+H
+
); HRMS calcd 
for C29H27N2O2 (M+H
+
): 435.2073, found 435.2063. 
 
 
 N-Benzyl-N-(1-benzylamino)-1-oxopentan-2-yl)benzamide (50). N-
Benzylformamide (113 mg, 0.839 mmol), Burgess reagent (200 mg, 0.839 mmol), 
butyraldehyde (30.1 mg, 0.419 mmol), benzylamine (44.8 mg, 0.419 mmol), and 
benzoic acid (51.1 mg, 0.419 mmol) afforded Ugi product 50 (10.6 mg, 0.0264 mmol, 
6.2%) as a yellow oil. The major rotamer is denoted by (

) where discernable. Rf = 
0.28 (25% EtOAc/Hex); 
1
H NMR at -30 ºC (500 MHz, CDCl3) δH 7.59-7.04 (m, 
15H), 6.13-5.26 (m, 1H), 5.04-3.97 (m, 4H), 2.22-0.59 (m, 7H); 
13
C NMR -30 ºC 
(125 MHz, CDCl3) δC 177.0, 173.9

, 173.8, 172.8

, 170.5

, 169.8, 168.9

, 161.3, 
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137.9

, 137.8, 137.7

, 137.3, 136.4, 136.3, 135.3

, 135.0, 134.1, 130.1, 130.0, 129.8, 
129.5

, 129.3, 129.0

, 128.8, 128.7, 128.5, 128.5

, 128.3

, 128.2

, 127.9, 127.9, 
127.8, 127.7, 127.6, 127.6, 127.4, 127.4

, 127.3, 127.2

, 127.1, 127.1, 127.0, 126.9

, 
126.6

, 126.5

, 126.4

, 126.1, 126.1, 64.5

, 63.6, 58.8, 54.2, 52.7

, 51.1, 47.1, 46.2, 
45.6, 43.4, 43.3

, 43.1, 42.9

, 41.7, 34.4, 30.8, 30.0

, 26.7, 20.6, 19.5

, 19.3, 13.9

, 
13.4; IR (neat) 1666, 1621, 1495, 1453, 1412 cm
-1
; MS (ES+) m/z 401.2 (M+H
+
); 
HRMS calcd for C26H29N2O2 (M+H
+
): 401.2229, found 401.2232. 
 
 
 N-Benzyl-N-(2-oxo-1-phenyl-2-(phenylamino)ethyl)benzamide (51). N-
Phenylformamide (101 mg, 0.839 mmol), Burgess reagent (200 mg, 0.839 mmol), 
benzaldehyde (44.4 mg, 0.419 mmol), benzylamine (44.8 mg, 0.419 mmol), and 
benzoic acid (51.1 mg, 0.419 mmol) afforded Ugi product 51 (58.0 mg, 0.138 mmol, 
33%) as a light yellow solid. The major rotamer is denoted by (

) where discernable. 
Rf = 0.22 (25% EtOAc/Hex); mp 64.7-70.4 ºC; 
1
H NMR at -30 ºC (500 MHz, CDCl3) 
δH 7.48-6.98 (m, 20H), 6.18 (s, 1H), 4.75 (m, 2H); 
13
C NMR -30 ºC (125 MHz, 
CDCl3) δC 173.4

, 173.1, 171.3, 168.1

, 167.5, 162.3, 137.5

, 137.0

, 135.1

, 
133.6

, 130.7, 130.2, 129.9

, 129.6

, 129.3, 128.8, 128.7, 128.7, 128.6, 128.5

, 
128.4

, 128.3, 128.2

, 128.1, 128.0, 127.9

, 127.8, 127.4, 127.1, 126.9, 126.8, 
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126.5

, 126.5

, 126.2

, 123.7, 119.5

, 119.2, 119.0, 67.4, 65.9, 64.9, 63.8

, 51.9

; 
IR (neat) 1691, 1618, 1599, 1548, 1495, 1443, 906 cm
-1
; MS (ES+) m/z 421.1 
(M+H
+
); HRMS calcd for C28H25N2O2 (M+H
+
): 421.1916, found 421.1925.  
 
 
 N-(4-Chlorophenyl)-N-(oxo-1-phenyl-2-(phenylamino)ethyl)benzamide 
(52). N-Phenylformamide (101 mg, 0.839 mmol), Burgess reagent (200 mg, 0.839 
mmol), benzaldehyde (44.4 mg, 0.419 mmol), 4-chloroaniline (53.2 mg, 0.419 
mmol), and benzoic acid (51.1 mg, 0.419 mmol) afforded Ugi product 52 (24.2 mg, 
0.0549 mmol, 13%) as a white solid. Rf = 0.28 (25% EtOAc/Hex); mp 193.0-197.7 
ºC; 
1
H NMR (500 MHz, CDCl3) δH 8.16 (s, NH), 7.39-6.85 (m, 19H), 6.42 (s, 1H); 
13
C NMR (125 MHz, CDCl3) δC 171.4, 168.0, 139.2, 137.6, 135.4, 133.7, 133.0, 
131.9, 130.3, 129.7, 128.8, 128.6, 128.4, 128.4, 127.7, 124.2, 119.9, 66.5; IR (neat) 
1693, 1625, 1600, 1549, 1490, 1443, 1376, 906 cm
-1
; MS (ES+) m/z 441.1 (M+H
+
); 
HRMS calcd for C27H22ClN2O2 (M+H
+
): 441.1370, found 441.1365.  
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 N-Benzyl-N-(2-(cyclohexylamino)-2-oxo-1-phenylethyl)benzamide (53). N-
Cyclohexyl formamide (106 mg, 0.839 mmol), Burgess reagent (200 mg, 0.839 
mmol), benzaldehyde (44.4 mg, 0.419 mmol), benzylamine (44.8 mg, 0.419 mmol), 
and benzoic acid (51.1 mg, 0.419 mmol) afforded Ugi product 53 (114 mg, 0.267 
mmol, 64%) as a white solid. The major rotamer is denoted by (

) where discernable. 
Rf = 0.17 (25% EtOAc/Hex); mp 133.3-136.7 ºC; 
1
H NMR at -30 ºC (500 MHz, 
CDCl3) δH 7.53-7.13 (m, 15H), 5.81-5.61 (m, 1H), 5.29 (s, 1H), 4.84-4.29 (m, 2H), 
3.81 (brs, 1H) 2.00-0.64 (m, 10H); 
13
C NMR -30 ºC (125 MHz, CDCl3) δC 173.1, 
172.7

, 167.8, 167.8

, 137.9, 136.5

, 135.5, 135.0

, 134.2

, 129.8

, 129.8, 129.2

, 
129.1, 128.8

, 128.7, 128.6, 128.5

, 128.4, 128.3

, 128.2, 128.1

, 127.3, 126.8

, 
126.7, 126.4

, 126.3

, 125.9, 67.0, 65.8, 64.1

, 52.3

, 48.5 (br)

, 46.9, 40.3

, 32.4

, 
25.0

, 24.8 (br)
 
; IR (neat) 2929, 1622, 1601, 1542, 1495, 1449, 1408 cm
-1
; MS 
(ES+) m/z 427.2 (M+H
+
); HRMS calcd for C28H31N2O2 (M+H
+
): 427.2386, found 
427.2379.  
 
 
 N-Benzyl-4-chloro-N-(2-cyclohexylamino)-2-oxo-1-
phenylethyl)benzamide (54). N-Cyclohexyl formamide (106 mg, 0.839 mmol), 
Burgess reagent (200 mg, 0.839 mmol), benzaldehyde (44.4 mg, 0.419 mmol), 
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benzylamine (44.8 mg, 0.419 mmol), and 4-chlorobenzoic acid (65.3 mg, 0.419 
mmol) afforded Ugi product 54 (82.3 mg, 0.178 mmol, 43%) as a white solid. Rf = 
0.33 (25% EtOAc/Hex); mp 142.4-145.4 ºC; 
1
H NMR (500 MHz, CDCl3) δH 7.40-
7.03 (m, 14H), 5.72 (s, 1H), 5.55 (s, 1H), 4.72-4.43 (m, 2H), 3.84-3.46 (m, 2H) 1.90-
1.05 (m, 10H); 
13
C NMR (125 MHz, CDCl3) δC 172.0, 167.9, 135.6, 134.5, 129.5, 
128.7, 128.6, 128.2, 128.0, 126.9, 64.1 (br), 52.6 (br), 48.5, 32.5, 25.2, 24.5 15.1; IR 
(neat) 2929, 1622, 1601, 1542, 1495, 1449, 1408 cm
-1
; MS (ES+) m/z 461.1 (M+H
+
); 
HRMS calcd for C28H30ClN2O2 (M+H
+
): 461.1996, found 461.1992.  
 
 
 N-Benzyl-N-(2-(cyclohexylamino)-2-oxo-1-phenylethyl)butyramide (55). 
N-Cyclohexyl formamide (106 mg, 0.839 mmol), Burgess reagent (200 mg, 0.839 
mmol), benzaldehyde (44.4 mg, 0.419 mmol), benzylamine (44.8 mg, 0.419 mmol), 
and butyric acid (36.8 mg, 0.419 mmol) afforded Ugi product 55 (127 mg, 0.323 
mmol, 77%) as a white solid. Rf = 0.35 (25% EtOAc/Hex); mp 131.0-134.1 ºC; 
1
H 
NMR (500 MHz, CDCl3) δH 7.35-6.98 (m, 10H), 6.00-5.90 (m, 1H), 4.77-4.54 (m, 
2H), 3.79-3.77 (m, 1H), 2.59-0.84 (m, 17H); 
13
C NMR (125 MHz, CDCl3) δC 174.8, 
168.6, 137.6, 135.2, 129.5, 128.6, 128.2, 128.1, 126.6, 125.9, 62.5, 49.8, 48.3, 35.7, 
32.6, 25.3, 24.6, 18.5, 13.6; IR (neat) 1628, 1542, 1451, 1412, 1200, 908 cm
-1
; MS 
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(ES+) m/z 393.2 (M+H
+
); HRMS calcd for C25H33N2O2 (M+H
+
): 393.2542, found 
393.2532.  
 
 
 2-(N-Benzylacetamido)-N-cyclohexyl-2-phenylacetamide (56). N-
Cyclohexyl formamide (106 mg, 0.839 mmol), Burgess reagent (200 mg, 0.839 
mmol), benzaldehyde (44.4 mg, 0.419 mmol), benzylamine (44.8 mg, 0.419 mmol), 
and acetic acid (25.1 mg, 0.419 mmol) afforded Ugi product 56 (77.7 mg, 0.213 
mmol, 51%) as a white solid. Rf = 0.17 (25% EtOAc/Hex); mp 166.0-168.5 ºC; 
1
H 
NMR (500 MHz, CDCl3) δH 7.35-6.97 (m, 10H), 6.03-5.94 (m, 1H), 4.75-4.56 (m, 
2H), 3.79-3.78 (m, 1H), 2.59-1.03 (m, 10H), 2.04 (s, 3H); 
13
C NMR (125 MHz, 
CDCl3) δC 172.6, 168.7, 137.6, 135.4, 129.6, 128.6, 128.4, 128.3, 126.8, 126.0, 62.4, 
50.7, 48.5, 32.7, 25.5, 24.7, 22.5; IR (neat) 1628, 1543, 1450, 1409, 907 cm
-1
; MS 
(ES+) m/z 365.2 (M+H
+
); HRMS calcd for C23H29N2O2 (M+H
+
): 365.2229, found 
365.2237. 
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Reaction Discovery Using Microfluidic-Based Screening of 
Polycyclic Iminium Ethers 
 
General procedure for reaction screening and profiling with the 
microfluidics system. Stock solutions of iminium ether substrate (0.25 M), reaction 
partner (0.70 M), and base (0.70 M) were prepared in DMSO and placed in oven-
dried glass sleeves that were fitted into a custom-designed 96-well aluminum holding 
block. The holding block was sealed with a cover containing a continuous flow inert 
gas chamber and attached to the microfluidics platform. System parameters were set 
to perform reactions by mixing 8 μL of each reagent at 30 °C for 5 min or at 90 °C for 
20 min. The reactions were quenched in the microreactor by flowing water into the 
quench port. Individual reactions were colleted according to a UV trigger into 96-well 
plates and analyzed by UPLC/MS/ELSD (10-90% CH3CN), 2 min. 
 
General procedure for reaction screening and profiling with orbital 
shaker. Stock solutions of substrate (0.25 M), reaction partner (0.70 M), and base 
(0.70 M) were prepared in DMSO. Individual reactions were prepared in oven-dried 
glass sleeves under inert atmosphere by combining 0.50 mL of each stock solution. 
The glass sleeves were individually capped and placed in a 96-well holding bock. 
Reaction blocks were mixed in an orbital mixer for 24 h at 90 °C. The reactions were 
quenched by the addition of water and analyzed by UPLC/MS/ELSD (10-90% 
CH3CN), 2min. 
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Synthesis of bicyclo[3.2.1]octanoid scaffold. 
 
 
3,4,4-Trimethoxycyclohexa-2,5-dienone (72). To a flame-dried flask was 
added dry MeOH (90 mL) followed by iodobenzene diacetate (6.26 g, 19.4 mmol) 
and potassium carbonate (5.89 g, 42.6 mmol). In a second flame-dried flask 3,4-
dimethoxyphenol (3.00 g, 29.4 mmol) was dissolved in dry MeOH (10 mL). The 
phenol solution was added to the first flask dropwise over 5 min and the reaction was 
stirred at rt for 2.5 h. The reaction was quenched with sat. aq. NaHCO3 solution, 
extracted with CH2Cl2 (3  50 mL), washed with brine, dried over anhydrous Na2SO4 
and reduced to give a thick yellow oil. The crude oil was purified by silica gel column 
chromatography (66% EtOAc/Hex) to afford 2.54 g (71%) as a white solid. Rf = 0.22, 
(66% EtOAc/Hex); mp 61.0-63.0 °C; 
1
H NMR (400 MHz, CDCl3) δH 6.59 (d, J = 
10.0 Hz, 1H), 6.32 (dd, J = 10.0, 1.6 Hz, 1H), 5.64 (d, J = 2.0 Hz, 1H), 3.82 (s, 3H), 
3.32 (s, 6H); 
13
C NMR (100 MHz, CDCl3) δc 186.1, 169.1, 140.2, 131.2, 104.1, 94.1, 
55.9, 51.4; IR (neat) 2945, 1666, 1633, 1604, 1460, 1367, 1097, 856 cm
-1
; MS (ES+) 
m/z 185.1 (M+H
+
); HRMS calcd for C9H12O4 (M+H
+
): 185.0814, found 185.0816. 
 
160 
 
 
(1R,5R,6R,7R)-3-Methoxy-6-methyl-7-phenylbicyclo[3.2.1]oct-3-ene-2,8-
dione (63). To a flame dried flask was added acetonitrile (20 mL) followed by dry 
(+)-10-camphorsulfonic acid (568 mg, 2.44 mmol) and β-trans-methylstyrene (0.633 
mL, 2.44 mmol). The solution was stirred until homogeneous. In a second flame dried 
flask 3,4,4-trimethoxycyclohexa-2,5-dienone (70) (450 mg, 2.44 mmol) was 
dissolved in acetonitrile (10 mL) and the dienone was added to the first flask. 
Acetonitrile (5 mL) was used to wash the dienone flask and the washings were also 
added to the first flask. Water (32.9 μL, 1.83 mmol) was added to the reaction and the 
solution became dark while it stirred at rt for 1.5 h. The reaction was quenched with 
triethylamine (0.342 mL, 2.44 mmol) and stirred for 15 min. The solution was 
washed with sat. aq. NaHCO3 and extracted with Et2O (3  20 mL). The organic 
extracts were combined, washed with brine, dried over anhydrous Na2SO4, and 
reduced. The resulting black oil was purified by silica gel column chromatography 
(20% EtOAc/Hex). The product appeared as a yellow solid and was then 
recrystallized by dissolving the residue in minimal EtOAc followed by adding 
hexanes carefully as to produce 2 layers. The mixture was placed in the freezer and as 
the two layers mixed, crystals formed. The supernanent was removed; the crystals 
were washed with cold hexanes and dried to afford 314.9 mg (50%) of 63 as flat clear 
needles. Rf = 0.55, (66% Hex/EtOAc); mp 129.5-130.0 °C; 
1
H NMR (500 MHz, 
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CDCl3) δH 7.29-7.32 (m, 2H), 7.25 (m, 1H), 7.08 (d, J = 7.5 Hz, 2H), 6.51 (d, J = 8.5 
Hz, 1H), 3.83 (d, J = 7.0 Hz, 1H), 3.74 (s, 3H), 3.23 (t, J = 6.5 Hz, 1H), 3.08 (d, J = 
8.5 Hz, 1H), 2.58 (p, J = 6.5 Hz, 1H), 1.28 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, 
CDCl3) δc 199.9, 190.0, 154.4, 137.7, 128.8, 128.3, 127.6, 117.7, 70.8, 55.8, 53.8, 
49.3, 42.9, 21.5; IR (neat) 2358, 1760, 1685, 1606, 1151, 1103 cm
-1
; MS (ES+) m/z 
257.1 (M+H
+
); HRMS calcd for C16H17O3 (M+H
+
): 257.1178, found 257.1171. 
 
 
Bicyclic iminium ether mixture (67a,b). To a solution of racemic 3-
methoxy-6-methyl-7-phenylbicyclo[3.2.1]oct-3-ene-2,8-dione (300 mg, 1.17 mmol), 
and 3-azido-1-propanol (118 mg, 1.17 mmol) in CH2Cl2 (15 mL) at 0 °C was added a 
1.17 M stock solution of TfOH (3.11 mL, 3.51 mmol) dropwise over 5 min. The acid 
stock solution was freshly prepared by the addition of TfOH (0.40 mL, 4.51 mmol) to 
a mixture of CH3CN (0.7 mL) and CH2Cl2 (2.9 mL). After 1 h at 0 °C the reaction 
was warmed to rt and stirred for 12 h. Upon dilution with water (10 mL) the solution 
was extracted with CH2Cl2 (3  20 mL), the organic extracts were combined, washed 
with brine, dried over anhydrous Na2SO4, and reduced to afford 527 mg (98%) of 
67a,b as a fluffy yellow solid and a mixture of regioisomers (3.5:1.0 regioisomeric 
ratio determined by 
1
NMR). Mp 88.5-91.0 °C; 
1
NMR (400 MHz, CDCl3) δH 7.19-
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7.32 (m, 3.9H), 7.13-7.15 (m, 2H), 7.05-7.07 (m, 0.6H), 6.70 (d, J = 9.0 Hz, 0.3H), 
6.38 (d, J = 10.0 Hz, 1H), 4.85-4.94 (m, 1.3H), 4.72-4.78 (m, 1.3H), 4.66 (m, 0.3H), 
4.45, (d, J = 5.0 Hz, 1H), 4.31 (m, 1H), 4.06-4.12 (m, 0.6H), 3.89 (m, 0.3H), 3.80 (m, 
1H), 3.70 (s, 3H), 3.69 (s, 0.9H), 3.64 (d, J = 11.0 Hz, 1H), 3.61 (m, 1H), 3.43 (m, 
0.3H), 2.74-2.80 (m, 1.3H), 2.39-2.43 (m, 1.3H), 2.16-2.30 (m, 1.3H), 1.30 (d, J = 7.0 
Hz, 0.9H), 1.25 (d, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 183.7, 181.3*, 
177.4, 171.9*, 154.2*, 153.1, 135.9*, 135.0, 129.2*, 129.1, 128.7, 128.4, 128.3*, 
127.3*, 117.2*, 114.1, 76.3, 71.0, 70.8*, 64.8*, 63.0*, 55.9*, 55.8, 48.8, 47.6*, 46.7, 
46.5*, 45.1, 42.0, 41.9*, 21.5, 20.5*, 19.7, 19.7*; IR (neat) 3055, 1700, 1662, 1265, 
1031, 738, 703, 639 cm
-1
; MS (ES+) m/z 312.1 (M
+
); HRMS calcd for C19H22NO3 
(M
+
): 312.1600, found 312.1582. 
 
 
Bicyclic iminium ether, minor regioisomer (67b). Compound 67b was 
proposed based on the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, and C15 
in addition to connectivity data derived from HMBC and COSY. C1 appears at 63.0 
ppm in the 
13
C and the 
1
H shows a doublet around 4.06 ppm, consistent with a 
bridgehead methylene between electron withdrawing groups such as an α-methoxy 
ketone and an iminium ether. C5 appears at 64.8 ppm in the 
13
C and the 
1
H shows a 
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multiplet around 4.75 ppm, consistent with the assignment of C5 as the bridgehead 
position between two electron withdrawing groups such as nitrogen and an olefin. 
C14 appears at 171.9 ppm in the 
13
C, supporting the presence of the iminium ether 
which typically exists slightly downfield from the corresponding lactam 
13
C value. 
C15 appears at 70.8 ppm in the 
13
C and the 
1
H shows a pair of multiplets around 4.98 
ppm and 4.66 ppm, suggesting C15 to be a methylene with diastereotopic hydrogens 
adjacent to a heteroatom, such as oxygen. The HMBC supports the retention of the 
major bicyclic structure though the 3-bond correlations between C2 and C7, C3 and 
C19, C3 and C5, C4 and C6, and C7 and C18. In addition, the HMBC supports the 
assigned regioisomer of nitrogen insertion with the 3-bond correlations between C7 
and C14, C14 and C15, and C15 and C17. The COSY reaffirms this conclusion by 
showing the retention of the carbon connectivity throughout the bicycle with 
correlations between C1, C4, C5, C6, C7, and C18, as well as between C11, C12, and 
C13. COSY data also showed the retention of the carbon connectivity in the 
heterocycle of the iminium ether with correlations between C15, C16, and C17. 
 
 
(E)-6-(3-Hydroxypropyl)-3-methoxy-8-methyl-9-phenyl-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (69a). Sat. aq NaHCO3 solution (5 mL) was 
added to a solution of bicyclic iminium ether 67 (100 mg, 2.17 mmol) in CH2Cl2 (5 
mL) and the biphasic mixture was stirred at rt for 2 h. The reaction was diluted with 
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water (5 mL), and was extracted with CH2Cl2 (3  10 mL). The organic extracts were 
combined, washed with brine, dried over anhydrous Na2SO4, and reduced to give a 
yellow oil. The crude material was purified by silica gel preparative thin layer 
chromatography (5% MeOH/CH2Cl2) to afford 33.1 mg (67%) of 69a as a yellow oil. 
Rf = 0.76 (10% MeOH/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 7.22-7.31 (m, 3H), 
7.07-7.10 (m, 2H), 6.34 (d, J = 10.4 Hz, 1H), 4.10 (d, J = 5.6 Hz, 1H), 3.69 (s, 3H), 
3.47-3.66 (m, 4H), 3.33 (dd, J = 10.0, 1.2 Hz, 1H), 3.10 (t, J = 6.0 Hz, 1H), 2.61 (t, J 
= 6.8 Hz, 1H), 1.68 (m, 2H), 1.22 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 
δC 188.9, 172.9, 153.3, 137.4, 129.0, 128.3, 127.9, 116.9, 73.0, 58.3, 55.5, 52.7, 48.9, 
43.4, 41.2, 30.5, 22.9; IR (neat) 3421, 2958, 1650, 1623, 1456, 1126 cm
-1
; MS (ES+) 
m/z 330.1 (M+H
+
); HRMS calcd for C19H24NO4 (M+H
+
): 330.1705, found 330.1378. 
 
 
(E)-6-(3-Hydroxypropyl)-3-methoxy-8-methyl-9-phenyl-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (69a). Compound 69a was proposed based on 
the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, C17, and C19 in addition to 
connectivity data derived from HMBC and COSY. C1 appears at 73.0 ppm in the 
13
C 
and the 
1
H shows a doublet at 4.10 ppm with an integration of 1.0, consistent with the 
assignment of C1 as the bridgehead position between two electron withdrawing 
groups such as nitrogen and an α-methoxy ketone. C5 appears at 48.9 ppm in the 
13
C 
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and the 
1
H shows a doublet at 3.10 ppm, consistent with a bridgehead methylene 
between slight electron withdrawing groups such as an olefin and an amide. C14 
appears at 172.9 ppm in the 
13
C, typical of a lactam. C17 and C19 appear at 43.4 ppm 
and 58.3 ppm respectively in the 
13
C and the 
1
H shows a multiplet at 3.47-3.66 ppm, 
suggesting C17 and C19 to be methylenes with diastereotopic hydrogens adjacent to 
heteroatoms such as nitrogen and oxygen. The HMBC supports the retention of the 
major bicyclic structure through the 3-bond correlations between C3 and C16, C3 and 
C5, C4 and C6, and C7 and C15. In addition, the HMBC supports the assigned 
regioisomer of nitrogen insertion with the 3-bond correlations between C4 and C14, 
C6 and C14, C14 and C17, and C17 and C19. The COSY reaffirms this conclusion by 
showing the retention of the carbon connectivity throughout the bicycle with 
correlations between C1, C4, C5, C6, C7, and C15, as well as between C11, C12, and 
C13. COSY data also shows the retention of the carbon connectivity between C15, 
C16, and C17. 
 
 
(E)-6-(3-Hydroxypropyl)-3-methoxy-9-methyl-8-phenyl-6-
azabicyclo[3.2.2]non-3-ene-2,7-dione (69b). Sat. aq NaHCO3 solution (5 mL) was 
added to a solution of bicyclic iminium ether 67 (100 mg, 2.17 mmol) in CH2Cl2 (5 
mL) and the biphasic mixture was stirred at rt for 2 h. The reaction was diluted with 
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water (5 mL), and was extracted with CH2Cl2 (3  10 mL). The organic extracts were 
combined, washed with brine, dried over anhydrous Na2SO4, and reduced to give a 
yellow oil. The crude material was purified by silica gel preparative thin layer 
chromatography (5% MeOH/CH2Cl2) to afford 11.0 mg (22%) of 69b as a yellow oil. 
Rf = 0.72 (10% MeOH/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 7.21-7.30 (m, 3H), 
7.02-7.04 (m, 2H), 6.37 (d, J = 9.2 Hz, 1H), 3.95 (d, J = 4.8 Hz, 1H), 3.89 (dd, J = 
9.2, 0.8 Hz, 1H), 3.82 (m, 1H), 3.67 (s, 3H), 3.59 (m, 1H), 3.41-3.51 (m, 2H), 3.24 
(m, 1H), 2.98 (dd, J = 6.4, 4.8 Hz, 1H), 2.64 (p, J = 6.8 Hz, 1H), 1.70-1.82 (m, 2H), 
1.23 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 186.3, 169.5, 154.9, 138.4, 
129.0, 128.0, 127.7, 118.2, 67.9, 59.7, 58.1, 55.5, 48.2, 44.4, 42.7, 30.6, 21.5; IR 
(neat) 3421, 2960, 1681, 1649, 1457, 1124 cm
-1
; MS (ES+) m/z 330.1 (M+H
+
); 
HRMS calcd for C19H24NO4 (M+H
+
): 330.1705, found 330.1538. 
 
 
(E)-6-(3-Hydroxypropyl)-3-methoxy-9-methyl-8-phenyl-6-
azabicyclo[3.2.2]non-3-ene-2,7-dione (69b). Compound 69b was proposed based on 
the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, C17 and C19 in addition to 
connectivity data derived from HMBC and COSY. C1 appears at 67.9 ppm in the 
13
C 
and the 
1
H shows a doublet at 3.95 ppm, consistent with a bridgehead methylene 
between electron withdrawing groups such as an α-methoxy ketone and a lactam. C5 
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appears at 59.7 ppm in the 
13
C and the 
1
H shows a doublet at 3.89 ppm, consistent 
with the assignment of C5 as the bridgehead position between two electron 
withdrawing groups such as nitrogen and an olefin. C14 appears at 169.5 ppm in the 
13
C, typical of a lactam. C17 and C19 appear at 44.4 ppm and 58.1 ppm, respectively 
in the 
13
C and the 
1
H shows multiplets at 3.82 ppm, 3.59 ppm, and 3.41-3.51, 
suggesting C17 and C19 to be methylenes with diastereotopic hydrogens adjacent to 
heteroatoms such as nitrogen and oxygen. The HMBC supports the retention of the 
major bicyclic structure through the 3-bond correlations between C3 and C16, C3 and 
C5, C4 and C6, C2 and C7, and C7 and C15. In addition, the HMBC supports the 
assigned regioisomer of nitrogen insertion with the 3-bond correlations between C7 
and C14, C14 and C17, and C17 and C19. The COSY reaffirms this conclusion by 
showing the retention of the carbon connectivity throughout the bicycle with 
correlations between C1, C4, C5, C6, C7, and C15, as well as between C11, C12, and 
C13. COSY data also shows the retention of the carbon connectivity between C15, 
C16, and C17. 
 
 
(E)-6-(3-Hydroxypropyl)-3-methoxy-8-methyl-9-phenyl-6-
azabicyclo[3.2.2]non-2-en-4-ol (83). Sodium borohydride (23.6 mg, 0.607 mmol) 
was added to a solution of bicyclic iminium ether 67 (70.0 mg, 0.152 mmol) in 
ethanol (7.0 mL). The reaction was stirred at rt for 3 h. The reaction was quenched 
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with sat. aq. NaHCO3 and was extracted with CH2Cl2 (3  10 mL). The organic 
extracts were combined, washed with brine, dried over anhydrous Na2SO4, and 
reduced to give a yellow oil. The crude material was purified by silica gel preparative 
thin layer chromatography to afford 21.4 mg (59% based on the major regioisomer in 
reactant) of 83 as a yellow oil. Rf = 0.29 (10% MeOH/CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3) δH 7.26-7.33 (m, 4H), 7.17 (tt, J = 6.8, 2.0 Hz, 1H), 5.18 (d, J = 9.6 Hz, 1H), 
4.42 (d, J = 6.0 Hz, 1H), 3.83 (m, 2H), 3.52 (s, 3H), 3.28 (dd, J = 6.0, 3.2 Hz, 1H), 
3.02 (m, 3H), 2.83 (dd, J = 10.4, 2.8 Hz, 1H), 2.69 (m, 2H), 2.15 (dt, J = 9.6, 2.8 Hz, 
1H), 1.75 (m, 2H), 0.99 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 157.3, 
141.8, 128.5, 128.3, 126.1, 102.2, 75.9, 65.4, 64.7, 57.2, 54.6, 49.9, 47.6, 37.6, 35.5, 
28.4, 19.9; IR (neat) 3421, 1645 cm
-1
; MS (ES+) m/z 318.2 (M+H
+
); HRMS calcd for 
C19H28NO3 (M+H
+
): 318.2069, found 318.2067. 
 
 
(E)-6-(3-Hydroxypropyl)-3-methoxy-8-methyl-9-phenyl-6-
azabicyclo[3.2.2]non-2-en-4-ol (83). Compound 83 was proposed based on the 
distinctive 
1
H and 
13
C chemical shift of C2, C14, and C19 in addition to connectivity 
data derived from HMBC and COSY. C2 appears at 75.9 ppm in the 
13
C and the 
1
H 
shows a doublet at 4.42 ppm with an integration of 1.0, consistent with the 
assignment of C2 as a secondary alcohol. C14 appears at 57.2 ppm in the 
13
C and the 
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1
H shows a multiplet at 3.02 ppm with an integration of two, evidence for the direct 
reduction of the iminium ether. C19 appears at 64.7 ppm in the 
13
C and the 
1
H shows 
a multiplet at 3.83 ppm, suggesting C19 to be a methylene to a heteroatom such as 
oxygen. The HMBC supports the retention of the major bicyclic structure through the 
3-bond correlations between C3 and C16, C3 and C5, C4 and C6, and C7 and C15. In 
addition, the HMBC supports the assigned regioisomer with the 3-bond correlations 
between C4 and C14, C6 and C14, C14 and C17, and C17 and C19. The COSY 
reaffirms this conclusion by showing the retention of the carbon connectivity 
throughout the bicycle with correlations between C1, C4, C5, C6, C7, and C15, as 
well as between C11, C12, and C13. COSY data also shows the retention of the 
carbon connectivity between C15, C16, and C17. NOSEY coupling of the proton on 
C2 with protons on C16, C17, and C14 support the assigned face of hydride addition. 
 
 
(E)-3-Methoxy-8-methyl-9-phenyl-6-(3-(phenylthio)propyl)-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (84). To a solution of potassium hydride (13.0 
mg, 0.325 mmol) in anhydrous DMF (0.5 mL) was added a solution of benzenethiol 
(33.0 μL, 0.325 mmol) in anhydrous DMF (0.5 mL). The mixture was stirred at rt for 
5 min and bicyclic iminium ether 67 was added to the flask. The reaction mixture was 
stirred at 80 °C for 24 h. After cooling, the solution was diluted with water and 
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extracted with diethyl ether (3  10 mL). The organic extracts were combined, 
washed with brine, dried over anhydrous Na2SO4, and reduced to give a yellow oil. 
The crude material was purified by silica gel preparative thin layer chromatography 
(3:2 EtOAc-Hex) to afford 21.2 mg (62% based on the major regioisomer in reactant) 
of 84 as a yellow oil. Rf = 0.46 (66% Hex/EtOAc); 
1
H NMR (400 MHz, CDCl3) δH 
7.17-7.35 (m, 8H), 7.02-7.05 (m, 2H), 6.32 (d, J = 10.4 Hz, 1H), 4.07 (d, J = 5.6 Hz, 
1H), 3.67 (s, 3H), 3.53 (t, J = 6.8 Hz, 2H), 3.30 (dd, J = 10.0, 1.2 Hz, 1H), 3.04 (t, J = 
6.2 Hz, 1H), 2.88 (t, J = 7.2 Hz, 2H), 2.57 (p, J = 6.8 Hz, 1H), 1.84 (p, J = 7.2 Hz, 
2H), 1.20 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 189.1, 171.4, 153.3, 
137.6, 135.7, 129.8, 129.1, 129.0, 128.4, 127.8, 126.3, 116.9, 72.8, 55.4, 52.9, 49.3, 
45.9, 41.1, 31.3, 27.8, 22.9; IR (neat) 2923, 1672, 1620, 1456, 1126, 700 cm
-1
; MS 
(ES+) m/z 422.1 (M+H
+
); HRMS calcd for C25H28NO3S (M+H
+
): 422.1790, found 
422.1785. 
 
 
(E)-3-Methoxy-8-methyl-9-phenyl-6-(3-(phenylthio)propyl)-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (84). Compound 84 was proposed based on 
the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, C17, and C19 in addition to 
connectivity data derived from HMBC and COSY. C1 appears at 72.8 ppm in the 
13
C 
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and the 
1
H shows a doublet at 4.07 ppm with an integration of 1.0, consistent with the 
assignment of C1 as the bridgehead position between two electron withdrawing 
groups such as nitrogen and an α-methoxy ketone. C5 appears at 49.3 ppm in the 
13
C 
and the 
1
H shows a doublet of doublets at 3.30 ppm, consistent with a bridgehead 
methylene between slight electron withdrawing groups such as an olefin and an 
amide. C14 appears at 171.4 ppm in the 
13
C, typical of a lactam. C17 and C19 appear 
at 45.9 ppm and 31.3 ppm respectively in the 
13
C. C17 appears as a clean triplet in the 
1
H at 3.53 ppm with an integration of 2.0. C19 appears as a clean triplet in the 
1
H 
NMR at 2.88 ppm with an integration of 2.0. This data supports C17 and C19 as 
methylenes adjacent to heteroatoms such as nitrogen and sulfur, respectively. The 
HMBC supports the retention of the major bicyclic structure through the 3-bond 
correlations between C3 and C16, C3 and C5, C4 and C6, and C7 and C15. In 
addition, the HMBC supports the assigned regioisomer of nitrogen insertion with 3-
bond correlations between C4 and C14, C6 and C14, C14 and C17, and C17 and C19. 
The connection of the aryl ring to the bicyclic core through the presence of a thioether 
bond is supported by the 3-bond HMBC correlation between C19 and C20. The 
COSY reaffirms this conclusion by showing the retention of the carbon connectivity 
throughout the bicycle with correlations between C1, C4, C5, C6, C7, and C15, as 
well as between C11, C12, and C13. COSY data also shows the retention of the 
carbon connectivity between C15, C16, and C17, as well as between C23, C24, and 
C25 of the thiophenol. 
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(E)-6-(3-Azidopropyl)-3-methoxy-8-methyl-9-phenyl-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (85). To a solution of sodium azide (21.1 mg, 
0.325 mmol) in acetonitrile was added bicyclic iminium ether 67 (50.0 mg, 0.108 
mmol). The reaction was heated to 80 °C for 24 h. After cooling, the reaction was 
diluted with water and extracted with diethyl ether (3  10 mL). The organic extracts 
were combined, washed with brine, dried over anhydrous Na2SO4, and reduced give a 
yellow oil. The crude material was purified by silica gel preparative thin layer 
chromatography (66% Hex/EtOAc) to afford 20.0 mg, (70% based on the major 
regioisomer in reactant) of 85 as a yellow oil. Rf = 0.36 (66% Hex/EtOAc); 
1
H NMR 
(400 MHz, CDCl3) δH 7.23-7.32 (m, 3H), 7.09-7.11 (m, 2H), 6.34 (d, J = 10.4 Hz, 
1H), 4.10 (d, J = 5.6 Hz, 1H), 3.70 (s, 3H), 3.61 (m, 1H), 3.42 (m, 1H), 3.32 (d, J = 
6.4 Hz, 1H), 3.30-3.31 (m, 2H), 3.11 (t, J = 6.0 Hz, 1H), 2.59 (p, J = 6.8 Hz, 1H), 
1.76 (p, J = 6.8 Hz, 2H), 1.22 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 
189.2, 171.3, 153.3, 137.6, 129.1, 128.3, 127.8, 116.9, 72.9, 55.5, 52.8, 49.2, 48.9, 
44.6, 41.2, 27.7, 22.9; IR (neat) 2925, 2096, 1670,1620, 1458, 1211 cm
-1
; MS (ES+) 
m/z 355.1 (M+H
+
); HRMS calcd for C19H23N4O3 (M+H
+
): 355.1770, found 
355.1824. 
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(E)-6-(3-Azidopropyl)-3-methoxy-8-methyl-9-phenyl-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (85). Compound 85 was proposed based on 
the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, C17, and C19 in addition to 
connectivity data derived from HMBC and COSY. C1 appears at 72.9 ppm in the 
13
C 
and the 
1
H shows a doublet at 4.10 ppm with an integration of 1.0, consistent with the 
assignment of C1 as the bridgehead position between two electron withdrawing 
groups such as nitrogen and an α-methoxy ketone. C5 appears at 48.9 ppm in the 
13
C 
and overlaps with C19 in the 
1
H showing a multiplet at 3.30 ppm. This data supports 
the assignment of C5 as a bridgehead methylene between slight electron withdrawing 
groups such as an olefin and an amide. C14 appears at 171.3 ppm in the 
13
C, typical 
of a lactam. C17 and C19 appear at 44.6 ppm and 49.2 ppm respectively in the 
13
C. 
C17 appears as a pair of multiplets in the 
1
H at 3.61 ppm and 3.42 ppm with an 
integration of 1.0 each, supporting the assignment of C17 as a methylene with 
diastereotopic hydrogens adjacent to a heteroatom such as nitrogen. C19 overlaps 
with C5 in the 
1
H, as previously mentioned, appearing at 3.30 ppm as a multiplet. 
This data plausibly supports C19 as a methylene adjacent to azide. The HMBC 
supports the retention of the major bicyclic structure through the 3-bond correlations 
between C3 and C16, C3 and C5, C4 and C6, and C7 and C15. In addition, the 
HMBC supports the assigned regioisomer of nitrogen insertion with 3-bond 
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correlations between C4 and C14, C6 and C14, C14 and C17, and C17 and C19. The 
COSY reaffirms this conclusion by showing the retention of the carbon connectivity 
throughout the bicycle with correlations between C1, C4, C5, C6, C7, and C15, as 
well as between C11, C12, and C13. COSY data also shows the retention of the 
carbon connectivity between C15, C16, and C17. 
 
 
7-Phenyl-3,5,6,7,8,9-hexahydro-2H-oxazolo[3,2-a]azepin-4-ium 
tetrafluoroborate salt (87). BF3·OEt2 (2.87 mL, 22.9 mmol) was added dropwise 
over 5 min to a solution of 4-phenyl cycohexanone (2.00 g, 11.4 mmol) and 2-azido-
1-ethanol (1.50 g, 17.2 mmol) in CH2Cl2 (60 mL) at 0 °C. Gas evolution appeared 
upon acid addition. The reaction was warmed to rt, stirred for 12 h and, upon 
concentration in vacuo, yielded a colorless oil. The crude oil was purified by silica gel 
column chromatography (10% MeOH/CH2Cl2) to afford 3.38 g (97%) of 87 as a 
white solid. Rf = 0.33 (10% MeOH/CH2Cl2); mp 127.0-128.5 °C; 
1
H NMR (400 
MHz, DMSO-d6) δH 7.31-7.35 (m, 2H), 7.22-7.24 (m, 3H), 4.86-4.97 (m, 2H), 4.28 
(app q, J = 10.0 Hz, 1H), 4.16 (app q, J = 10.0 Hz, 1H), 3.78-3.88 (m, 2H), 2.91-3.03 
(m, 3H), 1.83-2.03 (m, 4H); 
13
C NMR (100 MHz, DMSO-d6) δc 179.1, 146.2, 128.5, 
126.4 (2), 72.1, 52.4, 46.4, 45.5, 31.4, 27.6, 25.8; IR (neat) 2985, 1739, 1246, 1047 
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cm
-1
; MS (ES+) m/z 216.1 (M
+
); HRMS calcd for C14H18NO (M
+
): 216.1388, found 
216.1377. 
 
 
7-Phenyl-3,5,6,7,8,9-hexahydro-2H-oxazolo[3,2-a]azepin-4-ium 
tetrafluoroborate salt (87). Compound 87 was proposed based on the presence on 
the presence of a 3-bond correlation between C1 and C8 in addition to the three bond 
correlation between C2 and C3 in the HMBC. This supports the incorporation of the 
hydroxyalkyl azide to form a fused bicycle. The COSY reaffirms this conclusion by 
showing the retention of the expected carbon connectivity between C1 and C2, as 
well as between C3, C4, C5, C6, and C7. This information is in accordance with 
similar iminium ethers that were previously synthesized.
105,106
  
 
 
1-(2-Hydroxyethyl)-5-phenylazepan-2-one (88). 1M NaOH solution (1.0 
mL) was added to a solution of 7-phenyl-3,5,6,7,8,9-hexahydro-2H-oxazolo[3,2-
a]azepin-4-ium tetrafluoroborate salt 20 (100 mg, 0.330 mmol) in CH2Cl2 (1 mL) and 
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the biphasic mixture was stirred at rt for 2 h. The reaction was diluted with water (5 
mL) and extracted with CH2Cl2 (3  5 mL). The organic extracts were combined, 
washed with brine (10 mL), dried over anhydrous sodium sulfate, concentrated, and 
dried to afford 72.4 mg (94%) of 88 as a white solid. Rf = 0.43 (10% MeOH/CH2Cl2); 
mp 109.5-110.0 °C; 
1
H NMR (400 MHz, CDCl3) δH 7.26-7.29 (m, 2H), 7.14-7.20 (m, 
3H), 3.63-3.76 (m, 5H), 3.51 (dt, J = 13.8, 5.2 Hz, 1H), 3.38 (dd, J = 15.2, 5.6 Hz, 
1H), 2.59-2.78 (m, 3H), 1.97-2.00 (m, 2H), 1.74 (q, J = 12.0 Hz, 2H); 
13
C NMR (100 
MHz, CDCl3) δC 176.7, 145.9, 128.4, 126.5, 126.4, 61.3, 51.5, 50.1, 48.0, 36.3, 35.8, 
30.5; IR (neat) 3428, 1616, 1056, 701 cm
-1
; MS (ES+) m/z 234.1 (M+H
+
); HRMS 
calcd for C14H20NO2 (M+H
+
): 234.1494, found 234.1452. 
 
 
General procedure for the addition of nucleophiles to tetrafluoroborate 
salt (87). Diisopropylethylamine (86.0 μL, 0.495 mmol) was added to a solution of 
homophthalic anhydride (80.1 mg, 0.495 mmol) in anhydrous acetonitrile (1 mL) and 
the resulting solution was stirred at rt for 5 min. Iminium ether 7-phenyl-3,5,6,7,8,9-
hexahydro-2-H-oxazolo[3,2-a]azepin-4-ium tetrafluoroborate salt (50.0 mg, 0.164 
mmol) was added to the solution and the reaction was heated to 80 °C and stirred for 
24 h. After cooling to rt, the crude solution was directly analyzed by LCMS and 
purified by mass-directed fractionation. Additional purification for characterization 
(if necessary) was completed by SiO2 preparative thin layer chromatography (5:95 
MeOH-CH2Cl2).  
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2-(2-Oxo-5-phenylazepan-1-yl)ethyl-2-((1-oxo-1H-isochromen-3-
yl)methyl)benzoate (113). Yellow oil (35.0 mg, 43%); Rf = 0.34, (5% 
MeOH/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 8.23 (d, J = 8.0 Hz, 1H), 8.03 (dd, J 
= 8.0, 1.2 Hz, 1H), 7.64 (dt, J = 7.6, 1.6 Hz, 1H), 7.54 (dt, J = 7.6, 1.6 Hz, 1H), 7.37-
7.46 (m, 3H), 7.26-7.29 (m, 3H), 7.21 (m, 1H), 7.08-7.10 (m, 2H), 6.16 (s, 1H), 4.47 
(t, J = 5.8 Hz, 2H), 4.33 (s, 2H), 3.88 (m, 1H), 3.66-3.78 (m, 2H), 3.39 (dd, J = 6.2, 
1.2 Hz, 1H), 2.72 (tt, J = 12.4, 3.4 Hz, 1H), 2.61-2.67 (m, 2H), 1.92-2.01 (m, 2H), 
1.63-1.80 (m, 2H); 
13
C NMR (100 MHz, CDCl3) δC 175.5, 166.7, 162.7, 156.6, 145.9, 
137.5, 137.4, 134.7, 132.6, 132.1, 131.1, 129.4, 129.3, 128.5, 127.7, 127.5, 126.6, 
126.5, 125.3, 120.1, 103.9, 62.9, 49.9, 48.1, 47.4, 37.6, 36.4, 36.1, 30.7; IR (neat) 
1724, 1652, 1487, 1257, 1134 cm
-1
; MS (ES+) m/z 496.2 (M+H
+
); HRMS calcd for 
C31H30NO5 (M+H
+
): 496.2046, found 496.1951. 
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2-(2-Oxo-5-phenylazepan-1-yl)ethyl-2-((1-oxo-1H-isochromen-3-
yl)methyl)benzoate (113). Compound 113 was proposed based on the distinctive 
1
H 
and 
13
C data for C8, C16, and C18 in addition to connectivity data derived from 
HMBC and COSY. C8 appears at 62.9 ppm in the 
13
C and the 
1
H shows a triplet at 
4.47 ppm with an integration of 2.0. This evidence supports the assignments of C8 as 
a methylene adjacent to a heteroatom, such as oxygen. C16 appears at 37.6 ppm in the 
13
C and the 
1
H shows a sharp singlet at 4.33 ppm with an integration of 2.0, consistent 
with a benzylic methylene. Additionally, C18 appears at 103.9 ppm in the 
13
C and the 
1
H shows a sharp singlet at 6.16 ppm with an integration of 1.0, consistent with a 
conjugated tri-substituted olefin. Distinctive 3-bond correlations in the HMBC map 
through the extended structure of the side chain to give the proposed atom placement. 
Key connections include C8 to C9, C10 to C16, C16 to C18, C18 to C20, C18 to C24, 
C19 to C23, and C23 to C25. Important 2-bond HMBC correlations include C16 to 
C17, C17 to C18, and C18 to C19. The COSY reaffirms the proposed structure by 
showing the retention of the expected carbon connectivity between C7 and C8, as 
well as between C2, C3, C4, C5, and C6. In addition, the COSY data was vital in 
distinguishing the atoms of the aromatic rings of the side chain. Important 
connections exist between C11, C12, C13, and C14, as well as between C20, C21, 
C22, and C23. This information is in accordance with similar products derived from 
reactions of homophthalic anhydride.
105
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2-(2-(2-Oxo-5-phenylcycloheptyl)ethyl)isoxazole-5(2H)-one (114). 
Synthesized according to the general procedure where 3-phenyl-5-isoxazolone (79.7 
mg, 0.495 mmol) was substituted for homophthalic anhydride. Clear oil (47.5 mg, 
87%); Rf = 0.41, (5% MeOH/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 7.42-7.54 (m, 
5H), 7.24-7.27 (m, 2H), 7.17 (m, 1H), 7.10-7.12 (m, 2H), 5.44 (s, 1H), 3.79-3.90 (m, 
2H), 3.60-3.73 (m, 2H), 3.48 (m, 1H), 3.33 (dd, J = 15.1, 5.4 Hz, 1H), 2.71 (tt, J = 
12.0, 3.6 Hz, 1H), 2.54 (m, 2H), 1.97 (m, 2H), 1.62-1.73 (m, 2H); 
13
C NMR (100 
MHz, CDCl3) δC 175.4, 170.5, 169.2, 145.7, 131.7, 129.3, 128.5, 127.5, 126.9, 126.5, 
126.4, 90.9, 51.8, 50.8, 47.9, 47.1, 36.3, 35.9, 30.5; IR (neat) 2927, 1737, 1643, 1490, 
1450, 761, 700 cm
-1
; MS (ES+) m/z 377.1 (M+H
+
); HRMS calcd for C23H25N2O3 
(M+H
+
): 377.1991, found 377.1700. 
 
 
2-(2-(2-Oxo-5-phenylcycloheptyl)ethyl)isoxazole-5(2H)-one (114). 
Compound 114 was proposed based on the distinctive 
1
H and 
13
C chemical shifts of 
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C8 and C10 in addition to connectivity data derived from HMBC and COSY. C8 
appears at 51.8 ppm in the 
13
C and the 
1
H shows a pair of multiplets at 3.79-3.90 ppm 
and 3.60-3.73 ppm suggesting C8 to be a methylene with diastereotopic hydrogens 
adjacent to a heteroatom, such as nitrogen. C10 appears at 90.9 ppm, in the 
13
C and 
the 
1
H shows as a sharp singlet at 5.44 ppm with an integration of 1.0, this data 
supports the assignment of C10 as a carbon of the tri-substituted olefin. Additionally, 
the presence of two characteristic 3-bond HMBC correlations to C9 further supports 
the proposed structure. First, the correlation between C9 and C13 suggests that C9 
(169.2 ppm) is the isoxazolone carbon α to nitrogen and not the carbon of ester. 
Second, the correlation between C9 and C8 suggests that the isoxazolone ring is 
connected to the parent amide through a carbon-nitrogen bond to C8. The COSY 
reaffirms this conclusion by showing the retention of the expected carbon 
connectivity between C7 and C8, as well as between C2, C3, C4, C5, and C6. 
 
 
1-(2-(3,5-Dimethoxyphenoxy)ethyl)-5-phenylazepan-2-one) (115). 
Synthesized according to the general procedure where 3,5-dimethoxyphenol (76.3 
mg, 0.495 mmol) was substituted for homophthalic anhydride. Yellow oil (17.4 mg, 
29%); Rf 0.81, (10% MeOH/CH2Cl2); 
1
H NMR (400MHz, CDCl3) δH 7.26-7.29 (m, 
2H), 7.19 (m, 1H), 7.11-7.13 (m, 2H), 6.10 (m, 1H), 6.07-6.08 (m, 2H), 4.08-4.17 (m, 
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2H), 3.85 (m, 1H), 3.78-3.71 (m, 2H), 3.75 (s, 6H), 3.53 (ddd, J = 15.6, 6.0, 1.2 Hz, 
1H), 2.74 (tt, J = 12.4, 3.6 Hz, 1H), 2.62-2.69 (m, 2H), 1.96-2.04 (m, 2H), 1.66-1.85 
(m, 2H); 
13
C NMR (100 MHz, CDCl3) δC 175.4, 161.6, 160.4, 146.2, 128.6, 126.7, 
126.5, 93.3, 93.2, 66.9, 55.3, 50.8, 48.6, 48.2, 36.6, 36.0, 30.8; IR (neat) 2935, 1645, 
1600,1477, 1454, 1203, 1193, 1151, 1068 cm
-1
; MS (ES+) m/z 370.1 (M+H
+
); HRMS 
calcd for C22H28NO4 (M+H
+
): 370.1940, found 370.2029. 
 
 
1-(2-(3,5-Dimethoxyphenoxy)ethyl)-5-phenylazepan-2-one) (115). 
Compound 115 was proposed based on the distinctive 
1
H and 
13
C chemical shifts of 
C8, C9, C10, C11, and C12 in addition to connectivity data derived from HMBC and 
COSY. C8 appears at 66.9 ppm in the 
13
C and the 
1
H shows a multiplet at 4.08-4.17 
ppm with an integration of 2.0. This evidence supports the assignment of C8 as a 
methylene adjacent to a heteroatom, such as oxygen. C9 and C11 appear at 160.4 
ppm and 161.6 ppm in the 
13
C, respectively, typical of O-substituted methoxyphenols. 
C10 and C12 appear at 93.2 ppm and 93.3 ppm in the 
13
C and at 6.08 ppm and 
6.10ppm in the 
1
H respectively, data typical of symmetrical O-substituted 
methoxyphenols. The 3-bond HMBC correlations of C8 and C11 with C9 support the 
presence of an ether linkage between C8 and C9 connecting the parent amide to the 
phenol. The COSY reaffirms this conclusion by showing retention of the expected 
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connectivity of the parent amide between C7 and C8, as well as between C2, C3, C4, 
C5, and C6. 
 
 
Ethyl 2-(2-oxo-5-phenylazepan-1-yl)ethyl malonate (116). Synthesized 
according to the general procedure except diethylmalonate (75.0 μL, 0.495 mmol) 
was substituted for homophthalic anhydride. Yellow oil (13.0 mg, 23% yield); Rf = 
0.24 (66% Hex/EtOAc); 
1
H NMR (400 MHz, CDCl3) δH 7.16-7.32 (m, 5H), 4.27-
4.37 (m, 2H), 4.17 (q, J = 7.2 Hz, 2H), 3.61-3.78 (m, 3H), 3.41 (m, 1H), 3.37 (s, 2H), 
2.75 (tt, J = 12.4, 3.6 Hz, 1H), 2.64-2.68 (m, 2H), 1.98-2.03 (m, 2H), 1.62-1.80 (m, 
2H), 1.25 (t, J = 7.2 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δC 175.5, 166.4, 166.3, 
146.0, 128.6, 126.8, 126.5, 63.8, 61.6, 50.1, 48.2, 47.4, 41.5, 36.5, 36.2, 30.6, 14.1; 
IR (neat) 2927, 1751, 1731, 1647, 1031 cm
-1
; MS (ES+) m/z 348.2 (M+H
+
); HRMS 
calcd for C19H26NO5 (M+H
+
): 348.1733, found 348.1578. 
 
 
Ethyl 2-(2-oxo-5-phenylazepan-1-yl)ethyl malonate (116). Compound 116 
was proposed based on the distinctive 
1
H and 
13
C data for C8 and C10 in addition to 
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connectivity data derived from HMBC and COSY. C8 appears at 63.8 ppm in the 
13
C 
and the 
1
H shows a multiplet at 4.27-4.37 ppm with an integration of 2.0. This 
evidence supports the assignment of C8 as a methylene adjacent to a heteroatom, such 
as oxygen. C10 appears at 41.5 ppm in the 
13
C and in the 
1
H shows a sharp singlet at 
3.37 ppm with an integration of 2.0. This evidence supports the assignment of C10 as 
the α methylene of the malonate. The 3-bond HMBC correlations between C8 and C9 
along with the 2-bond HMBC correlations of C9 and C11 with C10 support the 
connection of the parent amide to malonate through an ester bond with C8. The 
COSY reaffirms this conclusion by showing retention of the expected connectivity of 
the parent amide between C7 and C8, as well as between C2, C3, C4, C5, and C6. In 
addition, the COSY correlation between C12 and C13 shows the retention of one 
ethyl ester from the parent diethyl malonate. 
 
 
1-(2-(3-Oxocyclohex-1-enyloxy)ethyl)-5-phenylazepan-2-one (117). 
Synthesized according to the general procedure where 1,3-cyclohexadione (55.4 mg, 
0.495 mmol) was substituted for homophthalic anhydride. Yellow oil (30.2 mg, 
58%); Rf = 0.38, (5% MeOH/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 7.25-7.30 (m, 
2H), 7.20 (m, 1H), 7.12-7.14 (m, 2H), 5.35 (s, 1H), 3.98 (t, J = 5.2 Hz, 2H), 3.68-3.81 
(m, 3H), 3.43 (m, 1H), 2.74 (t, J = 3.6 Hz, 1H), 2.63-2.67 (m, 2H), 2.31-2.40 (dt, J = 
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20.8, 6.4 Hz, 4H), 1.92-2.03 (m, 4H), 1.63-1.77 (m, 2H); 
13
C NMR (100 MHz, 
CDCl3) δC 199.4, 177.1, 175.4, 145.9, 128.6, 126.5 (2), 103.0, 66.9, 50.4, 48.0, 47.6, 
36.6, 36.4, 36.1, 30.6, 28.9, 21.1; IR (neat) 1639,1180 cm
-1
; MS (ES+) m/z 328.1 
(M+H
+
); HRMS calcd for C20H26NO3 (M+H
+
): 328.1834, found 328.1878.  
 
 
1-(2-(3-Oxocyclohex-1-enyloxy)ethyl)-5-phenylazepan-2-one (117). 
Compound 117 was proposed based on the distinctive 
1
H and 
13
C chemical shifts of 
C8 and C10 in addition to connectivity data derived from HMBC and COSY. C8 
appears at 66.9 ppm in the 
13
C and the 
1
H shows a triplet at 3.98 ppm with an 
integration of 2.0. This evidence supports the assignment of C8 as a methylene 
adjacent to a heteroatom, such as oxygen. C10 appears at 103 ppm, in the 
13
C and the 
1
H shows a sharp singlet at 5.35 ppm with an integration of 1.0, suggesting the 
identity of C10 as the α-carbon of an enol ether. The 3-bond HMBC correlations 
between C8 and C9, in addition to the 2-bond HMBC correlations of C9 and C11 
with C10 support the connection of the diketone to the parent amide through an enol 
ether bond to C8. The COSY reaffirms this conclusion by showing retention of the 
expected carbon connectivity of the parent amide between C7 and C8, as well as 
between C2, C3, C4, C5, and C6. In addition the carbon connectivity of the diketone 
was retained between C12, C13, and C14. 
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1-(2-(1-Oxo-1H-inden-3-yloxy)ethyl)-5-phenylazepan-2-one (118). 
Synthesized according to the general procedure where 1,3-indanedione (72.3 mg, 
0.495 mmol) was substituted for homophthalic anhydride. Yellow oil (14.8 mg, 
25%); Rf = 0.50, (5% MeOH/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 7.48 (m, 1H), 
7.33-7.38 (m, 2H), 7.26-7.29 (m, 2H), 7.21-7.23 (m, 2H), 7.10-7.12 (m, 2H), 5.11, (s, 
1H), 4.32-4.42 (m, 2H), 3.91-3.94 (m, 2H), 3.83 (dd, J = 15.2, 10.4 Hz, 1H), 3.55 
(ddd, J = 8.8, 6.4, 1.2 Hz, 1H), 2.79 (t, J = 3.6 Hz, 1H), 2.65-2.73 (m, 2H), 2.01-2.10 
(m, 2H), 1.72-1.85 (m, 2H); 
13
C NMR (100 MHz, CDCl3) δC 194.5, 178.4, 175.7, 
145.8, 139.3, 133.1, 132.2, 130.4, 128.6, 126.6, 126.5, 121.3, 118.5, 96.9, 70.5, 50.8, 
48.1 (2), 36.5, 36.1, 30.7; IR (neat) 1697, 1637, 1618, 1562, 754 cm
-1
; MS (ES+) m/z 
362.1 (M+H
+
); HRMS calcd for C23H24NO3 (M+H
+
): 362.1678, found 362.1725. 
 
 
1-(2-(1-Oxo-1H-inden-3-yloxy)ethyl)-5-phenylazepan-2-one (118). 
Compound 118 was proposed based on the distinctive 
1
H and 
13
C chemical shifts of 
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C8 and C10 in addition to connectivity data derived from HMBC and COSY. C8 
appears at 70.5 ppm in the 
13
C and the 
1
H shows a multiplet at 4.32-4.42 ppm with an 
integration of 2.0. This evidence supports the assignment of C8 as a methylene 
adjacent to a heteroatom, such as oxygen. C10 appears at 96.9 ppm, in the 
13
C and the 
1
H shows as a sharp singlet at 5.11 ppm with an integration of 1.0. This data supports 
the identity of C10 as the α-carbon of an enol ether in conjugation with the aromatic 
ring. The 3-bond HMBC correlations of C8 and C17 with C9, as well as 2-bond 
HMBC correlations of C9 and C11 with C10 support the connection of the diketone 
to the parent amide through the presence of an enol ether bond to C8. The COSY 
reaffirms this conclusion by showing retention of the expected carbon connectivity of 
the parent amide between C7 and C8, as well as between C2, C3, C4, C5, and C6. In 
addition the carbon connectivity of the diketone was retained between C13, C14, C15 
and C16. 
 
 
Ethyl 2-(2-(2-oxo-5-phenylazepan-1-yl)ethoxy)acetate (119). Synthesized 
according to the general procedure where ethyl bromoacetate (55.0 μL, 0.495 mmol) 
was substituted for homophthalic anhydride. Clear oil (3.8 mg, 7%); Rf = 0.84, (66% 
Hex/EtOAc); 
1
NMR (500 MHz, CDCl3) 7.75-7.30 (m, 2H), 7.17-7.21 (m, 3H), 4.62 
(dt, J = 11.5, 3.0 Hz, 1H), 4.13 (q, J = 7.5 Hz, 2H), 3.92 (d, J = 11.0 Hz, 1H), 3.45 (d, 
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J = 17.5 Hz, 1H), 3.32 (dd, J = 17.5, 1.0 Hz, 1H), 3.06 (m, 1H), 2.86-2.95 (m, 3H), 
2.76 (m, 1H), 2.49 (m, 1H), 2.37 (m, 1H), 2.11 (m, 1H), 1.82 (m, 1H), 1.72 (m, 1H), 
1.61 (m, 1H), 1.24 (t, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δC 173.7, 171.6, 
147.0, 128.4, 127.7, 126.0, 63.8, 60.3, 55.1, 53.4, 52.6, 39.7, 33.9 (2), 30.3, 14.3; IR 
(neat) 1731, 1633, 1454, 1195, 1029, 702 cm
-1
; MS (ES+) m/z 320.2 (M+H
+
); HRMS 
calcd for C18H26NO4 (M+H
+
): 320.1784, found 320.1788. 
 
 
Ethyl 2-(2-(2-oxo-5-phenylazepan-1-yl)ethoxy)acetate (119). Compound 
119 was proposed based on the distinctive 
1
H and 
13
C data for C8, C9, and C10 in 
addition to connectivity data derived from HMBC and COSY. C8 appears at 53.4 
ppm in the 
13
C and the 
1
H shows a pair of triplets at 3.00 ppm and 2.95 ppm. C9 
appears at 55.1 ppm in the 
13
C and the 
1
H shows a pair of doublets at 3.45 ppm and 
3.52 ppm. C 10 appears at 173.7 ppm in the 
13
C, consistent with an α-alkoxy ester. 
The 3-bond HMBC correlations between C8 and C9, as well as the 2-bond HMBC 
correlations between C7 and C8, and C9 and C10 support the connection of the ethyl 
ester to the parent amide through the presence of an ether linkage of C8 and C9. The 
COSY reaffirms this conclusion by showing retention of the expected carbon 
connectivity of the parent amide between C7 and C8, as well as between C2, C3, C4, 
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C5, and C6. In addition the carbon connectivity of the ethyl ester was retained 
between C11 and C12. 
 
 
  Ethyl 2-acetamido-4-(2-oxo-5-phenylazepan-1-yl)butanoate (120). 
Iminium ether 7-phenyl-3,5,6,7,8,9-hexahydro-2-H-oxazolo[3,2-a]azepin-4-ium 
tetrafluoroborate salt 87 (50.0 mg, 0.160 mmol) was added to a solution of 
ethyldiazoacetate (52.0 μL, 0.160 mmol) in anhydrous acetonitrile (1 mL). The 
resulting solution was sealed in a pressure tube and stirred at 135 °C for 24 h. After 
cooling to rt, the crude material was directly analyzed by LCMS and purified by 
mass-directed fractionation to afford 15.0 mg (13%) of 120 as a yellow oil. The 
product slowly decomposed upon purification under acidic conditions and the 
corresponding NMR appeared as a mixture of rotamers in an approximate 1:1 ratio, as 
estimated by 
13
C NMR. Rf = 0.38, (5% MeOH/CH2Cl2); 
1
H NMR (500 MHz, CDCl3) 
δH 7.28-7.32 (m, 2H), 7.19-7.24 (m, 1H), 7.15-7.16 (m, 2H), 4.04-4.25 (m, 4H), 3.62-
3.78 (m, 2H), 3.55 (t, J = 7.0 Hz, 1H), 3.29-3.46 (m, 2H), 2.76 (m, 1H), 2.55-2.67 (m, 
2H), 2.23 (s, 1H), 2.02 (s, 2H), 1.96-2.08 (m, 1H), 1.62-1.81 (m, 4H), 1.28 (dt, J = 
12.5, 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δC 175.7, 175.6*, 171.4, 171.3*, 
169.4, 169.4*, 146.0, 145.7*, 128.7*, 128.6, 126.7, 126.6*, 126.6*, 126.5, 61.7, 
61.3*, 50.7, 50.4* 49.4*, 48.2, 48.1*, 48.0, 47.9*, 47.7, 45.4*, 44.7, 36.5, 36.5*, 
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36.3*, 36.0, 30.8, 30.6*, 21.5, 21.0*, 14.2*, 14.1; IR (neat) 2931, 1743, 1645, 1205, 
1029 cm
-1
; MS (ES+) m/z 361.2 (M+H
+
); HRMS calcd for C20H29N2O4 (M+H
+
): 
361.2049, found 361.2122. 
 
 
Ethyl 2-acetamido-4-(2-oxo-5-phenylazepan-1-yl)butanoate (120). 
Compound 120 was proposed based on the distinctive 
1
H and 
13
C chemical shift of 
C9 in addition to connectivity data derived from HMBC and COSY. C9 appears at 
47.7 ppm in the 
13
C and the 
1
H shows a clear triplet at 3.55 ppm with an integration of 
1.0, suggesting C9 to be adjacent to a methylene in addition to a proximity to electron 
withdrawing groups such as nitrogen and an ester. The HMBC gives critical 
information regarding the position of C9, showing a 3-bond correlation between C9 
and C13, and a 2-bond correlation between C8 and C9. Further connectivity is 
established through the key 3-bond correlations between C1 and C7, C6 and C7, C8 
and C10, and C10 and C11. Key 2-bond correlations occur between C7 and C8, C8 
and C9, C11 and C12, and C13 and C14. The COSY reaffirms this conclusion by 
showing the retention of the expected carbon connectivity of between C2, C3, C4, C5 
and C6. COSY correlations between C7, C8, and C9 are in accordance with the 
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proposed carbon-carbon bond formation at C8, and the correlation between C11 and 
C12 shows retention of the ethyl ester of the starting ethyl diazoacetate compound. 
 
 
5-Phenyl-1-(2-tosylethyl)azepan-2-one (121). Method A: Synthesized 
according to the general procedure except p-toluenesulfonylmethyl isocyanate (96.5 
mg, 0.495 mmol) was substituted for homophthalic anhydride, clear oil (24.3 mg, 
40%). Method B: Thioether phenyl-1-(2-(p-tolythio)ethyl)azepan-2-one 122 (13.4 
mg, 0.0395 mmol) was dissolved in CCl4 (2 mL) and m-CPBA (20.4 mg, 0.118 
mmol), was added to the solution at 0 °C. The mixture was warmed to rt and stirred 
for 5 h. The reaction was quenched by the addition of 10% sodium sulfite solution 
and was diluted with CH2Cl2, and extracted (3  10 mL). The organic extracts were 
collected, washed with brine, dried over anhydrous Na2SO2, and reduced to give a 
yellow oil. The crude material was purified by SiO2 preparative thin layer 
chromatography (66% Hex/EtOAc) to afford 14.5 mg (99%) of 121 as a clear oil. Rf 
= 0.32, (66% Hex/EtOAc); 
1
H NMR (500 MHz, CDCl3) δH 7.79-7.81 (m, 2H), 7.37 
(d, J = 8.0 Hz, 2H), 7.29 (t, J = 7.5 Hz, 2H), 7.21 (tt, J = 7.0, 1.5 Hz, 1H), 7.13-7.15 
(m, 2H), 3.91 (ddd, J = 13.5, 7.5, 5.5 Hz, 1H), 3.61-3.69 (m, 2H), 3.40-3.49 (m, 2H), 
3.33 (ddd, J = 13.5, 7.5, 5.5 Hz, 1H), 2.72 (tt, J = 12.0, 3.5 Hz, 1H), 2.56-2.58 (m, 
2H), 2.45 (s, 3H), 1.94-2.04 (m, 2H), 1.65-1.73 (m, 2H); 
13
C NMR (125 MHz, 
191 
 
CDCl3) δC 175.5, 145.8, 144.9, 136.2, 129.9, 128.6, 127.8, 126.6, 126.5, 54.0, 50.5, 
48.1, 43.6, 36.4, 36.1, 30.5, 21.7; IR (neat) 2925, 1643, 1299, 1145 cm
-1
; MS (ES+) 
m/z 372.1 (M+H
+
); HRMS calcd for C21H26NO3S (M+H
+
): 372.1555, found 
372.1485. 
 
 
5-Phenyl-1-(2-tosylethyl)azepan-2-one (121). Compound 121 was proposed 
based on the distinctive 
1
H and 
13
C chemical shift of C8 in addition to connectivity 
data derived from HMBC and COSY. C8 appears at 54.0 ppm in the 
13
C and the 
1
H 
shows a pair of multiplets at 3.40-3.49 ppm and 3.33 ppm suggesting C8 to be a 
methylene with diastereotopic hydrogens adjacent to a heteroatom, like a sulfoxide 
group. Additionally, the HMBC spectrum shows two distinct regions of connectivity 
within the molecule. The 3-bond correlations between C11 and C15, C10 and C11, as 
well as C9 and C11 suggest the retention of p-toluenesulfonyl methyl moiety. The 2-
bond correlation between C7 and C8, in addition to the 3-bond correlations between 
C1 and C7, and C6 and C7 suggest attachment of the p-toluenesulfonyl methyl group 
to C8. The COSY reaffirms this conclusion by showing the retention of the expected 
carbon connectivity between C7 and C8, as well as between C2, C3, C4, C5, and C6. 
COSY data was also present for the p-toluenesulfonyl methyl group between C10 and 
C11. 
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5-Phenyl-1-(2-(p-tolythio)ethyl)azepan-2-one (122). To a solution of 
potassium hydride (10.0 mg, 0.247 mmol) in anhydrous DMF (1.0 mL) was added a 
solution of 4-methylbenzenethiol (30.7 mg, 0.247 mmol) in anhydrous DMF (0.5 
mL). The mixture was stirred at rt for 5 min and iminium ether 7-phenyl-3,5,6,7,8,9-
hexahydro-2-H-oxazolo[3,2-a]azepin-4-ium tetrafluoroborate salt 87 (25.0 mg, 
0.0824 mmol) was added to the flask. The reaction mixture was stirred at 80 °C for 
24 h. After cooling, the solution was diluted with water and extracted with diethyl 
ether (3  10 mL). The organic extracts were combined, washed with brine, dried 
over anhydrous Na2SO4, and reduced to give a yellow oil. The crude material was 
purified by silica gel preparative thin layer chromatography (66% Hex/EtOAc) to 
afford 26.3 mg (94%) of 122 as a clear oil. Rf = 0.61, (66% Hex/EtOAc); 
1
H NMR 
(400 MHz, CDCl3) 7.28-7.32 (m, 4H), 7.20 (m, 1H), 7.11-7.15 (m, 4H), 3.60-3.74 (m, 
2H), 3.52 (m, 1H), 3.29 (dd, J = 14.4, 6.4 Hz, 1H), 3.10 (t, J = 6.8 Hz, 2H), 2.72 (tt, J 
= 12.0, 3.6 Hz, 1H), 2.60-2.63, (m, 2H), 2.31 (s, 3H), 1.98-2.01 (m, 2H), 1.68-1.79 
(m, 2H); 
13
C NMR (100 MHz, CDCl3) δC 175.3, 146.0, 136.2, 131.8, 129.8, 129.6, 
128.6, 126.6, 126.5, 50.1, 48.8, 48.2, 36.5, 36.4, 32.0, 30.6, 20.9; IR (neat) 2921, 
1645, 1492, 1450,1419, 1176, 700 cm
-1
; MS (ES+) m/z 340.2 (M+H
+
); HRMS calcd 
for C21H26NOS (M+H
+
): 340.1735, found 340.1745. 
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5-Phenyl-1-(2-(p-tolythio)ethyl)azepan-2-one (122). Compound 122 was 
proposed based on the distinctive 
1
H and 
13
C chemical shift of C8 in addition to 
connectivity data derived from HMBC and COSY. C8 appears at 32.0 ppm in the 
13
C 
and the 
1
H shows a triplet at 3.10 ppm suggesting C8 to be a methylene adjacent to a 
heteroatom, such as sulfur. Additionally, the HMBC spectrum shows two distinct 
regions of connectivity within the molecule. The 3-bond correlations between C11 
and C15, C10 and C12, as well as C9 and C11 supports the retention of the 4-
methylthiobenzene moiety. The 2-bond correlation between C7 and C8, in addition to 
the 3-bond correlations between C1 and C7, and C6 and C7 suggest attachment of the 
4-methylthiobenzene group to C8. The COSY reaffirms this conclusion by showing 
the retention of the expected carbon connectivity between C7 and C8, as well as 
between C2, C3, C4, C5, and C6. COSY data was also present for the 4-
methylthiobenzene group between C10 and C11. 
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Control reaction: synthesis of 1-(benzylsulfonyl)-4-methylbenzene. 
 
Diisopropylethylamine (0.113 mL, 0.650 mmol) was added to a solution of p-
toluenesulfonylmethyl isocyanate (127 mg, 0.650 mmol) in anhydrous acetonitrile (1 
mL) and the resulting solution was stirred at rt for 5 min. Benzylbromide (20.0 μL, 
0.216 mmol) was added to the solution and the reaction was heated to 80 °C and 
stirred for 24 h. After cooling to rt, the crude solution was directly analyzed by 
LCMS and purified by mass-directed fractionation. Additional purification was 
completed with SiO2 preparative thin layer chromatography (20% EtOAc/Hex) to 
afford 17.4 mg, (33%) as a white solid. The observed characterization data matched 
that previously reported.
106
 Rf = 0.34 (20% EtOAc/Hex); mp 141.0-142.0 °C ; 
1
H 
NMR (400 MHz, CDCl3) δH 7.40-7.42 (d, J = 8.4 Hz, 2H), 7.13-7.24 (m, 5H), 6.98-
7.01 (d, J = 8.4 Hz, 2H), 4.20 (s, 2H), 2.33 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δC 
144.6, 134.9, 130.8, 129.4, 128.6, 128.5, 128.3, 128.1, 62.9, 21.6; IR (neat) 2923, 
1301, 1128, 783 cm
-1
; MS (ES+) m/z 247.1 (M+H
+
); HRMS calcd for C14H15O2S 
(M+H
+
): 247.0793, found 247.0803.  
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1-(Benzylsulfonyl)-4-methylbenzene. This compound was proposed based 
on the distinctive 
1
H and 
13
C chemical shift of C7 in addition to connectivity data 
derived from HMBC and COSY. C7 appears at 62.9 ppm in the 
13
C and the 
1
H shows 
a sharp singlet at 4.20 ppm suggesting C7 to be a benzylic methylene adjacent to a 
heteroatom, such as sulfoxide. Additionally, the HMBC spectrum shows two distinct 
regions of connectivity within the molecule. The 3-bond correlations between C8 and 
C10, C9 and C11, and C10 and C14, in addition to the 2-bond correlation between 
C11 and C14 suggest the presence of p-toluenesulfonyl methyl moiety. The 2-bond 
correlation between C1 and C7, and the 3-bond correlations between C2 and C4, and 
C2 and C7 suggest attachment of the 4-methylthiobenzene group to C7. The COSY 
reaffirms this conclusion by showing the retention of the expected carbon 
connectivity between the benzylic and p-toluenesulfonyl methyl regions of the 
molecule with correlations between C4, C5, and C6, as well as between C12 and C13. 
 
General procedure for the addition of nucleophiles to bicyclic iminium 
ether triflate salt. Diisopropylethylamine (112.0 μL, 0.650 mmol) was added to a 
solution of homophthalic anhydride (105 mg, 0.650 mmol) in anhydrous acetonitrile 
(2 mL) and the resulting solution was stirred at rt for 5 min. Bicyclic iminium ether 
67 (100.0 mg, 0.216 mmol) was added to the solution and the reaction was heated to 
80 °C and stirred for 24 h. After cooling to rt, the crude solution was directly 
analyzed by LCMS and purified by mass-directed fractionation. Additional 
purification for characterization (if necessary) was completed by silica gel preparative 
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thin layer chromatography (5% MeOH/CH2Cl2). Alternatively, some reactions were 
similarly completed on a 0.216 mmol scale using proportional amounts of the 
necessary reagents.  
 
 
(E)-3-(3-Methoxy-8-methyl-4,7-dioxo-9-phenyl-6-azabicyclo[3.2.2]non2-
en-6-yl)propyl 2-((1-oxo-1H-isochromen-3-yl)methyl)benzoate (123a) and (E)-3-
(3-methoxy-9-methyl-2,7-dioxo-8-phenyl-6-azabicyclo[3.2.2]non-3-en-6-
yl)propyl-2-((1-oxo-1H-isochromen-3-yl)mehtyl)benzoate (123b). Clear oil (32.6 
mg, 25% as an inseparable mixture of regioisomers); Rf = 0.25 (66% Hex/EtOAc); 
1
NMR (400 MHz, CDCl3) δH 8.21 (dd, J = 8.0, 0.4 Hz, 1H), 8.02 (dd, J = 8.0, 1.2 Hz, 
1H), 7.61 (dt, J = 7.6, 1.2 Hz, 1H), 7.51 (dt J = 7.6, 1.2 Hz, 1H), 7.36-7.43 (m, 3H), 
7.21-7.29 (m, 4H), 7.10 (m, 2H), 7.02* (m, 0.46), 6.42* (d, J = 9.2 Hz, 0.23H) 6.33 
(d, J = 10.4 Hz, 1H), 6.11 (s, 1H), 6.09* (s, 0.23H), 4.29 (s, 2H), 4.21-4.32 (m, 2H), 
4.11 (d, J = 5.6 Hz, 1H), 3.91* (d, J = 4.8 Hz, 0.23H), 3.88* (m, 0.23H), 3.77* (m, 
0.23H), 3.68 (s, 3H), 3.65* (s, 0.69H), 3.63 (m, 1H), 3.51 (m, 1H), 3.38* (m, 0.23H), 
3.29 (dd, J = 10.0, 1.2 Hz, 1H), 3.15 (t, J = 6.4 Hz, 1H), 2.94* (t, J = 5.4 Hz, 0.23H), 
2.58 (p, J = 6.8 Hz, 1H), 1.89-2.03 (m, 2H), 1.20 (d, J = 7.2 Hz, 3H), 1.18* (d, J = 6.8 
Hz, 0.69H); 
13
C NMR (100 MHz, CDCl3) δC 189.2, 186.6*, 171.3, 169.4*, 166.9*, 
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166.8, 162.7, 160.5*, 156.8, 153.3, 152.2*, 138.6*, 138.9*, 137.3, 137.4, 137.2, 
136.9*, 134.8*, 134.6, 132.3*, 132.5, 132.0*, 131.9, 131.2, 129.6, 129.4, 129.3*, 
129.0, 128.9*, 128.4, 128.0*, 127.8*, 127.7, 127.6, 127.5*, 127.4, 125.3*, 125.3, 
120.0, 118.6*, 117.5*, 117.0, 103.8, 103.8*, 72.7, 68.2*, 62.6*, 62.0, 59.4*, 55.4, 
55.4*, 52.7, 49.2, 48.1*, 44.9*, 43.7, 42.7*, 41.2, 37.8*, 37.6, 27.7*, 27.4, 22.9, 
21.4*; IR (neat) 1720, 1670, 1622, 1456, 1259, 1130, 730 cm
-1
; MS (ES+) m/z 592.2 
(M+H
+
); HRMS calcd for C36H34NO7 (M+H
+
): 592.2257, found 592.2310. 
 
 
(E)-3-(3-Methoxy-8-methyl-4,7-dioxo-9-phenyl-6-azabicyclo[3.2.2]non2-
en-6-yl)propyl 2-((1-oxo-1H-isochromen-3-yl)methyl)benzoate (123). Compound 
123 was proposed based on the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, 
C17, C19, C20, C27, C29 and C36 in addition to connectivity data derived from 
HMBC and COSY. C1 appears at 72.7 ppm in the 
13
C and the 
1
H shows a doublet at 
4.11 ppm with an integration of 1.0, consistent with the assignment of C1 as the 
bridgehead position between two electron withdrawing groups such as nitrogen and 
an α-methoxy ketone. C5 appears at 49.2 ppm in the 
13
C and the 
1
H shows a doublet 
of doublets at 3.29 ppm, consistent with a bridgehead methylene between slight 
electron withdrawing groups such as an olefin and an amide. C14 appears at 171.3 
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ppm in the 
13
C, typical of a lactam. C17 and C19 appear at 43.7 ppm and 62.0 ppm 
respectively in the 
13
C. C17 appears as a pair of multiplets in the 
1
H at 3.63 ppm and 
3.51 ppm, supporting the assignment of C17 as a methylene with diastereotopic 
hydrogens adjacent to a heteroatom such as nitrogen. C19 appears as a multiplet in 
the 
1
H
 
at 4.21-4.32 ppm. This data supports the assignment of C19 as a methylene 
adjacent to a heteroatom such as oxygen. C20 and C36 appear at 166.7 ppm and 
162.7 ppm respectively in the 
13
C, common shifts for benzylic esters and lactones. 
C27 appears at 37.6 ppm in the 
13
C and the 
1
H shows a sharp singlet at 4.29 ppm with 
an integration of 2.0, consistent with a benzylic methylene. Additionally, C29 appears 
at 103.8 ppm in the 
13
C and the 
1
H shows a sharp singlet at 6.11 ppm with an 
integration of 1.0, consistent with a conjugated tri-substituted olefin. Distinctive 3-
bond correlations in the HMBC map through the extended structure of the side chain 
to give the proposed atom placement. Key connections include C19 to C20, C21 to 
C27, C27 to C29, C29 to C31, C29 to C35, C30 to C34, and C34 to C36. In addition, 
the observed connection between C28 to C29 is an important 2-bond HMBC 
correlation. HMBC data also supports the assigned regioisomer of nitrogen insertion 
with the 3-bond correlations between C4 and C14, C6 and C14, C14 and C17, C1 and 
C17, and C17 and C19. The COSY reaffirms this conclusion by showing the retention 
of the carbon connectivity throughout the bicycle with correlations between C1, C4, 
C5, C6, C7, and C15, as well as between C11, C12, and C13. Retention of the carbon 
connectivity between C15, C16, and C17 is also observed. In addition, COSY was 
vital in distinguishing the atoms of the aromatic rings of the side chain. Important 
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connections exist between C22, C23, and C24, as well as between C31, C32, and 
C33. This information is in accordance with similar products derived from reactions 
of homophthalic anhydride.
124,126,166
 
 
 
(E)-3-Methoxy-8-methyl-6-(3-5-oxo-3-phenylisoxazol-2(5H)-yl)propyl)-9-
phenyl-6-azabicyclo[3.2.2]non-2-ene-4,7-dione (124). Synthesized according to the 
general procedure where 3-phenyl-5-isoxazolone (52.4 mg, 0.325 mmol) was 
substituted for homophthalic anhydride. Yellow oil (10.0 mg, 26% based on the 
major regioisomer in reactant); Rf = 0.75 (5% MeOH/CH2Cl2); 
1
NMR (500 MHz, 
CDCl3) δH 7.43-7.56 (m, 5H), 7.23-7.32 (m, 3H), 7.08-7.09 (m, 2H), 7.01-7.02* (m, 
0.34H), 6.45* (d, J = 9.0 Hz, 0.17H), 6.29 (d, J = 10.0 Hz, 1H), 5.48 (s, 1H), 5.30* (s, 
0.17H), 4.08 (d, J = 5.5 Hz, 1H), 3.90* (d, J = 5.0 Hz, 0.17 H), 3.81* (m, 0.17H), 
3.71* (s, 0.51H), 3.65 (s, 3H), 3.60 (m, 1H), 3.41-3.54 (m, 3H), 3.28 (dd, J = 10.0, 
1.5 Hz, 1H), 3.05 (t, J = 6.0 Hz, 1H), 2.92* (t, J = 6.0 Hz, 0.17H), 2.63* (p, J = 6.5 
Hz, 0.17H), 2.57 (p, J = 6.5 Hz, 1H), 1.85-2.03 (m, 2H), 1.21* (d, J = 7.0 Hz, 0.51H), 
1.16 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δC 188.9, 186.5*, 171.5, 
170.7*, 170.5, 170.0*, 169.8, 168.2*, 155.0*, 153.2, 138.5*, 137.5, 131.9*, 131.6, 
129.5*, 129.4, 129.0, 128.9*, 128.4, 128.0*, 127.9, 127.9*, 127.8, 127.7*, 127.6, 
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127.3*, 118.4*, 116.8, 92.6, 92.2*, 72.3, 68.2*, 59.1*, 55.6*, 55.4, 52.7, 51.7, 51.5*, 
49.2, 49.1*, 44.7*, 43.9, 42.6*, 41.2, 29.7*, 25.4, 22.9, 21.5*; IR (neat) 1739, 1670, 
1618, 1452, 1126, 912, 730 cm
-1
; MS (ES+) m/z 473.2 (M+H
+
); HRMS calcd for 
C28H29N2O5 (M+H
+
): 473.1998, found 473.2299. 
 
 
(E)-3-Methoxy-8-methyl-6-(3-5-oxo-3-phenylisoxazol-2(5H)-yl)propyl)-9-
phenyl-6-azabicyclo[3.2.2]non-2-ene-4,7-dione (124). Compound 124 was proposed 
based on the distinctive 
1
H and 
13
C chemical shifts of C1, C5, C14, C17, C19, and 
C21 in addition to connectivity data derived from HMBC and COSY. C1 appears at 
72.3 ppm in the 
13
C and the 
1
H shows a doublet at 4.08 ppm with an integration of 
1.0, consistent with the assignment of C1 as the bridgehead position between two 
electron withdrawing groups such as nitrogen and an α-methoxy ketone. C5 appears 
at 49.2 ppm in the 
13
C and 
1
H shows a doublet at 3.28 ppm. This data supports the 
assignment of C5 as a bridgehead methylene between slight electron withdrawing 
groups such as an olefin and an amide. C14 appears at 171.5 ppm in the 
13
C, typical 
of a lactam. C17 and C19 appear at 43.9 ppm and 51.7 ppm respectively in the 
13
C. 
C17 appears as a pair of multiplets in the 
1
H at 3.60 and 3.41-3.54 ppm, supporting 
the assignment of C17 as a methylene with diastereotopic hydrogens adjacent to a 
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heteroatom such as nitrogen. C19 overlaps with C17 in the 
1
H appearing at 3.41-3.54 
ppm as a multiplet. This data plausibly supports C19 as a methylene adjacent to a 
heteroatom such as nitrogen. C21 appears at 92.6 ppm, in the 
13
C and the 
1
H shows as 
a sharp singlet at 5.48 ppm with an integration of 1.0, this data supports the 
assignment of C21 as the carbon of the tri-substituted olefin. The presence of a key 3-
bond HMBC correlation between C22 and C24, in addition to two key 2-bond HMBC 
correlations between C20 and C21, and C21 and C22 suggests that C22 (169.8 ppm) 
is the isoxazolone carbon α to nitrogen, and not the carbon of ester, as the proposed 
point of attachment to the bicyclic structure. The HMBC also shows the retention of 
the major bicyclic structure through the 3-bond correlations between C3 and C16, C3 
and C5, C4 and C6, and C7 and C15. In addition, the HMBC supports the assigned 
regioisomer of nitrogen insertion with 3-bond correlations between C4 and C14, C6 
and C14, C14 and C17, and C17 and C19. The COSY reaffirms this conclusion by 
showing the retention of the carbon connectivity throughout the bicycle with 
correlations between C1, C4, C5, C6, C7, and C15, as well as between C11, C12, and 
C13. COSY data also shows the retention of the carbon connectivity between C15, 
C16, and C17, as well as between C24, C25, and C26 of the aryl group on the 
isoxazolone ring. 
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(E)-3-Methoxy-8-methyl-9-phenyl-6-(3-(3-phenylisoxazol-5-yloxy)propyl)-
6-azabicyclo[3.2.2]non-2-ene-4,7-dione (125). Synthesized according to the general 
procedure where 3-phenyl-5-isoxazolone (52.4 mg, 0.325 mmol) was substituted for 
homophthalic anhydride. Yellow oil (10.6 mg, 28% based on the major regioisomer 
in reactant); Rf = 0.58 (5% MeOH/CH2Cl2); 
1
NMR (400 MHz, CDCl3) δH 7.73-7.75 
(m, 2H), 7.43-7.45 (m, 3H), 7.22-7.31 (m, 3H), 7.09-7.10 (m, 2H), 6.34 (d, J = 10.4 
Hz, 1H), 5.53 (s, 1H), 4.27 (t, J = 6.4 Hz, 2H), 4.14 (d, J = 5.6 Hz, 1H), 3.75 (m, 1H), 
3.70 (s, 3H), 3.55 (m, 1H), 3.32 (dd, J = 10.4, 1.2 Hz, 1H), 3.16 (t, J = 6.0 Hz, 1H), 
2.61 (t, J = 6.8 Hz, 1H), 2.06 (p, J = 6.4 Hz, 2H), 1.22 (d, J = 6.8 Hz, 3H); 
13
C NMR 
(100 MHz, CDCl3) δC 189.2, 173.3, 171.5, 164.2, 153.3, 137.6, 130.0 (2), 129.0, 
128.8, 128.4, 127.8, 126.5, 116.9, 76.2, 73.0, 69.9, 55.5, 52.7, 49.2, 44.1, 41.2, 27.8, 
22.9; IR (neat) 1666, 1608, 1579, 1458, 1209, 732 cm
-1
; MS (ES+) m/z 473.2 
(M+H
+
); HRMS calcd for C28H29N2O5 (M+H
+
): 473.1998, found 473.1838. 
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(E)-3-Methoxy-8-methyl-9-phenyl-6-(3-(3-phenylisoxazol-5-yloxy)propyl)-
6-azabicyclo[3.2.2]non-2-ene-4,7-dione (125a). Compound 125a was proposed 
based on the distinctive 
1
H and 
13
C chemical shifts of C1, C5, C14, C17, C19, and 
C21 in addition to connectivity data derived from HMBC and COSY. C1 appears at 
73.0 ppm in the 
13
C and the 
1
H shows a doublet at 4.14 ppm with an integration of 
1.0, consistent with the assignment of C1 as the bridgehead position between two 
electron withdrawing groups such as nitrogen and an α-methoxy ketone. C5 appears 
at 49.2 ppm in the 
13
C and 
1
H shows a doublet at 3.32 ppm. This data supports the 
assignment of C5 as a bridgehead methylene between slight electron withdrawing 
groups such as an olefin and an amide. C14 appears at 171.5 ppm in the 
13
C, typical 
of a lactam. C17 and C19 appear at 44.1 ppm and 69.9 ppm respectively in the 
13
C. 
C17 appears as a pair of multiplets in the 
1
H at 3.75 and 3.55 ppm, supporting the 
assignment of C17 as a methylene with diastereotopic hydrogens adjacent to a 
heteroatom such as nitrogen. C19 appears as a triplet in the 
1
H
 
at 4.27 ppm. This data 
supports the assignment of C19 as a methylene adjacent to a heteroatom such as 
oxygen. C21 appears at 76.2 ppm, in the 
13
C and the 
1
H shows as a sharp singlet at 
5.53 ppm with an integration of 1.0, this data supports the assignment of C21 as the 
carbon of the tri-substituted olefin. Critical 3- and 2-bond HMBC correlations 
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between C20, C21, C22, and C14 identify C20 as the enol ether at 173.3 ppm and 
C22 as the carbon α to nitrogen in the isoxazolone ring at 164.2 ppm. The presence of 
a 3-bond HMBC correlation between C19 and C20 is consistent with the proposed 
point of attachment to the bicycle through the enol ether oxygen and not through the 
nitrogen of the isoxazolone ring. Also, the HMBC supports the retention of the major 
bicyclic structure through the 3-bond correlations between C3 and C16, C3 and C5, 
C4 and C6, and C7 and C15. It also supports the assigned regioisomer of nitrogen 
insertion with 3-bond correlations between C4 and C14, C6 and C14, C14 and C17, 
and C17 and C19. The COSY reaffirms this conclusion by showing the retention of 
the carbon connectivity throughout the bicycle with correlations between C1, C4, C5, 
C6, C7, and C15, as well as between C11, C12, and C13. COSY data also shows the 
retention of the carbon connectivity between C15, C16, and C17 of the side chain, as 
well as between C24, C25, and C26 of the aryl group on the isoxazolone ring. 
 
 
(E)-6-(3-(3,5-Dimethoxyphenoxy)propyl)-3-methoxy-8-methyl-9-phenyl-
6-azabicyclo[3.2.2]non-2-ene-4,7-dione (126). Synthesized according to the general 
procedure where 3,5-dimethoxyphenol (50.0 mg, 0.325 mmol) was substituted for 
homophthalic anhydride. Clear oil (32.3 mg, 57% based on the major regioisomer in 
reactant); Rf = 0.26 (66% Hex/EtOAc); 
1
NMR (400 MHz, CDCl3) δH 7.23-7.28 (m, 
3H), 7.00-7.02 (m, 2H), 6.34 (d, J = 10.4 Hz, 1H), 6.09-6.12 (m, 3H), 4.18 (d, J = 5.6 
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Hz, 1H), 3.92-3.98 (m, 2H), 3.76 (s, 6H), 3.70 (s, 3H), 3.62 (m, 2H), 3.32 (dd, J = 
10.4, 1.2 Hz, 1H), 3.13 (t, J = 6.4 Hz, 1H), 2.60 (p, J = 6.4 Hz, 1H), 1.99-2.07 (m, 
2H), 1.23 (d, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 189.2, 171.4, 161.5, 
160.5, 153.3, 137.7, 128.9, 128.3, 127.7, 116.8, 93.3, 93.4, 73.1, 65.1, 55.4, 55.3, 
52.6, 49.2, 44.6, 40.9, 27.9, 22.9; IR (neat) 2956, 1672, 1600, 1456, 1151, 1064 cm
-1
; 
MS (ES+) m/z 466.2 (M+H
+
); HRMS calcd for C27H32NO6 (M+H
+
):466.2151, found 
466.2200. 
 
 
(E)-6-(3-(3,5-Dimethoxyphenoxy)propyl)-3-methoxy-8-methyl-9-phenyl-
6-azabicyclo[3.2.2]non-2-ene-4,7-dione (126). Compound 126 was proposed based 
on the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, C17, C19, C20, C21, and 
C22 in addition to connectivity data derived from HMBC and COSY. C1 appears at 
73.1 ppm in the 
13
C and the 
1
H shows a doublet at 4.18 ppm with an integration of 
1.0, consistent with the assignment of C1 as the bridgehead position between two 
electron withdrawing groups such as nitrogen and an α-methoxy ketone. C5 appears 
at 49.2 ppm in the 
13
C and the 
1
H shows a doublet at 3.32 ppm, consistent with a 
bridgehead methylene between slight electron withdrawing groups such as an olefin 
and an amide. C14 appears at 171.4 ppm in the 
13
C, typical of a lactam. C17 and C19 
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appear at 44.6 ppm and 65.1 ppm respectively in the 
13
C. C17 appears as a multiplet 
in the 
1
H at 3.62 ppm, supporting the assignment of C17 as a methylene adjacent to a 
heteroatom such as nitrogen. C19 appears as a multiplet in the 
1
H
 
at 3.92-3.98 ppm. 
This data supports the assignment of C19 as a methylene adjacent to a phenol. C20 
and C22 appear at 160.5 ppm and 161.5 ppm in the 
13
C, typical of O-substituted 
methoxyphenols. C21 and C23 appear at 93.3 ppm and 93.4 ppm, respectively in the 
13
C and at 6.09-6.12 ppm in the 
1
H, data typical of symmetrical O-substituted 
methoxyphenols. The 3-bond HMBC correlations of C19 and C24 with C20 support 
the presence of an ether linkage between C19 and C20 connecting the parent amide to 
the phenol. The HMBC supports the retention of the major bicyclic structure through 
the 3-bond correlations between C3 and C16, C3 and C5, C4 and C6, and C7 and 
C15. In addition, the HMBC supports the assigned regioisomer of nitrogen insertion 
with the 3-bond correlations between C4 and C14, C6 and C14, C14 and C17, and 
C17 and C19. The COSY reaffirms this conclusion by showing the retention of the 
carbon connectivity throughout the bicycle with correlations between C1, C4, C5, C6, 
C7, and C15, as well as between C11, C12, and C13. COSY data also shows the 
retention of the carbon connectivity between C15, C16, and C17. 
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(E)-Ethyl-3-(3-methoxy-8-methyl-4,7-dioxo-9-phenyl-6-
azabicyclo[3.2.2]non-2-en-6-yl)propyl malonate (127a) and (E)-ethyl-3-(3-
methoxy-9-methyl-2,7-dioxo-8-phenyl-6-azabicyclo[3.2.2]non-3-en-6-yl)propyl 
malonate (127b). Synthesized according to the general procedure where diethyl 
malonate (49.0 μL, 0.325 mmol) was substituted for homophthalic anhydride. Yellow 
oil (10.1 mg, 21% as an inseparable mixture of regioisomers); Rf = 0.24 (66% 
Hex/EtOAc); 
1
H NMR (500 MHz, CDCl3) δH 7.23-7.31 (m, 4.8H), 7.09-7.11 (m, 
2H), 7.02-7.04* (m, 1.2H), 6.43* (d, J = 9.0 Hz, 0.6H), 6.33 (d, J = 10.0 Hz, 1H), 
4.22* (q, J = 7.0 Hz, 1.2H), 4.18 (q, J = 7.0 Hz, 2H), 4.13-4.27* (m, 1.2H), 4.10 (d, J 
= 5.5 Hz, 1H), 4.06-4.11 (m, 1H), 3.94* (d, J = 9.0 Hz, 0.6H), 3.92* (d, J = 5.0 Hz, 
0.6H), 3.80* (m, 0.6H), 3.69 (s, 3H), 3.68* (s, 1.8H), 3.57 (m, 1H), 3.47 (m, 1H), 
3.41* (d, J = 2.0 Hz, 1.2H), 3.38 (s, 2H), 3.35* (m, 0.6H), 3.30 (dd, J = 10.0, 1.0 Hz, 
1H), 3.14 (t, J = 6.0 Hz, 1H), 2.96* (t, J = 6.0 Hz, 0.6H), 2.56-2.63 (m, 1.6H), 1.91-
1.99* (m, 1.2H), 1.83-1.89 (m, 2H), 1.21-1.31 (m, 9.6H); 
13
C NMR (125 MHz, 
CDCl3) δC 189.2, 186.7*, 171.4, 168.1*, 166.8*, 166.5*, 166.5, 166.4, 154.9*, 153.3, 
138.7*, 137.7, 129.0, 128.9*, 128.4, 128.0*, 127.8, 127.5*, 118.6*, 116.9, 72.8, 
68.3*, 62.8*, 62.4, 61.7*, 61.6, 59.6*, 55.5, 55.5*, 52.7, 49.2, 48.1*, 44.9*, 43.8, 
42.7*, 41.5*, 41.4, 41.2, 27.4*, 27.2, 22.9, 21.4*, 14.1*, 14.0; IR (neat) 2960, 1747, 
1731, 1681, 1674, 1622, 1151, 1031 cm
-1
; MS (ES+) m/z 444.2 (M+H
+
); HRMS 
calcd for C24H30NO7 (M+H
+
): 444.1944, found 444.1896. 
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(E)-Ethyl-3-(3-methoxy-9-methyl-2,7-dioxo-8-phenyl-6-
azabicyclo[3.2.2]non-3-en-6-yl)propyl malonate (127b). Compound 127b was 
proposed based on the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, C17, 
C19, C20, C21, and C22, in addition to connectivity data derived from HMBC and 
COSY. C1 appears at 68.3 ppm in the 
13
C and the 
1
H shows a doublet at 3.92 ppm 
with an integration of 1.0, consistent with the assignment of C1 as a bridgehead 
methylene between electron withdrawing groups such as an α-methoxy ketone and a 
lactam. C5 appears at 59.6 ppm in the 
13
C and the 
1
H shows a doublet at 3.94 ppm, 
consistent with the assignment of C5 as the bridgehead position between two electron 
withdrawing groups such as nitrogen and an olefin. C14 appears at 168.1 ppm in the 
13
C, typical of a lactam. C17 and C19 appear at 45.0 ppm and 62.8 ppm respectively 
in the 
13
C. C17 appears as a pair of multiplets at 3.80 ppm and 3.35 ppm in the 
1
H, 
common for a methylene with diastereotopic hydrogens adjacent to a heteroatom such 
as nitrogen. C19 appears as a multiplet at 4.13-4.27 ppm in the 
1
H, common for a 
methylene adjacent to a heteroatom such as oxygen. C20 and C22 appear at 166.5 
ppm and 166.8 ppm in the 
13
C NMR, consistent with a 1,3-diester. C21 appears at 
41.2 ppm in the 
13
C and the 
1
H shows a sharp singlet at 3.38 ppm, corresponding to 
the methylene α to the malonate. The 3-bond HMBC correlation between C19 and 
C20 along with the 2-bond HMBC correlations of 20 and C22 with C21 support the 
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connection of the parent amide to malonate through an ester bond with C19. The 
HMBC supports the retention of the major bicyclic structure through the 3-bond 
correlations between C3 and C16, C3 and C5, C4 and C6, C2 and C7, and C7 and 
C15. In addition, the HMBC supports the assigned regioisomer of nitrogen insertion 
with the 3-bond correlations between C7 and C14, C14 and C17, and C17 and C19. 
The COSY reaffirms this conclusion by showing the retention of the carbon 
connectivity throughout the bicycle with correlations between C1, C4, C5, C6, C7, 
and C15, as well as between C11, C12, and C13. COSY data also shows the retention 
of the carbon connectivity between C15, C16, and C17. In addition a COSY 
correlation between C23 and C24 show the retention of one ethyl ester from the 
parent diethyl malonate. 
 
 
(E)-3-Methoxy-8-methyl-6-(3-(3-oxocyclohex-1-enyloxy)propyl)-9-phenyl-
6-azabicyclo[3.2.2]non-2-ene-4,7-dione (128). Synthesized according to the general 
procedure where 1,3-cyclohexadione (36.4 mg, 0.325 mmol) was substituted for 
homophthalic anhydride. Clear oil (21.6 mg, 63% based on the major regioisomer in 
reactant); Rf = 0.42 (5% MeOH/CH2Cl2); 
1
H
 
NMR (400 MHz, CDCl3) δH 7.24-7.31 
(m, 3H), 7.06-7.09 (m, 2H), 6.33 (d, J = 10.0 Hz, 1H), 5.29, (s, 1H), 4.08 (d, J = 5.2 
Hz, 1H), 3.77 (t, J = 6.0 Hz, 2H), 3.68 (s, 3H), 3.74 (m, 1H), 3.44 (m, 1H), 3.30 (dd, J 
= 10.0, 1.2 Hz, 1H), 3.08 (t, J = 6.0 Hz, 1H), 2.58 (t, J = 6.8 Hz, 1H), 2.39 (t, J = 6.4 
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Hz, 2H), 2.33 (t, J = 6.4 Hz, 2H), 1.94 (m, 4H), 1.20 (d, J = 7.2 Hz, 3H); 
13
C NMR 
(100 MHz, CDCl3) δC 199.7, 189.2, 177.6, 171.3, 153.2, 137.6, 129.0, 128.3, 127.8, 
117.0, 102.9, 73.0, 65.3, 55.5, 52.9, 49.2, 43.9. 41.2, 36.7, 28.8, 27.3, 22.8, 21.1; IR 
(neat) 1643, 1600, 1218, 1184 cm
-1
; MS (ES+) m/z 424.2 (M+H
+
); HRMS calcd for 
C25H30NO5 (M+H
+
): 424.2046, found 424.2112.  
 
 
(E)-3-Methoxy-8-methyl-6-(3-(3-oxocyclohex-1-enyloxy)propyl)-9-phenyl-
6-azabicyclo[3.2.2]non-2-ene-4,7-dione (128). Compound 128 was proposed based 
on the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, C17, C19, C20, C21, and 
C22, in addition to connectivity data derived from HMBC and COSY. C1 appears at 
73.0 ppm in the 
13
C and the 
1
H shows a doublet at 4.08 ppm with an integration of 
1.0, consistent with the assignment of C1 as the bridgehead position between two 
electron withdrawing groups such as nitrogen and an α-methoxy ketone. C5 appears 
at 49.2 ppm in the 
13
C and the 
1
H shows a doublet of doublets at 3.30 ppm, consistent 
with a bridgehead methylene between slight electron withdrawing groups such as an 
olefin and an amide. C14 appears at 171.3 ppm in the 
13
C, typical of a lactam. C17 
and C19 appear at 65.3 ppm and 73.0 ppm respectively in the 
13
C. C17 appears as a 
pair of multiplets at 3.44 ppm and 3.74 ppm in the 
1
H, common for a methylene with 
211 
 
diastereotopic hydrogens adjacent to a heteroatom such as nitrogen. C19 appears as a 
triplet at 3.77 ppm in the 
1
H, common for a methylene adjacent to a heteroatom such 
as oxygen. C20 and C22 appear at 177.6 ppm and 199.2 ppm respectively in the 
13
C 
NMR, consistent with an enol ether and a conjugated ketone. C21 appears at 102.9 
ppm in the 
13
C and the 
1
H shows a sharp singlet at 5.32 ppm, corresponding to the 
methylene α to the malonate. The 3-bond HMBC correlations between C19 and C20 
along with the 2-bond HMBC correlations of C20 and C22 with C21 support the 
connection of the diketone to the parent amide through the presence of an enol ether 
bond to C19. The HMBC shows the retention of the major bicyclic structure through 
the 3-bond correlations between C3 and C16, C3 and C5, C4 and C6, and C7 and 
C15. In addition, the HMBC supports the assigned regioisomer of nitrogen insertion 
with the 3-bond correlations between C4 and C14, C6 and C14, C14 and C17, C1 and 
C17, and C17 and C19. The COSY reaffirms the above conclusions by showing the 
preservation of the carbon connectivity throughout the bicycle with correlations 
between C1, C4, C5, C6, C7, and C15, as well as between C11, C12, and C13. COSY 
data also shows the retention of the carbon connectivity between C15, C16, and C17. 
In addition the carbon connectivity of the diketone was retained between C23, C24, 
and C25. 
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(E)-6-(3-Bromopropyl)-3-methoxy-8-methyl-9-phenyl-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (129). Synthesized according to the general 
procedure where ethyl bromoacetate (36.0 μL, 0.325 mmol) was substituted for 
homophthalic anhydride. Yellow oil (17.1 mg, 64% based on the major regioisomer 
in reactant); Rf = 0.74, (5% MeOH/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 7.22-
7.35 (m, 3H), 7.09-7.11 (m, 2H), 6.33 (d, J = 10.4 Hz, 1H), 4.14 (d, J = 5.6 Hz, 1H), 
3.69 (s, 3H), 3.64 (m, 1H), 3.49 (m, 1H), 3.29-3.37 (m, 3H), 3.12 (t, J = 6.4 Hz, 1H), 
2.59 (p, J = 6.8 Hz, 1H), 2.00-2.14 (m, 2H), 1.21 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3) δC 189.1, 171.5, 153.3, 137.6, 129.0, 128.3, 127.8, 116.9, 73.2, 55.5, 
52.8, 49.2, 46.1, 41.0, 31.1, 29.9, 22.9; IR (neat) 1664, 1649, 1209,702 cm
-1
; MS 
(ES+) m/z 392.0 (M+H
+
); HRMS calcd for C19H23BrNO3 (M+H
+
): 392.0783, found 
392.0631 and 394.0617.  
 
 
(E)-6-(3-Bromopropyl)-3-methoxy-8-methyl-9-phenyl-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (129). Compound 129 was proposed based on 
the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, C17, and C19 in addition to 
connectivity data derived from HMBC and COSY. C1 appears at 73.2 ppm in the 
13
C 
and the 
1
H shows a doublet at 4.14 ppm with an integration of 1.0, consistent with the 
assignment of C1 as the bridgehead position between two electron withdrawing 
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groups such as nitrogen and an α-methoxy ketone. C5 appears at 49.2 ppm in the 
13
C 
and overlaps with C19 in the 
1
H showing a multiplet at 3.29-3.37 ppm. This data 
supports the assignment of C5 as a bridgehead methylene between slight electron 
withdrawing groups such as an olefin and an amide. C14 appears at 171.5 ppm in the 
13
C, typical of a lactam. C17 and C19 appear at 46.1 ppm and 29.9 ppm respectively 
in the 
13
C. C17 appears as a pair of multiplets in the 
1
H at 3.64 ppm and 3.49 ppm 
with an integration of 1.0 each, supporting the assignment of C17 as a methylene with 
diastereotopic hydrogens adjacent to a heteroatom such as nitrogen. C19 overlaps 
with C5 in the 
1
H, as previously mentioned, appearing at 3.29-3.37 ppm as a 
multiplet. This data plausibly supports C19 as a methylene adjacent to bromide. The 
HMBC supports the retention of the major bicyclic structure through the 3-bond 
correlations between C3 and C16, C3 and C5, C4 and C6, and C7 and C15. In 
addition, the HMBC supports the assigned regioisomer of nitrogen insertion with 3-
bond correlations between C4 and C14, C6 and C14, C14 and C17, and C17 and C19. 
The COSY reaffirms this conclusion by showing the retention of the carbon 
connectivity throughout the bicycle with correlations between C1, C4, C5, C6, C7, 
and C15, as well as between C11, C12, and C13. COSY data also shows the retention 
of the carbon connectivity between C15, C16, and C17. 
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(E)-3-Methoxy-8-methyl-9-phenyl-6-(3-tosylpropyl)-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (130). Synthesized according to the general 
procedure where p-toluenesulfonylmethyl isocyanide (127 mg, 0.651 mmol) was 
substituted for homophthalic anhydride and the reaction was completed on a 0.216 
mmol scale. The corresponding NMR appeared as a mixture of rotamers in an 
approximate 1:1 ratio, as estimated by 
13
C NMR. Clear oil (48.6 mg, 64% based on 
the major regioisomer in reactant); Rf = 0.30, (66% Hex/EtOAc); 
1
NMR (400 MHz, 
CDCl3) δH 7.60-7.59 (ovrlp dd, J = 8.5, 8.0 Hz, 2H), 7.24-7.33 (m, 5H), 7.09-7.12 (m, 
2H), 6.31-6.30 (ovrlp dd, J = 10.4, 10.4 Hz, 1H), 4.10 (d, J = 5.6 Hz, 0.6H), 4.06* (d, 
J = 5.6 Hz, 0.4H), 4.01 (m, 1H), 3.68 (s, 1.8H), 3.67* (s, 1.2H), 3.62 (m, 1H), 3.40-
3.55 (m, 2H), 3.29-3.28 (ovrlp dd, J = 10.0, 1.2 Hz, 1H), 3.14 (t, J = 6.0 Hz, 0.6H), 
3.09* (t, J = 6.0 Hz, 0.4H), 2.57 (p, J = 6.8 Hz, 0.6H), 2.43* (m, 0.4H), 2.41 (s, 3H), 
1.77-1.88 (m, 2H), 1.19-1.18 (ovrlp dd, J = 7.2, 7.2 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3) δC 189.2, 171.4, 171.3*, 153.3, 153.3*, 142.9, 142.8*, 141.4*, 141.2, 137.7, 
137.7*, 129.8, 129.0, 128.4, 128.4*, 127.7, 125.3, 125.2*, 116.8*, 116.8, 72.9, 72.7*, 
61.7*, 60.7, 55.4, 55.4*, 52.6*, 52.5, 49.2, 44.1, 44.0*, 41.1*, 41.0, 28.5*, 28.4, 22.9, 
21.5; IR (neat) 1672, 1620, 1456, 1128 cm
-1
; MS (ES+) m/z 468.2 (M+H
+
); HRMS 
calcd for C26H30NO5S (M+H
+
): 468.1766, found 468.1831. 
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(E)-3-Methoxy-8-methyl-9-phenyl-6-(3-tosylpropyl)-6-
azabicyclo[3.2.2]non-2-ene-4,7-dione (130). Compound 130 was proposed based on 
the distinctive 
1
H and 
13
C chemical shift of C1, C5, C14, C17, and C19 in addition to 
connectivity data derived from HMBC and COSY. C1 appears at 72.9 ppm in the 
13
C 
and the 
1
H shows a doublet at 4.10 ppm with an integration of 1.0, consistent with the 
assignment of C1 as the bridgehead position between two electron withdrawing 
groups such as nitrogen and an α-methoxy ketone. C5 appears at 49.2 ppm in the 
13
C 
and the 
1
H shows a doublet of doublets at 3.28 ppm, consistent with a bridgehead 
methylene between slight electron withdrawing groups such as an olefin and an 
amide. C14 appears at 171.4 ppm in the 
13
C, typical of a lactam. C17 and C19 appear 
at 44.1 ppm and 60.7 ppm respectively in the 
13
C. C17 appears as a multiplet in the 
1
H at 3.40-3.55 ppm. C19 appears as a pair of multiplets in the 
1
H at 4.01 ppm and 
3.62 ppm. This data supports C17 and C19 as methylenes adjacent to heteroatoms 
such as nitrogen and a sulfoxide group, respectively. The HMBC spectrum shows two 
distinct regions of connectivity within the molecule. The 3-bond correlations between 
C20 and C22, C21 and C23, as well as C24 and C26 suggest the retention of p-
toluenesulfonyl methyl moiety with the point of attachment to the bicycle at C19. The 
HMBC supports the retention of the major bicyclic structure through the 3-bond 
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correlations between C3 and C16, C3 and C5, C4 and C6, and C7 and C15. In 
addition, the HMBC supports the assigned regioisomer of nitrogen insertion with 3-
bond correlations between C4 and C14, C6 and C14, C14 and C17, and C17 and C19. 
The COSY reaffirms the aforementioned conclusion by showing the retention of the 
carbon connectivity throughout the bicycle with correlations between C1, C4, C5, C6, 
C7, and C15, as well as between C11, C12, and C13. COSY data also shows the 
retention of the carbon connectivity between C15, C16, and C17, as well as between 
C21, and C22 p-methylthiophenol. 
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Reaction Discovery of Donor-Acceptor Cyclopropanes 
 
 General Procedure for the Synthesis of Polycyclic Cyclopropanes. 
(Synthesis of cyclopropanes 135 and 140-144). To a dry pyrex-rayonet tube 
containing a small magnetic cross stir bar was added bicyclo[3.2.1]octanoid (1.51 
mmol) followed by the addition of acetone (10 mL). The reaction vessel was capped 
with rubber septa and degassed by bubbling argon via balloon (15 min). The vessel 
was sealed by wrapping several layers of parafilm around the septa. Next the reaction 
vessel was placed in a Hanovia lamp photoreactor with no filter (quartz) and was 
stirred at approximately 20 
o
C (rt) for 4 h. A small aliquot was analyzed by 
UPLC/MS/ELS which indicated 100 % conversion to product. The reaction was 
concentrated to afford cyclopropane without the need for purification. Note: the 
cyclopropane products are generally not stable to purification via silica gel 
chromatography.  
 
 
Cyclopropane (135). Bicyclo[3.2.1]octanoid 63 (32 mg, 0.125 mmol) in 5 
mL acetone afforded cyclopropane 135 (32 mg, 0.125 mmol, 99%) as a white solid. 
mp = 95.0-98.0 ºC; 
1
H NMR (400 MHz, CDCl3) δH 7.35-7.27 (m, 3H), 7.14 (d, J = 
7.0 Hz, 2H), 3.61 (s, 3H), 3.11 (dd, J = 8.9, 1.8 Hz, 1H), 3.01 (dd, J = 6.4, 2.1 Hz, 
1H), 2.81 (dd, J = 8.9, 1.5 Hz, 1H), 2.68 (dd, J = 2.1, 1.8 Hz, 1H), 2.67-2.59 (dquin, J 
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= 6.8, 1.5 Hz, 1H), 1.25 (d, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δc 200.4, 
199.7, 140.7, 128.9, 127.7, 127.4, 83.5, 61.2, 59.1, 58.2, 49.5, 47.9, 34.3, 20.5; IR 
(thin film) 2963, 2935, 1762, 1716, 1456, 1298, 1206, 1162, 1080, 1063, 887, 758, 
735, 701 cm
-1
; MS (ES+) m/z 535.2 (2M+Na
+
); HRMS calcd for C32H32O6Na 
(2M+Na
+
): 535.2097, found 535.2091. 
 
 
N-Acylhemiaminal (136). To a dry vial containing a small magnetic stir bar 
was added cyclopropane 135 (50 mg, 0.195 mmol) and 1.2 mL DMSO followed by 
the addition of 4-bromobenzylamine (49.3 L, 0.390 mmol). Next DBU (35.0 L, 
d=1.018, 0.195 mmol) was added quickly and the reaction was stirred for 45 min at 
room temp. The reaction was stopped with the addition of acetic anhydride (390 L 
of 10% by volume in DMSO, approx. 0.390 mmol) followed by continued stirring for 
10 min. DMSO was removed by portioning the reaction into water and extracting the 
product with CH2Cl2 (x 3). The organic fractions were combined, dried over sodium 
sulfate, filtered, and concentrated in vacuo. The crude extract was purified by flash 
silica gel chromatography (50% EtOAc/Hex) to afford N-acylhemiaminal 136 as a 
white solid. mp 197-198 ºC; 
1
H NMR (400 MHz, CDCl3) δ 7.43-7.39 (m, 2H), 7.34-
7.30 (m, 2H), 7.28 (s, 2H), 7.24-7.18 (m, 1H), 6.91 (d, J = 6.6 Hz, 2H), 4.43 (d, J = 
14.8 Hz, 1H), 4.04 (d, J = 14.8 Hz, 1H), 3.59 (s, 3H), 3.49 (s, 1H), 2.33 (ddq, J = 
10.6, 6.6, 5.5 Hz, 1H), 2.24 (d, J = 9.8 Hz, 1H), 2.16 (dd, J = 9.8, 5.5 Hz, 1H), 2.08 
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(ovrlp d, J = 5.1 Hz, 1H), 2.07 (ovrlp d, J = 11.3 Hz, 1H), 1.70 (ddd, J = 11.3, 10.6, 
5.1 Hz, 1H), 0.92 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 170.1, 142.8, 
136.9, 131.6, 130.8, 128.6, 127.6, 126.9, 121.4, 87.7, 73.7, 58.4, 44.9, 42.1, 40.6, 
36.5, 35.3, 31.4, 18.4; IR (thin film) 3345, 2957, 2929, 1668, 1488, 1453, 1401, 1134, 
1070, 1013, 736, 703 cm
-1
; MS (ES+) m/z 442.1 (M+H
+
); HRMS calcd for 
C23H25BrNO3 (M+H
+
): 442.1018, found 442.1024. 
 
 
Cyclopropane (140). Bicyclo[3.2.1]octanoid 75 (405 mg, 1.51 mmol) and 10 
mL acetone afford cyclopropane 140 (391 mg, 1.46 mmol, 96%) as a white solid. 
1
H 
NMR (400 MHz, CDCl3-d) δH 7.26-7.21 (m, 2H), 7.18-7.10 (m, 2H), 3.62 (d, J = 3.5 
Hz, 1H), 3.50 (s, 3H), 3.31 (d, J = 17.2 Hz, 1H), 3.10 (dd, J = 9.0, 2.0 Hz, 1H), 3.05 
(d, J = 17.2 Hz, 1H), 2.91 (ovrlp d, J = 9.0 Hz, 1H), 2.91(ovrlp dd, J = 3.5, 2.0 Hz, 
1H), 1.42 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δC 200.3, 199.0, 140.8, 139.4, 128.6, 
127.5, 125.1, 124.1, 82.6, 64.3, 60.8, 58.0, 55.0, 48.4, 46.7, 40.9, 28.7; IR (thin film) 
2956, 1764, 1719, 1457, 1302, 1210, 1060, 758, 737 cm
-1
; MS (ES+) m/z 559.2 
(M+Na
+
); HRMS calcd for C34H32O6Na (M+Na
+
): 559.2097, found 559.2117. 
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Cyclopropane (141). Bicyclo[3.2.1]octanoid 137 (444 mg, 1.51 mmol) and 
10 mL acetone afford cyclopropane 141 (438 mg, 1.49 mmol, 99%) as a white solid. 
1
H NMR (400 MHz, CDCl3) δH 7.25-7.07 (m, 4H), 5.91 (ddd, J = 14.1, 8.3, 5.9 Hz, 
1H), 5.30-5.21 (m, 2H), 4.01 (dd, J = 9.2, 3.0 Hz, 1H), 3.53 (s, 3H), 3.40-3.26 (m, 
2H), 3.00-2.92 (ovrlp m, 1H), 2.94 (ovrlp dd, J = 3.0, 2.0 Hz, 1H), 2.88 (d, J = 2.0 
Hz, 1H), 2.60 (dd, J = 15.1, 8.3 Hz, 1H), 2.37 (dd, J = 15.1, 5.9 Hz, 1H); 
13
C NMR 
(100 MHz, CDCl3) δC 201.2, 199.3, 141.2, 139.7, 133.2, 128.4, 127.4, 124.9, 124.1, 
119.1, 85.8, 61.9, 58.2, 57.8, 55.8, 52.1, 37.6, 37.0, 35.1; IR (thin film) 2939, 1761, 
1710, 1450, 1284, 1220, 1093, 1010, 879, 762 cm
-1
; MS (ES+) m/z 317.1 (M+Na
+
); 
HRMS calcd for C19H18O3Na (M+Na
+
): 317.1154, found 317.1142. 
 
 
Cyclopropane (142). Bicyclo[3.2.1]octanoid 77 (489 mg, 1.50 mmol) and 10 
mL acetone afford cyclopropane 142 (474 mg, 1.45 mmol, 97%) as a viscous oil.
 1
H 
NMR (400 MHz, CDCl3) δH 7.03 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 5.85 
(dddd, J = 17.2, 9.9, 9.6, 4.5 Hz, 1H), 5.23-5.13 (m, 2H), 3.78 (s, 3H), 3.60 (s, 3H), 
2.97 (dd, J = 6.3, 2.5 Hz, 1H), 2.80 (d, J = 2.0 Hz, 1H), 2.76 (dd, J = 14.7, 9.6 Hz, 
1H), 2.66 (dd, J = 2.5, 2.0 Hz, 1H), 2.52 (dd, J = 6.6, 6.3 Hz, 1H), 2.32-2.24 (m, 1H), 
1.18 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 200.6, 199.8, 159.0, 133.3, 
132.7, 128.6, 118.7, 114.2, 86.9, 61.9, 58.2, 57.8, 56.5, 55.2, 51.9, 36.0, 35.0, 18.0; 
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IR (thin film) 2936, 1761, 1713, 1611, 1514, 1250, 1216, 1182, 1034, 838 cm
-1
; MS 
(ES+) m/z 327.1 (M+H
+
); HRMS calcd for C30H23O4 (M+H
+
): 327.1596, found 
327.1597. 
 
 
Tertiary alcohol (145). To an oven-dried vial was added cyclopropane 135 
(40 mg, 0.156 mmol) and anhydrous THF (4.0 mL). The reaction mixture was cooled 
to 0 
o
C while under argon. To this mixture was added 3.0 M methylmagnesium 
bromide in THF (167 L, 0.468 mmol) dropwise via syringe over 1 min while at 0 
o
C. The reaction was held at 0 
o
C for 1 h with continual stirring. The reaction was 
quenched while at 0 
o
C with the addition of water (40 L). This mixture was warmed 
to rt, diluted with water (20 mL), and extracted into CH2Cl2 (20 mL x 3). The organic 
fractions were combined, washed with brine (20 mL), dried over sodium sulfate, 
filtered and evaporated in vacuo. The crude product was purified by silica gel flash 
chromatography (0.03% EtOAc/CH2Cl2) to afford the tertiary alcohol 145 as a single 
diastereomer (31.9 mg, 0.117 mmol, 75%) as an amorphous white solid. 
1
H NMR 
(400 MHz, CDCl3) δH 7.32-7.25 (m, 2H), 7.24-7.18 (m, 1H), 7.15 (d, J = 7.0 Hz, 
2H), 3.53 (s, 3H), 3.24 (dd, J = 6.6, 2.3 Hz, 1H), 2.54-2.45 (m, 2H), 2.19 (dd, J = 8.2, 
2.0 Hz, 1H), 2.01 (dd, J = 2.3, 2.0 Hz, 1H), 1.99 (s, 1H), 1.46 (s, 3H), 1.28 (d, J = 6.6 
Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 207.7, 143.6, 128.5, 128.1, 126.8, 75.8, 
71.2, 58.7, 57.4, 49.4, 41.8, 41.1, 33.4, 28.4, 20.4; IR (thin film) 3446, 2962, 2930, 
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1717, 1456, 1375, 1148, 1110, 1053, 701 cm
-1
; MS (ES+) m/z 273.1 (M+H
+
); HRMS 
calcd for C17H21O3 (M+H
+
): 273.1491, found 273.1503. 
 
 
(3aS,4R,5S,7aR)-7a-Methoxy-2,4-dimethyl-5-phenyl-3a,4,5,6-tetrahydro 
benzofuran-7(7aH)-one (147). To an oven-dried vial was added cyclopropane 135 
(40 mg, 0.156 mmol) and anhydrous THF (4.0 mL). The reaction mixture was cooled 
to 0 
o
C while under argon. To this mixture was added 3.0 M methylmagnesium 
bromide in THF (167 L, 0.468 mmol) dropwise via syringe over 1 min while at 0 
o
C. The reaction was held at 0 
o
C with continued stirring for 15 min then warmed to rt 
for additional 1 h. The reaction was cooled back down to 0 
o
C then quenched with the 
addition of water (40 L). This mixture was warmed to rt, diluted with water (20 mL) 
and extracted into CH2Cl2 (20 mL x 3). The organic fractions were combined, washed 
with brine (20 mL), dried over sodium sulfate, filtered, and evaporated in vacuo. The 
crude product was purified by silica gel flash chromatography (0.03% 
EtOAc/CH2Cl2) to afford acetal 147 (34.8 mg, 0.128 mmol, 82%) as an amorphous 
white solid. 
1
H NMR (400 MHz, CDCl3) δH 7.33-7.28 (m, 2H), 7.25-7.19 (m, 1H), 
7.13 (d, J = 7.0 Hz, 2H), 4.78-4.72 (m, 1H), 3.49 (s, 3H), 3.26-3.18 (m, 1H), 3.03 (dd, 
J = 16.4, 8.2 Hz, 1H), 2.91 (ddd, J = 11.6, 9.0, 8.2 Hz, 1H), 2.51 (dd, J = 16.4, 9.0 
Hz, 1H), 2.06-1.94 (m, 4H), 0.62 (d, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 
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204.8, 155.1, 143.6, 128.6, 127.7, 126.6, 107.6, 95.5, 56.2, 51.5, 45.8, 43.1, 37.2, 
16.2, 13.5; IR (thin film) 3420, 2958, 2926, 1722, 1453, 1373, 1220, 1204, 1131, 
1095, 1056, 1037, 1007, 761, 702 cm
-1
; MS (ES+) m/z 295.1 (M+Na
+
); HRMS calcd 
for C17H20O3Na (M+Na
+
): 295.1310, found 295.1314. 
 
 
(3aS,4R,5S,7aR)-7a-Methoxy-2-(3-methoxyphenyl)-4-methyl-5-phenyl-
3a,4,5,6-tetrahydrobenzofuran-7(7aH)-one (148). To an oven-dried vial was added 
cyclopropane 135 (40 mg, 0.156 mmol) and anhydrous THF (4.0 mL). The reaction 
mixture was cooled to 0 
o
C while under argon. To this mixture was added 1.0 M 3-
methoxyphenylmagnesium bromide in THF (468 L, 0.468 mmol) dropwise via 
syringe over 1 min while at 0 
o
C. The reaction was held at 0 
o
C for 1 h with continual 
stirring. The reaction was quenched while at 0 
o
C with the addition of water (40 L). 
This mixture was warmed to rt, diluted with water (20 mL) and extracted into CH2Cl2 
(20 mL x 3). The organic fractions were combined, washed with brine (20 mL), dried 
over sodium sulfate, filtered, and evaporated in vacuo. The crude product was 
purified by silica gel flash chromatography (0.03% EtOAc/CH2Cl2) to afford the 
acetal 148 (43.9 mg, 0.120 mmol, 77 %) as an amorphous white solid. Rf = 0.27 
(50%, CH2Cl2/Hex); Rf = 0.67 (100% CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 7.36-
7.25 (m, 4H), 7.24-7.19 (m, 2H), 7.11 (d, J = 7.0 Hz, 2H), 6.96-6.91 (m, 1H), 5.56-
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5.47 (m, 1H), 3.87 (s, 3H), 3.56 (s, 3H), 3.46-3.37 (m, 1H), 3.12 (dd, J = 16.9, 8.5 Hz, 
1H), 2.98 (ddd, J = 11.9, 8.9, 8.5 Hz, 1H), 2.54 (dd, J = 16.9, 8.9 Hz, 1H), 2.14-2.00 
(m, 1H), 0.71 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 204.4, 159.7, 
155.8, 143.5, 130.9, 129.6, 128.7, 127.7, 126.7, 118.0, 114.8, 110.8, 107.3, 95.8, 56.6, 
55.4, 51.7, 45.9, 43.0, 37.6, 16.3; IR (thin film) 2959, 1732, 1601, 1582, 1490, 1454, 
1288, 1264, 1208, 1132, 1032, 771, 702 cm
-1
; MS (ES+) m/z 365.1 (M+H
+
); HRMS 
calcd for C23H25O4 (M+H
+
): 365.1753, found 365.1842. 
 
 
Tertiary alcohol (149). To an oven-dried vial was added cyclopropane 141 
(60 mg, 0.170 mmol) and anhydrous THF (6.0 mL). The reaction mixture was cooled 
to 0 
o
C while under argon. To this mixture was added 3.0 M methylmagnesium 
bromide in THF (219 L, 0.612 mmol) dropwise via syringe over 1 min while at 0 
o
C. The reaction was held at 0 
o
C for 1 h with continual stirring. The reaction was 
quenched while at 0 
o
C with the addition of water (40 L). This mixture was warmed 
to rt, diluted with water (20 mL), and extracted into CH2Cl2 (20 mL x 3). The organic 
fractions were combined, washed with brine (20 mL), dried over sodium sulfate, 
filtered, and evaporated in vacuo. The crude product was purified by silica gel flash 
chromatography (0.03% EtOAc/CH2Cl2) to afford the tertiary alcohol 149 as single 
diastereomer (51.7 mg, 0.167 mmol, 83%) as an amorphous white solid. 
1
H NMR 
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(400 MHz, CDCl3) δH 7.19-7.07 (m, 4H), 5.92 (dddd, J = 17.0, 10.1, 8.1, 5.7 Hz, 1H), 
5.29-5.14 (m, 2H), 3.97 (dd, J = 9.4, 3.5 Hz, 1H), 3.44-3.40 (m, 3H), 3.36 (dd, J = 
16.5, 9.8 Hz, 1H), 3.25-3.17 (m, 1H), 2.90 (dd, J = 16.5, 6.0 Hz, 1H), 2.56 (dd, J = 
14.9, 8.1 Hz, 1H), 2.38 (dd, J = 3.5, 1.6 Hz, 1H), 2.27 (d, J = 1.6 Hz, 1H), 2.16 (dd, J 
= 14.9, 5.7 Hz, 1H), 1.95 (s, 1H), 1.46 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δC 
205.9, 142.2, 141.6, 134.7, 127.3, 126.9, 124.6, 123.9, 117.8, 78.7, 71.7, 59.1, 57.6, 
48.3, 47.2, 46.5, 38.5, 34.9, 34.8, 27.8; IR (thin film) 3443, 2962, 2929, 1718, 1447, 
1377, 1178, 1149, 1102, 1024, 932, 752, 735 cm
-1
; MS (ES+) m/z 333.1 (M+Na
+
); 
HRMS calcd for C20H22O3Na (M+Na
+
): 333.1467, found 333.1462. 
 
 
Tertiary alcohol (150). To an oven-dried vial was added cyclopropane 141 
(50.0 mg, 0.170 mmol) and anhydrous THF (4.0 mL). The reaction mixture was 
cooled to 0 
o
C while under argon. To this mixture was added 1.0 M 3-
methoxyphenylmagnesium bromide in THF (510 L, 0.510 mmol) dropwise via 
syringe over 1 min while at 0 
o
C. The reaction was held at 0 
o
C for 1 h with continual 
stirring. The reaction was quenched while at 0 
o
C with the addition of water (40 L). 
This mixture was warmed to rt, diluted with water (20 mL) and extracted into CH2Cl2 
(20 mL x 3). The organic fractions were combined, washed with brine (20 mL), dried 
over sodium sulfate, filtered, and evaporated in vacuo. The crude product was 
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purified by silica gel flash chromatography (0.03% EtOAc/CH2Cl2) to afford tertiary 
alcohol 150 (56.3 mg, 0.140 mmol, 82%) as an amorphous white solid. Rf = 0.37 
(0.03%, EtOAc/CH2Cl2); Rf = 0.58 (0.05% EtOAc/CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3) δH 7.30-7.22 (m, 1H), 7.16-7.13 (m, 4H), 7.13-7.10 (m, 1H), 7.09-7.05 (m, 
1H), 6.83 (dd, J = 8.2, 2.3 Hz, 1H), 5.98 (dddd, J = 17.1, 10.2, 8.0, 5.7 Hz, 1H), 5.32-
5.18 (m, 2H), 4.20 (dd, J = 9.1, 3.7 Hz, 1H), 3.79 (s, 3H), 3.40 (dd, J = 15.8, 9.8 Hz, 
1H), 3.36-3.31 (m, 1H), 3.31 (s, 3H), 2.94 (dd, J = 15.8, 5.3 Hz, 1H), 2.86-2.79 (m, 
1H), 2.63 (dd, J = 15.1, 8.0 Hz, 1H), 2.55-2.47 (m, 1H), 2.23 (ovrlp dd, J = 15.1, 5.7 
Hz, 1H), 2.22 (ovrlp s, 1H); 
13
C NMR (100 MHz, CDCl3) δC 205.8, 160.0, 146.5, 
142.0, 141.7, 134.6, 129.9, 127.4, 126.9, 124.6, 124.0, 117.8, 117.2, 113.6, 111.0, 
78.8, 75.4, 59.0, 58.0, 55.3, 48.6, 48.2, 46.8, 38.6, 34.9, 34.8; IR (thin film) 3441, 
2935, 1730, 1601, 1486, 1292, 1261, 1047, 752, 735, 701 cm
-1
; MS (ES+) m/z 425.1 
(M+Na
+
); HRMS calcd for C26H26O4Na (M+Na
+
): 425.1729, found 425.1739. 
 
 
Tertiary alcohol (151). To an oven-dried vial was added cyclopropane 141 
(60 mg, 0.204 mmol) and anhydrous THF (6.0 mL). The reaction mixture was cooled 
to 0 
o
C while under argon. To this mixture was added 1.0 M 3-
methoxyphenylmagnesium bromide in THF (612 L, 0.612 mmol) dropwise via 
syringe over 1 min while at 0 
o
C. The reaction was stirred for 15 min then warmed to 
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rt with continued stirring for 1 h. The reaction was cooled back down to 0 
o
C and 
quenched while at 0 
o
C with the addition of water (40 L). This mixture was warmed 
to rt, diluted with water (20 mL) and extracted into CH2Cl2 (20 mL x 3). The organic 
fractions were combined, washed with brine (20 mL), dried over sodium sulfate, 
filtered, and evaporated in vacuo. The crude product was purified by silica gel flash 
chromatography (0.03% EtOAc/CH2Cl2) to afford the tertiary alcohol 150 (9.3 mg, 
0.023 mmol, 11%) and tertiary alcohol 151 (45.5 mg, 0.113 mmol, 55 %) as amorphic 
white solids. Tertiary alchohol 150: Rf = 0.37 (0.03% EtOAc/CH2Cl2); Rf = 0.58 
(0.05% EtOAc/CH2Cl2) ; Tertiary alcohol 151: Rf = 0.08 (0.03%, EtOAc/CH2Cl2); Rf 
= 0.19 (0.05% EtOAc/CH2Cl2); Characterization data for 151: 
1
H NMR (400 MHz, 
CDCl3) δH 7.37 (t, J = 8.0 Hz, 1H), 7.16 (d, J = 7.8 Hz, 1H), 7.13-7.06 (m, 4H), 7.02-
6.98 (m, 1H), 6.91 (dd, J = 8.2, 2.3 Hz, 1H), 6.23-6.09 (m, 1H), 5.35-5.27 (m, 2H), 
3.86 (s, 3H), 3.54 (s, 3H), 3.28 (ddd, J = 16.4, 9.4, 4.7 Hz, 1H), 3.02-2.96 (m, 2H), 
2.96-2.85 (m, 1H), 2.64 (dd, J = 14.8, 8.2 Hz, 1H), 2.62 (s, 1H), 2.55 (d, J = 2.0 Hz, 
1H), 2.49 (s, 1H), 2.37 (dd, J = 14.5, 7.0 Hz, 1H); 
13
C NMR (100 MHz, CDCl3) δC 
207.6, 160.0, 143.5, 141.5, 141.4, 134.3, 130.0, 127.5, 126.9, 124.5, 123.9, 118.7, 
118.5, 114.0, 111.9, 79.1, 75.5, 60.4, 57.9, 55.4, 49.3, 49.1, 44.1, 38.3, 35.4, 35.0; IR 
(thin film) 3365, 2934, 1734, 1487, 1457, 1436, 1262, 1036, 752 cm
-1
; MS (ES+) m/z 
425.1 (M+Na
+
); HRMS calcd for C26H26O4Na (M+Na
+
): 425.1729, found 425.1742. 
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Epi-Product derived from cyclopropane 140: Followed procedure for 
tertiary alcohol 151. Reaction using cyclopropane 140 (70 mg, 0.224 mmol) and 1 M 
3-methoxyphenylmagnesium bromide in THF (671 L, 0.671 mmol) afforded the 
tertiary alcohol (49.0 mg, 0.129 mmol, 50%) as an amorphic white solid. Rf = 0.31 
(11% EtOAc/CH2Cl2); Rf = 0.52 (20% EtOAc/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) 
δH 7.40 (t, J = 8.0 Hz, 1H), 7.20 (d, J = 7.8 Hz, 1H), 7.17-7.10 (m, 3H), 7.08-7.01 (m, 
2H), 6.92 (dd, J = 8.2, 2.7 Hz, 1H), 3.86 (s, 3H), 3.51 (s, 3H), 3.15 (d, J = 16.8 Hz, 
1H), 2.92 (dd, J = 8.6, 2.0 Hz, 1H), 2.85 (ovrlp s, 1H), 2.83 (ovrlp d, J = 16.8 Hz, 
1H), 2.73-2.66 (m, 2H), 2.48 (d, J = 8.6 Hz, 1H), 1.06 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δC 208.1, 159.9, 143.0, 141.3, 141.2, 130.0, 127.5, 126.9, 124.7, 124.1, 118.7, 
113.6, 112.7, 78.2, 72.3, 59.6, 57.5, 56.7, 55.3, 49.0, 47.5, 40.7, 40.0, 28.3; IR (thin 
film) 3420, 2957, 1742, 1452, 1265, 1072, 1030, 736 cm
-1
; MS (ES+) m/z 399.1 
(M+Na
+
); HRMS calcd for C24H24O4Na (M+Na
+
): 399.1572, found 399.1569. 
 
 
Epi-Product derived from cyclopropane 142: Followed procedure for 
tertiary alcohol 151. Reaction using cyclopropane 142 (70 mg, 0.214 mmol) and 1.0 
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M 3-methoxyphenylmagnesium bromide in THF (643 L, 0.643 mmol) afforded the 
tertiary alcohol (53.4 mg, 0.123 mmol, 67%) as an amorphic white solid. Rf = 0.42 
(10% EtOAc/CH2Cl2); Rf = 0.75 (20% EtOAc/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) 
δH 7.38 (t, J = 8.0 Hz, 1H), 7.07 (d, J = 7.4 Hz, 1H), 7.03 (s, 1H), 6.93 (dd, J = 8.2, 
2.3 Hz, 1H), 6.87 (d, J = 8.6 Hz, 2H), 6.74 (d, J = 8.6 Hz, 2H), 5.93 (dddd, J = 17.1, 
10.2, 9.8, 4.7 Hz, 1H), 5.15 (d, J = 17.2 Hz, 1H), 5.10 (d, J = 10.2 Hz, 1H), 3.85 (s, 
3H), 3.74 (s, 3H), 3.57 (s, 3H), 2.77 (dd, J = 14.7, 9.6 Hz, 1H), 2.56-2.53 (m, 2H), 
2.44-2.40 (m, 1H), 2.34-2.27 (m, 1H), 2.24-2.15 (m, 2H), 0.87 (d, J = 6.3 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δH 209.4, 160.0, 158.4, 143.5, 135.0, 134.8, 130.1, 
128.9, 118.7, 117.6, 113.8, 113.8, 112.5, 79.4, 76.8 59.3, 57.7, 55.3, 55.2, 51.0, 47.1, 
44.1, 36.0, 35.3, 17.0; IR (thin film) 3421, 2936, 1734, 1514, 1457, 1251, 1180, 1046, 
788 cm
-1
; MS (ES+) m/z 417.2 (M-H2O); HRMS calcd for C27H28O4 (M-H2O): 
417.2066, found 417.2078. 
 
 
3-(3-Hydroxypropyl)-6,8-dimethyl-7-phenyl-3-azabicyclo [3.2. 2]non-8-
ene-2,4-dione (152). 3-Azido-1-propanol (39.3 mg, 0.390 mmol) was added to a 
solution of 145 (106 mg, 0.390 mmol) in CH2Cl2 (1.0 mL) at 0 ºC and the solution 
was stirred for 5 min. Triflic acid stock solution (1.03 mL, 1.17 mmol) was slowly 
added dropwise and the solution gradually turned black. The acid stock solution was 
prepared fresh by the addition of triflic acid (0.20 mL) to a mixture of CH2Cl2 (1.45 
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mL) and MeCN (0.35 mL). The solution was gradually warmed to rt and stirred for 
12 h. The reaction was diluted with CH2Cl2 (5.0 mL) and quenched by the addition of 
sat. aq NaHCO3 (5.0 mL) and the biphasic solution was stirred at rt for 2 h. The layers 
were then separated and the aqueous layer was extracted with CH2Cl2 (10 mL x 3). 
The organic extracts were combined, washed with brine (10 mL), dried (anhydrous 
Na2SO4), filtered, and evaporated in vacuo. The crude material was purified by SiO2 
preparative TLC (10% MeOH/CH2Cl2) to afford 152 (21.5 mg, 0.0684 mmol, 18%) 
as a yellow oil. Rf = 0.20 (10% MeOH:CH2Cl2); 
1
H NMR (500 MHz, CDCl3) δH 
7.33-7.29 (m, 2H), 7.27-7.24 (m, 1H), 7.19-7.10 (m, 2H), 5.93 (d, J = 7.0 Hz, 1H), 
3.87 (td, J = 6.5, 2.0 Hz, 2H), 3.53 (dd, J = 7.5, 1.0 Hz, 1H), 3.51 (dd, J = 4.0, 1.5 Hz, 
1H), 3.48-3.40 (m, 2H), 2.67-2.62 (m, 1H), 2.59 (dd, J = 7.5, 4.0 Hz, 1H), 1.94 (d, J = 
1.5 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δC 175.2, 172.2, 141.4, 140.2, 128.8 (2), 
127.6 (2), 127.5, 120.0, 60.6, 59.0, 53.9, 51.8, 37.8, 37.0, 30.7, 22.5, 21.1; IR (neat) 
2962, 1729, 1710, 1656, 726 cm
-1
; MS (ES+) m/z 314.1 (M+H
+
); HRMS calcd for 
C19H24NO3 (M+H
+
): 314.1756, found 314.1771. 
 
 
(6,8-Dimethyl-2,4-dioxo-7-phenyl-3-azabicyclo [3.2.2]non-8-en-3-
yl)propyl-4-bromobenzoate (153). A solution of 145 (120 mg, 0.383 mmol) in 
CH2Cl2 (4.0 mL) was treated with pyridine (60.6 mg, 0.766 mmol), followed by 4-
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bromobenzoyl chloride (168 mg, 0.766 mmol). The reaction was stirred overnight at 
rt. The solution was quenched with brine (5.0 mL) and diluted with CH2Cl2 (5.0 mL). 
The layers were separated and the aqueous layer was extracted with CH2Cl2 (10 mL x 
3). The organic extracts were combined, washed with brine (10 mL), dried 
(anhydrous Na2SO4), filtered, and evaporated in vacuo. The crude material was 
purified by SiO2 preparative TLC (1:5 EtOAc:Hex) to afford 153 (139.7 mg, 0.281 
mmol, 73%) as a white solid. The pure material was recrystallized with EtOAc-Hex 
to give single crystals for X-ray analysis. Rf = 0.39 (20% EtOAc:Hex); mp 99.5- 
100.0 ºC; 
1
H NMR (400 MHz, CDCl3) δH 7.92 (dt, J = 7.2, 1.6 Hz, 2H), 7.56 (dt, J = 
7.2, 1.6 Hz, 2H), 7.32-7.29 (m, 2H), 7.27-7.23 (m, 1H), 7.12-7.10 (m, 2H), 5.91 (d, J 
= 5.6 Hz, 1H), 4.28 (t, J = 4.8 Hz, 2H), 3.91 (t, J = 6.0 Hz, 2H), 3.52 (dd, J = 6.0, 0.8 
Hz, 1H), 3.49 (dd, J = 3.2, 1.2 Hz, 1H), 2.64 (m, 1H), 2.58 (dd, J = 6.0, 3.2 Hz, 1H), 
2.00-1.94 (m, 2H), 1.93 (d, J = 1.2 Hz, 3H) 1.09 (d, J = 6.4 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3) δC 174.3, 171.3, 165.7, 141.3, 140.3, 131.6 (2), 131.1 (2), 129.1, 128.8 
(2), 127.9, 127.7 (2), 127.4, 120.0, 62.9, 60.7, 53.9, 52.0, 38.5, 37.1, 27.1, 22.6, 21.2; 
IR (neat) 2962, 1717, 1662, 1271 cm
-1
; MS (ES+) m/z 496.1 (M+H
+
); HRMS calcd 
for C26H27BrNO4 (M+H
+
): 496.1123, found 496.1129. 
 
 
232 
 
Indene-derived bicyclic imide (155). 3-Azido-1-propanol (17.5 mg, 0.173 
mmol) was added to a solution of 150 (69.0 mg, 0.171 mmol) in CH2Cl2 (2.0 mL) at 0 
ºC and the solution was stirred for 5 min. Triflic acid stock solution (0.455 mL, 0.514 
mmol) was slowly added dropwise and the solution gradually turned black. The acid 
stock solution was prepared fresh by the addition of triflic acid (0.20 mL) to a mixture 
of CH2Cl2 (1.45 mL) and MeCN (0.35 mL). The solution was gradually warmed to rt 
and stirred for 12 h. The reaction was diluted with CH2Cl2 (10 mL) and quenched by 
the addition of sat. aq NaHCO3 (5.0 mL) and the biphasic solution was stirred at rt for 
2 h. The layers were then separated and the aqueous layer was extracted with CH2Cl2 
(10 mL x 3). The organic extracts were combined, washed with brine (10 mL), dried 
(anhydrous Na2SO4), filtered, and evaporated in vacuo. The crude material was 
purified by SiO2 preparative TLC (5% MeOH/CH2Cl2) to afford 155 (15.0 mg, 
0.0337 mmol, 20%) as a yellow oil. Rf = 0.41 (5% MeOH/CH2Cl2); 
1
H NMR (500 
MHz, CDCl3) δ 7.35-7.31 (m, 2H), 7.24-7.16 (m, 3H), 7.12 (ddd, J = 7.5, 1.5, 1.0 Hz, 
1H), 7.05 (t, J = 2.5 Hz, 1H), 6.90 (ddd, J = 8.0, 2.5, 0.5 Hz, 1H), 6.40, (d, J = 1.5 Hz, 
1H), 6.00-5.91 (m, 1H), 5.32-5.26 (m, 2H), 4.75 (dd, J = 6.5, 2.0 Hz, 1H), 4.03 (dd, J 
= 10.0, 6.5 Hz, 1H), 3.87 (s, 3H), 3.62-3.57 (m, 1H), 3.55-3.49 (m, 1H), 3.26 (dd, J = 
17.5, 10.0 Hz, 1H), 3.01-2.95 (m, 2H), 2.92-2.87 (m, 1H), 2.84 (dd, J = 17.5, 4.0 Hz, 
1H), 2.65-2.60 (m, 1H), 2.54 (dd, J = 14.0, 8.5 Hz, 1H), 1.62-1.21 (m, 2H); 
13
C NMR 
(125 MHz, CDCl3) δC 173.4, 172.7, 159.9, 142.5,140.5, 140.5, 139.1, 133.8, 129.8, 
129.3, 128.1, 127.1, 125.0, 124.9, 119.7, 117.9, 113.7, 111.3, 58.3, 55.4, 55.3, 54.5, 
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48.0, 43.4, 40.5, 38.0, 33.2, 30.4; IR (neat) 3487, 1702, 1653 cm
-1
; MS (ES+H) m/z 
444.2 (M+H
+
); HRMS calcd for C28H30NO4 (M+H
+
): 444.2175, found 444.2151. 
 
 
Indene-derived macrocyclic ester (156). 3-Azido-1-propanol (17.5 mg, 
0.173 mmol) was added to a solution of 151 (69.0 mg, 0.171 mmol) in CH2Cl2 (2.0 
mL) at 0 ºC and the solution was stirred for 5 min. Triflic acid stock solution (0.455 
mL, 0.514 mmol) was slowly added dropwise and the solution gradually turned black. 
The acid stock solution was prepared fresh by the addition of triflic acid (0.20 mL) to 
a mixture of CH2Cl2 (1.45 mL) and MeCN (0.35 mL). The solution was gradually 
warmed to rt and stirred for 12 h. The reaction was diluted with CH2Cl2 (10 mL) and 
quenched by the addition of sat. aq NaHCO3 (5.0 mL) and the biphasic solution was 
stirred at rt for 2 h. The layers were then separated and the aqueous layer was 
extracted with CH2Cl2 (10 mL x 3). The organic extracts were combined, washed 
with brine (10 mL), dried (anhydrous Na2SO4), filtered, and evaporated in vacuo. The 
crude material was purified by SiO2 preparative TLC (5% MeOH/CH2Cl2) to afford 
156 (13.2 mg, 0.0297 mmol, 17%) as a yellow oil. Rf = 0.50 (5% MeOH/CH2Cl2); 
1
H 
NMR (500 MHz, CDCl3) δH 7.35 (t, J = 8.0 Hz, 1H), 7.24-7.14 (m, 6H), 6.92 (dd, J = 
8.0, 2.0 Hz, 1H), 6.45 (s, 1H), 6.33, (d, J = 8.0 Hz, NH), 5.86-5.78 (m, 1H), 5.26-5.19 
(m, 2H), 4.25 (ddd, J = 11.0, 8.0, 2.5 Hz, 1H), 4.07 (ddd, J = 11.0, 7.5, 3.0 Hz, 1H), 
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4.00 (d, J = 6.0 Hz, 1H), 3.90-3.83 (m, 1H), 3.86 (s, 3H), 3.51 (dd, J = 10.0, 5.5 Hz, 
1H), 3.25 (dd, J = 16.5, 9.0 Hz, 1H), 3.05-2.83 (m, 4H), 2.52 (dd, J = 13.5, 9.0 Hz, 
1H), 1.89-1.84 (m, 1H), 1.63-1.59 (m, 1H); 
13
C NMR (125 MHz, CDCl3) δC 173.3, 
169.7, 159.8, 144.4, 142.0, 141.8, 141.4, 133.7, 131.4, 129.7, 127.2, 126.3, 124.4, 
123.6, 119.5, 118.4, 113.1, 112.1, 65.5, 55.3, 52.1, 48.8, 48.4, 45.8, 45.3, 40.1, 36.8, 
26.4; IR (neat) 3413, 2929, 1726, 1665 cm
-1
; MS (ES+) m/z 444.2 (M+H
+
); HRMS 
calcd for C28H30NO4 (M+H
+
): 444.2175, found 444.2149. 
 
General procedure for the synthesis of polycyclic imines 157-160. To an 
oven-dried vial was added cyclopropane 135 (30 mg, 0.117 mmol) and anhydrous 
nitromethane (450 L) followed by the addition of benzonitrile (60 L, 0.585 mmol). 
To this mixture was added TMSOTf (21.0 L, 0.039 mmol) in anhydrous 
nitromethane (300 L) while at 0 
o
C. The reaction was warmed to rt and stirred for 4 
h. Next, the reaction was cooled to 0 
o
C and slowly quenched with the addition of 
saturated NaHCO3 (400 L), diluted with water (5 mL), and extracted into CH2Cl2 (5 
mL x 3). The organic fractions were combined, washed with brine (10 mL), dried 
over sodium sulfate, filtered, and evaporated in vacuo. The crude product was 
purified by flash chromatography (SiO2, 100 % CH2Cl2 to 30:1 CH2Cl2:EtOAc). 
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  Polycyclic imine (157). Reaction of cyclopropane 135 (40 mg, 0.156 mmol) 
with anhydrous acetonitrile (neat) afford polycyclic imine 157 (23.7 mg, 0.080 mmol, 
51%) as an amorphous white solid. The product was purified by silica gel flash 
chromatography (0.03% EtOAc/CH2Cl2 to 0.06% EtOAc/CH2Cl2). Rf = 0.22 (0.03 
EtOAc/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 7.36-7.25 (m, 3H), 7.15 (d, J = 6.6 
Hz, 2H), 3.90 (d, J = 5.1 Hz, 1H), 3.79 (s, 3H), 3.21-3.17 (m, 1H), 3.12-3.07 (m, 2H), 
2.67-2.57 (m, 1H), 2.18 (s, 3H), 1.17 (d, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3) δC 198.9, 197.8, 173.9, 139.4, 128.9, 128.1, 127.9, 105.2, 71.1, 64.1, 57.4, 
56.1, 53.0, 29.9, 21.0, 20.4; IR (thin film) 2959, 1749, 1718, 1624, 1272, 1142, 1032, 
731, 701 cm
-1
; MS (ES+) m/z 298.1 (M+H
+
); HRMS calcd for C18H20NO3 (M+H
+
): 
298.1443, found 298.1445. 
 
 
Polycyclic imine (158). Reaction of cyclopropane 135 (30 mg, 0.117 mmol) 
and benzonitrile (60 L, 0.585 mmol) afford polycyclic imine 158 (39.7 mg, 0.110 
mmol, 94%) as an amorphous off-white solid. The product was purified by silica gel 
flash chromatography (100% CH2Cl2 to 0.03% EtOAc/CH2Cl2). Rf = 0.49 (0.03% 
EtOAc/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 8.06 (d, J = 7.0 Hz, 2H), 7.57-7.51 
(m, 1H), 7.51-7.45 (m, 2H), 7.38-7.32 (m, 2H), 7.31-7.25 (m, 1H), 7.20 (d, J = 7.4 
Hz, 2H), 4.59 (d, J = 5.5 Hz, 1H), 3.87 (s, 3H), 3.25-3.18 (m, 3H), 2.76-2.65 (m, 1H), 
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1.25 (d, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 199.7, 197.4, 169.8, 139.5, 
132.5, 131.5, 128.9, 128.8, 128.6, 128.2, 127.9, 105.0, 71.5, 59.9, 57.7, 56.7, 53.0, 
30.0, 21.1; IR (thin film) 2959, 1749, 1723, 1568, 1456, 1210, 1147, 1070, 1032, 735, 
700 cm
-1
; MS (ES+) m/z 360.1 (M+H
+
); HRMS calcd for C23H22NO3 (M+H
+
): 
360.1600, found 360.1593. 
 
 
Polycyclic imine (159). Reaction of cyclopropane 135 (30 mg, 0.117 mmol) 
and 4-methoxybenzonitrile (78 L, 0.585 mmol) afford polycyclic imine 159 (36.4 
mg, 0.093 mmol, 80%) as an amorphic solid. The product was purified by silica gel 
flash chromatography (100% CH2Cl2 to 0.03% EtOAc/CH2Cl2). Rf = 0.39 (0.03% 
EtOAc/CH2Cl2);
 1
H NMR (400 MHz, CDCl3) δH 8.00 (d, J = 9.0 Hz, 2H), 7.37-7.32 
(m, 2H), 7.30-7.25 (m, 1H), 7.20 (d, J = 7.4 Hz, 2H), 6.97 (d, J = 9.0 Hz, 2H), 4.54 
(d, J = 5.1 Hz, 1H), 3.86 (s, 3H), 3.85 (s, 3H), 3.23-3.21 (m, 1H), 3.21-3.16 (m, 2H), 
2.76-2.65 (m, 1H), 1.24 (d, J = 7.0 Hz, 3H);
 13
C NMR (100 MHz, CDCl3) δC 199.9, 
197.5, 168.9, 163.1, 139.6, 130.6, 128.9, 128.2, 127.8, 124.2, 114.1, 105.0, 71.3, 59.7, 
57.3, 56.7, 55.4, 52.8, 30.0, 21.1; IR (thin film)x2959, 1750, 1723, 1607, 1513, 1256, 
1174, 1031, 735, 701 cm
-1
; MS (ES+) m/z 390.1 (M+H
+
); HRMS calcd for 
C24H24NO4 (M+H
+
): 390.1705, found 390.1717. 
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Polycyclic imine (160). Reaction with cyclopropane 135 (40 mg, 0.156 
mmol) and cinnamonitrile (98 L, 0.78 mmol) afford polycyclic imine 160 (28.6 mg, 
0.074 mmol, 47%) as an amorphous solid. The product was purified by silica gel 
flash chromatography (100% CH2Cl2 to 0.03% EtOAc/CH2Cl2). Rf = 0.14 (0.03% 
EtOAc/CH2Cl2). 
1
H NMR (400 MHz, CDCl3) δH 7.59-7.55 (m, 2H), 7.45 (d, J = 16.4 
Hz, 1H), 7.42-7.38 (m, 3H), 7.38-7.32 (m, 2H), 7.31-7.26 (m, 1H), 7.20 (d, J = 7.4 
Hz, 2H), 7.01 (d, J = 16.4 Hz, 1H), 4.41 (d, J = 5.1 Hz, 1H), 3.85 (s, 3H), 3.23 (d, J = 
2.0 Hz, 1H), 3.19-3.12 (m, 2H), 2.74-2.65 (m, 1H), 1.24 (d, J = 7.0 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3) δC 199.5, 197.4, 169.9, 144.2, 139.5, 134.9, 130.3, 129.0, 
128.9, 128.2, 128.0, 127.9, 121.9, 105.0, 71.4, 59.1, 57.4, 56.7, 53.1, 30.0, 21.1; IR 
(thin film) 2958, 1750, 1724, 1628, 1559, 1578, 1456, 1201, 1143, 754, 735, 700 cm
-
1
; MS (ES+) m/z 386.1 (M+H
+
); HRMS calcd for C25H24NO3 (M+H
+
): 386.1756, 
found 386.1765. 
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Polycyclic imine (161). Reaction with cyclopropane 141 (45.9 mg, 0.156 
mmol) and 4-methoxybenzonitrile (104 mg, 0.780 mmol) afford imine 161 (36.2 mg, 
0.085 mmol, 54%) as an amorphous solid. The product was purified by prep SiO2 
TLC (0.03% EtOAc/CH2Cl2). Rf = 0.76 (0.03% EtOAc/CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3) δH 7.96 (d, J = 9.0 Hz, 2H), 7.26-7.21 (m, 3H), 7.21-7.17 (m, 1H), 6.97 (d, J 
= 8.6 Hz, 2H), 5.78 (dddd, J = 16.8, 10.2, 7.4, 7.4 Hz, 1H), 5.13 (dd, J = 10.6, 1.6 Hz, 
1H), 5.04 (dd, J = 16.8, 1.2 Hz, 1H), 4.32 (s, 1H), 4.08 (dd, J = 9.0, 3.5 Hz, 1H), 3.90 
(s, 3H), 3.87 (s, 3H), 3.70-3.60 (m, 1H), 3.58 (d, J = 3.5 Hz, 1H), 3.18-3.14 (m, 2H), 
2.59 (dd, J = 14.5, 7.4 Hz, 1H), 2.18 (dd, J = 14.5, 7.4 Hz, 1H); 
13
C NMR (100 MHz, 
CDCl3) δH 200.2, 198.9, 168.0, 163.0, 142.3, 139.6, 133.1, 130.5, 128.4, 127.1, 125.2, 
124.5, 124.5, 119.4, 114.2, 105.2, 69.2, 67.5, 65.0, 56.4, 55.5, 51.5, 35.3, 33.7, 33.7; 
IR (thin film) 2943, 1719, 1606, 1513, 1251, 1174, 1027, 739 cm
-1
; MS (ES+) m/z 
428.1 (M+H
+
); HRMS calcd for C27H26NO4 (M+H
+
): 428.1862, found 428.1864. 
 
 
Methyl-3-(4-methoxyphenyl)-7-methyl-4-oxo-6-phenyl-4,5,6,7-tetrahydro-
2H-isoindole-1-carboxylate (162). A solution of 159 (100 mg, 0.256 mmol) 
dissolved in dry MeOH (5.0 mL) was heated in a sealed tube at 100 ºC for 12 h. After 
cooling, the solvent was removed in vacuo and the crude material was directly 
purified by SiO2 preparative TLC (66% Et2O/Hex) to afford 162 (83.5 mg, 0.214 
239 
 
mmol, 84%) as a white solid. Rf = 0.28 (66% Et2O/Hex); mp 86.6-90.0 ºC; 
1
H NMR 
(400 MHz, CDCl3) δH 10.04 (s, 1H), 7.53-7.50 (m, 2H), 7.28-7.24 (m, 2H), 7.20-7.17 
(m, 3H), 6.93-6.91 (m, 2H), 3.85 (s, 3H), 3.85-3.79 (m, 1H), 3.75 (s, 3H), 3.42 (q, J = 
4.0 Hz, 1H), 3.12 (dd, J = 17.2, 2.8 Hz, 1H), 2.78 (dd, J = 17.2, 4.0 Hz, 1H), 1.54 (d, 
J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δC 187.1, 164.8, 160.2, 144.1, 143.9, 
142.4, 130.6 (2), 128.3 (2), 127.4 (2), 126.5, 126.2, 123.0, 113.3 (2), 110.9, 55.2, 
50.9, 47.8, 39.4, 34.5, 20.9; IR (neat) 3209, 2953, 1702, 1634 cm
-1
; MS (ES+) m/z 
390.1 (M+H
+
); HRMS calcd for C24H24NO4 (M+H
+
): 390.1705, found 390.1678.  
 
 
Methyl-3-(4-methoxyphenyl)2,7-dimethyl-4-oxo-6-phenyl-4,5,6,7-
tetrahydro-2H-isoindole-1-carboxylate (163). A solution of 162 (100 mg, 0.256 
mmol), iodomethane (109 mg, 0.770 mmol), and K2CO3 (107 mg, 0.770 mmol) in dry 
MeCN (5.0 mL) was heated in a sealed tube at 82 ºC for 24 h. After cooling, the 
solvent was removed and the residue was taken up in CH2Cl2 (5.0 mL). The solution 
was washed with water (10 mL) and the aqueous layer was extracted with CH2Cl2 
(5.0 mL x 3). The organic extracts were collected, dried (anhydrous Na2SO4), filtered, 
and evaporated in vacuo to give a pale yellow oil. The crude material was purified by 
SiO2 column chromatography (66% Et2O/Hex) to afford 163 (55.5 mg, 0.137 mmol, 
54%) as a white solid. Rf = 0.43 (66% Et2O/Hex); mp 146.6-152.7 ºC; 
1
H NMR (500 
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MHz, CDCl3) δH 7.31-7.20 (m, 7H), 7.02 (d, J = 9.0 Hz, 2H), 3.95-3.89 (m, 1H), 3.90 
(s, 3H), 3.74 (s, 3H), 3.65 (s, 3H), 3.43-3.40 (m, 1H), 3.20 (dd, J = 17.0, 5.5 Hz, 1H), 
2.86 (dd, J = 17.0, 4.0 Hz, 1H), 1.57 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, 
CDCl3) δC 187.6, 164.5, 159.9, 145.7, 144.2, 141.4, 131.3 (2), 128.2 (2), 127.4 (2), 
126.1, 126.0, 122.4, 113.4 (2), 111.2, 55.1, 50.7, 46.9, 40.7, 34.3, 34.1 21.3; IR (neat) 
1702, 1649, 1456, 1247 cm
-1
; MS (ES+) m/z 404.1 (M+H
+
); HRMS calcd for 
C25H26NO4 (M+H
+
): 404.1862, found 404.1859. 
 
 
Cyclopropyl iminium ether (165). A solution of polycyclic iminium ethers 
67a/67b (5.00 mg, 0.011 mmol) dissolved in acetone-d6 (1.0 mL) in an NMR tube 
was irradiated in a photoreactor at 300 nm for 30 min. The solvent was then removed 
in vacuo. The isolated product required no additional purification and was unstable to 
SiO2. The reaction afforded 165 (4.31 mg, 0.0138 mmol, 86%) as a yellow oil. 
1
H 
NMR (500 MHz, Acetone-d6) δH 7.35-7.38 (m, 2H), 7.27-7.32 (m, 3H), 5.07 (ddt, J = 
11.0, 4.5, 2.0 Hz, 1H), 4.83 (ddd, J = 11.5, 10.5, 4.0 Hz, 1H), 4.23-4.28 (m, 1H), 4.04 
(d, J = 3.0 Hz, 1H), 3.98 (ddd, J = 14.5, 10.0, 5.5 Hz, 1H), 3.90 (s, 1H), 3.57 (s, 3H), 
3.30-3.34 (m, 3H), 2.54-2.66 (m, 2H), 1.47 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, 
Acetone-d6) δC 195.2, 172.6, 141.6, 130.6 (2), 129.7, 129.6 (2), 72.7, 72.4, 72.2, 58.9 
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53.9, 48.6, 45.2, 35.7, 34.3, 23.8, 21.4; IR (neat) 1739, 1652, 1274 cm
-1
; MS (ES+) 
m/z 312.1 (M
+
); HRMS calcd for C19H22NO3
 
(M
+
): 312.1600, found 312.1595. 
 
 
Cyclopropyl--thiophenyl lactam (166). A solution of polycyclic iminium 
ether 67a/67b (10.0 mg, 0.022 mmol) dissolved in acetone-d6 (1.0 mL) in an NMR 
tube was irradiated in a photoreactor at 300 nm for 30 min. The solution was 
transferred to a round-bottom flask and solvent was removed in vacuo. In a separate 
flask benzenethiol (9.55 mg, 0.086 mmol) was added to a mixture of potassium 
hydride (3.50 mg, 0.086 mmol) in DMF (1.0 mL). The cyclopropane iminium ether 
residue was taken up in DMF (0.50 mL) and added to the potassium hydride solution. 
The reaction was heated at 80 ºC for 24 h. After cooling, the reaction was quenched 
with water (5.0 mL) and extracted with Et2O (5.0 mL x 3). The organic extracts were 
combined, washed with brine (5.0 mL), dried (anhydrous Na2SO4), filtered and 
concentrated. The crude material was purified by SiO2 preparative TLC (7% 
MeOH/CH2Cl2) to afford -thiophenyl lactam 166 (6.80 mg, 0.0161 mmol, 99% 
derived according to reaction of the major regioisomer of substrate) as a yellow oil. 
Rf = 0.55 (7% MeOH/CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δH 7.25-7.34 (m, 7H), 
7.16-7.20 (m, 1H), 7.05-7.07 (m, 2H), 3.85 (ddd, J = 14.4, 13.6, 7.2 Hz, 1H), 3.55 (s, 
3H), 3.36 (d, J = 2.4 Hz, 1H), 3.14 (dt, J = 14.0, 6.8 Hz, 1H), 3.08 (t, J = 2.4 Hz, 1H), 
2.90-3.02 (m, 1H), 2.90 (t, J = 7.2 Hz, 2H), 2.65 (d, J = 10.4 Hz, 1H), 2.55 (ddd, J = 
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10.4, 5.2, 0.8 Hz, 1H), 1.86 (p, J = 7.2 Hz, 2H), 2.32 (d, J = 7.2 Hz, 3H); 
13
C NMR 
(125 MHz, CDCl3) δC 198.0, 166.5, 140.9, 136.9, 135.3, 130.6, 129.7, 129.1, 129.0 
(2), 127.6, 127.3, 127.0, 126.3, 70.0, 67.9, 57.4, 55.4, 45.6, 41.7, 36.9, 33.2, 31.0, 
27.3, 22.2; IR (neat) 1726, 1662, 1477 cm
-1
; MS (ES+) m/z 422.1 (M+H
+
); HRMS 
calcd for C25H28NO3S (M+H
+
): 422.1790, found 422.1777. 
 
 
Cyclopropyl--azido lactam (167). A solution of polycyclic iminium ether 
67a/67b (10.0 mg, 0.022 mmol) dissolved in acetone-d6 (1.0 mL) in an NMR tube 
was irradiated in a photoreactor at 300 nm for 30 min. The solution was transferred to 
a round-bottom flask and solvent was removed in vacuo. In a separate flask sodium 
azide (5.63 mg, 0.86 mmol) was dissolved in DMF (1.0 mL). The cyclopropane 
iminium ether residue was taken up in DMF (0.50 mL) and added to the sodium azide 
solution. The reaction was heated at 80 ºC for 24 h. After cooling, the reaction was 
quenched with water (5.0 mL) and extracted with Et2O (5.0 mL x 3). The organic 
extracts were combined, washed with brine (5.0 mL), dried (anhydrous Na2SO4), 
filtered and concentrated. The crude material was purified by SiO2 preparative TLC 
(7% MeOH/CH2Cl2) to afford -azido lactam 167 (5.20 mg, 0.0137 mmol, 91% 
derived according to reaction of the major regioisomer of substrate) as a yellow oil. 
Rf = 0.45 (7% MeOH/CH2Cl2); 
1
H NMR (500 MHz, CDCl3) δH 7.22-7.35 (m, 3H), 
7.10-7.12 (m, 2H), 3.90 (dt, J = 14.0, 7.0 Hz, 1H), 3.57 (s, 3H), 3.39 (d, J = 2.5 Hz, 
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1H), 3.32-3.36 (m, 2H), 3.13 (t, J = 2.5 Hz, 1H), 2.95-3.03 (m, 2H), 2.67 (d, J = 10.5 
Hz, 1H), 2.57 (ddd, J = 10.5, 5.5, 1.0 Hz, 1H), 1.77-1.84 (m, 2H), 1.34 (d, J = 7.0 Hz, 
3H); 
13
C NMR (125 MHz, CDCl3) δC 198.0, 166.6, 140.9, 129.1 (2), 127.7, 127.0 (2), 
70.0, 68.0, 57.4, 55.3, 48.7, 44.2, 41.7, 36.9, 33.3, 27.4, 22.2; IR (neat) 2098, 1726, 
1650 1456 cm
-1
; MS (ES+) m/z 377.1 (M+Na
+
); HRMS calcd for C19H22N4O3Na 
(M+Na
+
): 377.1590, found 377.1653. 
 
 
Cyclopropyl--hydroxy lactam (168). A solution of polycyclic iminium 
ether 67a/67b (400 mg, 0.867 mmol) dissolved in acetone-d6 (8.0 mL) divided 
amongst eight NMR tubes was irradiated in a photoreactor at 300 nm for 1 h. The 
solutions were combined and the solvent was removed in vacuo. The residue was 
taken up in CH2Cl2 (10 mL) and sat. aq NaHCO3 (10 mL) was added. The biphasic 
mixture was vigorously stirred for 3 h. The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (10 mL x 3). The organic extracts were combined, 
washed with brine, dried (anhydrous Na2SO4), filtered and concentrated to give pure 
product. The reaction afforded 168 (268 mg, 0.811 mmol, 94% derived according to 
reaction of the major regioisomer of substrate) as a fluffy yellow solid. Rf = 0.49 (7% 
MeOH/CH2Cl2); mp 98.0-100.0 ºC; 
1
H NMR (500 MHz, CDCl3) δH 7.33 (t, J = 7.5 
Hz, 2H), 7.25-7.28 (m, 1H), 7.11 (d, J = 7.0 Hz, 2H), 4.02 (ddd, J = 14.0, 10.0, 4.5 
Hz, 1H), 3.57-3.62 (m, 1H), 3.57 (s, 3H), 3.45 (ddd, J = 12.5, 9.5, 3.5 Hz, 1H), 3.36 
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(d, J = 2.5 Hz, 1H), 3.15 (t, J = 2.5 Hz, 1H), 2.99-3.04 (m, 2H), 2.68 (d, J = 10.5 Hz, 
1H), 2.59 (ddd, J = 10.5, 5.5, 0.5 Hz, 1H), 1.74-1.80 (m, 1H), 1.57-1.65 (m, 1H), 1.36 
(d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δC 198.0, 167.8, 140.9, 129.1 (2), 
127.7, 127.1 (2), 70.2, 67.7, 58.0, 57.4, 55.2, 42.9, 41.9, 36.8, 33.4, 30.1, 22.3; IR 
(neat) 3421, 1726, 1648, 1265 cm
-1
; MS (ES+) m/z 330.2 (M+H
+
); HRMS calcd for 
C19H24NO4 (M+H
+
): 330.1705, found 330.1709. 
 
 
Cyclopropyl--hydroxy lactam tertiary alcohol (Lithiate addition 
product) (169). Methylmagnesium bromide (0.097 mL of 3.0 M in Et2O, 0.291 
mmol) was added dropwise to a solution of 37 (32.0 mg, 0.97 mmol) in THF (0.75 
mL) at 0 ºC. The solution was warmed to rt and stirred for 1 h. The reaction was 
quenched with water (2.0 mL), dropwise, and the mixture was extracted with CH2Cl2 
(5.0 mL x 3). The organic extracts were collected, washed with brine, dried 
(anhydrous Na2SO4), filtered and concentrated to afford tertiary alcohol (18.5 mg, 
0.534 mmol, 55%) as a yellow oil. Rf = 0.30 (5% MeOH/CH2Cl2); 
1
H NMR (400 
MHz, CDCl3) δH 7.39-7.41 (m, 2H), 7.29-7.33 (m, 2H), 7.20-7.25 (m, 1H), 3.82-3.89 
(m, 1H), 3.59-3.66 (m, 1H), 3.50-5.58 (m, 1H), 3.49 (s, 3H), 3.23 (m, 1H), 3.04-3.10 
(m, 2H), 2.59 (d, J = 7.6 Hz, 1H), 2.17 (d, J = 10.4 Hz, 1H), 1.97 (dd, J = 10.4, 2.8 
Hz, 1H), 1.85 (brs, 1H), 1.71-1.80 (m, 1H), 1.53-1.64 (m, 1H), 1.48 (s, 3H), 1.15 (d, J 
= 7.2 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δC 170.1, 143.1, 128.7 (2), 128.5 (2), 
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126.8, 72.5, 69.2, 68.8, 58.3, 57.0, 52.4, 43.1, 33.1, 32.5, 30.0, 29.8, 24.3, 22.7; IR 
(neat) 3364, 2921, 1627 cm
-1
; MS (ES+) m/z 346.2 (M+H
+
); HRMS calcd for 
C20H28NO4 (M+H
+
): 346.2018, found 346.2014. 
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Appendix 
 
Single Crystal X-Ray Analysis 
 
 General methods.  All x-ray crystal structure determinations were performed by 
either Dr. Victor Day, Ph.D. (University of Kansas), Dr. Jeff Bacon Ph.D. (Boston 
University), or Dr. Emil Lobkovsky, Ph.D. (Cornell University).  Intensity data collected 
at the University of Kansas were collected using a Bruker APEX ccd area detector
1
 
mounted on a Bruker D8 goniometer with graphite-monochromated Mo Kα radiation (λ = 
0.71071 Å).  All samples were cooled to 100 K.
2
  The intenisty data were measured as a 
series of ω oscillation frames, each at the indicated angle and time per frame specified for 
each sample.  The detector operated in 512 x 512 mode and was positioned 5.054 cm 
from each sample. 
 
 
X-Ray crystallographic data for bicyclic imide (153).  Crystals of compound 
153 suitable for X-ray analysis were obtained by dissolving the material in a minimal 
amount of ethyl acetate, placing the vial of solution in a larger vial containing hexanes, 
and sealing the lid to allow slow solvent mixing.  Crystallographic data have been 
deposited with the Cambridge Crystallographic Data Centre (CCDC # 818811). Copies of 
the data can be obtained free of charge on application to the CCDC, 12 Union Road, 
Cambridge CB21EZ, UK (fax: (+44)-1223-336-033; e-mail: deposit@ccdc.cam.ac.uk. 
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Crystal data and structure refinement for compound 153. 
Identification Code Compound 153 
Empirical formula  C26H26BrNO4 
Formula weight  496.39 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1 – Ci
1
 (No. 2) 
Unit cell dimensions a = 7.867(4) Å  = 72.210(7)°. 
 b = 11.447(6) Å β = 86.597(8)°. 
 c = 13.759(7) Å  = 76.128(8)°. 
Volume                1145(1)Å
3
 
Z 2 
Density (calculated) 1.440 Mg/m
3
 
Absorption coefficient 1.828 mm
-1
 
260 
F(000) 512 
Crystal size 0.44 x 0.40 x 0.26 mm
3
 
Theta range for data collection 2.67 to 29.06°. 
Index ranges -10 ≤ h ≤ 10, -15 ≤ k ≤ 15, -18 ≤ l ≤ 18 
Reflections collected 10050 
Independent reflections 5356 [Rint = 0.086] 
Completeness to theta = 29.06° 87.4 %  
Absorption correction Multi-scan 
Max. and min. transmission 1.000 and 0.784 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 5356 / 0 / 393 
Goodness-of-fit on F
2
 1.036 
Final R indices [I>2sigma(I)] R1 = 0.049, wR2 = 0.133 
R indices (all data) R1 = 0.056, wR2 = 0.151 
Largest diff. peak and hole 1.11 and -0.89 e
-
/Å
3
 
 
Atomic coordinates ( x 10
4
) and equivalent isotropic displacement parameters 
(Å
2
x10
3
) for compound 153. U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
 
 x y z U(eq) 
Br 1232(1) 5683(1) -2597(1) 31(1) 
O(1) 3716(2) 3314(2) 2384(1) 21(1) 
O(2) 2356(3) 872(2) 1913(1) 23(1) 
O(3) 2019(2) -529(2) 5353(1) 20(1) 
O(4) 3334(3) 5358(2) 2283(2) 31(1) 
N 2105(3) 132(2) 3628(1) 15(1) 
C(1) 2324(3) -26(2) 2650(2) 16(1) 
C(2) 2561(3) -1333(2) 2531(2) 16(1) 
C(3) 871(3) -1862(2) 2803(2) 16(1) 
C(4) 508(3) -2164(2) 3957(2) 17(1) 
C(5) 2107(3) -2132(2) 4566(2) 16(1) 
C(6) 2078(3) -800(2) 4558(2) 16(1) 
C(7) 3820(3) -2688(2) 4152(2) 19(1) 
C(8) 4076(3) -2272(2) 3153(2) 18(1) 
C(9) 2038(3) 1409(2) 3676(2) 17(1) 
C(10) 3851(3) 1579(2) 3884(2) 21(1) 
C(11) 3964(4) 2949(3) 3477(2) 23(1) 
C(12) 3330(3) 4550(2) 1887(2) 22(1) 
C(13) 2884(3) 4793(2) 798(2) 20(1) 
C(14) 2675(4) 6017(2) 132(2) 25(1) 
C(15) 2189(4) 6291(3) -878(2) 27(1) 
C(16) 1922(4) 5318(3) -1217(2) 24(1) 
C(17) 2109(3) 4109(2) -574(2) 22(1) 
C(18) 2596(4) 3837(2) 435(2) 22(1) 
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C(19) -639(3) -1050(2) 2096(2) 16(1) 
C(20) -1871(3) -67(2) 2309(2) 19(1) 
C(21) -3217(4) 655(3) 1616(2) 22(1) 
C(22) -3346(4) 417(3) 689(2) 24(1) 
C(23) -2111(3) -546(3) 465(2) 23(1) 
C(24) -780(3) -1274(3) 1165(2) 20(1) 
C(25) 83(4) -3461(3) 4378(2) 26(1) 
C(26)       5668(4)    -2714(3)     2595(2)         25(1) 
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X-Ray crystallographic data for caged imine (159).  Crystals of compound 27 
suitable for X-ray analysis were obtained by slow evaporation from a minimal amount of 
ethyl acetate.  Crystallographic data have been deposited with the Cambridge 
Crystallographic Data Centre (CCDC # 819148). Copies of the data can be obtained free 
of charge on application to the CCDC, 12 Union Road, Cambridge CB21EZ, UK (fax: 
(+44)-1223-336-033; e-mail: deposit@ccdc.cam.ac.uk. 
 
 
Crystal data and structure refinement for compound 159. 
Identification code  compound 159 
Empirical formula  C24 H23 N O4 
Formula weight  389.43 
Temperature  102(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 13.337(4) Å  
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 b =17.093 (5) Å = 105.324 (18)° 
 c = 17.547 (5) Å  
Volume 3857.9 (19) Å
3 
Z, Z' 8, 4 
Density (calculated) 1.341 Mg/m
3 
Absorption coefficient 0.74 mm
-1 
F(000) 1648 
Crystal size 0.27 x 0.20 x 0.11 mm
3 
Theta range for data collection 2.6 to 66.5°. 
Index ranges -14<=h<=15, -20<=k<=20, -19<=l<=20 
Reflections collected 142546 
Independent reflections 13252 [R(int) = 0.0341] 
Completeness to theta = 66.5° 97 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.753 and 0.698 
Refinement method Full-matrix least-squares on F
2 
Data / restraints / parameters 13252 / 1 / 1058 
Goodness-of-fit on F
2
 1.002 
Final R indices [I>2sigma(I)] R1 = 0.0233, wR2 = 0.0667 
R indices (all data) R1 = 0.0233, wR2 = 0.0668 
Largest diff. peak and hole 0.21 and -0.13 e.Å
-3 
 
Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 
103) for compound 159.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 x y z Uiso*/Ueq 
O1C 1.02764 (7) 0.64277 (6) 1.10490 (5) 0.0280 (2) 
O4C 0.93883 (6) 0.53264 (5) 1.57238 (5) 0.02034 (17) 
O3C 0.87140 (6) 0.68541 (5) 1.55193 (5) 0.02434 (18) 
O2C 1.13723 (6) 0.77126 (5) 1.47301 (5) 0.02146 (17) 
O1A 1.19613 (7) 0.43665 (6) 1.37720 (5) 0.0298 (2) 
O4A 1.30047 (6) 0.54731 (5) 0.91550 (5) 0.02198 (18) 
O3A 1.34847 (6) 0.39026 (5) 0.92625 (5) 0.02353 (18) 
O2A 1.07358 (6) 0.32005 (5) 1.00339 (5) 0.02098 (17) 
O1D 0.47669 (8) 0.17306 (6) 0.89461 (5) 0.0364 (2) 
O3D 0.63009 (6) 0.22851 (5) 0.43617 (5) 0.02508 (18) 
O4D 0.60648 (6) 0.06812 (5) 0.44397 (5) 0.02259 (18) 
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O2D 0.34823 (7) 0.28404 (5) 0.51066 (5) 0.02538 (19) 
O1B 0.61044 (7) 0.44321 (6) 1.37784 (5) 0.0308 (2) 
O2B 0.57158 (7) 0.31910 (5) 1.01625 (5) 0.02501 (18) 
O3B 0.85633 (6) 0.38471 (5) 0.96390 (5) 0.02484 (18) 
O4B 0.81473 (6) 0.54215 (5) 0.94873 (5) 0.02230 (18) 
N1C 0.96961 (7) 0.57747 (6) 1.44959 (6) 0.0183 (2) 
N1A 1.26482 (7) 0.50091 (6) 1.03581 (5) 0.0190 (2) 
N1D 0.56209 (7) 0.12139 (6) 0.55750 (6) 0.0202 (2) 
N1B 0.75644 (7) 0.49731 (6) 1.06039 (6) 0.0193 (2) 
C1C 1.10790 (11) 0.68199 (8) 1.07976 (7) 0.0273 (3) 
H1CB 1.1726 0.6520 1.0966 0.041* 
H1CC 1.1185 0.7343 1.1034 0.041* 
H1CA 1.0877 0.6866 1.0220 0.041* 
C2C 1.04008 (10) 0.63447 (7) 1.18435 (7) 0.0216 (2) 
C7C 1.12894 (9) 0.65521 (7) 1.24267 (7) 0.0217 (2) 
H7C 1.1869 0.6771 1.2284 0.026* 
C6C 1.13274 (9) 0.64375 (7) 1.32225 (7) 0.0202 (2) 
H6C 1.1941 0.6571 1.3618 0.024* 
C5C 1.04806 (9) 0.61302 (7) 1.34446 (7) 0.0185 (2) 
C8C 1.04842 (9) 0.60336 (6) 1.42792 (7) 0.0165 (2) 
C9C 1.13764 (8) 0.63077 (7) 1.49740 (6) 0.0162 (2) 
H9C 1.2086 0.6219 1.4901 0.019* 
C14C 1.11350 (8) 0.58270 (6) 1.56546 (6) 0.0158 (2) 
H14B 1.1389 0.5278 1.5643 0.019* 
C16C 1.15210 (8) 0.61633 (7) 1.64932 (6) 0.0162 (2) 
H16B 1.1114 0.5906 1.6827 0.019* 
C18C 1.12909 (9) 0.70557 (7) 1.64864 (6) 0.0169 (2) 
H18B 1.1953 0.7329 1.6485 0.020* 
C19C 1.10034 (9) 0.73236 (7) 1.72309 (7) 0.0185 (2) 
C20C 1.01470 (9) 0.70242 (7) 1.74434 (7) 0.0232 (2) 
H20B 0.9695 0.6667 1.7103 0.028* 
C21C 0.99487 (10) 0.72475 (8) 1.81570 (7) 0.0251 (3) 
H21B 0.9359 0.7043 1.8296 0.030* 
C22C 1.06055 (10) 0.77661 (8) 1.86651 (7) 0.0251 (3) 
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H22B 1.0474 0.7910 1.9152 0.030* 
C13C 0.99385 (9) 0.58460 (7) 1.53685 (6) 0.0169 (2) 
C15C 0.95852 (10) 0.45123 (7) 1.56228 (7) 0.0255 (3) 
H15I 1.0292 0.4382 1.5930 0.038* 
H15G 0.9514 0.4405 1.5062 0.038* 
H15H 0.9084 0.4195 1.5807 0.038* 
C12C 0.95941 (8) 0.66833 (7) 1.55278 (6) 0.0174 (2) 
C11C 1.04818 (9) 0.72712 (7) 1.56826 (6) 0.0176 (2) 
H11B 1.0223 0.7820 1.5688 0.021* 
C17C 1.26643 (9) 0.60131 (7) 1.68794 (7) 0.0201 (2) 
H17H 1.3086 0.6270 1.6572 0.030* 
H17G 1.2798 0.5449 1.6898 0.030* 
H17I 1.2847 0.6224 1.7418 0.030* 
C23C 1.14495 (11) 0.80672 (8) 1.84513 (7) 0.0282 (3) 
H23B 1.1898 0.8427 1.8790 0.034* 
C24C 1.16512 (10) 0.78473 (7) 1.77403 (7) 0.0228 (2) 
H24B 1.2239 0.8058 1.7602 0.027* 
C10C 1.11155 (8) 0.71695 (7) 1.50788 (6) 0.0165 (2) 
C4C 0.95831 (9) 0.59367 (7) 1.28486 (7) 0.0215 (2) 
H4C 0.8994 0.5734 1.2990 0.026* 
C3C 0.95448 (10) 0.60371 (7) 1.20587 (7) 0.0242 (3) 
H3C 0.8936 0.5897 1.1663 0.029* 
C1A 1.11716 (11) 0.39364 (9) 1.39980 (8) 0.0327 (3) 
H1AA 1.1084 0.3426 1.3735 0.049* 
H1AB 1.0515 0.4227 1.3843 0.049* 
H1AC 1.1372 0.3861 1.4572 0.049* 
C2A 1.18559 (10) 0.44670 (7) 1.29793 (7) 0.0221 (2) 
C7A 1.09709 (10) 0.42783 (7) 1.23880 (7) 0.0223 (2) 
H7A 1.0383 0.4061 1.2520 0.027* 
C6A 1.09474 (9) 0.44094 (7) 1.15991 (7) 0.0210 (2) 
H6A 1.0335 0.4290 1.1197 0.025* 
C5A 1.18089 (9) 0.47123 (7) 1.13930 (7) 0.0179 (2) 
C8A 1.18272 (8) 0.48077 (7) 1.05640 (7) 0.0175 (2) 
C9A 1.09033 (9) 0.46075 (7) 0.98597 (6) 0.0170 (2) 
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H9A 1.0208 0.4742 0.9938 0.020* 
C14A 1.12058 (9) 0.50841 (7) 0.92012 (6) 0.0176 (2) 
H14A 1.1023 0.5648 0.9239 0.021* 
C16A 1.07485 (9) 0.47885 (7) 0.83529 (6) 0.0177 (2) 
H16A 1.1127 0.5056 0.8005 0.021* 
C18A 1.09325 (9) 0.38891 (7) 0.83038 (6) 0.0172 (2) 
H18A 1.0247 0.3627 0.8252 0.021* 
C19A 1.13134 (8) 0.36338 (7) 0.76000 (6) 0.0173 (2) 
C24A 1.08590 (9) 0.29930 (7) 0.71433 (7) 0.0202 (2) 
H24A 1.0308 0.2720 0.7275 0.024* 
C23A 1.12008 (9) 0.27487 (7) 0.64988 (7) 0.0228 (2) 
H23A 1.0883 0.2311 0.6197 0.027* 
C22A 1.20022 (9) 0.31400 (7) 0.62938 (7) 0.0232 (3) 
H22A 1.2229 0.2979 0.5849 0.028* 
C4A 1.26968 (9) 0.48980 (7) 1.19989 (7) 0.0208 (2) 
H4A 1.3292 0.5105 1.1868 0.025* 
C3A 1.27186 (9) 0.47845 (7) 1.27839 (7) 0.0230 (2) 
H3A 1.3320 0.4923 1.3189 0.028* 
C13A 1.23956 (9) 0.49785 (7) 0.94827 (6) 0.0177 (2) 
C15A 1.30043 (11) 0.62790 (8) 0.93807 (8) 0.0313 (3) 
H15F 1.3196 0.6319 0.9958 0.047* 
H15D 1.2309 0.6500 0.9166 0.047* 
H15E 1.3508 0.6569 0.9172 0.047* 
C10A 1.10555 (8) 0.37351 (7) 0.97137 (6) 0.0170 (2) 
C11A 1.16827 (9) 0.36055 (7) 0.91099 (6) 0.0174 (2) 
H11A 1.1874 0.3042 0.9084 0.021* 
C21A 1.24683 (9) 0.37725 (8) 0.67502 (7) 0.0230 (2) 
H21A 1.3025 0.4040 0.6620 0.028* 
C20A 1.21291 (9) 0.40188 (7) 0.73967 (7) 0.0208 (2) 
H20A 1.2456 0.4452 0.7702 0.025* 
C17A 0.96018 (9) 0.49881 (8) 0.80467 (7) 0.0249 (3) 
H17F 0.9513 0.5557 0.8047 0.037* 
H17E 0.9214 0.4747 0.8389 0.037* 
H17D 0.9339 0.4788 0.7507 0.037* 
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C12A 1.26351 (9) 0.41252 (7) 0.92809 (6) 0.0180 (2) 
C1D 0.38501 (13) 0.19095 (9) 0.91767 (8) 0.0359 (3) 
H1DA 0.3332 0.1498 0.8988 0.054* 
H1DB 0.3572 0.2413 0.8947 0.054* 
H1DC 0.4014 0.1941 0.9754 0.054* 
C2D 0.46908 (11) 0.16651 (8) 0.81593 (7) 0.0274 (3) 
C7D 0.37721 (10) 0.17078 (8) 0.75621 (8) 0.0262 (3) 
H7D 0.3132 0.1805 0.7686 0.031* 
C6D 0.37950 (10) 0.16072 (7) 0.67768 (7) 0.0238 (3) 
H6D 0.3164 0.1630 0.6370 0.029* 
C5D 0.47250 (9) 0.14741 (7) 0.65802 (7) 0.0209 (2) 
C8D 0.47677 (9) 0.13557 (7) 0.57620 (7) 0.0199 (2) 
C9D 0.38349 (9) 0.14465 (7) 0.50350 (7) 0.0203 (2) 
H9D 0.3157 0.1272 0.5119 0.024* 
C10D 0.38710 (8) 0.23149 (7) 0.48216 (6) 0.0200 (2) 
C11D 0.44616 (9) 0.24484 (7) 0.41937 (7) 0.0199 (2) 
H11 0.4565 0.3018 0.4108 0.024* 
C18D 0.37016 (9) 0.20589 (7) 0.34477 (7) 0.0200 (2) 
H18 0.2982 0.2217 0.3454 0.024* 
C19D 0.38602 (9) 0.23433 (7) 0.26664 (7) 0.0190 (2) 
C24D 0.30562 (9) 0.27277 (7) 0.21283 (7) 0.0224 (2) 
H24 0.2419 0.2819 0.2259 0.027* 
C23D 0.31706 (10) 0.29807 (7) 0.14011 (7) 0.0260 (3) 
H23 0.2608 0.3233 0.1038 0.031* 
C22D 0.40941 (10) 0.28676 (7) 0.12042 (7) 0.0253 (3) 
H22 0.4175 0.3047 0.0711 0.030* 
C4D 0.56480 (10) 0.14503 (8) 0.71918 (7) 0.0250 (3) 
H4D 0.6293 0.1369 0.7070 0.030* 
C3D 0.56275 (10) 0.15433 (8) 0.79679 (7) 0.0282 (3) 
H3D 0.6258 0.1524 0.8376 0.034* 
C16D 0.37599 (9) 0.11523 (7) 0.35504 (7) 0.0205 (2) 
H16 0.4252 0.0950 0.3255 0.025* 
C17D 0.27068 (10) 0.07693 (8) 0.31992 (8) 0.0274 (3) 
H17C 0.2218 0.0932 0.3499 0.041* 
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H17B 0.2784 0.0199 0.3226 0.041* 
H17A 0.2441 0.0930 0.2647 0.041* 
C14D 0.42141 (9) 0.09528 (7) 0.44270 (7) 0.0190 (2) 
H14 0.4115 0.0384 0.4517 0.023* 
C13D 0.53764 (9) 0.11629 (7) 0.47022 (7) 0.0188 (2) 
C12D 0.54884 (9) 0.20054 (7) 0.44087 (6) 0.0193 (2) 
C15D 0.60883 (10) -0.01167 (8) 0.46977 (7) 0.0270 (3) 
H15A 0.5488 -0.0398 0.4368 0.040* 
H15C 0.6062 -0.0132 0.5250 0.040* 
H15B 0.6731 -0.0366 0.4651 0.040* 
C21D 0.49053 (10) 0.24881 (8) 0.17362 (8) 0.0278 (3) 
H21 0.5546 0.2407 0.1607 0.033* 
C20D 0.47854 (10) 0.22256 (8) 0.24584 (7) 0.0258 (3) 
H20 0.5344 0.1962 0.2814 0.031* 
C1B 0.69766 (12) 0.43694 (9) 1.44557 (7) 0.0336 (3) 
H1BB 0.7391 0.4850 1.4511 0.050* 
H1BA 0.7406 0.3922 1.4390 0.050* 
H1BC 0.6730 0.4293 1.4929 0.050* 
C2B 0.63042 (10) 0.45213 (7) 1.30589 (7) 0.0240 (3) 
C7B 0.54449 (10) 0.44787 (8) 1.24051 (7) 0.0258 (3) 
H7B 0.4776 0.4386 1.2481 0.031* 
C6B 0.55525 (9) 0.45700 (7) 1.16454 (7) 0.0223 (2) 
H6B 0.4957 0.4545 1.1207 0.027* 
C5B 0.65347 (9) 0.46982 (7) 1.15207 (7) 0.0187 (2) 
C8B 0.66852 (9) 0.47861 (7) 1.07240 (7) 0.0177 (2) 
C9B 0.58531 (9) 0.45944 (7) 0.99562 (6) 0.0180 (2) 
H9B 0.5126 0.4729 0.9964 0.022* 
C14B 0.62788 (9) 0.50736 (7) 0.93601 (6) 0.0177 (2) 
H14C 0.6104 0.5639 0.9394 0.021* 
C16B 0.59501 (9) 0.48031 (7) 0.84925 (6) 0.0176 (2) 
H16C 0.6453 0.5033 0.8221 0.021* 
C18B 0.60394 (9) 0.38924 (7) 0.84535 (6) 0.0181 (2) 
H18C 0.5324 0.3679 0.8392 0.022* 
C19B 0.63735 (9) 0.36327 (7) 0.77291 (7) 0.0186 (2) 
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C24B 0.56202 (10) 0.34823 (8) 0.70256 (7) 0.0244 (3) 
H24C 0.4906 0.3506 0.7017 0.029* 
C23B 0.58960 (11) 0.32967 (8) 0.63322 (7) 0.0283 (3) 
H23C 0.5368 0.3208 0.5857 0.034* 
C22B 0.69273 (10) 0.32407 (7) 0.63309 (7) 0.0254 (3) 
H22C 0.7116 0.3110 0.5861 0.030* 
C4B 0.73868 (9) 0.47273 (7) 1.21825 (7) 0.0217 (2) 
H4B 0.8060 0.4805 1.2109 0.026* 
C3B 0.72820 (10) 0.46460 (7) 1.29452 (7) 0.0237 (3) 
H3B 0.7875 0.4676 1.3385 0.028* 
C13B 0.74456 (9) 0.49453 (7) 0.97354 (6) 0.0184 (2) 
C17B 0.48704 (9) 0.50909 (8) 0.80594 (7) 0.0231 (2) 
H17L 0.4860 0.5664 0.8064 0.035* 
H17K 0.4361 0.4890 0.8323 0.035* 
H17J 0.4695 0.4904 0.7512 0.035* 
C11B 0.67254 (9) 0.35864 (7) 0.92695 (7) 0.0184 (2) 
H11C 0.6908 0.3022 0.9242 0.022* 
C10B 0.60400 (8) 0.37182 (7) 0.98342 (6) 0.0184 (2) 
C12B 0.76909 (9) 0.40907 (7) 0.95505 (6) 0.0189 (2) 
C21B 0.76817 (10) 0.33788 (7) 0.70295 (7) 0.0253 (3) 
H21C 0.8395 0.3338 0.7038 0.030* 
C20B 0.74130 (9) 0.35760 (7) 0.77206 (7) 0.0230 (2) 
H20C 0.7944 0.3673 0.8191 0.028* 
C15B 0.80547 (11) 0.62427 (8) 0.96217 (8) 0.0292 (3) 
H15L 0.8047 0.6329 1.0172 0.044* 
H15J 0.7407 0.6440 0.9269 0.044* 
H15K 0.8647 0.6520 0.9516 0.044* 
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X-Ray crystallographic data of N-acylhemiaminal (163).  Crystals of 
compound 3 suitable for X-ray analysis were obtained by dissolving the residue in a 
minimal amount of ethyl acetate and adding hexane very carefully as to produce two 
layers; the product crystallized as the layers diffused.  Crystallographic data have been 
deposited with the Cambridge Crystallographic Data Centre (CCDC # 818952). Copies of 
the data can be obtained free of charge on application to the CCDC, 12 Union Road, 
Cambridge CB21EZ, UK (fax: (+44)-1223-336-033; e-mail: deposit@ccdc.cam.ac.uk. 
 
Crystal data and structure refinement for compound 163. 
Identification code  Compound 163 
Empirical formula  C23 H24 Br N O3 
271 
Formula weight  442.34 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 11.4651(3) Å α= 90°. 
 b = 10.4634(2) Å = 102.0840(10)°. 
 c = 17.3065(5) Å  = 90°. 
Volume 2030.15(9) Å3 
Z 4 
Density (calculated) 1.447 Mg/m3 
Absorption coefficient 2.048 mm-1 
F(000) 912 
Crystal size 0.40 x 0.35 x 0.30 mm3 
Theta range for data collection 2.29 to 30.51°. 
Index ranges -16<=h<=15, -14<=k<=14, -24<=l<=24 
Reflections collected 35229 
Independent reflections 6191 [R(int) = 0.0399] 
Completeness to theta = 30.51° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5785 and 0.4946 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6191 / 0 / 349 
Goodness-of-fit on F2 1.003 
Final R indices [I>2sigma(I)] R1 = 0.0341, wR2 = 0.0746 
R indices (all data) R1 = 0.0627, wR2 = 0.0851 
Largest diff. peak and hole 0.383 and -0.358 e.Å-3 
 
Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 
103) for compound 163.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 x y z U(eq) 
Br(1) 338(1) 2627(1) 1162(1) 40(1) 
O(1) 4385(1) 10803(1) 574(1) 24(1) 
O(2) 3348(1) 8799(1) -347(1) 24(1) 
O(3) 5705(1) 6982(1) 1808(1) 31(1) 
N(1) 4209(1) 7528(1) 761(1) 20(1) 
C(1) 4073(1) 9736(1) 969(1) 19(1) 
C(2) 3839(1) 9830(1) 1776(1) 22(1) 
C(3) 2779(1) 9216(1) 2025(1) 24(1) 
C(4) 2182(1) 8143(1) 1468(1) 20(1) 
C(5) 2182(1) 8438(1) 603(1) 21(1) 
C(6) 3434(1) 8624(1) 462(1) 18(1) 
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C(7) 5016(1) 7770(1) 1439(1) 21(1) 
C(8) 4966(1) 9153(1) 1622(1) 22(1) 
C(9) 3422(2) 11673(2) 314(1) 42(1) 
C(10) 3108(2) 8766(2) 2879(1) 37(1) 
C(11) 926(1) 7865(1) 1576(1) 24(1) 
C(12) 31(1) 8782(2) 1415(1) 34(1) 
C(13) -1118(1) 8492(2) 1495(1) 42(1) 
C(14) -1396(1) 7295(2) 1725(1) 42(1) 
C(15) -520(1) 6384(2) 1893(1) 37(1) 
C(16) 634(1) 6668(2) 1825(1) 29(1) 
C(17) 4128(1) 6294(1) 364(1) 26(1) 
C(18) 3211(1) 5382(1) 561(1) 23(1) 
C(19) 2217(1) 5051(1) -5(1) 26(1) 
C(20) 1359(1) 4225(1) 167(1) 26(1) 
C(21) 1516(1) 3738(1) 920(1) 24(1) 
C(22) 2509(1) 4025(1) 1496(1) 28(1) 
C(23)       3357(1)     4844(1)     1312(1)         27(1) 
 
 
 
References for X-Ray Structure Determinations 
 
(1) (a) Data Collection: SMART Software Reference Manual (1994). Bruker-AXS, 
6300 Enterprise Dr. Madison, WI 53719-1173, USA.  (b) Data Reduction: SAINT 
Software Reference Manual (1995). Bruker-AXS, 6300 Enterprise Dr. Madison, 
WI 53719-1173, USA. 
 
(2) G.M. Sheldrick (2000). SADABS. Program for Empirical Adsorption Correction 
of Area Detector Data. University of Göttingen, Germany. 
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1 
1H NMR (400 MHz, DMSO-d6)  
1 
13C NMR (100 MHz, DMSO-d6)  
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2 
1H NMR (400 MHz, DMSO-d6)  
2 
13C NMR (100 MHz, DMSO-d6)  
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3 
1H NMR (400 MHz, DMSO-d6)  
3 
13C NMR (100 MHz, DMSO-d6)  
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4 
1H NMR (400 MHz, DMSO-d6)  
4 
13C NMR (100 MHz, DMSO-d6)  
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5 
1H NMR (400 MHz, DMSO-d6)  
5 
13C NMR (100 MHz, DMSO-d6)  
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6 
1H NMR (400 MHz, DMSO-d6)  
6 
13C NMR (100 MHz, DMSO-d6)  
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7 
1H NMR (400 MHz, DMSO-d6)  
7 
13C NMR (100 MHz, DMSO-d6)  
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8 
1H NMR (400 MHz, DMSO-d6)  
8 
13C NMR (100 MHz, DMSO-d6)  
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9 
1H NMR (400 MHz, DMSO-d6)  
9 
13C NMR (100 MHz, DMSO-d6)  
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10 
1H NMR (400 MHz, DMSO-d6)  
10 
13C NMR (100 MHz, DMSO-d6)  
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11 
1H NMR (400 MHz, DMSO-d6)  
11 
13C NMR (100 MHz, DMSO-d6)  
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12 
1H NMR (400 MHz, DMSO-d6)  
12 
13C NMR (100 MHz, DMSO-d6)  
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13 
1H NMR (400 MHz, DMSO-d6)  
13 
13C NMR (100 MHz, DMSO-d6)  
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14 
1H NMR (400 MHz, DMSO-d6)  
14 
13C NMR (100 MHz, DMSO-d6)  
287 
 
 
15 
1H NMR (400 MHz, DMSO-d6)  
15 
13C NMR (100 MHz, DMSO-d6)  
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16 
1H NMR (400 MHz, DMSO-d6)  
16 
13C NMR (100 MHz, DMSO-d6)  
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17 
1H NMR (400 MHz, DMSO-d6)  
17 
13C NMR (100 MHz, DMSO-d6)  
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18 
1H NMR (400 MHz, DMSO-d6)  
18 
13C NMR (100 MHz, DMSO-d6)  
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19 
1H NMR (400 MHz, DMSO-d6)  
19 
13C NMR (100 MHz, DMSO-d6)  
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20 
1H NMR (400 MHz, DMSO-d6)  
20 
13C NMR (100 MHz, DMSO-d6)  
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21 
13C NMR (100 MHz, DMSO-d6)  
21 
1H NMR (400 MHz, DMSO-d6)  
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22 
13C NMR (100 MHz, DMSO-d6)  
22 
1H NMR (400 MHz, DMSO-d6)  
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23 
13C NMR (100 MHz, DMSO-d6)  
23 
1H NMR (400 MHz, DMSO-d6)  
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24 
1H NMR (400 MHz, DMSO-d6)  
24 
13C NMR (100 MHz, DMSO-d6)  
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25 
1H NMR (400 MHz, DMSO-d6)  
25 
13C NMR (100 MHz, DMSO-d6)  
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26 
13C NMR (100 MHz, DMSO-d6)  
26 
1H NMR (400 MHz, DMSO-d6)  
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27 
13C NMR (100 MHz, DMSO-d6)  
27 
1H NMR (400 MHz, DMSO-d6)  
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29 
1H NMR (400 MHz, DMSO-d6)  
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30 
1H NMR (400 MHz, DMSO-d6)  
30 
13C NMR (100 MHz, DMSO-d6)  
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31 
13C NMR (100 MHz, DMSO-d6)  
31 
1H NMR (400 MHz, DMSO-d6)  
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32a 
1H NMR (400 MHz, DMSO-d6)  
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32b 
13C NMR (100 MHz, DMSO-d6)  
32b 
1H NMR (400 MHz, DMSO-d6)  
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33a 
1H NMR (400 MHz, DMSO-d6)  
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33b 
13C NMR (100 MHz, DMSO-d6)  
33b 
1H NMR (400 MHz, DMSO-d6)  
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34a 
1H NMR (400 MHz, DMSO-d6)  
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34b 
13C NMR (100 MHz, DMSO-d6)  
34b 
1H NMR (400 MHz, DMSO-d6)  
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35 
1H NMR (400 MHz, DMSO-d6)  
35 
13C NMR (100 MHz, DMSO-d6)  
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36 
13C NMR (100 MHz, DMSO-d6)  
36 
1H NMR (400 MHz, DMSO-d6)  
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37a 
1H NMR (400 MHz, DMSO-d6)  
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37b 
1H NMR (400 MHz, DMSO-d6)  
37b 
13C NMR (100 MHz, DMSO-d6)  
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38 
13C NMR (100 MHz, DMSO-d6)  
38 
1H NMR (400 MHz, DMSO-d6)  
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39 
1H NMR (400 MHz, DMSO-d6)  
39 
13C NMR (100 MHz, DMSO-d6)  
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40 
1H NMR (400 MHz, DMSO-d6)  
40 
13C NMR (100 MHz, DMSO-d6)  
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41 
41 
1H NMR at -30 ºC (500 MHz, CDCl3)  
13C NMR at -30 ºC (125 MHz, CDCl3)  
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42 
1H NMR at -30 ºC (500 MHz, CDCl3)  
13C NMR at -30 ºC 
(125 MHz, CDCl3) 
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43 
43 
1H NMR at -30 ºC (500 MHz, CDCl3)  
13C NMR at -30 º (125 MHz, CDCl3)  
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44 
44 
13C NMR at -30 ºC 
(125 MHz, CDCl3) 
1H NMR at -30 ºC (500 MHz, CDCl3)  
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45 
45 
1H NMR at -30 ºC (500 MHz, CDCl3)  
13C NMR at -30 ºC 
(125 MHz, CDCl3) 
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46 
1H NMR at -30 ºC (500 MHz, CDCl3)  
13C NMR at -30 ºC (125 MHz, CDCl3) 
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47 
1H NMR at -30 ºC (500 MHz, CDCl3)  
13C NMR at -30 ºC (125 MHz, CDCl3) 
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48 
13C NMR at -30 ºC (125 MHz, CDCl3) 
1H NMR at -30 ºC (500 MHz, CDCl3)  
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49 
13C NMR at -30 ºC (125 MHz, CDCl3) 
1H NMR at -30 ºC (500 MHz, CDCl3)  
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50 
1H NMR at -30 ºC (500 MHz, CDCl3)  
13C NMR at -30 ºC (125 MHz, CDCl3) 
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51 
51 
1H NMR at -30 ºC (500 MHz, CDCl3)  
13C NMR at -30 ºC (125 MHz, CDCl3) 
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52 
52 
1H NMR (500 MHz, CDCl3)  
13C NMR (125 MHz, CDCl3)  
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53 
53 at 10 ºC 
53 at 0 ºC 
53 at -10 ºC 
53 at -20 ºC 
53 at -30 ºC 
Rotamer Resolution from 10 ºC to -30 ºC 
1H NMR at -30 ºC (500 MHz, CDCl3)  
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53 
53 
13C NMR at -30 ºC (125 MHz, CDCl3)  
HSQC NMR at -30 ºC (125 MHz, CDCl3)  
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54 
54 
13C NMR (125 MHz, CDCl3)  
1H NMR (500 MHz, CDCl3)  
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55 
 13C NMR (125 MHz, CDCl3)  
 
13C NMR (125 MHz, CDCl3)  
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56 
56 
1H NMR (500 MHz, CDCl3)  
13C NMR (125 MHz, CDCl3)  
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63 
63 
13C NMR (125 MHz, CDCl3)  
1H NMR (500 MHz, CDCl3)  
334 
63 
63 
COSY NMR (500 MHz, CDCl3)  
HSQC NMR (125 MHz, CDCl3)  
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63 
HSQC NMR (125 MHz, CDCl3)  
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67b 67a 
67a 67b 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
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67b 67a 
67b 67a 
DEPT NMR (100 MHz, CDCl3)  
COSY NMR (400 MHz, CDCl3)  
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67b 
67a 
67b 
67a 
HSQC NMR (100 MHz, CDCl3)  
HMBC NMR (100 MHz, CDCl3)  
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67b 67a 
19F NMR (100 MHz, CDCl3)  
340 
 
69a,b 
69a,b 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
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69a 
69a 
13C NMR (100 MHz, CDCl3)  
1H NMR (400 MHz, CDCl3)  
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69a 
69a 
DEPT NMR (100 MHz, CDCl3)  
COSY NMR (400 MHz, CDCl3)  
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69a 
69a 
HSQC NMR (100 MHz, CDCl3)  
HMBC NMR (100 MHz, CDCl3)  
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69b 
69b 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
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69b 
DEPT NMR (100 MHz, CDCl3)  
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72 
72 
13C NMR (100 MHz, CDCl3)  
1H NMR (400 MHz, CDCl3)  
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83 
83 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
348 
83 
83 
DEPT NMR (100 MHz, CDCl3)  
COSY NMR (400 MHz, CDCl3)  
349 
 
83 
83 
HSQC NMR (100 MHz, CDCl3)  
HMBC NMR (100 MHz, CDCl3)  
350 
84 
84 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
351 
84 
84 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
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84 
HMBC NMR (100 MHz, CDCl3)  
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85 
85 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
354 
85 
85 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
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85 
HMBC NMR (100 MHz, CDCl3)  
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87 
87 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
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87 
87 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
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87 
HMBC NMR (100 MHz, CDCl3)  
359 
88 
88 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
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88 
HMBC NMR (100 MHz, CDCl3)  
361 
113 
113 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
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113 
113 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
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113 
HMBC NMR (100 MHz, CDCl3)  
364 
46 
46 
 
114 
 
114 
 
 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
365 
 
 46 
 
 
 
 114 
114 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
366 
 
 
46 
 
 
 
114 
HMBC NMR (100 MHz, CDCl3)  
367 
115 
115 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
368 
115 
115 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
369 
 
115 
HMBC NMR (100 MHz, CDCl3)  
370 
116 
116 
1H NMR (500 MHz, CDCl3)  
13C NMR 
(125 MHz, CDCl3) 
371 
116 
116 
COSY NMR (500 MHz, CDCl3)  
HSQC NMR (125 MHz, CDCl3)  
372 
 
116 
HMBC NMR (125 MHz, CDCl3)  
373 
117 
117 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
374 
117 
117 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
375 
 
117 
HMBC NMR (100 MHz, CDCl3)  
376 
118 
118 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
377 
118 
118 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
378 
 
118 
HMBC NMR (100 MHz, CDCl3)  
379 
119 
119 
1H NMR (500 MHz, CDCl3)  
13C NMR (125 MHz, CDCl3)  
380 
119 
119 
DEPT NMR (125 MHz, CDCl3)  
COSY NMR (500 MHz, CDCl3)  
381 
119 
119 
HSQC NMR (125 MHz, CDCl3)  
NOESY NMR (500 MHz, CDCl3)  
382 
 
119 
HMBC NMR (125 MHz, CDCl3)  
383 
120 
120 
1H NMR (500 MHz, CDCl3)  
13C NMR 
(125 MHz, CDCl3) 
384 
120 
120 
DEPT NMR (125 MHz, CDCl3)  
COSY NMR (500 MHz, CDCl3)  
385 
 
120 
120 
HSQC NMR (125 MHz, CDCl3)  
HMBC NMR (125 MHz, CDCl3)  
386 
121 
121 
1H NMR (500 MHz, CDCl3)  
13C NMR 
(125 MHz, CDCl3) 
387 
121 
121 
COSY NMR (500 MHz, CDCl3)  
HSQC NMR (125 MHz, CDCl3)  
388 
 
121 
HMBC NMR (125 MHz, CDCl3)  
389 
122 
122 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
390 
 
122 
122 
122 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
391 
 
HMBC NMR (125 MHz, CDCl3)  
392 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3)  
393 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
394 
 
HMBC NMR (100 MHz, CDCl3)  
395 
123a 
123b 
123a 123b 
1H NMR (400 MHz, CDCl3)  
1H NMR 
(400 MHz, CDCl3) 
396 
123a 123b 
123a 123b 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
397 
 
123a 
123b 
HMBC NMR (100 MHz, CDCl3)  
398 
124 
124 
1H NMR (500 MHz, CDCl3)  
13C NMR 
(125 MHz, CDCl3) 
399 
124 
124 
COSY NMR (500 MHz, CDCl3)  
HSQC NMR (125 MHz, CDCl3)  
400 
 
124 
HMBC NMR (125 MHz, CDCl3)  
401 
125a 125b 
125a 125b 
1H NMR (400 MHz, CDCl3)  
13C NMR 
(100 MHz, CDCl3) 
402 
125a 125b 
125a 125b 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
403 
 
125a 
125b 
HMBC NMR (100 MHz, CDCl3)  
404 
126 
126 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3) 
405 
126 
126 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
406 
 
126 
HMBC NMR (100 MHz, CDCl3)  
407 
127a 127b 
127a 127b 
1H NMR (500 MHz, CDCl3)  
13C NMR  
(125 MHz, CDCl3) 
408 
127a 127b 
127a 127b 
COSY NMR (500 MHz, CDCl3)  
HSQC NMR (125 MHz, CDCl3)  
409 
 
127a 
127b 
HMBC NMR (125 MHz, CDCl3)  
410 
 
128 
128 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3) 
411 
129 
129 
1H NMR (400 MHz, CDCl3)  
13C NMR (100 MHz, CDCl3) 
412 
129 
129 
COSY NMR (400 MHz, CDCl3)  
HSQC NMR (100 MHz, CDCl3)  
413 
 
129 
HMBC NMR (100 MHz, CDCl3)  
414 
130 
130 
1H NMR (400 MHz, CDCl3)  
13C NMR  
(100 MHz, CDCl3) 
415 
130 
130 
13C NMR at 60 ºC 
(100 MHz, DMSO-d6) 
COSY NMR (400 MHz, CDCl3)  
416 
 
130 
130 
HSQC NMR (100 MHz, CDCl3)  
HMBC NMR (100 MHz, CDCl3)  
417 
 
 
 
 
 
 
 
 
 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
135 
13
C NMR (100 MHz, CDCl3)  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
135  
1H NMR (400 MHz, CDCl3)  
418 
 
 
 
 
 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
136 
1H NMR (400 MHz, CDCl3)  
200 192 184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 0
Chemical Shift (ppm)
136 
13C NMR (100 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
140 
1H NMR (400 MHz, CDCl3)  
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
140 
(±) 
13C NMR (100 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
141 
1
H NMR (400 MHz, CDCl3)  
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
141 
13C NMR (100 MHz, CDCl3)  
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230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
142 
13C NMR (100 MHz, CDCl3)  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
142 
1H NMR (400 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
145  
1H NMR (400 MHz, CDCl3)  
Ha 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
145 
13C NMR (100 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
147 
1H NMR (400 MHz, CDCl3)  
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
147 
13C NMR (100 MHz, CDCl3)  
424 
 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
148 
1H NMR (400 MHz, CDCl3)  
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
148 
13C NMR (100 MHz, CDCl3)  
425 
 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
149 
1H NMR (400 MHz, CDCl3)  
Ha Hb 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
149 
13C NMR (100 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
150 
1H NMR (400 MHz, CDCl3)  
Ha 
Hb 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
150 
13C NMR (100 MHz, CDCl3)  
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(400 MHz, CDCl3)  
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F2 Chemical Shift (ppm)
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NOESY for compound 150  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
151 
1H NMR (400 MHz, CDCl3)  
Hb 
Ha 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
151 
13C NMR (100 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
1H NMR (400 MHz, CDCl3)  
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
13C NMR (100 MHz, CDCl3)  
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230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
13C NMR (100 MHz, CDCl3)  
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
1H NMR (400 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
152 
1H NMR (500 MHz, CDCl3)  
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
152 
13C NMR (125 MHz, CDCl3)  
432 
 
 
152 
152  
 DEPT NMR (125 MHz, CDCl3)  
 COSY NMR (500 MHz, CDCl3)  
433 
 
 
152  
152 
 HMBC NMR (125 MHz, CDCl3)  
HSQC NMR (125 MHz, CDCl3)  
434 
 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
153 
1H NMR (500 MHz, CDCl3)  
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
153 
13C NMR (125 MHz, CDCl3)  
435 
 
 
COSY (500 MHz, CDCl3)  
153 
153 
HSQC (125 MHz, CDCl3)  
436 
HMBC (125 MHz, CDCl3)  
153 
437 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
155 
1H NMR (500 MHz, CDCl3)  
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
155 
13C NMR (125 MHz, CDCl3)  
438 
 
 
155 
155 
HSQC NMR (125 MHz, CDCl3)  
COSY NMR (500 MHz, CDCl3)  
439 
HMBC NMR (125 MHz, CDCl3)  
155 
440 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
156 
1H NMR (500 MHz, CDCl3)  
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
156 
13C NMR (125 MHz, CDCl3)  
441 
 
 
156 
156 
HSQC NMR (125 MHz, CDCl3)  
COSY NMR (500 MHz, CDCl3)  
442 
HMBC NMR (125 MHz, CDCl3)  
156 
443 
 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
157 
1H NMR (400 MHz, CDCl3)  
 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
157 
13C NMR (100 MHz, CDCl3)  
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8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
159 
1H NMR (400 MHz, CDCl3)  
 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
159 
13C NMR (100 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
159 
1H NMR (400 MHz, CDCl3)  
 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
159 
13C NMR (100 MHz, CDCl3)  
 
446 
 
 
DEPT NMR (125 MHz, CDCl3)  
159 
159 
COSY NMR (500 MHz, CDCl3)  
447 
 
HMBC NMR (125 MHz, CDCl3)  
159 
HSQC NMR (125 MHz, CDCl3)  
159 
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
160 
1H NMR (400 MHz, CDCl3)  
 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
160 
13C NMR (100 MHz, CDCl3)  
 
449 
 
 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
161 
1H NMR (400 MHz, CDCl3)  
 
230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
161 
13C NMR (100 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
162 
1H NMR (400 MHz, CDCl3)  
 
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
162 
13C NMR (100 MHz, CDCl3)  
 
451 
 
 
DEPT NMR (100 MHz, CDCl3)  
162 
162 
COSY NMR (400 MHz, CDCl3)  
452 
 
HSQC NMR (100 MHz, CDCl3)  
162 
162 
HMBC NMR (100 MHz, CDCl3)  
453 
 
 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
163 
1H NMR (500 MHz, CDCl3)  
 
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
163 
13C NMR (125 MHz, CDCl3)  
 
454 
 
 
COSY NMR (500 MHz, CDCl3)  
DEPT NMR (125 MHz, CDCl3)  
163  
163 
455 
 
HSQC NMR (125 MHz, CDCl3)  
HMBC NMR (125 MHz, CDCl3)  
163 
163 
456 
 
 
 
 
 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5
F2 Chemical Shift (ppm)
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Me 
(125 MHz, CDCl3)  
C1 
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HMBC for compound 163  
457 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
165 
1H NMR (500 MHz, Acetone)  
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
165 
13C NMR (125 MHz, Acetone)  
458 
 
 
DEPT NMR (125 MHz, Acetone)  
165 
165 
COSY NMR (500 MHz, Acetone)  
459 
 
 
165 
165 
NOESY NMR (500 MHz, Acetone)  
HSQC NMR (125 MHz, Acetone)  
460 
HMBC NMR (125 MHz, Acetone)  
165 
461 
 
 
 
 
 
 
 
166 
1H NMR (500 MHz, CDCl3)  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
166  
13C NMR (125 MHz, CDCl3)  
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
462 
 
 
COSY NMR (500 MHz, CDCl3)  
DEPT NMR (125 MHz, CDCl3)  
166 
166 
463 
 
HMBC NMR (125 MHz, CDCl3)  
HSQC NMR (125 MHz, CDCl3)  
166 
166 
464 
 
 
 
 
 
 
 
167 
1H NMR (500 MHz, CDCl3)  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
167 
13C NMR (125 MHz, CDCl3)  
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20
Chemical Shift (ppm)
465 
 
 
DEPT NMR (125 MHz, CDCl3)  
167 
167 
COSY NMR (500 MHz, CDCl3)  
466 
 
HSQC NMR (125 MHz, CDCl3)  
167  
167 
HMBC NMR (125 MHz, CDCl3)  
467 
 
 
 
 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
168 
1H NMR (500 MHz, CDCl3)  
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Chemical Shift (ppm)
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13C NMR (125 MHz, CDCl3)  
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COSY (500 MHz, CDCl3)  
DEPT (125 MHz, CDCl3)  
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168 
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HSQC (125 MHz, CDCl3)  
HMBC (125 MHz, CDCl3)  
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
169 
1H NMR (400 MHz, CDCl3)  
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Chemical Shift (ppm)
169 
13C NMR (100 MHz, CDCl3)  
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COSY (500 MHz, CDCl3)  
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169 
DEPT (125 MHz, CDCl3)  
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HSQC (125 MHz, CDCl3)  
HMBC (125 MHz, CDCl3)  
